0001193125-23-108202.txt : 20230420 0001193125-23-108202.hdr.sgml : 20230420 20230420151821 ACCESSION NUMBER: 0001193125-23-108202 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230420 DATE AS OF CHANGE: 20230420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fintech Ecosystem Development Corp. CENTRAL INDEX KEY: 0001852407 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 862438985 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40914 FILM NUMBER: 23832868 BUSINESS ADDRESS: STREET 1: 100 SPRINGHOUSE DRIVE STREET 2: SUITE 204 CITY: COLLEGEVILLE STATE: PA ZIP: 19420 BUSINESS PHONE: 610-226-8101 MAIL ADDRESS: STREET 1: 100 SPRINGHOUSE DRIVE STREET 2: SUITE 204 CITY: COLLEGEVILLE STATE: PA ZIP: 19420 10-K 1 d456943d10k.htm 10-K 10-K
Table of Contents
falseFY0001852407PA 0001852407 2021-12-31 0001852407 2022-12-31 0001852407 2021-03-05 2021-12-31 0001852407 2022-01-01 2022-12-31 0001852407 2022-10-01 2022-10-31 0001852407 2021-10-21 2021-10-21 0001852407 2021-10-21 0001852407 2021-10-31 0001852407 2022-06-30 0001852407 2022-08-16 2022-08-16 0001852407 2021-03-04 0001852407 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001852407 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassBMember fexd:RestrictionOnTransferMember fexd:InitialStockholdersMember 2022-01-01 2022-12-31 0001852407 fexd:SponsorMember fexd:GeneralAndAdministrativeServicesMember 2022-01-01 2022-12-31 0001852407 us-gaap:AdministrativeServiceMember fexd:SponsorMember 2022-01-01 2022-12-31 0001852407 us-gaap:PrivatePlacementMember fexd:PrivatePlacementWarrantsMember fexd:SponsorMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember 2022-01-01 2022-12-31 0001852407 us-gaap:CapitalUnitsMember 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001852407 fexd:OneShareOfClassACommonStockMember 2022-01-01 2022-12-31 0001852407 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember fexd:SharePriceTrigerringRedemptionOfWarrantsOneMember 2022-01-01 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassBMember 2022-01-01 2022-12-31 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember fexd:CaltechTradingCorpMember 2022-01-01 2022-12-31 0001852407 fexd:RepresentativeSharesMember 2022-01-01 2022-12-31 0001852407 us-gaap:IPOMember fexd:PrivatePlacementWarrantsMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 srt:MinimumMember fexd:RepresentativeMember 2022-01-01 2022-12-31 0001852407 fexd:RepresentativeMember srt:MaximumMember 2022-01-01 2022-12-31 0001852407 fexd:NewAcquirorClassACommonStockMember 2022-01-01 2022-12-31 0001852407 fexd:RanaBusinessCombinationAgreementMember 2022-01-01 2022-12-31 0001852407 fexd:AfinozBusinessCombinationAgreementMember 2022-01-01 2022-12-31 0001852407 fexd:NewAcquirorClassACommonStockMember fexd:AfinozBusinessCombinationAgreementMember 2022-01-01 2022-12-31 0001852407 fexd:RanaBusinessCombinationAgreementMember fexd:NewAcquirorClassACommonStockMember 2022-01-01 2022-12-31 0001852407 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassAMember 2021-12-31 0001852407 us-gaap:CommonClassBMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember fexd:PublicWarrantsMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember fexd:PublicWarrantsMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001852407 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember fexd:PrivatePlacementWarrantsMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember fexd:PrivatePlacementWarrantsMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember fexd:ForwardPurchaseUnitsMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember fexd:ForwardPurchaseUnitsMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001852407 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001852407 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 us-gaap:MeasurementInputExpectedTermMember fexd:PublicWarrantsMember 2021-12-31 0001852407 us-gaap:MeasurementInputExpectedTermMember fexd:PrivatePlacementWarrantsMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001852407 us-gaap:MeasurementInputExercisePriceMember fexd:PublicWarrantsMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001852407 us-gaap:MeasurementInputPriceVolatilityMember fexd:PublicWarrantsMember fexd:PostmergerMember 2021-12-31 0001852407 us-gaap:MeasurementInputPriceVolatilityMember fexd:PrivatePlacementWarrantsMember 2021-12-31 0001852407 fexd:PostmergerMember fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001852407 us-gaap:MeasurementInputRiskFreeInterestRateMember fexd:PrivatePlacementWarrantsMember 2021-12-31 0001852407 us-gaap:MeasurementInputRiskFreeInterestRateMember fexd:ForwardPurchaseUnitsMember 2021-12-31 0001852407 fexd:MeasurementInputProbabilityOfAcquisitionMember fexd:PublicWarrantsMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-12-31 0001852407 fexd:MeasurementInputProbabilityOfAcquisitionMember fexd:ForwardPurchaseUnitsMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001852407 us-gaap:MeasurementInputExpectedDividendRateMember fexd:ForwardPurchaseUnitsMember 2021-12-31 0001852407 fexd:WorkingCapitalLoansMember fexd:SponsorMember 2021-12-31 0001852407 us-gaap:CommonClassAMember 2022-12-31 0001852407 us-gaap:CommonClassBMember 2022-12-31 0001852407 us-gaap:CommonClassAMember srt:MinimumMember 2022-12-31 0001852407 fexd:RestrictionOnTransferMember fexd:InitialStockholdersMember us-gaap:CommonClassBMember 2022-12-31 0001852407 fexd:RestrictionOnTransferMember fexd:InitialStockholdersMember us-gaap:CommonClassBMember fexd:SharePriceEqualsOrExceedsTwelveUsdMember 2022-12-31 0001852407 fexd:WorkingCapitalWarrantsMember fexd:WorkingCapitalLoansMember 2022-12-31 0001852407 fexd:SponsorMember fexd:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-12-31 0001852407 fexd:ProspectiveRedemptionOfWarrantsMember fexd:PublicWarrantsMember 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember fexd:SharePriceTrigerringRedemptionOfWarrantsTwoMember 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember fexd:SharePriceTrigerringRedemptionOfWarrantsOneMember 2022-12-31 0001852407 us-gaap:IPOMember us-gaap:CommonClassAMember fexd:PrivatePlacementWarrantsMember us-gaap:WarrantMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-12-31 0001852407 fexd:FounderSharesMember fexd:SponsorMember 2022-12-31 0001852407 fexd:SponsorMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember fexd:CaltechTradingCorpMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001852407 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember fexd:PublicWarrantsMember 2022-12-31 0001852407 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember fexd:PublicWarrantsMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001852407 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001852407 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember fexd:ForwardPurchaseUnitsMember 2022-12-31 0001852407 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852407 us-gaap:MeasurementInputExpectedDividendRateMember fexd:ForwardPurchaseUnitsMember 2022-12-31 0001852407 us-gaap:MeasurementInputExpectedTermMember fexd:PublicWarrantsMember 2022-12-31 0001852407 us-gaap:MeasurementInputExpectedTermMember fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 us-gaap:MeasurementInputExpectedTermMember fexd:ForwardPurchaseUnitsMember 2022-12-31 0001852407 us-gaap:MeasurementInputExercisePriceMember fexd:PublicWarrantsMember 2022-12-31 0001852407 us-gaap:MeasurementInputExercisePriceMember fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001852407 fexd:PostmergerMember fexd:PublicWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001852407 us-gaap:MeasurementInputPriceVolatilityMember fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 fexd:PostmergerMember fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001852407 us-gaap:MeasurementInputRiskFreeInterestRateMember fexd:PublicWarrantsMember 2022-12-31 0001852407 us-gaap:MeasurementInputRiskFreeInterestRateMember fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001852407 us-gaap:MeasurementInputExpectedDividendRateMember fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 fexd:MeasurementInputProbabilityOfAcquisitionMember fexd:PublicWarrantsMember 2022-12-31 0001852407 fexd:MeasurementInputProbabilityOfAcquisitionMember fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2022-12-31 0001852407 us-gaap:MeasurementInputExpectedDividendRateMember fexd:PublicWarrantsMember 2022-12-31 0001852407 us-gaap:DomesticCountryMember 2022-12-31 0001852407 fexd:June2022NoteMember fexd:SponsorMember 2022-12-31 0001852407 fexd:August2022NoteMember fexd:SponsorMember 2022-12-31 0001852407 fexd:SponsorMember fexd:August2022NoteMember fexd:AccruedInterestMember 2022-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 fexd:NewAcquirorClassACommonStockMember 2022-12-31 0001852407 us-gaap:AdministrativeServiceMember 2022-12-31 0001852407 fexd:SharePriceEqualToOrExceedsTwelvePointZeroZeroMember fexd:RanaAndAfinozBusinessCombinationAgreementMember fexd:NewAcquirorClassACommonStockMember 2022-12-31 0001852407 fexd:WorkingCapitalLoansMember fexd:SponsorMember 2022-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:AdditionalPaidInCapitalMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassAMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassBMember us-gaap:AdditionalPaidInCapitalMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassBMember 2021-03-05 2021-12-31 0001852407 us-gaap:RetainedEarningsMember 2021-03-05 2021-12-31 0001852407 us-gaap:AdditionalPaidInCapitalMember 2021-03-05 2021-12-31 0001852407 fexd:SponsorMember us-gaap:AdministrativeServiceMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:RetainedEarningsMember 2021-03-05 2021-12-31 0001852407 us-gaap:IPOMember fexd:PublicWarrantsMember 2021-03-05 2021-12-31 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2021-03-05 2021-12-31 0001852407 us-gaap:IPOMember fexd:ForwardPurchaseUnitsMember 2021-03-05 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:IPOMember 2021-03-05 2021-12-31 0001852407 us-gaap:FairValueInputsLevel3Member 2021-03-05 2021-12-31 0001852407 us-gaap:IPOMember 2021-10-21 2021-10-21 0001852407 us-gaap:OverAllotmentOptionMember 2021-10-21 2021-10-21 0001852407 us-gaap:PrivatePlacementMember 2021-10-21 2021-10-21 0001852407 fexd:SponsorMember fexd:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2021-10-21 2021-10-21 0001852407 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-10-21 2021-10-21 0001852407 us-gaap:CommonClassAMember 2021-10-21 2021-10-21 0001852407 fexd:InitialPublicOfferingAndPrivatePlacementOfWarrantsMember 2021-10-21 2021-10-21 0001852407 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-10-21 0001852407 fexd:SponsorMember fexd:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2021-10-21 0001852407 fexd:PublicWarrantsMember 2021-10-21 0001852407 us-gaap:CommonClassAMember fexd:PublicWarrantsMember 2021-10-21 0001852407 us-gaap:MeasurementInputExercisePriceMember fexd:PrivatePlacementWarrantsMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExercisePriceMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-10-21 0001852407 us-gaap:MeasurementInputPriceVolatilityMember fexd:ForwardPurchaseUnitsMember fexd:PostmergerMember 2021-10-21 0001852407 us-gaap:MeasurementInputRiskFreeInterestRateMember fexd:PrivatePlacementWarrantsMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-10-21 0001852407 fexd:MeasurementInputProbabilityOfAcquisitionMember fexd:PrivatePlacementWarrantsMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-10-21 0001852407 us-gaap:MeasurementInputExercisePriceMember fexd:PublicWarrantsMember 2021-10-21 0001852407 fexd:PostmergerMember us-gaap:MeasurementInputPriceVolatilityMember fexd:PublicWarrantsMember 2021-10-21 0001852407 us-gaap:MeasurementInputRiskFreeInterestRateMember fexd:PublicWarrantsMember 2021-10-21 0001852407 us-gaap:MeasurementInputExpectedTermMember fexd:PublicWarrantsMember 2021-10-21 0001852407 us-gaap:MeasurementInputExpectedTermMember fexd:PrivatePlacementWarrantsMember 2021-10-21 0001852407 us-gaap:MeasurementInputExpectedTermMember fexd:ForwardPurchaseUnitsMember 2021-10-21 0001852407 fexd:PublicWarrantsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-10-21 0001852407 us-gaap:MeasurementInputExpectedDividendRateMember fexd:PublicWarrantsMember 2021-10-21 0001852407 us-gaap:CommonClassBMember fexd:SponsorMember 2021-03-08 2021-03-08 0001852407 fexd:SponsorMember fexd:UnsecuredPromissoryNoteMember 2021-03-08 0001852407 fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-08 0001852407 us-gaap:AdministrativeServiceMember 2021-10-31 0001852407 fexd:PublicWarrantsMember 2021-03-05 2021-03-05 0001852407 fexd:PrivatePlacementWarrantsMember 2021-03-05 2021-03-05 0001852407 fexd:PublicWarrantsMember 2021-03-05 0001852407 fexd:CaltechTradingMember srt:MinimumMember fexd:ForwardPurchaseAgreementMember fexd:ForwardPurchaseUnitsMember 2021-07-16 0001852407 fexd:CaltechTradingMember srt:MaximumMember fexd:ForwardPurchaseAgreementMember fexd:ForwardPurchaseUnitsMember 2021-07-16 0001852407 fexd:CaltechTradingMember fexd:ForwardPurchaseUnitsMember fexd:ForwardPurchaseAgreementMember 2021-07-16 0001852407 fexd:SponsorMember fexd:June2022NoteMember 2022-06-16 0001852407 fexd:August2022NoteMember fexd:SponsorMember 2022-08-02 0001852407 fexd:PromisoryNoteMember 2022-08-02 0001852407 fexd:UnsecuredPromissoryNoteMember fexd:SponsorMember 2022-10-19 0001852407 fexd:PromisoryNoteMember fexd:SponsorMember 2022-10-19 0001852407 fexd:ArcCapitaMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-11 2021-03-11 0001852407 fexd:ArcCapitaMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-11 0001852407 us-gaap:CommonClassAMember 2023-03-31 0001852407 us-gaap:CommonClassBMember 2023-03-31 0001852407 us-gaap:CommonClassBMember fexd:SponsorMember fexd:JennyJunkeerChiefFinancialOfficerMember 2021-03-27 2021-03-27 0001852407 fexd:MichaelTomczykIndependentDirectorMember us-gaap:CommonClassBMember fexd:SponsorMember 2021-03-27 2021-03-27 0001852407 fexd:SponsorMember us-gaap:CommonClassBMember fexd:RobinMeisterIndependentDirectorMember 2021-03-27 2021-03-27 0001852407 fexd:SponsorMember us-gaap:CommonClassBMember fexd:LynnPerkinsIndependentDirectorMember 2021-03-27 2021-03-27 0001852407 us-gaap:CommonStockMember fexd:SponsorAndInitialStockholdersMember 2021-03-27 2021-03-27 0001852407 fexd:JennyJunkeerChiefFinancialOfficerMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 0001852407 fexd:MichaelTomczykIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 0001852407 fexd:RobinMeisterIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 0001852407 fexd:LynnPerkinsIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 0001852407 fexd:RegistrationRightsMember 2021-10-18 2021-10-18 0001852407 fexd:InflationReductionActTwoThousandAndTwentyTwoMember 2022-08-16 0001852407 fexd:SponsorMember fexd:June2022NoteMember 2022-06-16 2022-06-16 0001852407 fexd:August2022NoteMember fexd:SponsorMember 2022-08-02 2022-08-02 0001852407 fexd:PrivatePlacementWarrantsMember fexd:SponsorMember 2022-10-21 2022-10-21 0001852407 fexd:SponsorMember 2022-10-21 2022-10-21 0001852407 fexd:SponsorMember fexd:PrivatePlacementWarrantsMember 2022-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:SubsequentEventMember 2023-01-20 2023-01-20 0001852407 us-gaap:SubsequentEventMember 2023-01-20 2023-01-20 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:SubsequentEventMember 2023-01-20 0001852407 fexd:January2023PromissoryNoteMember fexd:FexdSponsorMember 2023-01-20 0001852407 fexd:FexdSponsorMember fexd:ChiefMarketingOfficerMember 2022-12-20 2022-12-20 0001852407 fexd:FamaFinancialServicesMember fexd:ChiefMarketingOfficerMember 2022-12-20 2022-12-20 0001852407 fexd:FexdSponsorMember 2022-12-20 2022-12-20 0001852407 fexd:DeSpacServiceAgreementMember fexd:ServiceCompensationProvidedFormMonetaryMember 2022-12-12 0001852407 fexd:DeSpacServiceAgreementMember fexd:ServiceCompensationProvidedFormSharesMember 2022-12-12 0001852407 us-gaap:SubsequentEventMember 2023-04-20 2023-04-20 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:IPOMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:IPOMember 2022-12-31 0001852407 us-gaap:IPOMember us-gaap:WarrantMember 2022-12-31 0001852407 us-gaap:IPOMember fexd:ForwardPurchaseUnitsMember 2022-12-31 0001852407 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001852407 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-12-31 0001852407 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001852407 us-gaap:RetainedEarningsMember 2022-12-31 0001852407 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852407 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-04 0001852407 us-gaap:AdditionalPaidInCapitalMember 2021-03-04 0001852407 us-gaap:RetainedEarningsMember 2021-03-04 0001852407 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-04 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:IPOMember 2021-03-04 0001852407 fexd:PublicWarrantsMember us-gaap:IPOMember 2021-03-04 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2021-03-04 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember 2021-03-04 0001852407 us-gaap:IPOMember fexd:PrivatePlacementWarrantsMember 2021-12-31 0001852407 us-gaap:IPOMember fexd:PublicWarrantsMember 2021-12-31 0001852407 us-gaap:IPOMember us-gaap:WarrantMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember 2021-12-31 0001852407 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0001852407 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001852407 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001852407 us-gaap:RetainedEarningsMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel3Member 2021-03-04 0001852407 us-gaap:FairValueInputsLevel3Member 2021-12-31 iso4217:USD xbrli:shares utr:Day xbrli:pure utr:Month utr:Year iso4217:USD xbrli:shares fexd:Demand utr:Y
 
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-K
 
 
 
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2022
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to 
                    
Commission File Number:
001-40914
 
 
FINTECH ECOSYSTEM DEVELOPMENT CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
  
86-2438985
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)
 
100 Springhouse Drive, Suite 204
Collegeville, PA
19426
(610) 226-8101
  
19426
(
Address
of principal executive offices)
  
(Zip Code)
Registrant’s telephone number, including
area code: 909-843-6518
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange on which registered
Units, each consisting of one share of Class A common stock, one right and
one-half
of one redeemable warrant
  
FEXDU
  
The Nasdaq Stock Market LLC
Class A common stock, par value $0.0001 per share
  
FEXD
  
The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
  
FEXDW
  
The Nasdaq Stock Market LLC
Rights included as part of the units
  
FEXDR
  
The Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act:
 
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     Yes  ☐    No  ☒
Indicate by check mark if the registrant is not required to file reports pursuant Section 13 or 15(d) of the Exchange Act.    Yes  ☐    No  ☒
Note
– Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  ☒    No  ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K
(§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K.  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer,
smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in
Rule 12b-2 of
the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated filer   ☒    Smaller reporting company   ☒
       
         Emerging growth company   ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Act).    Yes  ☒     No  ☐
The Registrant’s Units began trading on the Nasdaq Global Market on October 19, 2021, and the Registrant’s shares of Class A common stock and public warrants included in the units began separate trading on the Nasdaq Global Market on January 11, 2022.
The aggregate market value of the Class A common stock, $0.0001 par value, of the registrant held by non-affiliates of the registrant as of June 30, 2022, based upon the last sale price of such stock on that date as reported by the Nasdaq Capital Market, was $79,187,378.
As of March 31, 2023, there were 
11,557,500 Class A common shares, $.0001 par value, and 2,875,000 Class B common shares, $0.0001 par value, issued and outstanding.
Documents Incorporated by Reference: None
 
 
 

Table of Contents

FINTECH ECOSYSTEM DEVELOPMENT CORP.

ANNUAL REPORT ON FORM

10-K

FOR THE FISCAL YEAR ENDED

DECEMBER 31, 2022

 

          Page  

PART I

      

ITEM 1.

    Business      2  

ITEM 1A.

    Risk Factors      11  

ITEM 1B.

    Unresolved Staff Comments      49  

ITEM 2.

    Properties      50  

ITEM 3.

    Legal Proceedings      50  

ITEM 4.

    Mine Safety Disclosures      50  

PART II

      

ITEM 5.

   

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

      51  

ITEM 6.

    Selected Financial Data      51  

ITEM 7.

    Management’s Discussion and Analysis of Financial Condition and Results of Operations      51  

ITEM 7A.

    Quantitative and Qualitative Disclosures about Market Risk      56  

ITEM 8.

    Financial Statements and Supplementary Data      F-1  

ITEM 9.

    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure      1  

ITEM 9A.

    Controls and Procedures      1  

ITEM 9B.

    Other Information      1  

PART III

      

ITEM 10.

    Directors, Executive Officers and Corporate Governance      2  

ITEM 11.

    Executive Compensation      9  

ITEM 12.

   

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

      10  

ITEM 13.

    Certain Relationships and Related Transactions, and Director Independence      12  

ITEM 14.

    Principal Accounting Fees and Services      14  

PART IV

      

ITEM 15.

    Exhibits and Financial Statement Schedules      1  

 

i

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements regarding our business, financial condition, results of operations and prospects. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this Annual Report on Form 10-K. Additionally, statements concerning future matters are forward-looking statements.

Although forward-looking statements in this Annual Report on Form 10-K reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the headings “Risks Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Annual Report on Form 10-K. We file reports with the SEC. The SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. You can obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.

We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Annual Report on Form 10-K, except as required by law. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this Annual Report on Form 10-K, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

 

1

Table of Contents

PART I

Item 1. Business.

Business Overview

Our Company

We are a newly organized blank check company incorporated on March 5, 2021 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this annual report as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf initiated any substantive discussions, directly or indirectly, with any business combination target. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region. While we may pursue an acquisition opportunity in any industry, sector, or geography, we intend to focus on the financial technology (“FinTech”) sector in South Asia.

Our goal is to identify and engage in a business combination with a business that has developed or is developing technology that addresses the needs of communities and businesses that require new ways to store and transfer money within developing countries and across international borders. We believe our management team is well positioned to seize this opportunity. We have a strong background in developing, launching and managing financial applications, with special expertise in mobile money platforms in emerging economies. Our team has helped develop e-wallet and digital payment solutions, an online payment gateway, and mobile loyalty applications. We are also assisting banks in the transition from traditional banking systems to digital money services.

One of the challenges facing emerging economies today is how to bring basic financial services to entire populations of adults residing in countries who lack access to such services. Without access to the financial system, unbanked communities generally do not have access to credit, savings or insurance. However, the proliferation of smartphones and greater access to mobile networks creates an opportunity for businesses to supply unbanked mobile customers with access to mobile banking services using emerging technologies that reduce money transfer costs and processing delays.

Globally, about 1.7 billion adults remain without access to a bank account, according to the 2017 “Global Findex,” published every three years by the World Bank. According to a 2020 BNP Paribas report, South Asia has one of the largest unbanked populations in the world, with 11% of adults in India, 6% of adults in Pakistan, 6% adults in Indonesia, and 3% of adults in Bangladesh without access to any traditional financial services, including savings accounts, credit cards or personal checks. South Asia, where our team has significant operational and investment experience, represents the second largest region in the world for mobile payments, with over 40 million people who have access to mobile money accounts, as described in the Global Findex.

We believe that there are a significant number of target companies globally that could become attractive public companies in our area of focus, and we will seek to capitalize on the extensive operational and investment experience of our sponsor and identify companies that we believe are attractively valued and have significant growth prospects with the potential to generate robust value for our stockholders.

Recent Developments

Rana Business Combination Agreement

On September 11, 2022, the Company announced that it, with Fama Financial Services, Inc., a Georgia corporation and wholly-owned subsidiary of the Company (“Merger Sub”), Rana Financial Inc., a Georgia corporation (“Rana”) and David Kretzmer, as representative of the Shareholders (“Shareholder Representative”), had entered into a business combination agreement (the “Rana Business Combination Agreement”), dated

 

2

Table of Contents

September 9, 2022, pursuant to which, among other things, Merger Sub will be merged with and into Rana (the “Merger”). The Company shall pay a combination of Rana Cash Consideration and Rana Equity Consideration for the Company Common Stock subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $5,711,662 (the “Rana Escrow Amount”). The Rana Cash Consideration means $7,800,000 and the Rana Equity Consideration means 7,020,000 shares of New Acquiror Class A Common Stock. The closing of the Proposed Rana Transactions (the “Rana Closing”) will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Rana Business Combination has not been closed.

Afinoz Business Combination Agreement

On September 11, 2022, the Company, announced that it, Fama Financial Services, Inc., a Georgia corporation and wholly owned subsidiary of the Company (“Merger Sub”), Monisha Sahni, Rachna Suneja and Ritscapital, LLC (collectively the “Members”) and Monisha Sahni as representative of the Members (“Member Representative”), had entered into a business combination agreement (the “Afinoz Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Mobitech International LLC, a limited liability company organized in the United Arab Emirates (“Afinoz”) will become as a wholly-owned subsidiary of the Company. The Company shall pay a combination of Afinoz Cash Consideration and Afinoz Equity Consideration for the Company Membership Interests subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $700,000 (the “Afinoz Escrow Amount”). The Afinoz Cash Consideration means $5,000,000 and the Afinoz Equity Consideration means 11,500,000 shares of New Acquiror Class A Common Stock. The Afinoz Closing will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Afinoz Business Combination has not been closed.

Extensions

On October 17, 2022, we extended the time by which we have to consummate a business combination by three months from October 21, 2022 to January 21, 2023. Furthermore, on January 20, 2023, we extended the time by which we have to consummate a business combination by three months from January 21, 2023 to April 21, 2023.

Letter to Rana

On April 10, 2023, timely, pursuant to the terms of the Rana Business Combination Agreement dated September 9, 2022, the Company sent a letter to Rana Financial, Inc. regarding its failure to deliver audited financial statements.

The Company also notified Rana of its intent to propose the termination of the Rana Business Combination Agreement and abandonment of the proposed business combination if the audited financial statements are not delivered to the Company by April 21, 2023.

Our Management Team

Our management team is led by Dr. Saiful Khandaker, D.M., our Chief Executive Officer and director, and Jenny Junkeer, our Chief Financial Officer, who will both be supported by our non-executive directors.

Dr. Saiful Khandaker

Dr. Khandaker was the Group Chief Executive Officer and Founder of FAMA Holdings, Inc., a global developer of FinTech platforms, applications and services established in 2009. FAMA is based in the U.S. with offices in the U.K., India, Bangladesh and Zambia.

 

3

Table of Contents

Dr. Khandaker also led the development of the FAMACASH™ network, a global FinTech ecosystem that is integrating blockchain, artificial intelligence and cloud computing technologies to provide fast, affordable mobile money services in under-served countries such as Bangladesh. To implement the FAMACASH network, Dr. Khandaker has negotiated partnerships and joint ventures with financial service providers and technology leaders in many countries, including a joint venture with Sonali Bank, the national bank of Bangladesh. This joint venture provides a mobile wallet called SonaliPay™ that enables Bangladeshi diaspora workers to use smartphones and laptops to send money to Bangladesh. Dr. Khandaker has also led the development of a stablecoin product called REMIT™ to facilitate cross-border money transfers, as well as a cross-border e-wallet called AfriPay™ to help Africans working overseas, and a neo-bank for Muslim workers called Tohura™.

Before founding FAMA, Dr. Khandaker spent more than two decades leading the development of software solutions for Fortune 100 companies as well as startups. He designed the architecture and managed networks that provided airline flight scheduling for Delta Airlines, cellular billing applications for AT&T and BellSouth, and network management software for Cox Communications; and established and managed GE’s outsourcing operation in Bangladesh. He also helped numerous clients modernize their FinTech services as Chief Technology Officer at Mi3. Since 2018 he has served as President of the U.S.-Bangladesh Technology Association of North America.

Dr. Khandaker has received numerous industry awards including a top innovation award from the Wireless Technology Forum, a top 40 software company award from the Technology Association of Georgia, and the National FinTech Award in Bangladesh. He has conducted seminars and workshops on cross-border payments and Blockchain systems for bank executives and regulators and senior decision makers across industries. He holds a Doctor of Management degree in Organizational Leadership from University of Phoenix, a Master of Science degree in Technology Management from Mercer University, Stetson School of Business and Economics, and a Bachelor of Science degree in Computer Information Systems from DeVry University.

Jenny Junkeer

Jenny Junkeer is a Chartered Accountant with over 17 years’ experience in financial management and consulting. As CEO of Junkeer New Era Consulting, she leads a team of consultants specializing in helping companies launch and optimize business operations in fast-changing industries. Her clients range from small and medium enterprises to large multi-nationals. As a senior level consultant in business acceleration, Jenny has extensive experience helping organizations scale their operations to maximize value. Jenny is an Adjunct Association Professor at Deakin University in Melbourne, Australia, a Board Member of the Global Health Initiative Foundation, and Director of Implementation at ConnectCV. She holds a Bachelor of Commerce Degree (Honors) from Monash University.

Non-Executive Directors

Mubasshir Karim

Along with Saiful Khandaker, Mubasshir Karim will serve as one of our two non-independent directors. Mr. Karim is the Director of Operations at FAMA and has managed global cross-functional teams in the UK, India, Bangladesh, and Zambia for technical development, sales, marketing, and customer support functions. Mubasshir is experienced with third-party application programing interface integrations, the development of blockchain cross-border payment systems, and the development of identity management solutions. He is a certified project management professional, has a Bachelor of Science degree in Computer Science from Wichita State University, and is pursuing an Executive Master of Business Administration from Ohio University.

Michael S. Tomczyk

Michael S. Tomczyk will serve as one of our three independent directors. He is an authority on best practices and strategies for managing emerging technologies and applications. For 18 years he led innovation initiatives at the prestigious Wharton School at the University of Pennsylvania as Managing Director of the Mack Institute for

 

4

Table of Contents

Innovation Management, Mack Center for Technological Innovation and Emerging Technologies Research Program. He also served as Innovator in Residence at Villanova University and was a member of the Advanced Computing committee at Temple University. For ten years he was a member of the Translational Medicine Committee at the University of Pennsylvania Medical School. His degrees include an Masters of Business Administration from UCLA, a Masters in Environmental Studies from the University of Pennsylvania, and a BA in literature and journalism from the University of Wisconsin-Oshkosh. He was a captain in the United States Army, where he was awarded the Bronze Star.

Robin Meister

Robin Meister will also serve as one of our three independent directors. Ms. Meister is a seasoned C-Suite executive with extensive expertise in global financial services, risk management and regulation. Robin understands the regulatory challenges and opportunities facing the financial services industry, with special expertise helping businesses to navigate complex regulatory challenges. She has extensive experience in international sanctions, regulatory regimes, and money laundering safeguards. She spent over 20 years in senior management positions at BNP Paribas, and prior to her retirement, was the Head of U.S. Regulatory Affairs for the global asset management division. Her wide-ranging experience includes managing compliance, risk, and legal functions in the United States, Asia-Pacific and European Union. Robin has served as a director on the boards of global asset management companies as well as public and private funds. She was recently appointed to the board of a dedicated multi-strategy family of funds for California based government pension plans. She is experienced in managing critical issues facing the governance, audit, and risk committees of boards of directors. She began her career as a futures trader and currently teaches financial services regulation to law students as an adjunct faculty member of New York Law School. Robin earned a Juris Doctor degree from New York Law School, a BS in Finance and BA in Economics from State University of New York.

Lynn Perkins

Lynn Perkins will serve alongside Michael Tomczyk and Robin Meister as an independent director. Ms. Perkins is an accomplished senior executive with extensive experience as a chief financial officer, chief operating officer and chief administrative officer at major asset management businesses and global investment banks. Her expertise includes growth management, strategic planning and modeling, organizational development, and management of financial systems and processes. For seven years she served as Chief Financial Officer/Senior Vice President at First Eagle Investment Management, based in New York. Previously she was Managing Director, Global Chief Operating Officer, Asset Management Distribution and Marketing at Credit Suisse (New York), and Founding Partner and Chief Administrative Officer at Perella Weinberg Partners. For 20 years she held a variety of senior management positions at Morgan Stanley, including Chief Operating Officer, Investment Banking Division and Head of Institutional Liquidity Sales. As a business leader, Lynn is known for her integrity, work ethic and empathy. She holds a BA in Accounting and Economics from the University of North Carolina. She is a Board Member at CMC Berkshires.

The past performance of the members of our management team is not a guarantee that we will be able to identify a suitable candidate for our initial business combination or of success with respect to any business combination we may consummate. You should not rely on the historical record of the performance of our management team as indicative of our future performance. Additionally, in the course of their respective careers, members of our management team have been involved in businesses and deals that were unsuccessful. None of our officers and directors has experience with special purpose acquisition companies.

We believe our ability to complete an initial business combination will be enhanced by our having entered into a forward purchase agreement with Caltech Trading Corp., which we refer to as our anchor investor. Founded in 2003, Caltech Trading is a New Jersey corporation engaged in commodities trading across a number of sectors, including the industrial, agricultural, metal and mineral, petroleum, and chemical sectors. Pursuant to the forward purchase agreement, our anchor investor has agreed to purchase from us a minimum of 8,000,000 and a

 

5

Table of Contents

maximum of 9,000,000 forward purchase units, with each forward purchase unit consisting of one Class A common share, or a forward purchase share, one right to purchase one-tenth of one Class A common share, or a forward purchase right, and one-half of one warrant to purchase one Class A common share, or a forward purchase warrant, for $10.00 per unit, for a minimum aggregate purchase price of $80.0 million and a maximum aggregate purchase price of up to $90.0 million, in a private placement that will close concurrently with the closing of our initial business combination. Caltech Trading’s commitment under the forward purchase agreement is subject to customary closing conditions described in “Description of Securities—Forward Purchase Units,” including that our initial business combination must be consummated substantially concurrently with the purchase of the forward purchase units. The forward purchase shares, the forward purchase rights and forward purchase warrants will be identical to the Class A common shares, the rights and warrants, respectively, included in the units being sold in this offering, except that they will be subject to certain transfer restrictions and registration rights, as described herein. The obligations of Caltech Trading under the forward purchase agreement do not depend on whether any Class A common shares held by public shareholders are redeemed by us. There is no assurance that Caltech Trading will comply with its obligations under the forward purchase agreement. If Caltech Trading does not comply with its obligations, it could have an adverse effect on the Company’s ability to complete an initial business combination.

In addition, Caltech Trading indicated an interest in purchasing 9.9% of the units in this offering at the initial public offering price of $10.00 per unit and we have agreed to direct the underwriters to sell to Caltech Trading up to such number of units. Because indications of interest are not binding agreements or commitments to purchase, however, Caltech Trading could have determined not to purchase any such units, or to purchase fewer units than they have indicated an interest in purchasing. Furthermore, we are not under any obligation to sell any such units to the anchor investor and to the extent our anchor investor purchases units for which it has indicated an interest in purchasing, the underwriters will not receive any upfront underwriting discounts or commissions on that portion of the units purchased by our anchor investor, but will receive deferred underwriting commissions with respect to such units. On October 20, 2021, the Company announced that Caltech Trading informed our sponsor that it has elected not to purchase any units in this offering.

In 2014, Caltech International Trading Corporation (“Caltech International”), which is a former affiliate of Caltech Trading Corp., our anchor investor and the purchaser under the forward purchase agreement with us, was involved in a commercial dispute. The dispute also involved certain executives of Caltech International, including Mohammed S. Rahman, who was then the President of Caltech International and is currently the Chief Executive Officer of our anchor investor. The dispute resulted in litigation claiming that Caltech International and certain of its affiliates had breached certain contracts and engaged in fraud relating to transactions in which Caltech International borrowed money from third party investors. The court entered judgment against Caltech International for approximately $1,250,000 and against the executive defendants, including Mr. Rahman, for approximately $600,000. Mr. Rahman and the other executive defendants subsequently filed for personal bankruptcy, and the judgment against the executive defendants, including Mr. Rahman, was discharged in that bankruptcy.

Business Strategy

Our goal is to identify and engage in a business combination with a business that has developed or is developing technology that addresses the needs of the communities and businesses that require new ways to store and transfer money within developing countries and across international borders.

Merging With a Successful FinTech Company Ready to Expand in Developing Markets. To achieve our goal, we plan to identify high-growth global FinTech acquisition targets primarily operating in South Asia with a high volume of customers and growing demand. We believe there are several FinTech companies poised to become multi-billion dollar enterprises by leveraging emerging technologies and expanding into developing markets.

We believe our experience in the FinTech sector will help us identify potential targets that have a strong foundation that can be expanded into the global marketplace with a diverse portfolio of products and services for consumers and businesses in the United States, Europe, Africa, Asia and Latin America.

 

6

Table of Contents

Applying Our Marketing and Management Experience. Our team includes experienced professionals with experience in FinTech, banking, technology, regulatory affairs, and international business development and marketing.

We believe the experience of our management team can help transition and expand target businesses into a global financial services platform. Our management team has experience developing and leading global FinTech companies that launched mobile payment products in the United States, Europe, Africa and South Asia. Our team has helped develop platforms applications and services for cross-border payments, mobile lifestyle products, digital banking products, bill payments, online payment gateways, interchangeable and multicurrency systems.

Our team also maintains a robust network in the FinTech sector, including successful high growth companies in India, Bangladesh, Vietnam, Indonesia, Singapore, Malaysia as well as FinTech companies in Europe and the United States. We believe these contacts and partners will help facilitate the sourcing of potential business combination targets.

Leveraging Emerging Technologies. We believe there are opportunities to leverage emerging technologies such as blockchain, cryptocurrencies and decentralized finance, as well as artificial intelligence (AI), machine learning, deep learning and cloud computing, to reduce costs and processing time, create real time settlements, and improve the money delivery process.

Our team has experience in the design and development of digital payment products, payment gateways, ACH systems, cybersecurity, scalable architecture, blockchain, and AI. We also believe we will benefit from leveraging a broad network of contacts and corporate relationships in the software development markets of India, Bangladesh, Lithuania, Ukraine, Latvia, and the United States. We have extensive experience in international marketing and business development from both our management team and through our network of consultants and advisors.

Acquisition Criteria

Consistent with our business strategy, we have identified the following general criteria and guidelines that we believe are important to evaluate prospective business targets. We expect to evaluate acquisition opportunities and acquire a target FinTech company that has the following characteristics:

 

  •  

Organizational Vision We will seek partners that have quantifiable track records of developing innovative FinTech solutions for the world’s unbanked populations.

 

  •  

An Innovation Culture We will seek out businesses that have demonstrated a talent for inventing, adopting and/or deploying new technologies to meet the growing financial needs of emerging markets and would benefit from our management’s extensive network and experience to drive improved financial performance.

 

  •  

Middle-Market Growth Business. We will seek to acquire one or more middle-market growth businesses (generally considered a business or businesses with total enterprise values ranging between $200,000,000 and $1,000,000,000), which have demonstrated predictable revenue streams and definable low working capital and capital expenditure requirements. We believe there are a substantial number of potential target businesses meeting these criteria with the potential to generate strong, stable and increasing free cash flows to enhance shareholder value.

 

  •  

Businesses that are Strategically Significant to the South Asian Markets. We will seek to acquire businesses that are strategically significant in South Asian FinTech markets, where our management team has extensive experience.

 

  •  

Business with Revenue and Earnings Growth Potential. We will seek to acquire one or more businesses that have the potential for significant revenue and earnings growth through a combination of existing and new product development, increased production capacity, expense reduction and synergistic follow-on acquisitions resulting in increased operating leverage.

 

7

Table of Contents
  •  

Benefit from Being a Public Company. We intend to acquire a business or businesses that will benefit from being publicly traded and which can effectively utilize access to broader sources of capital and a public profile that is associated with being a publicly traded company to meet the challenges of financing businesses in emerging markets.

These criteria are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be based, to the extent relevant, on these general guidelines as well as other considerations, factors and criteria that our management may deem relevant. In the event that we decide to enter into our initial business combination with a target business that does not meet the above criteria and guidelines, we will disclose that the target business does not meet the above criteria in our stockholder communications related to our initial business combination, which, as discussed in this annual report, would be in the form of tender offer documents or proxy solicitation materials that we would file with the SEC.

Our Acquisition Process

We plan to identify acquisition targets using our existing FinTech network of industry influencers, insiders, partners, clients, and consultants. We will also rely on our FinTech industry experience and our understanding of countries, cultures and markets. We will qualify acquisition targets based on our acquisition criteria.

In assessing potential opportunities for an initial business combination, we expect to conduct thorough due diligence to assess a potential target’s market opportunity, competitive positioning, business model and financial profile. Our review process may include, among other things, interviews with incumbent management and employees, competitors, customers and vendors, document reviews, inspections of facilities, analyses of significant risks and opportunities, and review of other relevant information, including financial, operational and legal information made available to us. If we determine to move forward with a particular target, we will proceed to structure and negotiate the terms of the business combination transaction.

Our executive officers are not required to commit any specified amount of time to our affairs, and, accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential business combination targets and monitoring the related due diligence.

Initial Business Combination

So long as we obtain and maintain a listing for our securities on the Nasdaq, our initial business combination must be with one or more target businesses that together have an aggregate fair market value equal to at least 80% of the value of the assets held in the trust account (excluding any deferred underwriters fees and taxes payable on the interest earned on the trust account) at the time of our signing a definitive agreement in connection with our initial business combination. The fair market value of the target or targets will be determined by our board of directors based upon one or more standards generally accepted by the financial community (such as actual and potential sales, earnings, cash flow and/or book value). Although our board of directors will rely on generally accepted standards, our board of directors will have discretion to select the standards employed. In addition, the application of the standards generally involves a substantial degree of judgment. Accordingly, investors will be relying on the business judgment of the board of directors in evaluating the fair market value of the target or targets. The proxy solicitation materials or tender offer documents used by us in connection with any proposed transaction will provide public stockholders with our analysis of the fair market value of the target business, as well as the basis for our determinations. If our board of directors is not able to independently determine the fair market value of the target business or businesses, we will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting firm with respect to the satisfaction of such criteria. Additionally, pursuant to the Nasdaq rules, any initial business combination must be approved by a majority of our independent directors.

We currently anticipate structuring our initial business combination so that the post-transaction company in which our public stockholders own shares will own or acquire 100% of the equity interests or assets of the target

 

8

Table of Contents

business or businesses. We may, however, structure our initial business combination such that the post-transaction company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or stockholders or for other reasons. However, we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act. Even if the post-transaction company owns or acquires 50% or more of the voting securities of the target, our stockholders prior to the business combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new shares, our stockholders immediately prior to our initial business combination could own less than a majority of our outstanding shares subsequent to our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% fair market value test. If the business combination involves more than one target business, the 80% fair market value test will be based on the aggregate value of all of the target businesses and we will treat the target businesses together as the initial business combination for purposes of a tender offer or for seeking stockholder approval, as applicable.

Sourcing of Potential Business Combination Targets

We believe our management team’s significant operating and transaction experience and relationships with companies will provide us with a substantial number of potential business combination targets. Over the course of their careers, such individuals have developed a broad network of contacts and corporate relationships around the world. This network has grown through the activities of our management team sourcing, acquiring, financing and selling businesses, our management team’s relationships with sellers, financing sources and target management teams and the experience of such individuals in executing transactions under varying economic and financial market conditions.

In addition, members of our management team have developed contacts from serving on the boards of directors of several companies in diverse sectors, as described more fully in “Management.”

This network is expected to provide us with acquisition opportunities. In addition, we anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment market participants, private equity funds and large business enterprises seeking to divest non-core assets or divisions.

We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors. In the event we seek to complete our initial business combination with a company that is affiliated with our sponsor, officers or directors, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm which is a member of FINRA or an independent accounting firm that our initial business combination is fair to our company from a financial point of view.

As more fully discussed in “Management—Conflicts of Interest,” if any of our executive officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity to which such officer or director has pre-existing fiduciary or contractual obligations, such officer or director may be required to present such business combination opportunity to such entity prior to presenting such business combination opportunity to us. Our executive officers and directors currently have fiduciary duties or contractual obligations to several entities that may present a conflict of interest. As a result of these duties and obligations, situations may arise in which business opportunities may be given to one or more of these other entities prior to being presented to us.

 

9

Table of Contents

Status as a Public Company

We believe our structure will make us an attractive business combination partner to target businesses. As a public company, we will offer a target business an alternative to the traditional initial public offering through a merger or other business combination. In this situation, the owners of the target business would exchange their shares of stock in the target business for shares of our stock or for a combination of shares of our stock and cash, allowing us to tailor the consideration to the specific needs of the sellers. Although there are various costs and obligations associated with being a public company, we believe target businesses will find this method a more certain and cost effective method to becoming a public company than the typical initial public offering. In a typical initial public offering, there are additional expenses incurred in marketing, road show and public reporting efforts that may not be present to the same extent in connection with a business combination with us.

Furthermore, once a proposed business combination is completed, the target business will have effectively become public, whereas an initial public offering is always subject to the underwriter’s ability to complete the offering, as well as general market conditions, which could delay or prevent the offering from occurring. Once public, we believe the target business would then have greater access to capital and an additional means of providing management incentives consistent with stockholders’ interests. It can offer further benefits by augmenting a company’s profile among potential new customers and vendors and aid in attracting talented employees.

While we believe that our structure and our management team’s backgrounds will make us an attractive business partner, some potential target businesses may view our status as a blank check company, without an operating history, and the uncertainty relating to our ability to obtain stockholder approval of our proposed initial business combination and retain sufficient funds in our trust account in connection therewith, negatively.

Emerging Growth Company

We are an “emerging growth company,” as defined in the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period. Accordingly, the information we provide to you may be different than you might get from other public companies in which you hold securities.

We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the closing of this offering, (ii) the last day of the fiscal year in which we have total annual gross revenue of at least $1.07 billion, (iii) the last day of the fiscal year in which we are deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year or (iv) the date on which we have issued more than $1.00 billion in non-convertible debt securities during the prior three-year period.

Corporate Information

Our executive offices are located at 100 Springhouse Drive, Suite 204, Collegeville PA 19426, and our telephone number is (610) 226-8101.

 

10

Table of Contents

Item 1A. Risk Factors.

Risks Relating to our Search for, Consummation of, or Inability to Consummate a Business

Combination and Post-Business Combination Risks

There are no assurances that Caltech Trading will comply with its obligations under the forward purchase agreement, which may have an adverse effect on our ability to consummate our initial business combination.

We have entered into a binding forward purchase agreement with Caltech Trading, pursuant to which Caltech Trading agreed to purchase forward purchase units for a minimum aggregate purchase price of $80.0 million and a maximum aggregate purchase price of up to $90.0 million.

Caltech Trading had previously expressed to the Company a non-binding interest to purchase up to 9.9% of the units in the initial public offering. Caltech Trading elected not to purchase any units in the initial public offering.

In consideration of the fact that Caltech Trading elected not to purchase any units in the initial public offering, there is a risk that Caltech Trading may not comply with its obligations under the forward purchase agreement.

If Caltech Trading does not comply with its obligations under the forward purchase agreement, we will need to secure alternative financing. There can be no assurances that we will be able to find such alternative financing arrangements. If we are able to find such alternative financing arrangements, such financing may be more expensive or otherwise on terms that are less favorable to the Company than our existing forward purchase agreement with Caltech Trading. If we are unable to obtain alternative financing arrangements from other third-party sources, it may have an adverse effect on our ability to consummate our initial business combination and we would be required to dissolve and liquidate the Company if we cannot consummate an initial business combination in the time frames discussed in this annual report.

Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the recent coronavirus (COVID-19) outbreak.

The COVID-19 pandemic has resulted in a widespread health crisis and is adversely affecting the economies and financial markets in the United States and worldwide, and could adversely affect the business of any potential target business with which we consummate a business combination could be materially and adversely affected. Furthermore, we may be unable to complete a business combination if continued concerns relating to COVID-19 continue to restrict travel, continue to limit the ability to have meetings with potential investors or the target company’s personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a timely manner. The extent to which COVID-19 impacts our search for a business combination will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global concern continue for an extensive period of time, our ability to consummate a business combination, or the operations of a target business with which we ultimately consummate a business combination, may be materially adversely affected.

Our public stockholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our public stockholders do not support such a combination.

We may choose not to hold a stockholder vote to approve our initial business combination unless the initial business combination would require stockholder approval under applicable law or stock exchange listing requirements or if we decide to hold a stockholder vote for business or other legal reasons. Except as required by applicable law or stock exchange requirements, the decision as to whether we will seek stockholder approval of a proposed initial business combination or will allow stockholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors, such as the timing of the

 

11

Table of Contents

transaction and whether the terms of the transaction would otherwise require us to seek stockholder approval. Accordingly, we may complete our initial business combination even if holders of a majority of our public shares do not approve of the initial business combination we complete.

If we seek stockholder approval of our initial business combination, our sponsor and our initial stockholders, have agreed to vote in favor of such initial business combination.

Unlike many other blank check companies in which the initial stockholders agree to vote their founder shares in accordance with the majority of the votes cast by the public stockholders in connection with an initial business combination, our sponsor, who is our sole initial stockholder, has agreed to vote all shares of our common stock having voting rights that it then owns in favor of our initial business combination. Our sponsor and initial stockholders will collectively own 20% of our outstanding shares of common stock immediately following the completion of this offering (assuming our sponsor does not purchase any units in this offering). As a result, in addition to the founder shares, we could need as few as 3,750,001, or approximately 37.5%, of the 10,000,000 public shares sold in this offering to be voted in favor of a transaction (assuming all outstanding shares are voted and that the 50,000 representative shares are voted in favor of the transaction) in order to have our initial business combination approved (assuming the underwriter’s over-allotment option is not exercised).

Accordingly, if we seek stockholder approval of our initial business combination, it is more likely that the necessary stockholder approval will be received than would be the case if our sponsor agreed to vote its shares in accordance with the majority of the votes cast by our public stockholders.

Concentration of ownership among our sponsor and anchor investor may prevent other investors from influencing significant corporate decisions or adversely affect the trading price of our common shares.

There can be no assurance that our anchor investor will acquire any units in this offering, or as to the amount of such units our anchor investor will retain, if any, prior to or upon the consummation of our initial business combination. If our anchor investor elects to purchase the full amount described in “Principal Shareholders—Expression of Interest,” our sponsor and our anchor investor will own collectively 27.9% of our outstanding common shares. In the event that such anchor investor purchases such units (either in this offering or after) and votes them in favor of our initial business combination, it is possible that no votes from other public stockholders would be required to approve our initial business combination, depending on the number of shares that are present at the meeting to approve such transaction. As a result, these shareholders could have substantial control over us and be able to exercise significant influence over all matters requiring shareholder approval. In addition, this potential significant concentration of share ownership may adversely affect the trading price of our common shares because investors often perceive disadvantages in owning shares in companies with principal shareholders.

Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash, unless we seek stockholder approval of the business combination.

At the time of your investment in us, you may not be provided with an opportunity to evaluate the specific merits or risks of one or more target businesses. Since our board of directors may complete a business combination without seeking stockholder approval, public stockholders may not have the right or opportunity to vote on the business combination, unless we seek such stockholder vote. Accordingly, if we do not seek stockholder approval, your only opportunity to affect the investment decision regarding a potential business combination may be limited to exercising your redemption rights within the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public stockholders in which we describe our initial business combination.

 

12

Table of Contents

The ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.

We may seek to enter into a business combination transaction agreement with a prospective target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. If too many public stockholders exercise their redemption rights, we would not be able to meet such closing condition and, as a result, would not be able to proceed with the business combination. Furthermore, in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 upon the consummation of our initial business combination (so that we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial business combination. Consequently, if accepting all properly submitted redemption requests would cause our net tangible assets to be less than $5,000,001 upon the consummation of our initial business combination or such greater amount necessary to satisfy a closing condition as described above, we would not proceed with such redemption and the related business combination and may instead search for an alternate business combination. Prospective targets will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction with us.

The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.

At the time we enter into an agreement for our initial business combination, we will not know how many stockholders may exercise their redemption rights, and therefore will need to structure the transaction based on our expectations as to the number of shares that will be submitted for redemption. If our business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, we will need to reserve a portion of the cash in the trust account to meet such requirements, or arrange for third party financing. In addition, if a larger number of shares are submitted for redemption than we initially expected, we may need to restructure the transaction to reserve a greater portion of the cash in the trust account or arrange for third party financing. Raising additional third party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. The above considerations may limit our ability to complete the most desirable business combination available to us or optimize our capital structure, or may incentivize us to structure a transaction whereby we issue shares to new investors and not to sellers of target businesses, such that our sponsor will receive additional shares.

The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your stock.

If our business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, the probability that our initial business combination would be unsuccessful is increased. If our initial business combination is unsuccessful, you would not receive your pro rata portion of the trust account until we liquidate the trust account. If you are in need of immediate liquidity, you could attempt to sell your stock in the open market; however, at such time our stock may trade at a discount to the pro rata amount per share in the trust account. In either situation, you may suffer a material loss on your investment or lose the benefit of funds expected in connection with our redemption until we liquidate or you are able to sell your stock in the open market.

 

13

Table of Contents

The requirement that we complete our initial business combination within 18 months (upon exercising our option to extend the initial 12-month term for two additional three month terms) from the effective date of the registration statement of which this annual report is a part may give potential target businesses leverage over us in negotiating a business combination and may decrease our ability to conduct due diligence on potential business combination targets as we approach our dissolution deadline, which could undermine our ability to complete our business combination on terms that would produce value for our stockholders.

Any potential target business with which we enter into negotiations concerning a business combination will be aware that we must complete our initial business combination within 18 months (after we elected to extend the initial 12-month term for two additional three month terms) from October 21, 2021, the effective date of the registration statement consummating the Company’s initial public offering. Consequently, such target business may obtain leverage over us in negotiating a business combination, knowing that if we do not complete our initial business combination with that particular target business, we may be unable to complete our initial business combination with any target business. This risk has increased as we utilize our options to extend the consummation deadline. In addition, we may have limited time to conduct due diligence and may enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation. On October 17, 2022, we extended the time by which we have to consummate a business combination by three months, from October 21, 2022, to January 21, 2023. On January 20, 2023, we extended the time by which we have to consummate a business combination by three months, from January 21, 2023, to April 21, 2023.

We may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate.

We must complete our initial business combination within 18 months from October 21, 2021, the effective date of the registration statement consummating the initial public offering (the initial 12-month term plus two three month extensions). If we have not completed our initial business combination within such time period, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at aper-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

If we seek stockholder approval of our initial business combination, our sponsor, officers, directors, advisors and their affiliates may elect to purchase shares from public stockholders, which may influence a vote on a proposed business combination and reduce the public “float” of our common stock.

If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our business combination pursuant to the tender offer rules, our sponsor, directors, executive officers, advisors or their affiliates may purchase shares in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination, although they are under no obligation to do so. Such a purchase may include a contractual acknowledgement that such stockholder, although still the record holder of our shares is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that our sponsor, directors, executive officers, advisors or their affiliates purchase shares in privately negotiated transactions from public stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares. The purpose of such purchases could be to vote such shares in favor of the business combination and thereby increase the likelihood of obtaining stockholder approval of the business combination or to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a

 

14

Table of Contents

certain amount of cash at the closing of our business combination, where it appears that such requirement would otherwise not be met. This may result in the completion of a business combination that may not otherwise have been possible.

In addition, if such purchases are made, the public “float” of our common stock and the number of beneficial holders of our securities may be reduced, possibly making it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.

If a stockholder fails to receive notice of our offer to redeem our public shares in connection with our business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.

We will comply with the tender offer rules or proxy rules, as applicable, when conducting redemptions in connection with our business combination. Despite our compliance with these rules, if a stockholder fails to receive our tender offer or proxy materials, as applicable, such stockholder may not become aware of the opportunity to redeem its shares. In addition, the tender offer documents or proxy materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will describe the various procedures that must be complied with in order to validly tender or redeem public shares. In the event that a stockholder fails to comply with these procedures, its shares may not be redeemed. See “Proposed Business—Business Strategy—Tendering stock certificates in connection with a tender offer or redemption rights.”

You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced to sell your public shares, rights or warrants, potentially at a loss.

Our public stockholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) the completion of our initial business combination and (ii) our redemption of all of our public shares if we are unable to complete our business combination within 18 months. In no other circumstances will a public stockholder have any right or interest of any kind in the trust account. Accordingly, to liquidate your investment, you may be forced to sell your public shares, rights or warrants, potentially at a loss.

The representative may have a conflict of interest if they render services to us in connection with our initial business combination.

We may elect to engage EF Hutton, division of Benchmark Investments, LLC (who is the representative of the underwriters of this offering) to assist us in connection with our initial business combination. The representative shares held by the representative and/or its designees of the representative will also be worthless if we do not consummate an initial business combination. Therefore, if the representative provides services to us in connection with our initial business combination, these financial interests may result in the representative having a conflict of interest when providing such services to us.

You will not be entitled to protections normally afforded to investors of many other blank check companies.

Since the net proceeds of this offering and the sale of the private placement warrants are intended to be used to complete an initial business combination with a target business that has not been identified, we may be deemed to be a “blank check” company under United States securities laws. However, because we will have net tangible assets (i.e., total assets less intangible assets and liabilities) in excess of $5,000,000 upon the successful completion of this offering and the sale of the private placement warrants and will file a Current Report on Form 8-K, including an audited balance sheet demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors in blank check companies, such as Rule 419. Accordingly, investors will not be afforded the benefits or protections of those rules. Among other things, this means our units will be immediately tradable and we will have a longer period of time to complete our business combination than do companies subject to Rule 419. Moreover, if this offering were subject to Rule 419, that rule would prohibit the release of any interest earned on funds held in the trust account to us unless and until the funds in the trust account were

 

15

Table of Contents

released to us in connection with our completion of an initial business combination. For a more detailed comparison of our offering to offerings that comply with Rule 419, please see “Proposed Business—Comparison of This Offering to Those of Blank Check Companies Subject to Rule 419.”

If we seek stockholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of stockholders are deemed to hold in excess of 15% of our Class A common stock, you will lose the ability to redeem all such shares in excess of 15% of our Class A common stock.

If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in this offering without our prior consent, which we refer to as the “Excess Shares.” However, we would not be restricting our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our initial business combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required to sell your stock in open market transactions, potentially at a loss.

Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we are unable to complete our initial business combination after 18 months (the initial 12-month term and two three month extensions), our public stockholders may receive only approximately $10.10 per share, on our redemption, and our rights and warrants will expire worthless.

We expect to encounter intense competition from other entities having a business objective similar to ours, including private investors (which may be individuals or investment partnerships), other blank check companies and other entities, domestic and international, competing for the types of businesses we intend to acquire. Many of these individuals and entities are well-established and have extensive experience in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries. Many of these competitors possess greater technical, human and other resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted with those of many of these competitors. While we believe there are numerous target businesses we could potentially acquire with the net proceeds of this offering and the sale of the private placement warrants, our ability to compete with respect to the acquisition of certain target businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain target businesses. Furthermore, if we are obligated to pay cash for the shares of common stock redeemed and, in the event we seek stockholder approval of our business combination, we make purchases of our common stock, the resources available to us for our initial business combination will potentially be reduced. Any of these obligations may place us at a competitive disadvantage in successfully negotiating a business combination. If we are unable to complete our initial business combination after 18 months, our public stockholders may receive only approximately $10.10 per share on the liquidation of our trust account and our rights and warrants will expire worthless.

 

16

Table of Contents

If the net proceeds of this offering and the sale of the private placement warrants not being held in the trust account are insufficient to allow us to operate for at least 18 months (the initial 12-month term and two three month extensions) following the effective date of the registration statement, we may be unable to complete our initial business combination.

The funds available to us outside of the trust account may not be sufficient to allow us to operate for at least 18 months (the initial 12-month term and two three month extensions) following October 21, 2021 the effective date of the registration statement consummating the initial public offering of the Company, assuming that our initial business combination is not completed during that time. We believe that, upon the closing of this offering, the funds available to us outside of the trust account will be sufficient to allow us to operate for at least 24 months following the effective date of the registration statement consummating the initial public offering of the Company; however, we cannot assure you that our estimate is accurate. Of the funds available to us, we could use a portion of the funds available to us to pay fees to consultants to assist us with our search for a target business. We could also use a portion of the funds as a down payment or to fund a “no-shop” provision (a provision in letters of intent designed to keep target businesses from “shopping” around for transactions with other companies on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into a letter of intent where we paid for the right to receive exclusivity from a target business and were subsequently required to forfeit such funds (whether as a result of our breach or otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business. If we are unable to complete our initial business combination after 18 months, our public stockholders may receive only approximately $10.10 per share on the liquidation of our trust account and our rights and warrants will expire worthless.

If the net proceeds of the offering and the sale of the private placement warrants not being held in the trust account are insufficient, it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination and we will depend on loans from our sponsor or management team to fund our search, to pay our taxes and to complete our business combination.

Of the net proceeds of this offering and the sale of the private placement warrants, only approximately $750,000 will be available to us initially outside the trust account to fund our working capital requirements. In the event that our offering expenses (excluding underwriting discounts and commissions) exceed our estimate of $750,000, we may fund such excess with funds not to be held in the trust account. In such case, the amount of funds we intend to be held outside the trust account would decrease by a corresponding amount. Conversely, in the event that the offering expenses (excluding underwriting discounts and commissions) are less than our estimate of $750,000, the amount of funds we intend to be held outside the trust account would increase by a corresponding amount. If we are required to seek additional capital, we would need to borrow funds from our sponsor, management team or other third parties to operate or may be forced to liquidate. None of our sponsor, members of our management team or any of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances would be repaid only from funds held outside the trust account or from funds released to us upon completion of our initial business combination. As of the date of this annual report, if we are unable to complete our initial business combination after 18 months (the initial 12-month term and two three month extensions) because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public stockholders may only receive approximately $10.30 per share (before taking interest income and taxes into account) on our redemption of our public shares, and our rights and warrants will expire worthless.

Subsequent to our completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and our stock price, which could cause you to lose some or all of your investment.

Even if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will surface all material issues that may be present inside a particular target business, that it

 

17

Table of Contents

would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of the target business and outside of our control will not later arise. As a result of these factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment or other charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be subject as a result of assuming pre-existing debt held by a target business or by virtue of our obtaining post-combination debt financing. Accordingly, any stockholders who choose to remain stockholders following the business combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the tender offer materials or proxy statement relating to the business combination contained an actionable material misstatement or material omission.

If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by stockholders may be less than $10.10 per share.

Our placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to have all creditors, vendors, service providers, prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public stockholders, such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly more beneficial to us than any alternative. We are not aware of any product or service providers who have not or will not provide such waiver other than the underwriter of this offering.

Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we are unable to complete our business combination within 18 months from the effective date of the registration statement consummating the initial public offering of the Company, or upon the exercise of a redemption right in connection with our business combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount received by public stockholders could be less than the $10.10 per share initially held in the trust account, due to claims of such creditors. Our sponsor has agreed that it will be liable to us if and to the extent any claims by our a creditor or a vendor for services rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amount of funds in the trust account to below (i) $10.10 per public share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under indemnity of the underwriter of this offering against certain

 

18

Table of Contents

liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third party claims. We have not asked our sponsor to reserve for such indemnification obligations, and our sponsor’s only assets are securities of our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations.

Our directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in the trust account available for distribution to our public stockholders.

In the event that the proceeds in the trust account are reduced below the lesser of (i) $10.10 per share or (ii) other than due to the failure to obtain a waiver from a creditor or vendor waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public stockholders, such lesser amount per share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, and our sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular instance. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution to our public stockholders may be reduced below $10.10 per share.

We may not have sufficient funds to satisfy indemnification claims of our directors and executive officers.

We have agreed to indemnify our officers and directors to the fullest extent permitted by law. However, our officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account and to not seek recourse against the trust account for any reason whatsoever. Accordingly, any indemnification provided will be able to be satisfied by us only if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination. Our obligation to indemnify our officers and directors may discourage stockholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions.

If, after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our board of directors and us to claims of punitive damages.

If, after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover all amounts received by our stockholders. In addition, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by paying public stockholders from the trust account prior to addressing the claims of creditors.

 

19

Table of Contents

If, before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our stockholders and the per-shareamount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.

If, before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the trust account, the per-share amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.

If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our business combination.

If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including, without limitation, restrictions on the nature of our investments, and restrictions on the issuance of our securities, each of which may make it difficult for us to complete our business combination. In addition, we may have imposed upon us burdensome requirements, including, without limitation, registration as an investment company; adoption of a specific form of corporate structure; and reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.

In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business will be to identify and complete a business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.

We do not believe that our anticipated principal activities will subject us to the Investment Company Act. The proceeds held in the trust account may be invested by the trustee only in United States government treasury bills with a maturity of 180 days or less or in money market funds investing solely in United States Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act. Because the investment of the proceeds will be restricted to these instruments, we believe we will meet the requirements for the exemption provided in Rule 3a-1 promulgated under the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to consummate a business combination. As of the date of this annual report, if we are unable to complete our initial business combination after 18 months (the initial 12-month term and two additional three month terms), our public stockholders may receive only approximately $10.30 per share (before taking interest income and taxes into account) on the liquidation of our trust account and our rights and warrants will expire worthless.

Our stockholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.

Under the General Corporation Law of the State of Delaware, or the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by them in a dissolution. The pro rata portion of our trust account distributed to our public stockholders upon the redemption of our public shares in the event we do not complete our initial business combination within the prescribed time frame may be

 

20

Table of Contents

considered a liquidation distribution under Delaware law. If a corporation complies with certain procedures set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution. However, it is our intention to redeem our public shares as soon as reasonably possible following the 12th month (or 15th or 18th month, depending on whether we elect to extend the term for up to two additional three month terms) from the effective date of the registration statement consummating the Company’s initial public offering in the event we do not complete our business combination and, therefore, we do not intend to comply with those procedures.

Because we will not be complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide for our payment of all existing and pending claims or claims that may be potentially brought against us within the 10 years following our dissolution. However, because we are a blank check company, rather than an operating company, and our operations will be limited to searching for prospective target businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. If our plan of distribution complies with Section 281(b) of the DGCL, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would likely be barred after the third anniversary of the dissolution. We cannot assure you that we will properly assess all claims that may be potentially brought against us. As such, our stockholders could potentially be liable for any claims to the extent of distributions received by them (but no more) and any liability of our stockholders may extend beyond the third anniversary of such date. Furthermore, if the pro rata portion of our trust account distributed to our public stockholders upon the redemption of our public shares in the event we do not complete our initial business combination within the prescribed time frame is not considered a liquidation distribution under Delaware law and such redemption distribution is deemed to be unlawful (potentially due to the imposition of legal proceedings that a party may bring or due to other circumstances that are currently unknown), then pursuant to Section 174 of the DGCL, the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidation distribution.

We may not hold an annual meeting of stockholders until after our consummation of a business combination and you will not be entitled to any of the corporate protections provided by such a meeting.

In accordance with the Nasdaq corporate governance requirements, we are not required to hold an annual meeting until one year after our first fiscal year end following our listing on the Nasdaq. Under Section 211(b) of the DGCL, we are, however, required to hold an annual meeting of stockholders for the purposes of electing directors in accordance with a company’s bylaws unless such election is made by written consent in lieu of such a meeting. We may not hold an annual meeting of stockholders to elect new directors prior to the consummation of our initial business combination, and thus, we may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting prior to our consummation of a business combination, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery in accordance with Section 211(c) of the DGCL.

The grant of registration rights to our initial shareholders, holders of the representative shares, and holders of our private placement warrants and forward purchase securities may make it more difficult to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our Class A common shares.

Pursuant to an agreement to be entered into concurrently with the issuance and sale of the securities in this offering, (i) our initial shareholders and their permitted transferees can demand that we register the Class A

 

21

Table of Contents

common shares into which founder shares are convertible, (ii) holders of our private placement warrants and their permitted transferees can demand that we register the private placement warrants and the Class A common shares issuable upon exercise of the private placement warrants and their permitted transferees can demand that we register the underlying Class A common shares, (iii) holders of our forward purchase securities can demand that we register the forward purchase shares and the forward purchase warrants and the underlying Class A common shares (iv) holders of warrants that may be issued upon conversion of working capital loans may demand that we register the Class A common shares issuable upon exercise of such warrants and (v) holders of the representative shares can demand that we register the representative shares. We will bear the cost of registering these securities. The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect on the market price of our Class A common shares. In addition, the existence of the registration rights may make our initial business combination more costly or difficult to conclude. This is because the shareholders of the target business may increase the equity stake they seek in the combined entity or ask for more cash consideration to offset the negative impact on the market price of our Class A common shares that is expected when the common shares owned by our initial shareholders, holders of our private placement warrants, holders of our forward purchase securities, or holders of our working capital loans or their respective permitted transferees are registered.

In evaluating a prospective target business for our initial business combination, our management will rely on the availability of all the funds from the sale of the forward purchase units to be used as part of the consideration to the sellers in the initial business combination. If the sale of the forward purchase units fails to close, we may lack sufficient funds to consummate our initial business combination.

In connection with the consummation of this offering, we have entered into a forward purchase agreement with Caltech Trading, pursuant to which Caltech Trading has agreed to purchase from us a minimum of 8,000,000 forward purchase units and a maximum of 9,000,000 forward purchase units, each unit consisting of one Class A common share, or a forward purchase share, one right to purchase one-tenth (1/10) of one Class A common share, or a forward purchase right, and one-half of one warrant to purchase one Class A common share, or a forward purchase warrant, for $10.00 per unit, for an aggregate minimum amount of $80.0 million and an aggregate maximum amount of $90.0 million in a private placement that will close concurrently with the closing of our initial business combination. Caltech Trading’s commitment under the forward purchase agreement is subject to customary closing conditions described in “Description of Securities—Forward Purchase Units,” including that our initial business combination must be consummated substantially concurrently with the purchase of the forward purchase units.

The proceeds from the sale of forward purchase securities may be used as part of the consideration to the sellers in our initial business combination, expenses in connection with our initial business combination or for working capital in the post-transaction company. If the sale of the forward purchase units does not close for any reason, we may lack sufficient funds to consummate our initial business combination.

Caltech International Trading Corporation (“Caltech International”), which is a former affiliate of Caltech Trading Corp., our anchor investor and the purchaser under the forward purchase agreement with us, was involved in a commercial dispute in 2014. The dispute also involved certain executives of Caltech International, including Mohammed S. Rahman, who was then the President of Caltech International and is currently the Chief Executive Officer of our anchor investor. The dispute resulted in a litigation claiming that Caltech International and certain of its affiliates had breached certain contracts and engaged in fraud relating to transactions in which Caltech International borrowed money from third party investors. The court entered judgment against Caltech International for approximately $1,250,000 and against the executive defendants, including Mr. Rahman, for approximately $600,000. Mr. Rahman and the other executive defendants subsequently filed for personal bankruptcy, and the judgment against the executive defendants, including Mr. Rahman, was discharged in that bankruptcy.

 

22

Table of Contents

Because we are not limited to a particular industry or any specific target businesses with which to pursue our initial business combination, you will be unable to ascertain the merits or risks of any particular target business’ operations.

Although we expect to focus our search for a target business in the financial technology services industry, we may seek to complete a business combination with an operating company in any industry or sector. However, we will not, under our amended and restated certificate of incorporation, be permitted to effectuate our business combination with another blank check company or similar company with nominal operations. Because we have not yet identified or approached any specific target business with respect to a business combination, there is no basis to evaluate the possible merits or risks of any particular target business’ operations, results of operations, cash flows, liquidity, financial condition or prospects. To the extent we complete our business combination, we may be affected by numerous risks inherent in the business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business. We also cannot assure you that an investment in our units will ultimately prove to be more favorable to investors than a direct investment, if such opportunity were available, in a business combination target. Accordingly, any stockholders who choose to remain stockholders following the business combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the tender offer materials or proxy statement relating to the business combination contained an actionable material misstatement or material omission.

We may seek acquisition opportunities in companies that may be outside of our management’s areas of expertise.

We will consider a business combination outside of our management’s areas of expertise if a business combination candidate is presented to us and we determine that such candidate offers an attractive acquisition opportunity for our company. In the event we elect to pursue an acquisition outside of the areas of our management’s expertise, our management’s expertise may not be directly applicable to its evaluation or operation, and the information contained in this annual report regarding the areas of our management’s expertise would not be relevant to an understanding of the business that we elect to acquire. As a result, our management may not be able to adequately ascertain or assess all of the significant risk factors. Accordingly, any stockholders who choose to remain stockholders following our business combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the tender offer materials or proxy statement relating to the business combination contained an actionable material misstatement or material omission.

Although we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines.

Although we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business with which we enter into our initial business combination will not have all of these positive attributes. If we complete our initial business combination with a target that does not meet some or all of these guidelines, such combination may not be as successful as a combination with a business that meets all of

 

23

Table of Contents

our general criteria and guidelines. In addition, if we announce a prospective business combination with a target that does not meet our general criteria and guidelines, a greater number of stockholders may exercise their redemption rights, which may make it difficult for us to meet any closing condition with a target business that requires us to have a minimum net worth or a certain amount of cash. In addition, if stockholder approval of the transaction is required by law, or we decide to obtain stockholder approval for business or other legal reasons, it may be more difficult for us to attain stockholder approval of our initial business combination if the target business does not meet our general criteria and guidelines. As of the date of this annual report, if we are unable to complete our initial business combination 18 months, our public stockholders may receive only approximately $10.30 per share (before taking interest income and taxes into account) on the liquidation of our trust account and our rights and warrants will expire worthless. In certain circumstances, our public stockholders may receive less than $10.30 per share (before taking interest income and taxes into account) on the redemption of their shares.

We may seek acquisition opportunities with a financially unstable business or an entity lacking an established record of revenue or earnings.

To the extent we complete our initial business combination with a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by numerous risks inherent in the operations of the business with which we combine. These risks include volatile revenues or earnings and difficulties in obtaining and retaining key personnel. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we may not be able to properly ascertain or assess all of the significant risk factors and we may not have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business.

Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. As of the date of this annual report, if we are unable to complete our initial business combination after 18 months, our public stockholders may receive only approximately $10.30 per share (before taking interest income and taxes into account) on the liquidation of our trust account and our rights and warrants will expire worthless.

We anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management time and attention and substantial costs for accountants, attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target business, we may fail to complete our initial business combination for any number of reasons including those beyond our control. Any such event will result in a loss to us of the related costs incurred which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. As of the date of this annual report, if we are unable to complete our initial business combination after 18 months, our public stockholders may receive only approximately $10.30 per share (before taking interest income and taxes into account) on the liquidation of our trust account and our rights and warrants will expire worthless.

We may have a limited ability to assess the management of a prospective target business which, as a result, may affect our initial business combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company.

When evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the target business’ management may be limited due to a lack of time, resources or information. Our assessment of the capabilities of the target’s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should the target’s management not possess the skills, qualifications or abilities necessary to manage a public company, the operations and profitability of the post-combination business may be negatively impacted. Accordingly, any

 

24

Table of Contents

stockholders who choose to remain stockholders following the business combination could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the tender offer materials or proxy statement relating to the business combination contained an actionable material misstatement or material omission.

The officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The departure of a business combination target’s key personnel could negatively impact the operations and profitability of our post-combination business. The role of an acquisition candidate’s key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that certain members of an acquisition candidate’s management team will remain associated with the acquisition candidate following our initial business combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.

We will likely only be able to complete one business combination with the proceeds of this offering and the sale of the private placement warrants, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.

The net proceeds from this offering and the sale of the private placement warrants will provide us with $101,000,000 (or approximately $116,150,000 if the underwriter’s over-allotment option is exercised in full) that we may use to complete our business combination.

We may effectuate our business combination with a single target business or multiple target businesses simultaneously or within a short period of time. However, we may not be able to effectuate our business combination with more than one target business because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating results and the financial condition of several target businesses as if they had been operated on a combined basis. By completing our initial business combination with only a single entity, our lack of diversification may subject us to numerous economic, competitive and regulatory risks. Further, we would not be able to diversify our operations or benefit from the possible spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete several business combinations in different industries or different areas of a single industry. Accordingly, the prospects for our success may be:

 

  •  

solely dependent upon the performance of a single business, property or asset, or

 

  •  

dependent upon the development or market acceptance of a single or limited number of products, processes or services.

This lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to our business combination.

We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.

If we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make it more difficult for us, and delay our ability, to complete our initial business combination. With multiple business combinations, we could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence investigations (if

 

25

Table of Contents

there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations.

We may attempt to complete our initial business combination with a private company about which little information is available, which may result in an initial business combination with a company that is not as profitable as we suspected, if at all.

In pursuing our initial business combination strategy, we may seek to effectuate our initial business combination with a privately held company. Very little public information generally exists about private companies, and we could be required to make our decision on whether to pursue a potential initial business combination on the basis of limited information, which may result in an initial business combination with a company that is not as profitable as we suspected, if at all.

Our management may not be able to maintain control of a target business after our initial business combination. We cannot provide assurance that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business.

We may structure a business combination so that the post-transaction company in which our public stockholders own shares will own less than 100% of the equity interests or assets of a target business, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for us not to be required to register as an investment company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities of the target, our stockholders prior to the business combination may collectively own a minority interest in the post business combination company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new shares of common stock in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial number of new shares of common stock, our stockholders immediately prior to such transaction could own less than a majority of our outstanding shares of common stock subsequent to such transaction. In addition, other minority stockholders may subsequently combine their holdings resulting in a single person or group obtaining a larger share of the company’s stock than we initially acquired. Accordingly, this may make it more likely that our management will not be able to maintain our control of the target business.

We do not have a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 upon the consummation of our initial business combination. The absence of such a redemption threshold may make it possible for us to complete a business combination with which a substantial majority of our stockholders do not agree.

Our amended and restated certificate of incorporation does not provide a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 upon the consummation of our initial business combination (such that we become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial business combination. As a result, we may be able to complete our business combination even though a substantial majority of our public stockholders do not agree with the transaction and have redeemed their shares or, if we seek stockholder approval of our initial business combination and do not conduct redemptions in connection with our business combination pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our sponsor, officers, directors, advisors or their affiliates. In the event the aggregate cash consideration we would be required to pay for all shares of common stock that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash

 

26

Table of Contents

available to us, we will not complete the business combination or redeem any shares, all shares of common stock submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination.

In order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of their charters and modified governing instruments. We cannot assure you that we will not seek to amend our amended and restated certificate of incorporation or governing instruments in a manner that will make it easier for us to complete our initial business combination that our stockholders may not support.

In order to effectuate a business combination, blank check companies have, in the recent past, amended various provisions of their charters and modified governing instruments. For example, blank check companies have amended the definition of business combination and increased redemption thresholds. We cannot assure you that we will not seek to amend our charter or governing instruments in order to effectuate our initial business combination.

Certain agreements may be amended without stockholder approval.

Certain agreements, including the trust agreement between us and Continental Stock Transfer & Trust Company, the letter agreement among us and our sponsor, executive officers and directors, the registration rights agreement among us and our sponsor, and the administrative services agreement between us and our sponsor may be amended without stockholder approval. These agreements contain various provisions that our public stockholders might deem to be material. While we do not expect our board of directors to approve any amendment to any of these agreements prior to our initial business combination, it may be possible that our board of directors, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to any such agreement in connection with the consummation of our initial business combination. Any such amendment may have an adverse effect on the value of an investment in our securities.

We may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to restructure or abandon a particular business combination.

We have not yet identified any prospective target business, and thus, cannot ascertain the capital requirements for any particular transaction. If the net proceeds of this offering, the sale of the private placement warrants and the proceeds from the sale of the forward purchase units prove to be insufficient to allow us to complete our initial business combination, either because of the size of our initial business combination, the depletion of the available net proceeds in search of a target business, the obligation to repurchase for cash a significant number of shares from stockholders who elect redemption in connection with our initial business combination or the terms of negotiated transactions to purchase shares in connection with our initial business combination, we may be required to seek additional financing or to abandon the proposed business combination. We cannot assure you that such financing will be available on acceptable terms, if at all. To the extent that additional financing proves to be unavailable when needed to complete our initial business combination, we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative target business candidate. In addition, even if we do not need additional financing to complete our business combination, we may require such financing to fund the operations or growth of the target business. The failure to secure additional financing could have a material adverse effect on the continued development or growth of the target business. None of our officers, directors or stockholders is required to provide any financing to us in connection with or after our business combination. As of the date of this annual report, if we are unable to complete our initial business combination after 18 months (the initial 12-month term and two three month extensions), our public stockholders may only receive approximately $10.30 per share (before taking interest income and taxes into account) on the liquidation of our trust account, and our rights and warrants will expire worthless.

 

27

Table of Contents

Our sponsor and the initial stockholders control a substantial interest in us and thus may exert a substantial influence on actions requiring a stockholder vote, potentially in a manner that you do not support.

On March 8, 2021, we issued 2,875,000 founder shares to our sponsor (up to 375,000 shares of which are subject to forfeiture depending on the extent to which the underwriter’s over-allotment option is exercised), at a price of $0.009 per share, for an aggregate purchase price of $25,000 in cash. On March 27, 2021, our sponsor sold 15,000 founder shares to our Chief Financial Officer, Jenny Junkeer, and 10,000 founder shares to each of our three independent directors, Michael Tomczyk, Robin Meister and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which our sponsor purchased such founder shares from us. Additionally, on March 11, 2021, our sponsor transferred 50,000 founder shares to ARC Capital, for financial advisory services rendered in connection with this offering. The founder shares held by our independent directors and financial advisor are not subject to forfeiture in the event that the underwriters’ over-allotment is not exercised. Upon the closing of this offering, our sponsor and initial stockholders will collectively own approximately 20% of our issued and outstanding shares of common stock (assuming our sponsor does not purchase units in this offering).

Accordingly, our sponsor and the initial stockholders may exert a substantial influence on actions requiring a stockholder vote, potentially in a manner that you do not support. If our sponsor purchases any additional shares of common stock in the aftermarket or in privately negotiated transactions, this would increase its influence.

Neither our sponsor nor, to our knowledge, any of our officers or directors, have any current intention to purchase additional securities, other than as disclosed in this annual report. Factors that would be considered in making such additional purchases would include consideration of the current trading price of our common stock. In addition, our board of directors, whose members were elected by our sponsor, is and will be divided into two classes, each of which will generally serve for a term of two years with only one class of directors being elected in each year. We may not hold an annual meeting of stockholders to elect new directors prior to the completion of our business combination, in which case all of the current directors will continue in office until at least the completion of the business combination. If there is an annual meeting, as a consequence of our “staggered” board of directors, only half of the board of directors will be considered for election and our sponsor, because of their ownership position, will have considerable influence regarding the outcome. Accordingly, our sponsor will continue to exert control at least until the completion of our business combination.

Our sponsor paid an aggregate of $25,000, or approximately $0.01 per share for 2,500,000 shares of Class B common stock and, upon the consummation of the private placement, paid an aggregate of $3,900,250 for 3,900,250 private placement warrants that are convertible into shares of Class A common stock on a 1-to-1 basis, or $1.00 a share for 3,900,250 shares resulting in immediate and substantial dilution.

The difference between the public offering price per share (allocating all of the unit purchase price to the common stock and none to the right and warrant included in the unit) and the pro forma net tangible book value per share of our common stock constitutes the dilution to you and the other investors in this offering. Our sponsor acquired the founder shares at a nominal price and the private placement warrants at a substantial discount and the holders of the representative shares acquired the representative shares at a nominal price, significantly contributing to this dilution. Upon the closing of this offering, and assuming no value is ascribed to the rights and warrants included in the units, you and the other public stockholders will incur an immediate and substantial dilution of approximately 130.9% (or $13.09 per share, assuming no exercise of the underwriter’s over-allotment option), the difference between the pro forma net tangible book value per share of $3.09 per share and the effective initial offering price of $10.00 per unit. In addition, because of the anti-dilution rights of the founder shares, any equity or equity-linked securities issued or deemed issued in connection with our initial business combination would be disproportionately dilutive to our Class A common stock.

The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.

We are offering our units at an offering price of $10.00 per unit and the amount in our trust account is initially anticipated to be $10.00 per public share, implying an initial value of $10.00 per public share. However, prior to

 

28

Table of Contents

this offering, our sponsor paid a nominal aggregate purchase price of $25,000 for the founder shares, or approximately $0.009 per share. As a result, the value of your public shares may be significantly diluted upon the consummation of our initial business combination, when the founder shares are converted into public shares. For example, the following table shows the dilutive effect of the founder shares on the implied value of the public shares upon the consummation of our initial business combination, assuming that our equity value at that time is $96,500,000, which is the amount we would have for our initial business combination in the trust account after payment of $3,500,000 of deferred underwriting commissions, assuming the underwriters’ over-allotment option is not exercised, no interest is earned on the funds held in the trust account, and no public shares are redeemed in connection with our initial business combination, and without taking into account any other potential impacts on our valuation at such time, such as the trading price of our public shares, the business combination transaction costs, any equity issued or cash paid to the target’s sellers or other third parties, or the target’s business itself, including its assets, liabilities, management and prospects, as well as the value of our public and private warrants. At such valuation, each of our shares of common stock would have an implied value of $7.69 per share upon consummation of our initial business combination, which would be a 23% decrease as compared to the initial implied value per public share of $10.00 (the price per unit in this offering, assuming no value to the public warrants).

 

Public shares

      11,550,000  

Founder shares

      2,500,000  

Total shares

      14,050,000  

Total funds in trust available for initial business combination (less deferred underwriting commissions)

    $ 96,500,000

Initial implied value per public share

    $ 10.00  

Implied value per share upon consummation of initial business combination

    $ 7.69  

The value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our common stock at such time is substantially less than $10.00 per share.

Upon the closing of this offering, assuming no exercise of the underwriters’ over-allotment option, our sponsor will have invested in us an aggregate of $3,587,750, comprised of the $25,000 purchase price for the founder shares and the $3,562,750 purchase price for the private placement warrants (or $3,925,250 if the over-allotment option is exercised in full, consisting of $25,000 purchase price for the founder shares and $3,900,250 for the private placement warrants). Assuming a trading price of $10.00 per share upon consummation of our initial business combination, the 2,500,000 founder shares would have an aggregate implied value of $25,000,000 (or $28,750,000 if the over-allotment option is exercised in full). Even if the trading price of our common stock was as low as $1.09 per share, and the private placement warrants were worthless, the value of the founder shares would be equal to the sponsor’s initial investment in us. As a result, our sponsor is likely to be able to recoup its investment in us and make a substantial profit on that investment, even if our public shares have lost significant value. Accordingly, certain members of our management team, which own interests in our sponsor, may have an economic incentive that differs from that of the public shareholders to pursue and consummate an initial business combination rather than to liquidate and to return all of the cash in the trust to the public shareholders, even if that business combination were with a riskier or less-established target business. For the foregoing reasons, you should consider our management team’s financial incentive to complete an initial business combination when evaluating whether to redeem your shares prior to or in connection with the initial business combination.

Because we must furnish our stockholders with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination with some prospective target businesses.

The federal proxy rules require that a proxy statement with respect to a vote on a business combination meeting certain financial significance tests include historical and/or pro forma financial statement disclosure in periodic

 

29

Table of Contents

reports. We will include the same financial statement disclosure in connection with our tender offer documents, whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in accordance with, or be reconciled to, accounting principles generally accepted in the United States of America, or U.S. GAAP, or international financial reporting standards depending on the circumstances and the historical financial statements may be required to be audited in accordance with the standards of the Public Company Accounting Oversight Board (United States), or PCAOB. These financial statement requirements may limit the pool of potential target businesses we may acquire because some targets may be unable to provide such financial statements in time for us to disclose such financial statements in accordance with federal proxy rules and complete our initial business combination within the prescribed time frame.

Compliance obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate our initial business combination, require substantial financial and management resources, and increase the time and costs of completing an initial business combination.

Section 404 of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls beginning with our Annual Report on Form 10-K for the year ending December 31, 2022. Only in the event we are deemed to be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth company, will we be required to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting. Further, for as long as we remain an emerging growth company, we will not be required to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting. The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public companies because a target company with which we seek to complete our initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such business combination.

If we are unable to maintain an effective system of disclosure controls and procedures and internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and financial results.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely basis. Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud.

In connection with the preparation of the Annual Report on Form 10-K for the year ended December 31, 2022, the Company identified the following material weaknesses as of December 31, 2022: (i) lack of proper segregation of duties due to the Chief Executive Officer’s ability to approve invoices and prepare and approve payments; (ii) lack of review controls over financial reporting, including formal accounting policies, procedures and controls over significant financial statement accounts and disclosures to achieve complete, accurate and timely financial accounting, reporting and disclosures, resulting in adjustments to several accounts and disclosures; (iii) lack of review controls over related party transactions, which resulted in related party loans not being approved by the board of directors; and (iv) ineffective oversight on the part of the Company’s audit committee.

In light of these material weaknesses, management has concluded that we did not maintain effective internal control over financial reporting as of December 31, 2022, based on the criteria established in “2013 Internal Control-Integrated Framework” issued by COSO.

 

30

Table of Contents

We recognize the importance of the control environment as it sets the overall tone for the Company and is the foundation for all other components of internal control. Consequently, we will devote resources to design and implement remediation measures to address the material weakness related to the Company’s financial accounting and reporting and enhance our internal control over financial reporting. In light of the material weakness, we enhanced our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements, including providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding financial accounting and reporting.

We can give no assurance that the measures we have taken and plan to take in the future will remediate the material weakness identified or that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure to implement and maintain adequate internal control over financial reporting or circumvention of these controls. In addition, even if we are successful in strengthening our controls and procedures, in the future those controls and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our financial statements.

If we effect our initial business combination with a company with operations or opportunities outside of the United States, we would be subject to a variety of additional risks that may negatively impact our operations.

If we effect our initial business combination with a company with operations or opportunities outside of the United States, we would be subject to any special considerations or risks associated with companies operating in an international setting, including any of the following:

 

  •  

higher costs and difficulties inherent in managing cross-border business operations and complying with different commercial and legal requirements of overseas markets;

 

  •  

rules and regulations regarding currency redemption;

 

  •  

complex corporate withholding taxes on individuals;

 

  •  

laws governing the manner in which future business combinations may be effected;

 

  •  

tariffs and trade barriers;

 

  •  

regulations related to customs and import/export matters;

 

  •  

local or regional economic policies and market conditions;

 

  •  

unexpected changes in regulatory requirements;

 

  •  

longer payment cycles;

 

  •  

tax issues, such as tax law changes and variations in tax laws as compared to the United States;

 

  •  

currency fluctuations and exchange controls;

 

  •  

rates of inflation;

 

  •  

challenges in collecting accounts receivable;

 

  •  

cultural and language differences;

 

  •  

employment regulations;

 

  •  

underdeveloped or unpredictable legal or regulatory systems;

 

  •  

corruption;

 

  •  

protection of intellectual property;

 

31

Table of Contents
  •  

social unrest, crime, strikes, riots, civil disturbances, regime changes, political upheaval, terrorist attacks, natural disasters and wars;

 

  •  

deterioration of political relations with the United States; and

 

  •  

government appropriation of assets.

We may not be able to adequately address these additional risks. If we are unable to do so, our operations might suffer, which may adversely impact our results of operations and financial condition.

If our management team following our initial business combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws, which could lead to various regulatory issues.

Following our initial business combination, our founding team may resign from their positions as officers or directors of the company and the management of the business combination partner will may assume the roles of executive officers and directors of our company. Such officers and directors may not be familiar with United States securities laws. If our new management following our initial business combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws. This could be expensive and time-consuming and could lead to various regulatory issues which may adversely affect our operations.

After our initial business combination, substantially all of our assets may be located in a foreign country and substantially all of our revenue may be derived from our operations in such country. Accordingly, our results of operations and prospects will be subject, to a significant extent, to the economic, political and social conditions and government policies, developments and conditions in the country in which we operate and the world in general.

As we may acquire a business located outside of the United States as part of our initial business combination, the economic, political and social conditions, as well as government policies, of the country in which our operations would be located following our initial business combination could affect our business. Economic growth could be uneven, both geographically and among various sectors of the economy and such growth may not be sustained in the future. If in the future such country’s economy experiences a downturn or grows at a slower rate than expected, there may be less demand for spending in certain industries. A decrease in demand for spending in certain industries could materially and adversely affect our ability to find an attractive target business with which to consummate our initial business combination and if we effect our initial business combination, the ability of that target business to become profitable.

Recently, the outbreak of war in Ukraine has already affected global economic markets, and the uncertain resolution of this conflict could result in protracted and/or severe damage to the global economy. Russia’s recent military interventions in Ukraine have led to, and may lead to, additional sanctions being levied by the United States, European Union and other countries against Russia. Russia’s military incursion and the resulting sanctions could adversely affect global energy and financial markets and thus could affect our client’s business and our business, even though we do not have any direct exposure to Russia or the adjoining geographic regions. The extent and duration of the military action, sanctions, and resulting market disruptions are impossible to predict, but could be substantial. Any such disruptions caused by Russian military action or resulting sanctions may magnify the impact of other risks described in this section. We cannot predict the progress or outcome of the situation in Ukraine, as the conflict and governmental reactions are rapidly developing and beyond their control. Prolonged unrest, intensified military activities, or more extensive sanctions impacting the region could have a material adverse effect on the global economy, and such effect could in turn have a material adverse effect on our ability to find an attractive target business with which to consummate our initial business combination and if we effect our initial business combination, the ability of that target business to become profitable.

 

32

Table of Contents

Exchange rate fluctuations and currency policies may cause our target business’ ability to succeed in the international markets to be diminished.

In the event we acquire a non-U.S. business as part of our initial business combination, all revenues and income would likely be received in a foreign currency, and the dollar equivalent of our net assets and distributions, if any, could be adversely affected by reductions in the value of the local currency. The value of the currencies in our target regions fluctuate and are affected by, among other things, changes in political and economic conditions. Any change in the relative value of such currency against our reporting currency may affect the attractiveness of any target business or, following consummation of our initial business combination, our financial condition and results of operations. Additionally, if a currency appreciates in value against the dollar prior to the consummation of our initial business combination, the cost of a target business as measured in dollars will increase, which may make it less likely that we are able to consummate such transaction.

We may reincorporate in another jurisdiction in connection with our initial business combination, and the laws of such jurisdiction may govern some or all of our future material agreements and we may not be able to enforce our legal rights.

In connection with our initial business combination, we may relocate the home jurisdiction of our business from the U.S. to another jurisdiction. If we determine to do this, the laws of such jurisdiction may govern some or all of our future material agreements. The system of laws and the enforcement of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities or capital.

We may issue our shares to investors in connection with our initial business combination at a price that is less than the prevailing market price of our shares at that time.

In connection with our initial business combination, we may issue shares to investors in private placement transactions (so-called PIPE transactions) at a price that is less than the prevailing market price of our shares at that time. The purpose of such issuances will be to enable us to provide sufficient liquidity to the post-business combination entity. The price of the shares we issue may therefore be less, and potentially significantly less, than the market price for our shares at such time.

We are not required to obtain an opinion from an independent investment banking firm or from an independent accounting firm, and consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our company from a financial point of view.

Unless we complete our business combination with an affiliated entity, or our board cannot independently determine the fair market value of the target business or businesses, we are not required to obtain an opinion from an independent investment banking firm that is a member of FINRA or from an independent accounting firm that the price we are paying for a target is fair to our company from a financial point of view. If no opinion is obtained, our stockholders will be relying on the judgment of our board of directors, who will determine fair market value based on one or more standards generally accepted by the financial community. Such standards used will be disclosed in our tender offer documents or proxy solicitation materials, as applicable, related to our initial business combination.

We may issue notes or other debt securities, or otherwise incur substantial debt, to complete an initial business combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our stockholders’ investment in us.

Although we have no commitments as of the date of this annual report to issue any notes or other debt securities, or to otherwise incur outstanding debt following this offering, we may choose to incur substantial debt to complete our initial business combination. We have agreed that we will not incur any indebtedness unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in

 

33

Table of Contents

the trust account. As such, no issuance of debt will affect the per-share amount available for redemption from the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects, including:

 

  •  

default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;

 

  •  

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

 

  •  

our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

 

  •  

our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;

 

  •  

our inability to pay dividends on our common stock;

 

  •  

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes;

 

  •  

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

 

  •  

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;

 

  •  

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and

 

  •  

other disadvantages compared to our competitors who have less debt.

In order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of their charters and other governing instruments, including their warrant agreements. We cannot assure you that we will not seek to amend our amended and restated certificate of incorporation or governing instruments in a manner that will make it easier for us to complete our initial business combination that our stockholders may not support.

In order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of their charters and modified governing instruments, including their warrant agreements. For example, blank check companies have amended the definition of business combination, increased redemption thresholds and extended the time to consummate an initial business combination and, with respect to their warrants, amended their warrant agreements to require the warrants to be exchanged for cash and/or other securities. Amending our amended and restated certificate of incorporation requires the approval of holders of a majority of our common stock, and amending our warrant agreement will require a vote of holders of at least a majority of the public warrants (which may include public warrants acquired by our sponsor or its affiliates in this offering or thereafter in the open market). In addition, our amended and restated certificate of incorporation requires us to provide our public stockholders with the opportunity to redeem their public shares for cash if we propose an amendment to our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or certain amendments to our charter prior thereto or to redeem 100% of our public shares if we do not complete our initial business combination within 12 months (or 15 or 18 months, depending on whether we elect to extend the initial 12-month term for up to two additional three month terms) from the closing of this offering or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity.

To the extent any such amendments would be deemed to fundamentally change the nature of any securities offered through this registration statement, we would register, or seek an exemption from registration for, the

 

34

Table of Contents

affected securities. We cannot assure you that we will not seek to amend our charter or governing instruments or extend the time to consummate an initial business combination in order to effectuate our initial business combination.

Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination.

In recent months, the market for directors and officers liability insurance for special purpose acquisition companies has changed in ways adverse to us and our management team. Fewer insurance companies are offering quotes for directors and officers liability coverage, the premiums charged for such policies have generally increased and the terms of such policies have generally become less favorable. These trends may continue into the future.

The increased cost and decreased availability of directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination. In order to obtain directors and officers liability insurance or modify its coverage as a result of becoming a public company, the post-business combination entity might need to incur greater expense and/or accept less favorable terms. Furthermore, any failure to obtain adequate directors and officers liability insurance could have an adverse impact on the post-business combination’s ability to attract and retain qualified officers and directors.

In addition, after completion of any initial business combination, our directors and officers could be subject to potential liability from claims arising from conduct alleged to have occurred prior to such initial business combination. As a result, in order to protect our directors and officers, the post-business combination entity may need to purchase additional insurance with respect to any such claims (“run-off insurance”).

The need for run-off insurance would be an added expense for the post-business combination entity and could interfere with or frustrate our ability to consummate an initial business combination on terms favorable to our investors.

Our public stockholders may not be afforded an opportunity to vote on our proposed business combination, which means we may complete our initial business combination even though a majority of our public stockholders do not support such a combination.

We may not hold a stockholder vote to approve our initial business combination unless the business combination would require stockholder approval under applicable state law or the rules of the Nasdaq or if we decide to hold a stockholder vote for business or other reasons. For instance, the Nasdaq rules currently allow us to engage in a tender offer in lieu of a stockholder meeting but would still require us to obtain stockholder approval if we were seeking to issue more than 20% of our outstanding shares to a target business as consideration in any business combination. Therefore, if we were structuring a business combination that required us to issue more than 20% of our outstanding shares, we would seek stockholder approval of such business combination. However, except as required by law, the decision as to whether we will seek stockholder approval of a proposed business combination or will allow stockholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors, such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek stockholder approval. Accordingly, we may consummate our initial business combination even if holders of a majority of the outstanding shares of our common stock do not approve of the business combination we consummate. Please see the section entitled “Proposed Business—Stockholders May Not Have the Ability to Approve Our Initial Business Combination” for additional information.

Our letter agreement with our sponsor, directors and officers may be amended without stockholder approval.

Our letter agreement with our sponsor, directors and officers contains provisions relating to transfer restrictions of our founder shares and placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidation distributions from the trust account. This letter agreement may be amended

 

35

Table of Contents

without stockholder approval (although releasing the parties from the restriction not to transfer our founder shares for a period of one year following the date we complete our initial business combination except in certain circumstances will require the prior written consent of the underwriters). While we do not expect our board to approve an amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to this agreement. Any such amendments to the letter agreement would not require approval from our stockholders and may have an adverse effect on the value of an investment in our securities.

Risks Relating to our Securities

The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the per-share redemption amount received by public stockholders may be less than $10.10 per share.

The proceeds held in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that we are unable to complete our initial business combination or make certain amendments to our amended and restated certificate of incorporation, our public stockholders are entitled to receive their pro-rata share of the proceeds held in the trust account, plus any interest income, net of taxes paid or payable (less, in the case we are unable to complete our initial business combination, $100,000 of interest). Negative interest rates could reduce the value of the assets held in trust such that the per-share redemption amount received by public stockholders may be less than $10.10 per share.

The Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.

We have been approved to have our units listed on Nasdaq on the date of this annual report and our shares of Class A common stock, rights and warrants on or promptly after their date of separation. Although after giving effect to this offering we expect to meet, on a pro forma basis, the minimum initial listing standards set forth in Nasdaq’s listing standards, our securities may not be, or may not continue to be, listed on Nasdaq in the future or prior to the completion of our initial business combination. In order to continue listing our securities on Nasdaq prior to the completion of our initial business combination, we must maintain certain financial, distribution and share price levels. Generally, we must maintain a minimum amount in shareholders’ equity (generally $2,500,000) and a minimum number of holders of our securities (generally 300 public holders). Additionally, our units will not be traded after completion of our initial business combination and, in connection with our initial business combination, we will be required to demonstrate compliance with Nasdaq’s initial listing requirements, which are more rigorous than Nasdaq’s continued listing requirements, in order to continue to maintain the listing of our securities on Nasdaq. For instance, the share price of our securities would generally be required to be at least $4.00 per share and our shareholders’ equity would generally be required to be at least $5,000,000 and we would be required to have a minimum of 300 round-lot holders. We may not be able to meet those initial listing requirements at that time. We may not be able to meet those listing requirements at that time.

If Nasdaq delists our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:

 

  •  

a limited availability of market quotations for our securities;

 

  •  

reduced liquidity for our securities;

 

36

Table of Contents
  •  

a determination that our shares of Class A common stock are a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;

 

  •  

a limited amount of news and analyst coverage; and

 

  •  

a decreased ability to issue additional securities or obtain additional financing in the future.

We are not registering the shares of Class A common stock issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time, and such registration may not be in place when an investor desires to exercise warrants, thus precluding such investor from being able to exercise its warrants except on a cashless basis. If the issuance of the shares upon exercise of warrants is not registered, qualified or exempt from registration or qualification, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless.

We are not registering the shares of Class A common stock issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time. However, under the terms of the warrant agreement, we have agreed that as soon as practicable, but in no event later than 15 business days after the closing of our initial business combination, we will use our best efforts to file with the SEC a registration statement for the registration under the Securities Act of the issuance of the shares of Class A common stock issuable upon exercise of the warrants and thereafter will use our best efforts to cause the same to become effective within 60 business days following our initial business combination and to maintain a current prospectus relating to the Class A common stock issuable upon exercise of the warrants, until the expiration of the warrants in accordance with the provisions of the warrant agreement. We cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not current, complete or correct or the SEC issues a stop order. If the shares of Class A common stock issuable upon exercise of the warrants are not registered under the Securities Act, we will be required to permit holders to exercise their warrants on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.

Notwithstanding the foregoing, if a registration statement covering the issuance of the Class A common stock issuable upon exercise of the warrants is not effective within a specified period following the consummation of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. We will use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In no event will we be required to net cash settle any warrant, or issue securities or other compensation in exchange for the warrants in the event that we are unable to register or qualify the shares underlying the warrants under applicable state securities laws and there is no exemption available. If the issuance of the shares upon exercise of the warrants is not so registered or qualified or exempt from registration or qualification, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In such event, holders who acquired their warrants as part of a purchase of units will have paid the full unit purchase price solely for the shares of Class A common stock included in the units. If and when the warrants become redeemable by us, we may not exercise our redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification. We will use our best efforts to register or qualify such shares of common stock under the blue sky laws of the state of residence in those states in which the warrants were offered by us in this

 

37

Table of Contents

offering. However, there may be instances in which holders of our public warrants may be unable to exercise such public warrants but holders of our placement warrants may be able to exercise such private placement warrants.

If you exercise your public warrants on a “cashless basis,” you will receive fewer shares of Class A common stock from such exercise than if you were to exercise such warrants for cash.

There are circumstances in which the exercise of the public warrants may be required or permitted to be made on a cashless basis. First, if a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 90th day after the closing of our initial business combination, warrant holders may, until such time as there is an effective registration statement, exercise warrants on a cashless basis in accordance with Section 3(a)(9) of the Securities Act or another exemption. Second, if a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective within a specified period following the consummation of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available; if that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. Third, if we call the public warrants for redemption, our management will have the option to require all holders that wish to exercise warrants to do so on a cashless basis. In the event of an exercise on a cashless basis, a holder would pay the warrant exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable. As a result, you would receive fewer shares of Class A common stock from such exercise than if you were to exercise such warrants for cash.

Unlike many other similarly structured special purpose acquisition companies, our initial stockholders will receive additional shares of Class A common stock if we issue shares to consummate an initial business combination.

The founder shares will automatically convert into Class A common stock at the time of the consummation of our initial business combination, on a one-for-one basis, subject to adjustment as provided herein. In the case that additional shares of Class A common stock, or equity-linked securities convertible or exercisable for Class A common stock, are issued or deemed issued in excess of the amounts offered in the prospectus consummating our initial public offering and related to the closing of the initial business combination, the ratio at which founder shares shall convert into Class A common stock will be adjusted so that the number of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, approximately 20% of the total number of all outstanding shares of common stock upon completion of the initial business combination, excluding the representative shares, private placement warrants and underlying securities and any shares or equity-linked securities issued, or to be issued, to any seller in the business combination and any private placement-equivalent units and their underlying securities issued to our sponsor or its affiliates upon conversion of loans made to us. This is different from most other similarly structured blank check companies in which our sponsor and initial stockholders will only be issued an aggregate of 20% of the total number of shares to be outstanding prior to the initial business combination. Additionally, the aforementioned adjustment will not take into account any shares of Class A common stock redeemed in connection with the business combination. Accordingly, the holders of the founder shares could receive additional shares of Class A common stock even if the additional shares of Class A common stock, or equity-linked securities convertible or exercisable for Class A common stock, are issued or deemed issued solely to replace those shares that were redeemed in connection with the business combination. The foregoing may make it more difficult and expensive for us to consummate an initial business combination.

 

38

Table of Contents

We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least a majority of the then outstanding public warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of shares of our Class A common stock purchasable upon exercise of a warrant could be decreased, all without your approval.

Our warrants will be issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in our prospectus, or defective provision, but requires the approval by the holders of at least a majority of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants (which may include public warrants acquired by our sponsor or its affiliates in this offering or thereafter in the open market). Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least a majority of the then outstanding public warrants approve of such amendment. Although our ability to amend the terms of the public warrants with the consent of at least a majority of the then outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash or stock, shorten the exercise period or decrease the number of shares of our Class A common stock purchasable upon exercise of a warrant.

Our warrant agreement and rights agreement will designate the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants or rights, which could limit the ability of warrant or rights holders to obtain a favorable judicial forum for disputes with our company.

Our warrant agreement and rights agreement will provide that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement or rights agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.

Notwithstanding the foregoing, these provisions of the warrant agreement or rights agreement will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented to the forum provisions in our warrant agreement and rights agreement. If any action, the subject matter of which is within the scope the forum provisions of the warrant agreement or rights agreement, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any holder of our warrants or rights, such holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder or rights holder in any such enforcement action by service upon such warrant holder’s or rights holder’s counsel in the foreign action as agent for such warrant holder or rights holder. This choice-of-forum provision may limit a warrant holder’s or rights holder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Alternatively, if a court were to find this provision of our warrant agreement or rights agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and board of directors

 

39

Table of Contents

We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.

We have the ability to redeem outstanding warrants (and the forward purchase warrants) at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the reported last sale price of our Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading-day period commencing once the warrants become exercisable and ending on the third trading day prior to the date on which we give proper notice of such redemption and provided certain other conditions are met. If and when the warrants become redeemable by us, we may not exercise our redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification. We will use our best efforts to register or qualify such shares of common stock under the blue sky laws of the state of residence in those states in which the warrants were offered by us in this offering. Redemption of the outstanding warrants could force you (i) to exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (ii) to sell your warrants at the then-current market price when you might otherwise wish to hold your warrants or (iii) to accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, is likely to be substantially less than the market value of your warrants. None of the private placement warrants will be redeemable by us so long as they are held by the sponsor or its permitted transferees.

Our warrants, rights and founder shares may have an adverse effect on the market price of our Class A common stock and make it more difficult to effectuate our initial business combination.

We will be issuing (i) warrants to purchase 5,000,000 shares of our Class A common stock (or up to 5,750,000 shares of Class A common stock if the underwriters’ over-allotment option is exercised in full) and (ii) rights convertible into 1,000,000 shares of our Class A common stock (or up to 1,150,000 shares of Class A common stock if the underwriters’ over-allotment option is exercised in full) as part of the units offered by our initial public offering prospectus. Concurrently with the closing of this offering, our sponsor will purchase in a private placement 3,562,750 private placement warrants (or 3,900,250 if the over-allotment option is exercised in full), at a price of $1.00 per warrant, for an aggregate purchase price of $3,562,750 (or $3,900,250 if the over-allotment option is exercised in full), entitling our sponsor to receive upon conversion of such warrants 3,562,750 shares of Class A common stock. Our initial stockholders currently own an aggregate of 2,875,000 founder shares. The founder shares are convertible into shares of Class A common stock on a one-for-one basis, subject to adjustment as set forth herein. In addition, if our sponsor makes any working capital loans, up to $1,500,000 of such loans may be converted into working capital warrants, at a price of $1.50 per working capital warrants, upon consummation of our initial business combination. The working capital warrants would be identical to the private placement warrants. To the extent we issue shares of Class A common stock to effectuate an initial business combination, the potential for the issuance of a substantial number of additional shares of Class A common stock upon exercise of these warrants, conversion of these rights and loan conversion rights could make us a less attractive business combination vehicle to a target business. Any such issuance will increase the number of issued and outstanding shares of our Class A common stock and reduce the value of the shares of Class A common stock issued to complete the initial business combination. Therefore, our warrants, rights and founder shares may make it more difficult to effectuate an initial business combination or increase the cost of acquiring the target business.

Because each unit contains one-half of one redeemable warrant and only a whole warrant may be exercised, the units may be worth less than units of other special purpose acquisition companies.

Each unit contains one-half of one redeemable warrant. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least two units, you will not be able to receive or trade a whole warrant. This is different from other offerings similar to ours whose units include

 

40

Table of Contents

one share of common stock and one warrant to purchase one whole share. We have established the components of the units in this way in order to reduce the dilutive effect of the warrants upon completion of an initial business combination since the warrants will be exercisable in the aggregate for one-half of the number of shares compared to units that each contain a warrant to purchase one whole share, thus making us, we believe, a more attractive partner for target businesses. Nevertheless, this unit structure may cause our units to be worth less than if they included a warrant to purchase one whole share.

The determination of the offering price of our units, the size of this offering and the terms of the units is more arbitrary than the pricing of securities and size of an offering of an operating company in a particular industry. You may have less assurance, therefore, that the offering price of our units properly reflects the value of such units than you would have in a typical offering of an operating company.

Prior to this offering there has been no public market for any of our securities. The public offering price of the units and the terms of the warrants and rights were negotiated between us and the underwriters. In determining the size of this offering, management held customary organizational meetings with the representative of the underwriters, both prior to our inception and thereafter, with respect to the state of capital markets, generally, and the amount the underwriters believed they reasonably could raise on our behalf. Factors considered in determining the size of this offering, prices and terms of the units, including the Class A common stock, warrants and rights underlying the units, include:

 

  •  

the history and prospects of companies whose principal business is the acquisition of other companies;

 

  •  

prior offerings of those companies;

 

  •  

our prospects for acquiring an operating business;

 

  •  

a review of debt to equity ratios in leveraged transactions;

 

  •  

our capital structure;

 

  •  

an assessment of our management and their experience in identifying operating companies;

 

  •  

general conditions of the securities markets at the time of this offering; and

 

  •  

other factors as were deemed relevant.

Although these factors were considered, the determination of our offering price, size and terms of the units is more arbitrary than the pricing of securities of an operating company in a particular industry since we have no historical operations or financial results.

There is currently no market for our securities and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities.

There is currently no market for our securities. Stockholders therefore have no access to information about prior market history on which to base their investment decision. Following this offering, the price of our securities may vary significantly due to one or more potential business combinations and general market or economic conditions. Furthermore, an active trading market for our securities may never develop or, if developed, it may not be sustained. You may be unable to sell your securities unless a market can be established and sustained.

Provisions in our amended and restated certificate of incorporation and Delaware law may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our common stock and could entrench management.

Our amended and restated certificate of incorporation contains provisions that may discourage unsolicited takeover proposals that stockholders may consider to be in their best interests. These provisions include a staggered board of directors and the ability of the board of directors to designate the terms of and issue new series of preferred shares, which may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.

 

41

Table of Contents

We are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a change of control. Together these provisions may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.

Provisions in our amended and restated certificate of incorporation and Delaware law may have the effect of discouraging lawsuits against our directors and officers.

Our amended and restated certificate of incorporation requires, unless we consent in writing to the selection of an alternative forum, that (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee to us or our stockholders, (iii) any action asserting a claim against us, our directors, officers or employees arising pursuant to any provision of the DGCL or our amended and restated certificate of incorporation or bylaws, or (iv) any action asserting a claim against us, our directors, officers or employees governed by the internal affairs doctrine may be brought only in the Court of Chancery in the State of Delaware, except any claim (A) as to which the Court of Chancery of the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or (C) for which the Court of Chancery does not have subject matter jurisdiction. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder’s counsel. Although we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against our directors and officers, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder.

Our amended and restated certificate of incorporation provides that the exclusive forum provision will be applicable to the fullest extent permitted by applicable law, subject to certain exceptions. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. In addition, our amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder. We note, however, that there is uncertainty as to whether a court would enforce this provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

A provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.

Unlike most blank check companies, if:

 

  •  

we issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at a Newly Issued Price of less than $9.20 per share;

 

  •  

the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and

 

  •  

the Market Value is below $9.20 per share,

 

42

Table of Contents

then the exercise price of the warrants will be adjusted to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price. This may make it more difficult for us to consummate an initial business combination with a target business.

Due to certain provisions contained in our warrant agreement, the warrants will be treated as a derivative liability, which could cause us to recognize certain adverse changes to our consolidated financial statements from similar special purpose companies that do not have these provision.

Due to certain provisions contained in our warrant agreement, both the public warrants and the private placement warrants will be treated as a derivative liability and we will be required to record the fair value of each warrant as a liability in accordance with the guidance contained in ASC 815-40. As a result, each quarter, we will be required to determine the fair value of each warrant and record the change on the value of the warrants from the prior quarter as a gain or a loss on our income statement, which will change the value of the liability for the warrants on our balance sheets. This accounting treatment could cause the market to react negatively to our financial performance and the obligation of a company with which we pursue our initial business combination to continue this accounting treatment could make it less likely that we will be able to consummate our initial business combination.

We may issue additional shares of common stock or preferred stock to complete our initial business combination or under an employee incentive plan after completion of our initial business combination, and any such issuances would dilute the interest of our stockholders and likely present other risks.

Our amended and restated certificate of incorporation authorizes the issuance of up to 200,000,000 shares of Class A common stock, par value $0.0001 per share, 20,000,000 shares of Class B common stock, par value $0.0001 per share, and 1,000,000 shares of undesignated preferred stock, par value $0.0001 per share. There are 185,000,000 (assuming that the underwriter has not exercised the underwriter’s over-allotment option) authorized but unissued shares of Class A common stock and Class B common stock available for issuance, which amount takes into account shares of common stock reserved for issuance upon exercise of outstanding warrants and the conversion of the rights, including the private warrants and rights to be issued in the private placement. There are no shares of preferred stock issued and outstanding.

We may issue a substantial number of additional shares of common stock, and may issue shares of preferred stock, in order to complete our initial business combination or under an employee incentive plan after completion of our initial business combination (although our amended and restated certificate of incorporation provides that we may not issue securities that can vote with common stockholders on matters related to our pre-business combination activity). However, our amended and restated certificate of incorporation provides, among other things, that prior to our initial business combination, we may not issue additional shares of capital stock that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote on any initial business combination. The issuance of additional shares of common or preferred stock:

 

  •  

may significantly dilute the equity interest of investors in this offering;

 

  •  

may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock;

 

  •  

could cause a change in control if a substantial number of common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and

 

  •  

may adversely affect prevailing market prices for our units, common stock, rights and/or warrants.

 

43

Table of Contents

Our rights and warrants may have an adverse effect on the market price of our common stock and make it more difficult to effectuate our business combination.

We will be issuing rights to purchase 1,000,000 shares of our Class A common stock (or up to 1,150,000 shares of common stock if the underwriter’s over-allotment option is exercised in full) and warrants to purchase 5,000,000 shares of our common stock (or up to 5,750,000 shares of common stock if the underwriter’s over-allotment option is exercised in full) as part of the units offered by our initial public offering prospectus and, simultaneously with the closing of this offering, we will be issuing 3,562,750 private placement warrants exercisable to purchase an aggregate of 3,562,750 shares of our Class A common stock. Our sponsor has also agreed that if the over-allotment option is exercised by the underwriter in full or in part, our sponsor and/or its designees will purchase from us additional private placement warrants on a pro rata basis in an amount that is necessary to maintain in the trust account $10.10 per unit sold to the public in this offering. To the extent we issue shares of common stock to effectuate a business combination, the potential for the issuance of a substantial number of additional shares of common stock upon exercise of these rights and warrants could make us a less attractive acquisition vehicle to a target business. Such rights and warrants, if and when converted or exercised, would increase the number of issued and outstanding shares of our common stock and reduce the value of the shares of common stock issued to complete the business combination. Therefore, our rights and warrants may make it more difficult to effectuate a business combination or increase the cost of acquiring the target business.

Because each unit contains one-tenth of one right, the units may be worth less than units of other blank check companies.

Each unit contains one-tenth of one right. Pursuant to the rights agreement, the rights may only be exercised for a whole number of shares, which means you must hold 10 rights in order to receive one share of common stock. We have established the components of the units in this way in order to reduce the dilutive effect of the rights upon completion of our initial business combination. While we believe this makes us a more attractive merger partner for target businesses, this unit structure may nevertheless cause our units to be worth less than if they included a right to purchase one whole share.

Risks Relating to our Sponsor and Management Team

Our ability to successfully effect our initial business combination and to be successful thereafter will be dependent upon the efforts of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.

Our ability to successfully effect our initial business combination is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however, cannot presently be ascertained. Although some of our key personnel may remain with the target business in senior management or advisory positions following our initial business combination, it is likely that some or all of the management of the target business will remain in place. While we intend to closely scrutinize any individuals we employ after our initial business combination, we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements. In addition, the officers and directors of an initial business combination candidate may resign upon completion of our initial business combination. The departure of an initial business combination target’s key personnel could negatively impact the operations and profitability of our post-combination business. The role of an initial business combination candidate’s key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that certain members of an initial business combination candidate’s management team will remain associated with the initial business combination candidate following our initial business combination, it is possible that members of the management of an initial business combination candidate will not wish to remain in place. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.

 

44

Table of Contents

We are dependent upon our executive officers and directors and their departure could adversely affect our ability to operate.

Our operations are dependent upon a relatively small group of individuals. We believe that our success depends on the continued service of our executive officers and directors, at least until we have completed our business combination. In addition, our executive officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential business combinations and monitoring the related due diligence. We do not have an employment agreement with, or key-man insurance on the life of, any of our directors or executive officers. The unexpected loss of the services of one or more of our directors or executive officers could have a detrimental effect on us.

Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation following our business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.

Our key personnel may be able to remain with the company after the completion of our business combination only if they are able to negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would render to us after the completion of the business combination. The personal and financial interests of such individuals may influence their motivation in identifying and selecting a target business. However, we believe the ability of such individuals to remain with us after the completion of our business combination will not be the determining factor in our decision as to whether or not we will proceed with any potential business combination. There is no certainty, however, that any of our key personnel will remain with us after the completion of our business combination. We cannot assure you that any of our key personnel will remain in senior management or advisory positions with us. The determination as to whether any of our key personnel will remain with us will be made at the time of our initial business combination.

Our executive officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.

Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our business combination. Each of our executive officers is engaged in several other business endeavors for which they may be entitled to substantial compensation and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. Our independent directors also serve as officers and board members for other entities. If our executive officers’ and directors’ other business affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels, it could limit their ability to devote time to our affairs which may have a negative impact on our ability to complete our initial business combination. For a complete discussion of our executive officers’ and directors’ other business affairs, please see “Management—Directors and Executive Officers.”

Certain of our executive officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities similar to those intended to be conducted by us following our initial business combination and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.

Following the completion of this offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses. Our executive officers and

 

45

Table of Contents

directors are, or may in the future become, affiliated with entities that are engaged in business activities similar to those intended to be conducted by us following our initial business combination. See a description of our executive officers’ and directors’ current affiliations under the headings “Management” and “Management—Conflicts of Interest” below.

Our officers and directors also may become aware of business opportunities which may be appropriate for presentation to us and the other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us. Our amended and restated certificate of incorporation provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue.

For a complete discussion of our executive officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Management—Directors and Executive Officers,” “Management—Conflicts of Interest” and “Certain Relationships and Related Party Transactions.”

Our executive officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.

We have not adopted a policy that expressly prohibits our directors, executive officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a target business that is affiliated with our sponsor, our directors or executive officers, although we do not currently intend to do so. We also do not have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours.

We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor, executive officers, directors or existing holders which may raise potential conflicts of interest.

In light of the involvement of our sponsor, executive officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, executive officers and directors. Our directors also serve as officers and board members for other entities, including, without limitation, those described under “Management—Conflicts of Interest.” Such entities may compete with us for business combination opportunities. Our sponsor, officers and directors are not currently aware of any specific opportunities for us to complete our business combination with any entities with which they are affiliated, and there have been no preliminary discussions concerning a business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria for a business combination as set forth in “Proposed Business—Effecting our initial business combination—Selection of a target business and structuring of our initial business combination” and such transaction was approved by a majority of our disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm that is a member of FINRA, or from an independent accounting firm, regarding the fairness to our company from a financial point of view of a business combination with one or more domestic or international businesses affiliated with our executive officers, directors or existing holders, potential conflicts of interest may still exist and, as a result, the terms of the business combination may not be as advantageous to our public stockholders as they would be absent any conflicts of interest.

 

46

Table of Contents

Since our sponsor will lose some or all of its investment in us if our business combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.

Upon the closing of this offering, our sponsor and the initial stockholders will collectively hold 2,875,000 founder shares as of the date of our initial public offering prospectus (up to 375,000 of which are subject to forfeiture), for which it paid $0.009 per founder share. On March 27, 2021, our sponsor sold 15,000 founder shares to our Chief Financial Officer, Jenny Junkeer, and 10,000 founder shares to each of our three independent directors, Michael Tomczyk, Robin Meister and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which our sponsor purchased such founder shares from the company. Prior to our sponsor’s initial investment of $25,000, we had no assets, tangible or intangible. Moreover, as consideration for financial advisory services rendered in connection with this offering, on March 11, 2021, ARC Capital received from our sponsor 50,000 of our sponsor’s 2,500,000 founder shares (assuming forfeiture of 375,000 founder shares in the event the underwriter’s over-allotment option is exercised), at a price of $0.009 per share. The per-share price of the founder shares was determined by dividing the amount contributed to our company by the number of founder shares issued. Our sponsor has agreed not to transfer any of its ownership interest in the founder shares (except to certain permitted transferees) until the earlier of (i) the first anniversary of the completion of our initial business combination and (ii) the date on which we complete a liquidation, merger, stock exchange or other similar transaction after our initial business combination that results in all of our public stockholders having the right to exchange their shares of common stock for cash, securities or other property. In addition, our sponsor and initial shareholders have entered into a letter agreement with us, pursuant to which they has agreed to waive (i) their redemption rights with respect to all shares of our common stock then owned by them in connection with the completion of our initial business combination and (ii) their rights to liquidating distributions from the trust account with respect to their founder shares and private placement warrants if we fail to complete our initial business combination within 18 months (after we elected to extend the initial 12-month term for two additional three month terms) from the effective date of the registration statement consummating our initial public offering (although it will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our business combination within the prescribed time frame).

Our sponsor has purchased an aggregate of 3,900,250 private placement warrants (assuming the underwriter’s over-allotment option is not exercised) for a purchase price of $3,900,250, or $1.00 per warrant. Our sponsor has also agreed that if the over-allotment option is exercised by the underwriter in full or in part, our sponsor and/or its designees will purchase from us additional private placement warrants on a pro rata basis in an amount that is necessary to maintain in the trust account $10.10 per unit sold to the public in this offering. Caltech Trading previously indicated its intention to provide financing to our sponsor in connection with our sponsor’s purchase of the private placement warrants. On October 20, 2021, the Company announced that Caltech Trading will not provide financing to our sponsor. As a result, our sponsor expects to admit a third party institutional investor as a new member which would make a capital contribution to raise the funds required to purchase the private placement warrants. The Investor would own 95% of the equity of our sponsor and Saiful Khandaker, our Chief Executive Officer, would own 5% of the equity of our sponsor. Mr. Khandaker will remain our Chief Executive Officer and will remain the sole managing member with voting and dispositive control over our sponsor’s securities.

The founder shares and the private placement warrants will be worthless if we do not complete an initial business combination. This and other personal and financial interests of our executive officers and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination and influencing the operation of the business following the initial business combination. This risk may become more acute as the 18-month anniversary (after we elected to extend the term for two additional three month terms) of the effective date of the registration statement consummating our initial public offering nears, which is the deadline for our completion of an initial business combination.

 

47

Table of Contents

Since our sponsor and officers will not be eligible to be reimbursed for their out-of-pocket expenses if our business combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.

Our sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred in connection with activities on our behalf; provided, however, that to the extent such expenses exceed the available proceeds not deposited in the trust account, such expenses would not be reimbursed by us unless we consummate an initial business combination. These financial interests of our sponsor, executive officers and directors may influence their motivation in identifying and selecting a target business combination and completing an initial business combination.

Our ability to successfully effect our initial business combination and to be successful thereafter will be dependent upon the efforts of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.

Our ability to successfully effect our business combination is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however, cannot presently be ascertained. Although some of our key personnel may remain with the target business in senior management or advisory positions following our business combination, it is likely that some or all of the management of the target business will remain in place. While we intend to closely scrutinize any individuals we engage after our business combination, we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements.

General Risk Factors

We are a recently incorporated company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.

We are a recently incorporated company under the laws of Delaware with no operating results, and we will not commence operations until obtaining funding through this offering. Because we lack an operating history, you have no basis upon which to evaluate our ability to achieve our business objective of completing our initial business combination with one or more target businesses. We have no plans, arrangements or understandings with any prospective target business concerning a business combination and may be unable to complete our initial business combination. If we fail to complete our initial business combination, we will never generate any operating revenues.

Past performance by our sponsor, our founders and our management team or their respective affiliates may not be indicative of future performance of an investment in us.

Information regarding performance by, or businesses associated with, our founding team, our management team or their affiliates is presented for informational purposes only. Any past experience of and performance by our founding team or their affiliates, is not a guarantee either: (1) that we will be able to successfully identify a suitable candidate for our initial business combination; or (2) of any results with respect to any initial business combination we may consummate. You should not rely on the historical record of our founding team or any of their affiliates’ as indicative of the future performance of an investment in us or the returns we will, or are likely to, generate going forward.

 

48

Table of Contents

We are an emerging growth company within the meaning of the Securities Act, and we intend to take advantage of certain exemptions from disclosure requirements available to emerging growth companies, which could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.

We are an “emerging growth company” within the meaning of the Securities Act, and we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, our stockholders may not have access to certain information they may deem important. We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the closing of this offering, (ii) the last day of the fiscal year in which we have total annual gross revenue of at least $1.07 billion, (iii) the last day of the fiscal year in which we are deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year or (iv) the date on which we have issued more than $1.00 billion in non-convertible debt securities during the prior three-year period.

We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile. Further, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an “emerging growth company,” can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an “emerging growth company” nor an “emerging growth company” which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used.

Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.”

As of December 31, 2022, we had $10,335 in cash and a working capital deficit of $1,759,163, respectively. Further, we have incurred and expect to continue to incur significant costs in pursuit of our finance and acquisition plans. Management’s plans to address this need for capital through this offering are discussed in the section of this annual report titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” We cannot assure you that our plans to raise capital or to consummate an initial business combination will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.

The financial statements contained elsewhere in this annual report do not include any adjustments that might result from our inability to consummate this offering or our inability to continue as a going concern.

Item 1B. Unresolved Staff Comments.

None.

 

49

Table of Contents

Item 2. Properties.

Our principal executive office is located at 100 Springhouse Drive, Suite 204, Collegeville, PA 19426. Our telephone number is (610) 226-8101. The cost for this space is included in the $5,000 per month fee that we will pay to our sponsor for office space, utilities, secretarial and administrative services. We believe that the amount we will pay under the administrative services agreement is comparable to the cost of similar services that we could obtain from unaffiliated persons. We consider our current office space adequate for our current operations.

Item 3. Legal Proceedings.

There are no actions, suits, proceedings, inquiries or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

Item 4. Mine Safety Disclosures.

Not Applicable.

 

50

Table of Contents

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our Units, shares of Class A common stock, rights and warrants are each traded on the Nasdaq Global Market under the symbol “FEXDU”, “FEXD,” “FEXDR,” and “FEXDW,” respectively. Our Units commenced public trading on October 19, 2021. Our shares of Class A common stock and warrants began separate trading on January 11, 2022.

Transfer Agent

The transfer agent for the common stock is Continental Stock Transfer & Trust Company. The transfer agent’s address is 1 State St 30th floor, New York, NY 10004, and its telephone number is (212) 509-4000.

Dividend Policy

We have not paid any cash dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination will be within the discretion of our board of directors at such time. In addition, our board of directors is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future, except if we increase the size of the offering, in which case we will effect a stock dividend or other appropriate mechanism immediately prior to the consummation of the offering in an amount as to maintain the ownership of our sponsor prior to this offering at 20% of our issued and outstanding shares of common stock upon the consummation of this offering. Further, if we incur any indebtedness in connection with our business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.

Recent Sales of Unregistered Securities

Substantially concurrently with the closing of our initial public offering, we consummated the private placement of 3,900,250 Private Placement Warrants to the Sponsor at an aggregate price of, and generating gross proceeds to the Company of $3,900,250 and $2,923,400, which was placed in the Trust Account.

On October 21, 2022, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “October 2022 Private Placement Warrants”), generating total proceeds of $1,150,000, which was placed in the Trust Account.

On January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “January 2023 Private Placement Warrants”), generating total proceeds of $1,150,000, which was placed in the Trust Account.

In connection with our initial public offering, our sponsor had agreed to loan us an aggregate of up to $400,000 pursuant to an unsecured promissory note. As of December 31, 2022, the loan balance was $0.

Item 6. Selected Financial Data.

RESERVED

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to “we,” “us,” “company” or “our company” are to Fintech Ecosystem Development Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read

 

51

Table of Contents

in conjunction with the consolidated financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Annual Report on FORM 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward- looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission (“SEC”) filings.

Overview

We are a blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of this offering and the private placement of the private placement warrants, our capital stock, debt or a combination of cash, stock and debt. For additional detail regarding our initial public offering and related transactions, see “Note 1- Description Of Organization And Business Operations and Going Concern.”

The issuance of additional shares of our stock in a business combination:

 

  •  

may significantly dilute the equity interest of investors in this offering;

 

  •  

may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock;

 

  •  

could cause a change of control if a substantial number of shares of our common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

 

  •  

may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and

 

  •  

may adversely affect prevailing market prices for our common stock, rights and/or warrants. Similarly, if we issue debt securities, it could result in:

 

  •  

default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;

 

  •  

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of such covenants;

 

  •  

our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

 

  •  

our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;

 

52

Table of Contents
  •  

our inability to pay dividends on our common stock;

 

  •  

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;

 

  •  

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

 

  •  

increased vulnerability to adverse changes in general economic, industry, and competitive conditions and adverse changes in government regulation; and

 

  •  

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes, and other disadvantages compared to our competitors who have less debt.

As indicated in the accompanying financial statements, as of December 31, 2022, we had an accumulated deficit of $6,458,042. Further, we expect to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful. On January 20, 2023, we announced the time by which we have to consummate our initial business combination has been extended until April 21, 2023.

Recent Developments

Initial Public Offering

On October 21, 2021, Fintech Ecosystem Development Corp. (the “Company”) consummated its initial public offering (the “IPO”) of 11,500,000 units (the “Units”), including the issuance of 1,500,000 Units as a result of the underwriters’ exercise of their over-allotment option. Each Unit consists of one share of Class A common stock of the Company, par value of $0.0001 per share (“Class A Common Stock”), one right of the Company (a “Right”) and one-half of one redeemable warrant of the Company (a “Warrant”). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $115,000,000.

Substantially concurrently with the closing of the IPO, the Company completed the sale, in a private placement, of 3,900,250 warrants (the “Private Placement Warrants”), to the Company’s sponsor, Revofast LLC, at an aggregate price of, and generating gross proceeds to the Company of $3,900,250, $2,923,400 of which was placed in a trust account. The Private Placement Warrants will not be transferable, assignable or salable until 30 days after the Company’s initial business combination, and will have certain registration rights.

Business Combinations

Rana Business Combination Agreement

On September 11, 2022, the Company announced that it, with Fama Financial Services, Inc., a Georgia corporation and wholly-owned subsidiary of the Company (“Merger Sub”), Rana Financial Inc., a Georgia corporation (“Rana”) and David Kretzmer, as representative of the Shareholders (“Shareholder Representative”), had entered into a business combination agreement (the “Rana Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Merger Sub will be merged with and into Rana (the “Merger”). The Company shall pay a combination of Rana Cash Consideration and Rana Equity Consideration for the Company Common Stock subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $5,711,662 (the “Rana Escrow Amount”). The Rana Cash Consideration means $7,800,000 and the Rana Equity Consideration means 7,020,000 shares of New Acquiror Class A Common Stock. The closing of the Proposed Rana Transactions (the “Rana Closing”) will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Rana Business Combination has not been closed.

 

53

Table of Contents

Afinoz Business Combination Agreement

On September 11, 2022, the Company, announced that it, Fama Financial Services, Inc., a Georgia corporation and wholly owned subsidiary of the Company (“Merger Sub”), Monisha Sahni, Rachna Suneja and Ritscapital, LLC (collectively the “Members”) and Monisha Sahni as representative of the Members (“Member Representative”), had entered into a business combination agreement (the “Afinoz Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Mobitech International LLC, a limited liability company organized in the United Arab Emirates (“Afinoz”) will become as a wholly-owned subsidiary of the Company. The Company shall pay a combination of Afinoz Cash Consideration and Afinoz Equity Consideration for the Company Membership Interests subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $700,000 (the “Afinoz Escrow Amount”). The Afinoz Cash Consideration means $5,000,000 and the Afinoz Equity Consideration means 11,500,000 shares of New Acquiror Class A Common Stock. The Afinoz Closing will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Afinoz Business Combination has not been closed.

Extensions

On October 17, 2022, we extended the time by which we have to consummate a business combination by three months from October 21, 2022 to January 21, 2023. Furthermore, on January 20, 2023, we extended the time by which we have to consummate a business combination by three months from January 21, 2023 to April 21, 2023

Private placement

On October 21, 2022, the Company consummated a private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “October 2022 Private Placement Warrants”), generating total proceeds of $1,150,000. The October 2022 Private Placement Warrants were purchased by Revofast LLC (the “Sponsor”), the Company’s sponsor, and are substantially similar to the private placement warrants issued to the Sponsor at the time of the Company’s IPO in October 2021.

Liquidity and Capital Resources

As of December 31, 2022, the Company had $10,335 in its operating bank account, $118,985,048 investments held in its trust account, and a working capital deficit of approximately $1,759,163.

The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (as defined in Note 5), and a loan from the Sponsor of approximately $141,768 under the Note (as defined in Note 5). The $141,768 loan was fully repaid as of December 31, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of December 31, 2022, there were no amounts owed.

We may also need to obtain additional financing either to complete a business combination or because we become obligated to redeem a significant number of shares of our Class A common stock upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with the business combination.

Based on the foregoing, management does not believe that we will have sufficient working capital to meet its needs through the earlier of the consummation of an initial business combination or one year from this Report.

 

54

Table of Contents

Over this time period, we will be using the funds held outside of the trust account for paying existing accounts payable and accrued liabilities, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the initial business combination. We believe we may need to raise additional funds in order to meet the expenditures required for operating the business. Furthermore, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate the business prior to the initial business combination. Moreover, we may need to obtain additional financing either to complete the initial business combination or to redeem a significant number of our public shares upon completion of the initial business combination, in which case we may issue additional securities or incur debt in connection with such initial business combination. Our sponsor, officers and directors may, but are not obligated to, loan us funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. The factors, among others, raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that result from our inability to continue as a going concern.

There is no assurance that our plans to consummate an initial business combination will be successful by April 21, 2023. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Off-Balance Sheet Arrangements; Commitments and Contractual Obligations

As of December 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and we did not have any commitments or contractual obligations.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for our initial public offering. We will not be generating any operating revenues until the closing and completion of our initial business combination.

For the year ended December 31, 2022, we had net income of $3,837,124, which consisted of $4,471,921 non-operating income resulting from the change in fair value of derivative liabilities and forward purchase agreement and $1,682,935 interest income generated from the investments held in the trust account. These other incomes are offset by $2,027,390 in general and administrative expenses and income tax expenses of $290,342.

For the period from March 5, 2021 (inception) to December 31, 2021, we had net a loss of $1,882,603, which consisted of $102,600 offering costs associated with derivative warrant liabilities, $1,538,267 non-operating loss resulting from the change in fair value of derivative liabilities and forward purchase agreement, $102,466 franchise tax expense, and $141,383 in general and administrative expense. These loss and expenses were offset by $2,113 interest income generated from the investments held in the trust account.

Related Party Transactions

Please refer to Note 5, Related Party Transactions, in “Item 8. Financial Statements and Supplementary Data” for a discussion of our related party transactions.

 

55

Table of Contents

Critical Accounting Policies and Estimates

Our management makes a number of significant estimates, assumptions and judgments in the preparation of our consolidated financial statements. See “Note 2, Summary of Significant Accounting Policies, in “Item 8. Financial Statements and Supplementary Data” for a discussion of the estimates and judgments necessary in our accounting for common stock subject to possible redemption, and net income (loss) per common share. Any new accounting policies or updates to existing accounting policies as a result of new accounting pronouncements have been included in the notes to our consolidated financial statements contained in this Annual Report on FORM 10-K. The application of our critical accounting policies may require management to make judgments and estimates about the amounts reflected in the consolidated financial statements. Management uses historical experience and all available information to make these estimates and judgments. Different amounts could be reported using different assumptions and estimates.

Recent Accounting Standards

Please refer to Note 2, Summary of Significant Accounting Policies, in “Item 8. Financial Statements and Supplementary Data” for a discussion of recent accounting pronouncements and their anticipated effect on our business.

JOBS Act

The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and, under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions, we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal control over financial reporting pursuant to Section 404 of the Sarbanes Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that the PCAOB may adopt regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the consolidated financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for five years following the completion of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk.

As of December 31, 2022, we were not subject to any significant market or interest rate risk. The net proceeds of our initial public offering and the sale of the private placement warrants held in the trust account are invested in U.S. government treasury bills with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

 

56

Table of Contents
0.1http://fasb.org/us-gaap/2022#OperatingExpenses
Item 8. Financial Statements and Supplementary Data
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
  
PAGE
 
  
 
F-2
 
Consolidated Balance Sheets as of December 31, 2022 and 2021
  
 
F-3
 
Consolidated Statements of Operations for the Year Ended December 31, 2022 and for the Period from March 5, 2021 (Inception) through December 31, 2021
  
 
F-4
 
Consolidated Statements of Changes in Stockholder’s Deficit for the Year Ended December 31, 2022 and for the Period from March 5, 2021 (Inception) through December 31, 2021
  
 
F-5
 
Consolidated Statements of Cash Flows for the Year Ended December 31, 2022 and for the Period from March 5, 2021 (Inception) through December 31, 2021
  
 
F-6
 
  
 
F-7
 
 
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of Fintech Ecosystem Development Corp.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Fintech Ecosystem Development Corp. (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations, changes in stockholders’ deficit and cash flows for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) through December 31, 2021, and the related notes
(collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) through December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.
Explanatory Paragraph – Going Concern
The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note
1, if the Company is unable to complete a business combination by April 21, 2023, then the Company will cease all operations except for the purpose of liquidating. Additionally, the Company’s business plan is dependent on the completion of a business combination and the Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. The date for mandatory liquidation and subsequent dissolution and the Company’s liquidity condition raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating
the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial
statements
. We believe that our audits provide a reasonable basis for our
opinion
.
/s/ Marcum
LLP
Marcum
LLP
We have
served
as the Company’s auditor since 2021.
Boston, MA
April 
20
, 2023
 
F-2
FINTECH ECOSYSTEM DEVELOPMENT CORP.
CONSOLIDATED BALANCE SHEETS
 
    
December 31,
2022
    
December 31,
2021
  
ASSETS
                 
Current assets
                 
Cash
    $ 10,335     $ 612,750  
Prepaid expenses
      38,951       86,557  
    
 
 
    
 
 
  
Total current assets
   
 
49,286
 
  
 
699,307
 
Long-term prepaid expenses
      —         38,633  
Investments held in trust account
      118,985,048       116,152,113  
    
 
 
    
 
 
  
Total assets
   
$
119,034,334
 
  
$
116,890,053
 
    
 
 
    
 
 
  
LIABILITIES, COMMON SHARES SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
                 
Current liabilities
                 
Accounts payable and accrued liabilities
    $ 990,605     $ 179,371  
Income tax payable
      290,342       —    
Promissory notes from related parties
      527,502       —    
    
 
 
    
 
 
  
Total current liabilities
   
 
1,808,449
 
  
 
179,371
 
Derivative forward purchase liability
      285,567       1,726,908  
Derivative warrant liabilities
      756,018       3,706,098  
Deferred underwriter fee payable
      3,737,500       3,737,500  
    
 
 
    
 
 
  
Total liabilities
   
 
6,587,534
 
  
 
9,349,877
 
    
 
 
    
 
 
  
COMMITMENTS AND CONTINGENCIES (NOTE 6)
                 
Class A common stock subject to possible redemption; 11,500,000 shares at redemption value
      118,392,240       116,150,000  
Stockholders’ deficit:
                 
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
      —         —    
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 57,500 shares issued and outstanding (excludes 11,500,000 shares subject to redemption)
      6       6  
Class B common stock, par value $0.0001; 20,000,000 shares authorized; 2,875,000 issued and outstanding
      288       288  
Additional paid-in capital
      —       —    
Accumulated deficit
      (5,945,734 )      (8,610,118 ) 
    
 
 
    
 
 
  
Total stockholders’ deficit
   
 
(5,945,440
 )
 
  
 
(8,609,824
) 
    
 
 
    
 
 
  
Total liabilities, common shares subject to possible redemption and stockholders’ deficit
   
$
119,034,334
 
  
$
116,890,053
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of these consolidated financial statements
 
F-3
FINTECH ECOSYSTEM DEVELOPMENT CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Year Ended December 31, 2022 and for the Period From
March 5, 2021 (Inception) Through December 31, 2021
 
 
  
For the year ended
December 31, 2022
 
  
For the period from
March 5, 2021
(inception) through
December 31, 2021
 
Operating Expenses:
  
  
Formation and Operating Costs
    $ 2,027,390      $ 243,849  
    
 
 
     
 
 
  
Total operating expenses
     
2,027,390
       
243,849
  
    
 
 
     
 
 
  
Other Income (Expenses):
                  
Offering costs associated with derivative warrant liabilities
      —          (102,600 ) 
Change in fair value of derivative warrant liabilities
      3,030,580        (1,312,034 ) 
Change in fair value of derivative forward purchase liability
      1,441,341        (226,233 ) 
Income from investments held in Trust Account
      1,682,935        2,113  
    
 
 
     
 
 
  
Total other income (expenses), net
      6,154,856        (1,638,754 ) 
    
 
 
     
 
 
  
Income (loss) before income taxes
   
$
4,127,466
 
   
$
(1,882,603
) 
Income taxes
   
 
290,342
 
   
 
—  
 
    
 
 
     
 
 
  
Net income (loss)
   
$
3,837,124
 
   
$
(1,882,603
) 
    
 
 
     
 
 
  
Basic & diluted net income (loss) per share (Class A)
    $ 0.27      $ (0.34 )
    
 
 
     
 
 
  
Weighted average number of common share-basic and diluted
(Class A)
   
 
11,557,500
 
   
 
2,726,188
 
Basic & diluted net income (loss) per share (Class B)
    $ 0.27      $ (0.34 )
    
 
 
     
 
 
  
Weighted average number of common shares-basic and diluted
(Class B)
   
 
2,875,000
 
   
 
2,875,000
 
 
The accompanying notes are an integral part of these consolidated financial statements
 
F-4
FINTECH ECOSYSTEM DEVELOPMENT CORP.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
For the Year Ended December 31, 2022 and for the Period From March 5, 2021 (Inception)
Through December 31, 2021

 
 
  
Common Stock
 
  
Additional

Paid-in

Capital
 
 
Accumulated

Deficit
 
 
Total
 
 
  
Class A
 
  
Class B
 
 
  
Shares
 
  
Amount
 
  
Share
 
  
Amount
 
Balance, March 5, 2021 (inception)
      —        $ —          —        $ —        $ —       $ —       $ —    
Share issuance – Class A
      57,500        6        —          —          351,032       —         351,038  
Share issuance – Class B
      —          —          2,875,000        288        24,712       —         25,000  
Net loss
      —          —          —          —          —         (1,882,603 )      (1,882,603 ) 
Sale of Private Placement Warrants
      —          —          —          —          2,886,185       —         2,886,185  
Accretion of Class A common stock subject to possible redemption amount
      —          —          —          —          (3,261,929 )      (6,727,515 )      (9,989,444 ) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
December 31, 2021
   
 
57,500
 
   
$
6
 
   
 
2,875,000
 
   
$
288
 
   
$
—  
 
  
$
(8,610,118
) 
  
$
(8,609,824
) 
Net Income
      —          —          —          —          —         3,837,124       3,837,124  
Sale of Private Placement Warrants
     —          —          —          —          1,069,500       —         1,069,500  
Remeasurement of Class A common stock subject to possible redemption
      —          —          —          —          (1,069,500
) 
     (1,172,740 )      (2,242,240 ) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
December 31, 2022
   
 
57,500
 
   
$
6
 
   
 
2,875,000
 
   
$
288
 
   
$
—
 
  
$
(5,945,734
 )
 
  
$
(5,945,440
 )
 
The accompanying notes are an integral part of these consolidated financial statements
 
F-5
FINTECH ECOSYSTEM DEVELOPMENT CORP.
CONSOLIDATED STATEMENTS OF CASH FLOW
For the Year Ended December 31, 2022 and for the Period From
March 5, 2021 (Inception) Through December 31, 2021

 
 
   
For the year
ended December

31, 2022
    
For the period
from March 5,
2021 (inception)
through December

31, 2021
  
Cash flows from operating activities:
                 
Net income (loss)
    $ 3,837,124     $ (1,882,603 ) 
Adjustments to reconcile net income (loss) to net cash used in operating activities:
                 
Offering costs associated with derivative warrant liabilities
      —         102,600  
Change in fair value of derivative forward purchase liability
      (1,441,341 )      226,233  
Change in fair value of warrant liabilities
      (3,030,580 )      1,312,034  
Related party promissory note accrued interest 
 
 
7,545
 
 
 
—  
 
Income from investments held in trust account
      (1,682,935 )      (2,113 ) 
Changes in operating assets and liabilities:
                  
Prepaid expenses
     
86,239
      
(125,190
)
Accounts payable and accrued liabilities
      811,234       179,371  
Income tax payable
      290,342       —    
    
 
 
    
 
 
  
Net cash used in operating activities
    $ (1,122,372 )   $ (189,669 ) 
    
 
 
    
 
 
  
Cash flows from investing activities:
                 
Cash deposited in Trust Account
      (1,150,000 )      (116,150,000 ) 
    
 
 
    
 
 
  
Net cash used in investing activities
      (1,150,000 )      (116,150,000 ) 
    
 
 
    
 
 
  
Cash flows from financing activities:
                 
Proceeds from issuance of common shares to Sponsor
      —         25,000  
Proceeds from issuance of warrants to Sponsor
      1,150,000       —    
Proceeds from promissory notes from related parties
      520,000       35,000  
Repayment of promissory notes
      (43 )      (141,768 ) 
Proceeds from the Initial Public Offering, gross
      —         115,000,000  
Proceeds from private placement
      —         3,900,250  
Payment of underwriter commission fee
      —         (1,437,500 ) 
Payment of offering costs
      —         (428,563 ) 
    
 
 
    
 
 
  
Net cash provided by financing activities
      1,669,957       116,952,419  
    
 
 
    
 
 
  
Net (decrease) increase in cash
      (602,415 )      612,750  
Cash, beginning of period
      612,750       —    
    
 
 
    
 
 
  
Cash, end of period
    $ 10,335     $ 612,750  
    
 
 
    
 
 
  
Supplemental Disclosures of Noncash Financing Activities
                 
Offering costs paid by related party under promissory note
    $ —       $ 106,768  
Deferred underwriter commission for the Initial Public Offering
    $ —       $ 3,737,500  
Issuance of Class A shares in connection with Initial Public Offering
    $ —       $ 351,038  
Remeasurement of Class A shares subject to redemption
  
$
2,242,240
 
 
$
—  
 
The accompanying notes are an integral part of these consolidated financial statements
 
F-6
FINTECH ECOSYSTEM DEVELOPMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN
Fintech Ecosystem Development Corp. (the “Company” or “FEXD”) is a blank check company incorporated in the State of Delaware on 
March 5, 2021. The Company was formed for the purpose of acquiring, merging with, engaging in capital stock exchange with, purchasing all or substantially all of the assets of, engaging in contractual arrangements, or engaging in any other similar business combination with a single operating entity, or one or more related or unrelated operating entities operating in any sector (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies in the financial technology development industry.
On December 31, 2022, the Company had not yet commenced any operations. All activity through December 31, 2022, relates to the Company’s formation, general operating expenses, the search for a target business with which to consummate an initial business combination and the Initial Public Offering (the “Initial Public Offering” or “IPO”) as described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will
generate non-operating income
in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its
fiscal year-end.
The Company is an early stage and emerging growth company, and, as such, the Company is subject to all of the risks associated with early-stage and emerging growth companies.
The Company’s sponsor is Revofast LLC, a Wyoming limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on October 18, 2021, and on October 21, 2021. On October 21, 2021, the Company consummated its Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $115,000,000, and incurring offering costs of $6,061,368, of which $3,737,500 was for deferred underwriting commissions (see Note 6). In addition, the Company granted the underwriter a
45-day
option to purchase an additional 1,500,000 Units at the Initial Public Offering price to cover over-allotments, if any. Simultaneous with the close of the Initial Public Offering, the over-allotment option was exercised in full.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement of an aggregate of 3,900,250 warrants (the “Private Placement Warrants”) to the Sponsor, for $1.00 per Private Placement Warrant, generating total gross proceeds of $3,900,250 (the “Private Place”) (see Note 4).
Following the closing of the Initial Public Offering on October 21, 2021, an amount of $116,150,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and held as cash items or invested only in U.S. government securities within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of paragraph (d) of
Rule 2a-7 of
the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s Stockholders, as described below.
The Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a
 
F-7
proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which public stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.
If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Class A Common Shares without the Company’s prior written consent.
The public stockholders will be entitled to redeem their Class A Common Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The
per-share
amount to be distributed to public stockholders who redeem their Class A Common Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants or rights. All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and restated certificate of incorporation. In accordance with SEC and its guidance on redeemable equity instruments, which has been codified in
ASC 480-10-S99, redemption
provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A common stock classified as temporary equity will be the allocated proceeds determined in accordance with ASC
470-20.
The Class A common stock is subject to
ASC 480-10-S99. If
it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in the absence of retained earnings,
additional paid-in capital).
While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.
If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
The Sponsor has agreed (a) to vote its Class B Common Stock, the Class A Common Shares underlying the Private Placement Warrants and any Class A Common Shares purchased during or after the Proposed Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation with respect to the
Company’s pre-Business Combination
activities prior to the consummation of a Business Combination unless the Company provides dissenting public stockholders with the opportunity to redeem their Class A Common Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Class B Common Stock) and into the right to receive cash from the Trust Account in
 
F-8
connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights
of pre-Business Combination
activity and (d) that the Class B Common Stock and Private Placement Warrants (including underlying Class A Common Shares) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Class A Common Shares purchased during or after the Proposed Offering if the Company fails to complete its Business Combination.
The Company will have until 12 months, being October 21, 2022, (or 15 or 18
 
months, depending on whether we elect to extend the initial 12-month term for up to two additional three-month terms) from the effective date of the registration statement to consummate a Business Combination (the “Combination Period”)
.
If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 
100
% of the outstanding Class A Common Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to
 
$
50,000),
 
divided by the number of then outstanding Class A Common Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Class A Common Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Proposed Offering price per Unit 
($10.00).
The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.10 per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Proposed Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Business Combinations
On September 11, 2022, the Company entered into two business combination agreements. Refer to Note 6.
On October 21, 2022, the Company’s board of directors approved to extend the time by which the Company has to consummate a business combination from October 21, 2022 until January 21, 2023.
On January 20, 2023, the Company’s board of directors further approved to extend the time by which the Company has to consummate a business combination from January 21, 2023 to April 21, 2023 (Note 11).

 
F-9
On April 10, 2023, the Company sent a letter to Rana Financial, Inc. and David Kretzmer a letter notifying Rana Financial, Inc. of its failure to deliver audited financial statements pursuant to the business combination agreement dated September 9, 2022. The Company notified Rana of its intent to propose the termination of the agreement and abandonment of the contemplated business combination within if the audited financial statements are not received by April 21, 2023. Refer to Note 11.
Liquidity and Capital Resources
As of December 31, 2022, the Company had $10,335 in its operating bank account, $118,985,048 investments held in its trust account, and working capital deficit of approximately $1,759,163.
The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (as defined in Note 5), and a loan from the Sponsor of approximately $141,768 under the Note (as defined in Note 5). The $141,768 loan was fully repaid as of December 31, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of December 31, 2022, there were no amounts outstanding under any Working Capital Loan.
On August 2, 2022, the Company borrowed $200,000 through a promissory note with HRT North America Ltd. LLC to support its liquidity needs. The Company borrowed an additional $300,000 through a promissory note with the Sponsor on October 19, 2022 (refer to Note 5).
On January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant generating total proceeds of $1,150,000 (refer to Note 11).
On January 20, 2023, the Company entered into a $200,000 promissory note with its Sponsor (refer to Note 11).
Based on the foregoing, management does not believe that the Company will have sufficient working capital to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. The Company believes it may need to raise additional funds in order to meet the expenditures required for operating the business. Furthermore, if the Company’s estimate of the costs of identifying a target business, undertaking
in-depth
due diligence and negotiating an Initial Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate the business prior to the Initial Business Combination. Moreover, the Company may need to obtain additional financing either to complete the Initial Business Combination or to redeem a significant number of our public shares upon completion of the Initial Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Initial Business Combination. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in what ever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The
con
solidate
d
financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.
In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic
205-40,
“Presentation of Financial
 
F-10
Statements – Going Concern,” the Company has until April 21, 2023, to consummate an initial business combination. It is uncertain that the Company will be able to consummate an initial business combination by this time. If an initial business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and the mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 21, 2023.

Risks and Uncertainties
Management is currently evaluating the impact of
the COVID-19 pandemic
on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States of America, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these consolidated financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Principle of consolidation
The consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Fama Financial Services, Inc. (“Fama”), which was incorporated on August 23, 2022 in the State of Georgia. There were no material business activities in Fama for the period from its incorporation date to December 31, 2022. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.
Emerging growth company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act’’), and it may take advantage of certain exemptions from various reporting requirements that apply to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can opt-out of
the extended transition period and comply with the requirements that apply
 
F-11
to non-emerging growth
companies, but any such election
to opt-out is
irrevocable. The Company has elected not
to opt-out of
such an extended transition period, which means that when a standard is issued or
 
revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison of the Company’s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult
or
impossible because of the potential differences in accounting standards used.
Use of estimates
The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As a result, the Company had cash of $10,335 and no cash equivalents on December 31, 2022. The Company had cash of $612,750 and no cash equivalents on December 31, 2021.
Investment Held in Trust Account
As of December 31, 2022 and 2021, the Company had $118,985,048 and $116,152,113 investments held in the Trust Account, respectively. The investments held in the Trust Account were held in marketable treasury funds. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest income in the accompanying statements of operations. The estimated fair value of investments held in Trust Account are determined using available market information.
Income taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. In addition, valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as an income tax expense. There were 
no
 unrecognized tax benefits and 
no
 amounts accrued for interest and penalties as of December 
31
,
2022
and
2021
. The Company is currently not aware of any issues under review resulting in significant payments, accruals, or material deviation from its position.
 
F-12
The Company may be subject to potential examination by federal, state, and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions, and compliance with federal, state, and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company has been subject to income tax examinations by major taxing authorities since its inception.
O
n August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023.
 
The exercise tax imposes a 1% tax on covered corporations on the fair market value of any stock of the corporation which is repurchased by such corporation for taxable years beginning after December 31, 2022. The exercise tax is applicable to certain SPAC redemptions, including in connection with a SPAC’s business combination. The amount of a redemption subject to the exercise tax is reduced by the fair market value of any stock issued by the SPAC during the taxable year of the redemption. The Company has not completed its initial business combination and there were no share redemptions during the year ended December 31, 2022. The exercise tax will only be applicable to the Company for its taxable years post December 31, 2022. The Company is still in the process of assessing the effects of the exercise tax to its consolidated financial statements.
Net income (loss) per common share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.
The calculation of diluted net income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 9,650,250 shares of Class A Common Stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from inception to December 31, 2022. Accretion associated with the redeemable Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021:
Year ended December 31, 2022
 
Description
   
Class A
     
Class B
  
Basic and diluted net income per common stock:
                  
Numerator:
                  
Allocation of net income
    $ 3,072,757      $ 764,367  
Denominator:
                  
Basic and diluted weighted average common stock outstanding
      11,557,500        2,875,000  
Basic and diluted net income per common stock
    $ 0.27      $ 0.27  
 
F-13
Period from March 5, 2021 (inception) to December 31, 2021
 
Description
   
Class A
     
Class B
  
Basic and diluted net income per common stock:
                  
Numerator:
                  
Allocation of net loss
    $ (916,293 )     $ (966,310 ) 
Denominator:
                  
Basic and diluted weighted average common stock outstanding
      2,726,188        2,875,000  
Basic and diluted net loss per common stock
    $ (0.34 )     $ (0.34 ) 
Concentration of credit risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account.
Fair value of financial instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative financial instruments
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC
480 and ASC 815-15. The classification of
derivative instruments, including whether such instruments
 
F-14
should be recorded as liabilities or
as equity, is re-assessed at the end
of each reporting period. In accordance with ASC
825-10
“Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statements of operations as incurred.
The 5,750,000 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,900,250 Private Placement Warrants are recognized as derivative liabilities in accordance
with ASC 815-40. Accordingly,
the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject
to re-measurement at
each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo or Black-Scholes simulation model at each measurement date. Derivative warrant liabilities are classified
as non-current liabilities as their
liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements
of ASC 340-10-S99-1 and
SEC Staff Accounting Bulletin Topic 5A-
Expenses of offering.
 Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented
as non-operating expenses
in the statements of operations. Offering costs associated with the Class A common stock were charged to stockholders’ deficit upon the completion of the Initial Public Offering.
Class A Common Stock Subject to Possible Redemption
All of the 11,500,000 shares of Class A common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with ASC 480, conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, 11,500,000 shares of Class A common stock subject to possible redemption at the redemption
amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
 
F-15
As of December 31, 2022 and 2021, the common shares reflected on the balance sheets are reconciled in the following table:

 
Gross proceeds from IPO
   
$
 115,000,000  
Less:
         
Proceeds allocated to Public Warrants
      (1,380,000 ) 
Class A common share issuance costs
      (6,309,800 ) 
    
 
 
  
Plus:
         
Accretion of carrying value to redemption value
      8,839,800  
    
 
 
  
Class A common shares subject to redemption at December 31, 2021
   
$
116,150,000
 
    
 
 
  
Plus:
         
Remeasurement to common stock subject to possible redemption amount
      2,242,240  
Class A common shares subject to redemption at December 31, 2022
   
$
118,392,240
 
    
 
 
  
Issued and adopted accounting standards
In August 2020, the FASB issued
ASU 2020-06, Debt-Debt
with Conversion and Other Options
(Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity’s Own Equity
(Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity
(“ASU 2020-06”), which
simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions required for equity-linked contracts to qualify for scope exception. In addition, it simplifies the diluted earnings per share calculation in certain areas.
ASU 2020-06
is effective January 1, 2024 for fiscal years beginning after December 15, 2023 for smaller reporting companies, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021.
 The Company adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have a material impact on the Company’s consolidated financial statements.
Outside of the above, management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s
consolidated
financial
statements
.
NOTE 3. INITIAL PUBLIC
OFFERING
On October 21, 2021, the Company consummated its
Initial
Public Offering of 10,000,000 Units at $10.00 per Unit, generating gross proceeds of $100,000,000. Simultaneously, the underwriters exercised over-allotments, purchasing 1,500,000 additional Units, generating gross proceeds of $15,000,000.
Each Unit consists of one share of Class A Common
Stock, one-half of
one Public Warrant, and one Public Right. Each Public Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $11.50 per share (see Note 7). Each Public Right entitles the holder to
receive one-tenth of
one share of Class A Common Stock upon completion of a Business Combination (see Note 8).
The Company incurred offering costs related to the Initial Public Offering of $6,061,368, of which $1,437,500 was for underwriting fees, $3,737,500 was for deferred underwriting commissions, and $886,368 was for other offering costs.
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased an aggregate of 3,900,250 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($3,900,250 
in the
 
F-16
agg
regate). The excess of the proceeds over the fair value of the Private Placement Warrants has been recognized as a capital contribution from the Sponsor.
Each Private Placement Warrant is exercisable to purchase one share of Class A Common Stock at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Proposed Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Class A Common Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.
On October 21, 2022, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “October 2022 Private Placement Warrants”), generating total proceeds of $1,150,000. The October 2022 Private Placement Warrants were purchased by the Sponsor and are substantially similar to the private placement warrants issued to the Sponsor at the time of IPO in October 2021. The October 2022 Private Placement Warrants have been issued pursuant to and are governed by a Warrant Agreement that is substantially similar to the Warrant Agreement that the Company entered into at the time of the IPO. Similar to the private placement warrants issued at the time of the IPO, the October 2022 Private Placement Warrants will not be transferable, assignable or salable until 30 days after the Company’s initial business combination and, unlike such private placement warrants, are not redeemable by the Company at any time (including following transfer by the Sponsor or its permitted transferees).
The proceeds received by the Company in connection with the issuance of the October 2022 Private Placement Warrants have been deposited in the trust account (the “Trust Account”) established at the time of the IPO. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account on or prior to October 21, 2022 will extend by three months until January 21, 2023, which is the time the Company will have to consummate an initial business combination.
On January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “January 2023 Private Placement Warrants”), generating total proceeds of $1,150,000. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account
 
will extend by another three months until April 21, 2023, which is the time the Company will have to consummate an initial business combination.
NOTE 5. RELATED PARTY TRANSACTIONS
Class B Common Stock
On March 8, 2021, the Company issued an aggregate of 2,875,000 shares of Class B common stock (“Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000 in cash. In addition, such Founder Shares includes an aggregate of up to 375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor and initial stockholders will collectively own 20% of the Company’s issued and outstanding shares after the Proposed Offering (assuming our Sponsor and initial stockholders do not purchase any Class A Common Shares in the Proposed Offering and excluding the Private Placement Warrants and underlying securities).
On March 27, 2021, the Sponsor sold 15,000 Founder Shares to the Chief Financial Officer, Jenny Junkeer, and 10,000 Founder Shares to each of the Company’s three independent directors, Michael Tomczyk, Robin Meister, and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which the Sponsor purchased such Founder Shares from the Company. Thus, after giving effect to the issuance of Founder Shares, our Sponsor and initial stockholders will collectively own approximately 20% of the outstanding common stock following the offering, assuming they do not purchase any units in this offering or the public market.
Additionally, as consideration for financial advisory services rendered in connection with this offering, on March 11, 2021, ARC Capital received 50,000 shares of Class B Common Stock from our Sponsor at a
price of
 
F-17
$0.009 per share. The Founder Shares held by the independent directors and financial advisor are not subject to forfeiture in the event that the underwriters’ over-allotment is not exercised.
The initial stockholders have agreed not to transfer, assign or sell any of the Class B common stock (except to certain permitted transferees) until, with respect to 50% of the Class B common stock, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any
30-trading day
period commencing after a Business Combination, with respect to the remaining 50% of the Class B common stock, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property.
Promissory Notes
On March 8, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Sponsor Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $400,000, of which $141,768 was borrowed by the Company during 2021. The Sponsor Note
was non-interest bearing
and was fully repaid as of December 31, 2021.
On June 16, 2022, an affiliate of the Sponsor issued an unsecured promissory note (“June 2022 Note”) to the Company, pursuant to which the Company borrowed principal amount of $20,000. The June 2022 Note is
non-interest
bearing and matures on the earlier of: i) the consummation of the Company’s initial business combination;
or
 ii) May 15, 2023. As of December 31, 2022, $19,957 remains outstanding on this June 2022 Note.
On August 2, 2022, a company owned by a director of our potential business combination target, issued an unsecured promissory note (“August 2022 Note”), pursuant to which the Company borrowed principal amount of $200,000. The August 2022 Note has an interest rate of 9% per annum and matures on the earlier of: i) the consummation of the Company’s initial business combination;
or
 ii) February 2, 2023.
The Company is currently renewing the August 2022 Note with the lender.
 As 
of December 31, 2022, there was $200,000 outstanding on the August 2022 Note and accrued interest of $7,545.
On October 19, 2022, the Sponsor issued an unsecured promissory note (“October 2022 Note”), pursuant to which the Company borrowed principal amount of $300,000. The October 2022 Note is
non-interest
bearing and matures on May 15, 2023.
Administrative services agreement
The Company’s Sponsor has agreed, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $5,000 per month for these services. For the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021, the Company has paid $30,000 and $20,000 to the Sponsor for these administrative services, respectively. As of December 31, 2022 and 2021,
 
the Company accrued $
30,000 and $nil, respectively, for unpaid administrative services.
Related party loans
To finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or the Company’s officers and directors may, but are not obligated to, loan the Company funds as
 
F-18
may be requir
ed (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants (“Working Capital Warrants”) at a price of $1.50 per Working Capital Warrant. The Working Capital Warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021,
 
there have been no amounts borrowed under
 
the 
Working Capital Loans.
Forward Purchase Agreement
In connection with the IPO, the Company entered into a forward purchase agreement with Caltech Trading Corp., providing for the purchase by Caltech Trading Corp. of an aggregate of 9,000,000 forward purchase units at a purchase price of $10.00 per unit. The purchase of the Forward Purchase Units will occur concurrently and only in connection with the closing of the Business Combination.
The terms and provisions of the forward purchase warrants to be issued as part of the forward purchase units are identical to those of the Private Placement Warrants.
Representative Shares
In connection with the IPO, the Company issued the Representative 57,500 shares upon full exercise of the Over-allotment Option (the “Representative Shares”). The Representative has agreed not to transfer, assign or sell any such Representative Shares without prior consent of the Company until the completion of the initial Business Combination. In addition, the Representative has agreed (i) to waive its redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of the initial Business Combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete the initial Business Combination within 12 months (or up to 18 months, if applicable) from the Closing of the Offering.
The Representative will not sell, transfer, assign, pledge or hypothecate the Representative Shares, or cause the Representative Shares to be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the Representative Shares by any person, for a period of 180 days (pursuant to Rule 5110(e)(1) of the Conduct Rules of FINRA) following the Effective Date to anyone other than (i) the Representative or an underwriter or selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Representative or of any such underwriter or selected dealer. On and after the 181st day following the Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws.
Private Placement Warrants
The Company consummated certain private placement warrants with its Sponsor. Refer to Note 4 for details.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration rights
The holders of shares Class B Common Stock, Private Placement Warrants (and underlying securities), and any securities issued in payment of working capital loans made to the Company will be entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of Proposed Public Offering. The majorit
y
 
of
 these securities holders are entitled to make up to 
two
 demands that the Company registers such
securities.

 
F-19
Notwithstanding anything to the contrary, the underwriters (and/or their designees) may only make a demand registration (i) on one occasion and (ii) during the five-year period beginning on the effective date of the Proposed Public Offering. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these Common Stock are to be released from escrow. The holders of a majority of the Private Placement Warrants (and underlying securities) and securities issued in payment of working capital loans (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. Notwithstanding anything to the contrary, the underwriters (and/or their designees) may participate in a “piggy-back” registration only during the seven year period beginning on the effective date of the Proposed Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Notwithstanding anything to the contrary, under FINRA Rule 5110, the underwriters and/or their designees may only make a demand registration (i) on one occasion and (ii) during the five-year period beginning on the effective date of the registration statement relating to the Proposed Public Offering, and the underwriters and/ or their designees may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the registration statement relating to the Proposed Public Offering.
Underwriting agreement
The Underwriter purchased the 1,500,000 of additional Units to cover over-allotments, less the underwriting discounts and commissions.
The underwriters received a cash underwriting discount
of one and one-quarter percent (1.25%) of
the gross proceeds of the Initial Public Offering, or $1,437,500, as the underwriters’ over-allotment was exercised in full. In addition, upon closing of the Business Combination, the underwriters are entitled to a deferred fee of three and
one-quarter
percent (3.25%) of the gross proceeds of the Initial Public Offering, or $3,737,500, as the underwriters’ over- allotment was exercised in full. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.
Right of First Refusal
For a period beginning on the closing of this offering and ending on the earlier of the twelve (12) month anniversary of the closing of a Business Combination or the three year anniversary of the effective date of the registration statement, we have granted EF Hutton a right of first refusal to act as lead-left book-running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statement
consummating our initial public offering
.
Forward Purchase Agreement
On July 16, 2021, the Company entered into a forward purchase agreement with an anchor investor. Refer to Note 7 below for details.
Business Combination Agreements
Rana Business Combination Agreement
On September 11, 2022, the Company announced that it, with Fama Financial Services, Inc., a Georgia corporation and wholly-owned subsidiary of the Company (“Merger Sub”), Rana Financial Inc., a Georgia
 
F-20
corporation (“Rana”) and David Kretzmer, as representative of the Shareholders (“Shareholder Representative”), had entered into a business combination agreement (the “Rana Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Merger Sub will be merged with and into Rana (the “Merger”), with Rana surviving the Merger as a wholly-owned subsidiary of the Company. The key terms of the Rana Business Combination Agreement are as follows:
Structure of the Rana Business Combination
 
  (a)
The transaction is structured as a reverse triangular merger. Pursuant to the Rana Business Combination Agreement, on the closing date, Merger Sub will be merged with and into Rana, with Rana surviving the Merger (together with the other transactions related thereto, the “Proposed Rana Transactions”) as a wholly-owned direct subsidiary of the Company (the “Surviving Company”).
 
  (b)
At the effective time of the Merger (the “Effective Time”), the certificate of incorporation of Rana, as in effect immediately prior to the Effective Time, shall be the certificate of incorporation of the Surviving Company, until thereafter amended as provided by law and such certificate of incorporation.
 
  (b)
At the Effective Time, the bylaws of Merger Sub, as in effect immediately prior to the Effective Time, shall be the bylaws of the Surviving Company until thereafter amended as provided by law, the certificate of incorporation of the Surviving Company and such bylaws, as applicable.
 
  (c)
At the closing, the Company shall amend and restate, effective as of the Effective Time, its certificate of incorporation to be as set forth in the Rana Business Combination Agreement, pursuant to which the Company shall have a single class structure with shares of Class A common stock, par value $0.0001 per share, having voting rights of one vote per share (the “New Acquiror Class A Common Stock”).
 
  (d)
The Company shall pay a combination of Rana Cash Consideration and Rana Equity Consideration for the Company Common Stock subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $5,711,662 (the “Rana Escrow Amount”).
The Rana Cash Consideration means $7,800,000 and the Rana Equity Consideration means 7,020,000 shares of New Acquiror Class A Common Stock.
Rana Representations, Warranties and Covenants
The Rana Business Combination Agreement contains customary representations, warranties and covenants of Rana, FEXD and Merger Sub, relating to, among other things, their ability to enter into the Rana Business Combination Agreement and their outstanding capitalization. Rana has agreed to customary “no shop” obligations.
Conditions to Rana Closing
Mutual
The obligations of Rana, FEXD and Merger Sub to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Rana Closing, of the following conditions:
 
 
(a)
the Acquiror Proposals have been approved and adopted by the requisite affirmative vote of the stockholders of Acquiror in accordance with the Proxy Statement, the Delaware General Corporation Law, the organizational documents of FEXD and the rules and regulations of Nasdaq;
 
 
(b)
no Governmental Authority has enacted, issued, promulgated, enforced or entered any Law, rule, regulation, judgment, decree, executive order or award which is then in effect and has the effect of making the Proposed Rana Transactions illegal or otherwise prohibiting consummation of the Proposed Rana Transactions, including the Merger; and
 
F-21
  (c)
the shares of New Acquiror Class A Common Stock to be issued in connection with the Proposed Rana Transactions shall have been approved for listing on Nasdaq, and immediately following the Rana Closing Acquiror shall satisfy any applicable listing requirements of Nasdaq and Acquiror shall not have received any notice
of non-compliance therewith.
FEXD and Merger Sub
The obligations of FEXD and Merger Sub to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Rana Closing, of the following additional conditions:
 
  (a)
the representations and warranties of Rana contained in the sections titled (i) Organization and Qualification; Subsidiaries, (ii) Capitalization, (iii) Authority Relative to this Business Combination Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Rana contained in the Rana Business Combination Agreement shall be true and correct (without giving any effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect;
 
  (b)
Rana, the Shareholders and the Shareholder Representative, as applicable, have performed or complied in all material respects with all agreements and covenants required by the Rana Business Combination Agreement to be performed or complied with by each of them on or prior to the Effective Time;
 
  (c)
the Shareholder Representative has delivered to Acquiror the Escrow Agreement, duly executed by the Shareholder Representative;
 
  (d)
Rana has delivered to FEXD a customary officer’s certificate, dated the date of the Rana Closing, certifying as to the satisfaction of certain conditions;
 
  (d)
no Company Material Adverse Effect has occurred between the date of the Rana Business Combination Agreement and the Closing Date;
 
  (e)
on or prior to the Rana Closing, Rana delivered to Acquiror a properly executed certification, in form and substance reasonably acceptable to Acquiror, that the Company Common Stock, capital stock of Enova and capital stock of Fama, as applicable, are not “U.S. real property interests” in accordance with the Treasury Regulations under Sections 897 and 1445 of the Code, together with a notice to the IRS (which will be filed by Acquiror with the IRS following the Rana Closing) in accordance with the provisions
of Section 1.897-2(h)(2) of
the Treasury Regulations;
 
  (f)
Rana has delivered to Acquiror the PCAOB Financials together with an unqualified report therein of the auditors of the Company and its subsidiaries, if applicable, and the PCAOB Financials for periods covered by the Unaudited Financials and Latest Balance Sheet (and the related unaudited consolidated statements of operations and comprehensive loss and cash flows of the Company and its subsidiaries for
the six-month period
then ended) do not differ from those disclosed on the Company Disclosure Schedule;
 
  (g)
all conditions to consummation of the Afinoz Business Combination Agreement have been satisfied or waived by the applicable parties thereto; and
 
F-22
  (j)
the Trust Fund contains funds sufficient to pay the Rana Cash Consideration and the Afinoz Cash Consideration (defined below), in full.
Rana
The obligations of Rana to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to Rana Closing of the following additional conditions:
 
  (a)
the representations and warranties of FEXD and Merger Sub contained in the sections titled (i) Corporation Organization (ii) Capitalization, (iii) Authority Relative to this Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Acquiror and Merger Sub contained in the Rana Business Combination Agreement are true and correct (without giving any effect to any limitation as to “materiality” or “Acquiror Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in an Acquiror Material Adverse Effect;
 
  (b)
FEXD and Merger Sub have performed or complied in all material respects with all agreements and covenants required by the Rana Business Combination Agreement to be performed or complied with by them on or prior to the Effective Time;
 
  (c)
FEXD has delivered to the Shareholder Representative, the Escrow Agreement, duly executed by FEXD; and
 
  (d)
FEXD has delivered to Rana a customary officer’s certificate dated the date of the Rana Closing, certifying as to the satisfaction of certain conditions.
Termination
The Rana Business Combination Agreement may be terminated and the Proposed Rana Transactions may be abandoned at any time prior to the Effective Time, notwithstanding any requisite approval and adoption of the Rana Business Combination Agreement and the Proposed Rana Transactions by the stockholders of Rana or Acquiror, as follows:
 
  (a)
by mutual written consent of Rana and the Company;
 
  (b)
by either FEXD or Rana, if: (i) the Effective Time has not occurred prior to the twelve-month anniversary of the date of the Rana Business Combination Agreement (the “
Rana Outside Date
”); provided, however, that the Rana Business Combination Agreement may not be terminated by or on behalf of any party (A) that either directly or indirectly through its affiliates is in breach or violation of any representation, warranty, covenant, agreement or obligation contained in the Rana Business Combination Agreement and such breach or violation is the principal cause of the failure of a condition to the Proposed Rana Transactions on or prior to the Rana Outside Date, or (B) against which any legal proceeding is brought by a party to the Rana Business Combination Agreement for specific performance or injunctive or other forms of equitable relief in connection with the Rana Business
 
F-23
 
Combination Agreement (which prohibition on such party’s right to terminate the Rana Business Combination Agreement continues throughout the pendency of such legal proceeding); (ii) any Governmental Authority in the United States has enacted, issued, promulgated, enforced or entered any permanent injunction, order, decree or ruling which has become final
and non-appealable and
has the effect of making consummation of the Proposed Rana Transactions, including the Merger, illegal or otherwise prevents or prohibits consummation of the Proposed Rana Transactions or the Merger; or (iii) any of the Acquiror Proposals fail to receive the requisite vote for approval at the Acquiror Stockholders’ Meeting;
 
 
(c)
by FEXD if (i) there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of the Company set forth in the Rana Business Combination Agreement, or if any representation or warranty of the Company has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of the Company specified above would not be satisfied (“
Terminating Company Breach
”); provided, however, that FEXD has not waived such Terminating Company Breach and FEXD and Merger Sub are not then in material breach of their representations, warranties, covenants or agreements in the Rana Business Combination Agreement; provided further, however, that, if such Terminating Company Breach is curable by Rana, FEXD may not terminate the Rana Business Combination Agreement under this provision for so long as the Company continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by FEXD to Rana; (ii) the PCAOB Financials (together with an unqualified report therein of the auditors of Rana and its subsidiaries, if applicable) are not delivered to FEXD by Rana on or before the dates required under the Rana Business Combination Agreement; or (iii) if the PCAOB Financials delivered to Acquiror by the Company for periods covered by the Unaudited Financials and Latest Balance Sheet (and the related unaudited consolidated statements of operations and comprehensive loss and cash flows of the Company and its subsidiaries for the
six-month
period then ended) differ from those disclosed on the Company Disclosure Schedule;
 
 
(d)
by Rana if there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of FEXD and Merger Sub set forth in the Rana Business Combination Agreement, or if any representation or warranty of FEXD and Merger Sub has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of FEXD and Merger Sub specified above would not be satisfied (“
Terminating Acquiror/Merger Sub Breach
”); provided, however, that Rana has not waived such Terminating Acquiror/Merger Sub Breach and Rana is not then in material breach of its representations, warranties, covenants or agreements in the Rana Business Combination Agreement; provided further, however, that, if such Terminating Acquiror/Merger Sub Breach is curable by FEXD and Merger Sub, Rana may not terminate the Rana Business Combination Agreement under this section for so long as FEXD and Merger Sub continue to exercise their reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by Rana to FEXD.
Effect of Termination
If the Rana Business Combination Agreement is terminated, the agreement will forthwith become void, and there will be no liability under the Rana Business Combination Agreement on the part of any party thereto, except as set forth in the Rana Business Combination Agreement or in the case of termination subsequent to a willful material breach of the Rana Business Combination Agreement by a party thereto.
The closing of the Proposed
Rana
Transactions (the “Rana Closing”) will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Rana Business Combination has not been closed.
 
F-24
Afinoz Business Combination Agreement
On September 11, 2022, the Company, announced that it, Fama Financial Services, Inc., a Georgia corporation and wholly owned subsidiary of the Company (“Merger Sub”), Monisha Sahni, Rachna Suneja and Ritscapital, LLC (collectively the “Members”) and Monisha Sahni as representative of the Members (“Member Representative”), had entered into a business combination agreement (the “Afinoz Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Mobitech International LLC, a limited liability company organized in the United Arab Emirates (“Afinoz”) will become as a wholly-owned subsidiary of the Company. The key terms of the Afinoz Business Combination Agreement are as follows:
 
(a)
The transaction is structured as a purchase of limited liability company membership interests. Pursuant to the Afinoz Business Combination Agreement, on the closing date, the Company will purchase the limited liability company membership interests of Afinoz, with Afinoz continuing as a wholly-owned direct subsidiary of the Company (together with the other transactions related thereto, the “Proposed Afinoz Transactions”).
 
(b)
The Company shall pay a combination of Afinoz Cash Consideration and Afinoz Equity Consideration for the Company Membership Interests subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $700,000 (the “Afinoz Escrow Amount”).
The Afinoz Cash Consideration means $5,000,000 and the Afinoz Equity Consideration means 11,500,000 shares of New Acquiror Class A Common Stock.
Afinoz Representations, Warranties and Covenants
The Afinoz Business Combination Agreement contains customary representations, warranties and covenants of Afinoz and FEXD relating to, among other things, their ability to enter into the Afinoz Business Combination Agreement and their outstanding capitalization. Afinoz has agreed to customary “no shop” obligations.
Conditions to Afinoz Closing
Mutual
The obligations of Afinoz and FEXD to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to the Afinoz Closing, of the following conditions:
 
  (a)
the Acquiror Proposals have been approved and adopted by the requisite affirmative vote of the stockholders of Acquiror in accordance with the Proxy Statement, the Delaware General Corporation Law, the organizational documents of FEXD and the rules and regulations of Nasdaq;
 
  (b)
no Governmental Authority has enacted, issued, promulgated, enforced or entered any Law, rule, regulation, judgment, decree, executive order or award which is then in effect and has the effect of making the Proposed Afinoz Transactions illegal or otherwise prohibiting consummation of the Proposed Afinoz Transactions; and
 
  (c)
the shares of New Acquiror Class A Common Stock to be issued in connection with the Proposed Afinoz Transactions shall have been approved for listing on Nasdaq, and immediately following the Closing Acquiror shall satisfy any applicable listing requirements of Nasdaq and Acquiror shall not have received any notice
of non-compliance therewith.
FEXD
The obligations of FEXD to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to the Afinoz Closing of the following additional conditions:
 
  (a)
the representations and warranties of FEXD contained in the sections titled (i) Organization and Qualification; Subsidiaries, (ii) Capitalization, (iii) Authority Relative to this Business Combination
 
F-25
Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Afinoz contained in the Afinoz Business Combination Agreement shall be true and correct (without giving any effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect;
 
  (b)
Afinoz, the Members and Member Representative, as applicable, have performed or complied in all material respects with all agreements and covenants required by the Afinoz Business Combination Agreement to be performed or complied with by each of them on or prior to the Afinoz Closing;
 
  (c)
the Member Representative has delivered to Acquiror the Escrow Agreement, duly executed by the Member Representative;
 
  (d)
Afinoz has delivered to FEXD a customary officer’s certificate, dated the date of the Afinoz Closing, certifying as to the satisfaction of certain conditions;
 
  (e)
no Company Material Adverse Effect has occurred between the date of the Rana Business Combination Agreement and the Closing Date;
 
  (f)
on or prior to the Afinoz Closing, each of the Members shall deliver to Acquiror a properly executed and duly completed Internal Revenue Service
Form W-8BEN;
 
  (g)
on or prior to the Afinoz Closing, each of the Members delivered to Acquiror the relevant ‘Tax residency certificate’ or any other similar requirements/certifications or evidences, as mandated under any of the domestic tax laws of their respective jurisdiction or territory, in order to claim the benefits of
the India-UAE Double
Tax Avoidance Agreement and to establish that no Indian withholding Tax is required to be deducted or withheld from the payment of consideration to such Member;
 
  (h)
Afinoz has delivered to Acquiror the PCAOB Financials required to be delivered under the Afinoz Business Combination Agreement;
 
  (i)
Afinoz has delivered to Acquiror evidence that it has executed certain regulatory filings with either the free-zone authority in the Sharjah Media City Free-Zone of the United Arab Emirates or the United Arab Emirates Ministry of Economy, as required pursuant to the Afinoz Business Combination Agreement;
 
  (j)
the Rana Business Combination Agreement has been consummated;
 
  (k)
the Trust Fund contains funds sufficient to pay the Rana Cash Consideration and the Afinoz Cash Consideration, in full; and
 
  (l)
Acquiror has completed its due diligence exercise on Afinoz and its subsidiaries, and Afinoz and its subsidiaries has resolved to Acquiror’s satisfaction any issues arising therefrom, including but not limited to, confirmation that each of the Members, Afinoz and its subsidiaries, have complied with certain conditions set forth in schedules to the Afinoz Business Combination Agreement.
 
F-26
Afinoz
The obligations of the Members and the Member Representative to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to Closing of the following additional conditions:
 
 
(a)
the representations and warranties of FEXD contained in the sections titled (i) Corporation Organization (ii) Capitalization, (iii) Authority Relative to this Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Acquiror contained in the Afinoz Business Combination Agreement are true and correct (without giving any effect to any limitation as to “materiality” or “Acquiror Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in an Acquiror Material Adverse Effect;
 
 
(b)
FEXD has performed or complied in all material respects with all agreements and covenants required by the Afinoz Business Combination Agreement to be performed or complied with by it on or prior to the Afinoz Closing;
 
 
(c)
FEXD has delivered to the Member Representative, the Escrow Agreement, duly executed by FEXD; and
 
 
(d)
FEXD has delivered to Afinoz a customary officer’s certificate dated the date of the Afinoz Closing, certifying as to the satisfaction of certain conditions.
Termination
The Afinoz Business Combination Agreement may be terminated and the Proposed Afinoz Transactions may be abandoned at any time prior to the Closing, notwithstanding any requisite approval and adoption of the Afinoz Business Combination Agreement and the Proposed Afinoz Transactions by the Members and stockholders of Acquiror, as follows:
 
 
(a)
by mutual written consent of the Acquiror and Member Representative;
 
 
(b)
by either FEXD or the Member Representative, if: (i) the Closing has not occurred prior to the twelve-month anniversary of the date of the Afinoz Business Combination Agreement (the “
Afinoz Outside
Date
”); provided, however, that the Afinoz Business Combination Agreement may not be terminated by or on behalf of any party (A) that either directly or indirectly through its affiliates is in breach or violation of any representation, warranty, covenant, agreement or obligation contained in the Afinoz Business Combination Agreement and such breach or violation is the principal cause of the failure of a condition to the Proposed Afinoz Transactions on or prior to the Afinoz Outside Date, or (B) against which any legal proceeding is brought by a party to the Rana Business Combination Agreement for specific performance or injunctive or other forms of equitable relief in connection with the Afinoz Business Combination Agreement (which prohibition on such party’s right to terminate the Afinoz Business Combination Agreement continues throughout the pendency of such legal proceeding); (ii) any Governmental Authority in the United States has enacted, issued, promulgated, enforced or entered any permanent injunction, order, decree or ruling which has become final and
non-appealable
and has the effect of making consummation of the Proposed Afinoz Transactions, illegal or otherwise
 
F-27
prevents or prohibits consummation of the Proposed Afinoz Transactions; or (iii) any of the Acquiror Proposals fail to receive the requisite vote for approval at the Acquiror Stockholders’ Meeting;
 
 
(c)
by FEXD if: (i) there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of any Member set forth in the Afinoz Business Combination Agreement, or if any representation or warranty of any Member has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of the Members specified above would not be satisfied (“
Terminating Member Breach
”); provided, however, that FEXD has not waived such Terminating Member Breach and FEXD is not then in material breach of its representations, warranties, covenants or agreements in the Afinoz Business Combination Agreement; provided further, however, that, if such Terminating Member Breach is curable by the applicable Member, FEXD may not terminate the Afinoz Business Combination Agreement under this provision for so long as such Member continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by FEXD to the applicable Member; (ii) the PCAOB Financials are not delivered to FEXD by the Member Representative on or before the dates required under the Afinoz Business Combination Agreement; (iii) the Rana Business Combination Agreement is terminated; or (iv) if Afinoz fails to comply, within thirty days of signing the Afinoz Business Combination Agreement, with certain specific conditions precedent set forth in schedules to the Afinoz Business Combination Agreement.
 
 
(d)
by the Member Representative if there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of FEXD set forth in the Afinoz Business Combination Agreement, or if any representation or warranty of FEXD has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of FEXD specified above would not be satisfied (“
Terminating Acquiror Breach
”); provided, however, that Afinoz has not waived such Terminating Acquiror Breach and Afinoz is not then in material breach of its representations, warranties, covenants or agreements in the Afinoz Business Combination Agreement; provided further, however, that, if such Terminating Acquiror Breach is curable by FEXD, Afinoz may not terminate the Afinoz Business Combination Agreement under this section for so long as FEXD continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by Afinoz to FEXD.
Effect of Termination
If the Afinoz Business Combination Agreement is terminated, the agreement will forthwith become void, and there will be no liability under the Afinoz Business Combination Agreement on the part of any party thereto, except as set forth in the Afinoz Business Combination Agreement or in the case of termination subsequent to a willful material breach of the Afinoz Business Combination Agreement by a party thereto.
The Afinoz Closing will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Afinoz Business Combination has not been closed.
Lock-Up Agreements
The Company has entered into the three general forms
of lock-up agreements
described below with stockholders and employees of Rana and Afinoz. The general terms below apply to
all lock-up agreements.
The employee-specific terms apply to the Employee
Stockholder Lock-Up and
Protective Covenant Agreement and the Employee
Optionholder Lock-Up, Unvested
Stock & Protective Covenant Agreement. The employee optionholder-specific terms apply only to the Employee
Optionholder Lock-Up, Unvested
Stock & Protective Covenant Agreement. Capitalized terms used but not otherwise defined in the description of the
lock-up
agreements below have the meanings given to them in the applicable form of
lock-up
agreement.
 
F-28
General Terms
The stockholders and certain employees of Rana and Afinoz that own equity interests have entered into lock-up agreements with Acquiror wherein they have agreed not to Transfer any shares of New Acquiror Class A Common Stock for the period commencing upon the Effective Time and ending one year after the Effective Time, provided, however, that such restriction shall expire if the reported last sale price of New Acquiror Class A Common Stock equals or exceeds $
12.00
per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any
twenty trading days within any thirty-trading day period commencing at least 150 days after the Effective Time.
Such
stockholders and employees have further agreed not to Transfer more than 200,000 Shares during any three-month period until the three-year anniversary of the Effective Date and not to Transfer more than 1,000,000 Shares during a further period thereafter, in each case subject to Permitted Transfers and the termination of restrictions upon expiration or termination of the
applicable lock-up agreement.
Employee-Specific Terms
The lock-up agreements
of certain employees of Rana and Afinoz also contain restrictive covenants regarding confidentiality, conflicts of interest, non-competition,
non-solicitation,
non-inducement
and
non-interference
during a Restricted Period commencing on the Effective Time and ending on the later to occur of (a) the fifth anniversary of the Effective Time and (b) the second anniversary of the date on which the employee’s employment with FEXD and its subsidiaries terminates for any reason.
Employee Optionholder-Specific Terms
The lock-up agreements
of the optionholder employees of Afinoz (“
Employee Optionholders
”) provide that Afinoz options outstanding prior to the Closing will convert into unvested shares of New Acquiror Class A Common Stock at Closing. The resulting Unvested Stock shall be eligible to vest on the following schedule: (a) the first quarter, as of twelve months from the Effective Time; (b) the second quarter, as of twenty-four months from the Effective Time; (c) the third quarter, as of thirty months from the Effective Time and (d) the fourth quarter, as
of thirty-six months
from the Effective Time. If the Employee Optionholder terminates the Employee Optionholder’s employment with FEXD and its subsidiaries, at any time before the Unvested Stock has vested and become Vested Stock, then the Employee Option holder’s Unvested Stock outstanding on the date of termination of employment shall be automatically forfeited. If the Employee Optionholder’s employment with FEXD and its subsidiaries is terminated by FEXD or any of its subsidiaries for Cause at any time before all of the Unvested Stock has vested and become Vested Stock, then all of the Employee Optionholder’s Unvested Stock and Vested Stock shall be automatically forfeited.
Employment Offer Letters
On December 20, 2022, the Company entered into a conditional offer letter with an individual for the position of Chief Marketing Officer of FEXD (the “CMO Offer Letter”). Pursuant to the CMO Offer Letter, the individual will become the Chief Marketing Officer of FEXD on June 1, 2023. The appointment is contingent upon the consummation of the business combination among FEXD, Rana and Afinoz and shareholder approval. Upon effectiveness, the Chief Marketing Officer will receive an annual salary of $
400,000
, up to $
150,000
in performance bonuses with $
15,000
guaranteed, $
200,000
in FEXD stock vesting over
three
years with a
12-month
cliff and standard benefits.
On December 20, 2022, the Company entered into a conditional offer letter with an individual for the position of Chief Executive Officer of Fama Financial Services (the “CEO Offer Letter”). Pursuant to the CEO Offer Letter, the individual will become the Chief Executive Officer of FEXD on June 1, 2023. The appointment is contingent upon the consummation of the business combination among FEXD, Rana and Afinoz and shareholder approval. Upon effectiveness, the Chief Executive Officer will receive an annual salary of $
500,000, a minimum cash
 
F-2
9
bonus of 30 percent of the annual salary year one, 20% percent on year two and 15% from year three onwards (subject to a objective based target bonus of up to 200% of prevailing salary which will be split equally with stocks vested over a period of three years and cash), $50,000 in FEXD stock vesting over three years with a
12-month
cliff and standard
benefits
.
De-SPAC Service agreement
On December 12, 2022, the Company entered a service agreement, effective January 15, 2023, with a
third-party
de-SPAC
service provider. Pursuant to the agreement, the service provider will provide investor relation services to the Company for an initial
12-month
period. The service provider will receive compensation of $90,000 from the Company for its services covering the initial
12-month
period. In addition, the service provider will receive $22,500 worth of shares in the de-SPAC company quarterly, with the value accruing from the effective date of the service agreement.
NOTE 7. DERIVATIVE FINANCIAL INSTRUMENTS
Warrant Liability
Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units, and only whole Public Warrants will trade. The Public Warrants will become exercisable on the date tha
t is 30 days after the completion of the initial Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable, and the Company will not be obligated to issue any shares of Class A common stock upon exercise of a Public Warrant unless Class A common stock issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Public Warrants.
The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, the Company will use its best efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the Public Warrants. The Company will use its reasonable best efforts to maintain the effectiveness of such registration statement and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the Public Warrant agreement. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $11.50 per share of Class A common
stock

F-30
(with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 
60
% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of Class A common stock during the 
10-trading day
period starting on the trading day after to the day
on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $
9.20
 
per share, then the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Description of Securities—Warrants—Public Stockholders’ Warrants—Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the 
higher of the Market Value and the Newly Issued Price, and the $
10.00
 
per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the market value and the Newly Issued Price. 
The Company may call the Public Warrants for redemption:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption, or
the 30-day
redemption period, to each warrant holder; and
 
  •  
if, and only if, the last reported sale price of Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like and for certain issuances of Class A common stock and equity-linked securities as described above) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant holders.
If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and the number of shares of Class A Common Stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances, including in the event of a stock dividend or recapitalization, reorganization, merger, or consolidation. However, the Public Warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period or during any Extension Period, and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
The Private Placement Warrants, including the October 2022 Private Placement Warrants, will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Private Placement Warrants and the Class A Common Stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and
be non-redeemable so
long as they are held by the initial purchasers or their permitted transferees (except as set forth above). If the Private Placement Warrants are held by someone other than th
e

 
F-31
initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Company accounted for the 9,650,250 warrants issued in connection with the Initial Public Offering (including
5,750,000
Public Warrants and
3,900,250
Private Placement Warrants as the underwriters’ over-allotment option was exercised in full) and the 1,150,000 October 2022 Private Placement Warrants in accordance with the guidance contained in
ASC 815-
40.
Su
ch guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The warrant agreement contains an Alternative Issuance provision that if less than 
70
% of the consideration receivable by the holders of the Class A Common Stock in the Business Combination is payable in the form of common equity in the successor entity, and if the holders of the warrants properly exercise the warrants within thirty days following the public disclosure of the consummation of Business Combination by the Company, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration paid to holders of the common stock consists exclusively of cash, the amount of such cash per common stock, and (ii) in all other cases, the volume-weighted average price of the common stock as reported during
the ten-trading day
period ending on the trading day prior to the effective date of the Business Combination.
The Company believes that the adjustments to the exercise price of the warrants are based on a variable that is not an input to the fair value of
a “fixed-for-fixed” option
as defined under FASB ASC Topic
No
. 
815
–
40
, and thus the warrants are not eligible for an exception from derivative accounting. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon closing the Proposed Public Offering. Accordingly, the Company will classify its Public Warrant, Private Placement Warrant as a liability at its fair value, and the warrants will be estimated using a valuation model prepared by an outside valuation firm. The valuation model uses inputs such as assumed share prices, volatility, discount factors, and other assumptions and may not reflect the price at which they can be settled. This liability is subject to remeasurement at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.
Forward Purchase Agreement
On July 
16
,
2021
, the Company entered into a forward purchase agreement (the “Forward Purchase Agreement”) with Caltech Trading Corp., an anchor investor. Pursuant to the Forward Purchase Agreement, Caltech Trading Corp. will agree to purchase a minimum of 
8,000,000
 units and a maximum of 
9,000,000
 units (the “Forward Purchase Units”), with each Forward Purchase Unit consisting of
one
share of Class A common stock (a “Forward Purchase Share”),
one
right to
receive one-tenth (1/10)
of
one
share of its Class A common stock (a “Forward Purchase Right”)
and one-half of
one
warrant to purchase
one
share of Class A common stock (a “Forward Purchase Warrant”), at a price of $
10.00
 per Forward Purchase Unit, for a minimum aggregate purchase price of $
80.0
 million and a maximum aggregate purchase price of up to $
90.0
 million. The shares of Class A common stock to be issued under the Forward Purchase Agreement will have
no
redemption rights and
no
right to liquidate distributions from the Trust Account. The Forward Purchase Shares, the Forward Purchase Rights and Forward Purchase Warrants will be identical to the shares of Class A Common Stock, the Public Rights, and the Public Warrants, respectively, included in the Public Units to be sold in the Proposed Offering. The purchase of the Forward Purchase Units will occur concurrently and only in connection with the closing of the Business Combination. The Forward Purchase Shares, Forward Purchase Rights and Forward Purchase
 
F-32
Warrants (and the shares of Class A common stock underlying such securities) are subject to registration rights. Caltech’s Trading commitment under the Forward Purchase Agreement is subject to customary closing conditions, including that the Business Combination must be consummated substantially concurrently with the purchase of the Forward Purchase Units. The obligations of Caltech Trading under the Forward Purchase Agreement do not depend on whether any Class A common shares held by public shareholders are redeemed by the Company.
The Company accounted for the Forward Purchase Agreement in accordance with the guidance
in ASC 815-40 and accounts
for such agreement as a derivative liability. The liability is subject to
re-measurement
at each balance sheet date, with changes in fair value recognized in the statements of operations.
NOTE 8. FAIR VALUE OF FINANCIAL INSTRUMENTS
The following table presents information about the Company’s derivative warrant liabilities and forward purchase agreement liability that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:
As of December 31, 2022
 
Description
   
Quoted Prices in
Active Markets
(Level 1)
     
Significant Other
Observable Inputs
(Level 2)
     
Significant Other
Unobservable Inputs
(Level 3)
  
Public Warrants
    $ 402,500      $ —        $ —    
Private Placement Warrants
      —          353,518        —    
Forward Purchase Agreement Liability
      —          —          285,567  
    
 
 
     
 
 
     
 
 
  
Total
    $ 402,500      $ 353,518      $ 285,567  
As of December 31, 2021
 
Description
   
Quoted Prices in
Active Markets
(Level 1)
     
Significant Other
Observable Inputs
(Level 2)
     
Significant Other
Unobservable Inputs
(Level 3)
  
Public Warrants
    $ —        $ —        $ 2,185,000  
Private Placement Warrants
      —          —          1,521,098  
Forward Purchase Agreement Liability
      —          —          1,726,908  
    
 
 
     
 
 
     
 
 
  
Total
    $ —        $ —        $ 5,433,006  
The estimated fair value of the Forward Purchase Agreement is determined using Level 3 inputs. Inherent in a Monte Carlo or Black-Scholes simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on
the U.S. Treasury zero-coupon yield curve on
the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
 
F-33
The change in the fair value of the derivative liabilities, measured using level 3 inputs, for the year ended December 31, 2022
 
and for the period from March 5, 2021 (inception) through December 31, 2021, is summarized as follows:
 
Derivative liabilities – level 3, at March 5, 2021 (inception)
  
$
 —  
 
Issuance of public warrants, private placement warrants, forward purchase agreement – level 3
  
  
3,894,740
 
Change in fair value
  
 
1,538,266
 
  
 
 
 
Derivative liabilities – level 3, at December 31, 2021
  
$
5,433,006
 
Transfer of public warrants to level 1 measurement
  
 
(2,185,000
) 
Transfer of private placement warrants to level 2 measurement
  
 
(1,521,098
) 
Change in fair value
  
 
(1,441,341
) 
  
 
 
 
Derivative liabilities – level 3, at December 31, 2022
  
$
285,567
 
  
 
 
 
The following table presents information about the Company’s liabilities that are measured at fair value at October 21, 2021 (Initial Public Offering date):
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      6.5 %      6.5 %      6.5 % 
Expected term
      5.75 years       5.75 years       0.75 year  
Risk-free rate
      1.33 %      1.33 %      0.09 % 
Probability of acquisition
      100.0 %      100.0 %      100.0 % 
Dividend yield
      0 %      0 %      0 % 
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2021:
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      8.4 %      8.4 %      8.4 % 
Expected term
      5.56 years       5.56 years       0.56 year  
Risk-free rate
      1.30 %      1.30 %      0.21 % 
Probability of acquisition
      100.0 %      100.0 %      100.0 % 
Dividend yield
      0 %      0 %      0 % 
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2022:
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      4.6 %      4.6 %      5.2 % 
Expected term
      5.06 years       5.06 years       0.06 year  
Risk-free rate
      3.91 %      3.91 %      4.04 % 
Probability of acquisition
      7.5 %      7.5 %      7.5 % 
Dividend yield
      0 %      0 %      0 % 
 
F-34
The following table provides a summary of the changes in the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis:
 
 
  
Private
Placement
warrants
 
  
Public
Warrants
 
  
Total
Warrant
Liability
 
  
Forward
Purchase
Agreement
 
Fair value as of March 5, 2021 (inception)
    $ —        $ —        $ —        $ —    
Issuance of Public Warrants, Private Warrants upon IPO
   
 

 1,014,065     
 

 1,380,000     
 

 2,394,065     
 

 —    
Signing of Forward Purchase Agreement upon IPO
      —          —          —          1,500,675  
Change in fair value
      507,033        805,000        1,312,033        226,233  
    
 
 
     
 
 
     
 
 
     
 
 
  
Fair value as of December 31, 2021
    $ 1,521,098      $ 2,185,000      $ 3,706,098      $ 1,726,908  
Issuance of Private Warrants
      80,500        —          80,500        —    
Change in fair value
      (1,248,080 )       (1,782,500 )       (3,030,580 )       (1,441,341 ) 
    
 
 
     
 
 
     
 
 
     
 
 
  
Fair value as of December 31, 2022
    $ 353,518      $ 402,500      $ 756,018      $ 285,567  
    
 
 
     
 
 
     
 
 
     
 
 
  
NOTE 9. STOCKHOLDER’S EQUITY
Preferred Shares
The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At December 31, 2022 and 2021, there were no preferred shares issued or outstanding.
Class A Common Stock
The Company is authorized to issue 200,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 57,500 Class A Common Stock issued and outstanding excluding 11,500,000 shares subject to redemption.
Class B Common Stock
The Company is authorized to issue 20,000,000 shares of Class B Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class B Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 2,875,000 shares of Class B Common Stock issued and outstanding. Class B common stock will automatically convert into shares of Class A common stock at the time of the initial business combination
on a 
one-for-one
 basis.
Public Rights
Each holder of a Public Right will be entitled to
receive one-tenth (1/10) of
 
one share of Class A Common Stock upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon the exchange of the Public Rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination as the consideration related thereto has been included in the unit purchase price paid for by investors in the Proposed Offering. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the Class A Common Stock will receive in the transaction on
an as-converted into
Class A Common Stock
 
F-35
basis and each holder of a right will be required to affirmatively convert its rights in order to receive 1/10 share underlying each right (without paying additional consideration). The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company).
NOTE 10. INCOME TAX
The Company’s net deferred tax assets are as follows:

 
 
  
December 31,
2022
 
  
December 31,
2021
 
Deferred tax asset
                  
Start-up
costs
    $ 187,396      $ 29,691  
Net operating loss
      —          21,704  
    
 
 
     
 
 
  
Total deferred tax asset
      187,396        50,765  
    
 
 
     
 
 
  
Valuation allowance
      (187,396 )       (50,765 ) 
    
 
 
     
 
 
  
Deferred tax asset, net of allowance
    $ —        $ —    
    
 
 
     
 
 
  
The income tax provision consists of the following:

 
    
For the year
ended
December 31,

2022
     
From March 5, 2021
(inception) through
December 31,

2021
  
Federal
                  
Current
    $ 290,342      $ —    
Less:
                  
Loss carryforward
                  
Deferred
      (136,631 )       (50,765 ) 
State
                  
Current
      —          —    
Deferred
      —          —    
Change in valuation allowance
      136,631        50,765  
Income tax provision
    $ 290,342      $ —    
As of December 31, 2022, the Company has $nil of U.S. federal net operating loss carryovers.
In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2022 and for the period from March 5 (inception) through to December 31, 2021, the change in the valuation allowance was $136,631 and $50,765, respectively.
 
F-36
A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and 2021 is as follows:
 
 
  
December 31,
2022
 
 
December 31,
2021
 
Statutory federal income tax rate
      21 %      21 % 
Transaction costs associated with the Initial Public Offering
      6 %      (1 )% 
Change in valuation allowance
      3 %      (3 )% 
Change in fair value of warrant liabilities and forward purchase agreement
      (23 )%     (17 )% 
 
 
 
 
 
 
 
 
 
Income tax provision
      7 %      0 % 
Income tax is generally
open
for three years
for
examination by IRS.
NOTE 11. SUBSEQUENT EVENTS
In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued. Based on this review, except the event below, the Company did not identify any subsequent events through the date of the issuance of the
consolidated
financial statements that would have required disclosure or adjustment in the
consolidated
financial statements:
O
n January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “January 2023 Private Placement Warrants”), generating total proceeds of $1,150,000. The January 2023 Private Placement Warrants were purchased by the Sponsor and are substantially similar to the private placement warrants issued to the Sponsor at the time of IPO in October 2021. The January 2023 Private Placement Warrants have been issued pursuant to and are governed by a Warrant Agreement that is substantially similar to the Warrant Agreement that the Company entered into at the time of the IPO. Similar to the private placement warrants issued at the time of the IPO, the January 2023 Private Placement Warrants will not be transferable, assignable or salable until 30 days after the Company’s initial business combination and, unlike such private placement warrants, are not redeemable by the Company at any time (including following transfer by the Sponsor or its permitted transferees).
The proceeds received by the Company in connection with the issuance of the January 2023 Private Placement Warrants have been deposited in the trust account (the “Trust Account”) established at the time of the IPO. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account on or prior to January 21, 2023 will extend by three months until April 21, 2023, the time the Company will have to consummate an initial business combination.
On January 20, 2023, the Company entered into a $200,000 promissory note (the “January 2023 Note”) with its Sponsor. The January 2023 Note is
non-interest
bearing and has a maturity date on the earlier of: (i) the Initia
l
 Business Combination date; and (ii) July 15, 2023.
On April 10, 2023, timely, pursuant to the terms of the Rana Business Combination Agreement dated September 9, 2022, the Company sent a letter to Rana Financial, Inc. regarding its failure to deliver audited financial statements.
The Company also notified Rana of its intent to propose the termination of the Rana Business Combination Agreement and abandonment of the proposed business combination if the audited financial statements are not delivered to the Company by April 21, 2023.
 
F-37
On April 20, 2023, the Company held a special meeting of stockholders in lieu of its 2023 annual meeting to consider and vote upon (a) a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company has to consummate its initial business combination for a maximum of twelve (12) additional one month periods, from April 21, 2023 to April 21, 2024, or such earlier date as determined by its board of directors and (b) a proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the aforementioned extension. In connection with this vote, the Company expects that eighty (80) holders will redeem an aggregate of 7,527,997 shares of the Company at an estimated redemption price of $10.48 per share or $78,893,408.56 in the aggregate.
 
F-38

Table of Contents

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal year ended December 31, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were not effective during the period covered by this report due to the material weaknesses in our internal controls over financial reporting discussed below.

Management’s Report on Internal Controls over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over our financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework. A material weakness is a deficiency or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. We have identified the following material weaknesses as of December 31, 2022: (i) lack of proper segregation of duties due to the Chief Executive Officer’s ability to approve invoices and prepare and approve payments; (ii) lack of review controls over financial reporting, including formal accounting policies, procedures and controls over significant financial statement accounts and disclosures to achieve complete, accurate and timely financial accounting, reporting and disclosures, resulting in adjustments to several accounts and disclosures; (iii) lack of review controls over related party transactions, which resulted in related party loans not being approved by the board of directors; and (iv) ineffective oversight on the part of our audit committee. We will devote resources to remediate these material weaknesses as we grow and such resources required for implementing proper internal controls for financial reporting are available.

Because of these material weaknesses, management has concluded that we did not maintain effective internal control over financial reporting as of December 31, 2022, based on the criteria established in “2013 Internal Control-Integrated Framework” issued by COSO.

This Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended December 31, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information.

None.

 

1

Table of Contents

PART III

Item 10. Directors, Executive Officers and Corporate Governance.

The following table sets forth certain information with respect to our directors, executive officers and significant employees:

 

Name

   

Age

   

Position

Saiful Khandaker    58    Chief Executive Officer
Jenny Junkeer    42    Chief Financial Officer
Mubassir Karim    25    Director
Michael S. Tomczyk    73    Director
Robin Meister    64    Director
Lynn Perkins    60    Director

Dr. Saiful Khandaker

Dr. Khandaker was the Group Chief Executive Officer and Founder of FAMA Holdings, Inc., a global developer of FinTech platforms, applications and services established in 2009. FAMA is based in the U.S. with offices in the U.K., India, Bangladesh and Zambia. Dr. Khandaker also led the development of the FAMACASH™ network, a global FinTech ecosystem that is integrating blockchain, artificial intelligence and cloud computing technologies to provide fast, affordable mobile money services in under-served countries such as Bangladesh. To implement the FAMACASH network, Dr. Khandaker has negotiated partnerships and joint ventures with financial service providers and technology leaders in many countries, including a joint venture with Sonali Bank, the national bank of Bangladesh. This joint venture provides a mobile wallet called SonaliPay™ that enables Bangladeshi diaspora workers to use smartphones and laptops to send money to Bangladesh. Dr. Khandaker has also led the development of a stablecoin product called REMIT™ to facilitate cross-border money transfers, as well as a cross-border e-wallet called AfriPay™ to help Africans working overseas, and a neo-bank for Muslim workers called Tohura™.

Before founding FAMA, Dr. Khandaker spent more than two decades leading the development of software solutions for Fortune 100 companies as well as startups. He designed the architecture and managed networks that provided airline flight scheduling for Delta Airlines, cellular billing applications for AT&T and BellSouth, and network management software for Cox Communications; and established and managed GE’s outsourcing operation in Bangladesh. He also helped numerous clients modernize their FinTech services as Chief Technology Officer at Mi3. Since 2018 he has served as President of the U.S.-Bangladesh Technology Association of North America.

Dr. Khandaker has received numerous industry awards including a top innovation award from the Wireless Technology Forum, a top 40 software company award from the Technology Association of Georgia, and the National FinTech Award in Bangladesh. He has conducted seminars and workshops on cross-border payments and Blockchain systems for bank executives and regulators and senior decision makers across industries. He holds a Doctor of Management degree in Organizational Leadership from University of Phoenix, a Master of Science degree in Technology Management from Mercer University, Stetson School of Business and Economics, and a Bachelor of Science degree in Computer Information Systems from DeVry University.

Jenny Junkeer

Jenny Junkeer is a Chartered Accountant with over 17 years’ experience in financial management and consulting. As CEO of Junkeer New Era Consulting, she leads a team of consultants specializing in helping companies launch and optimize business operations in fast-changing industries. Her clients range from small and medium enterprises to large multi-nationals. As a senior level consultant in business acceleration, Jenny has extensive

 

2

Table of Contents

experience helping organizations scale their operations to maximize value. Jenny is an Adjunct Association Professor at Deakin University in Melbourne, Australia, a Board Member of the Global Health Initiative Foundation, and Director of Implementation at ConnectCV. She holds a Bachelor of Commerce Degree (Honors) from Monash University.

Non-Executive Directors

Mubasshir Karim

Along with Saiful Khandaker, Mubasshir Karim will serve as one of our two non-independent directors. Mr. Karim is the Director of Operations at FAMA and has managed global cross-functional teams in the UK, India, Bangladesh, and Zambia for technical development, sales, marketing, and customer support functions. Mubasshir is experienced with third-party application programing interface integrations, the development of blockchain cross-border payment systems, and the development of identity management solutions. He is a certified project management professional, has a Bachelor of Science degree in Computer Science from Wichita State University, and is pursuing an Executive Master of Business Administration from Ohio University.

Michael S. Tomczyk

Michael S. Tomczyk will serve as one of our three independent directors. He is an authority on best practices and strategies for managing emerging technologies and applications. For 18 years he led innovation initiatives at the prestigious Wharton School at the University of Pennsylvania as Managing Director of the Mack Institute for Innovation Management, Mack Center for Technological Innovation and Emerging Technologies Research Program. He also served as Innovator in Residence at Villanova University and was a member of the Advanced Computing committee at Temple University. For ten years he was a member of the Translational Medicine Committee at the University of Pennsylvania Medical School. His degrees include an Masters of Business Administration from UCLA, a Masters in Environmental Studies from the University of Pennsylvania, and a BA in literature and journalism from the University of Wisconsin-Oshkosh. He was a captain in the United States Army, where he was awarded the Bronze Star.

Robin Meister

Robin Meister will also serve as one of our three independent directors. Ms. Meister is a seasoned C-Suite executive with extensive expertise in global financial services, risk management and regulation. Robin understands the regulatory challenges and opportunities facing the financial services industry, with special expertise helping businesses to navigate complex regulatory challenges. She has extensive experience in international sanctions, regulatory regimes, and money laundering safeguards. She spent over 20 years in senior management positions at BNP Paribas, and prior to her retirement, was the Head of U.S. Regulatory Affairs for the global asset management division. Her wide-ranging experience includes managing compliance, risk, and legal functions in the United States, Asia-Pacific and European Union. Robin has served as a director on the boards of global asset management companies as well as public and private funds. She was recently appointed to the board of a dedicated multi-strategy family of funds for California based government pension plans. She is experienced in managing critical issues facing the governance, audit, and risk committees of boards of directors. She began her career as a futures trader and currently teaches financial services regulation to law students as an adjunct faculty member of New York Law School. Robin earned a Juris Doctor degree from New York Law School, a BS in Finance and BA in Economics from State University of New York.

Lynn Perkins

Lynn Perkins will serve alongside Michael Tomczyk and Robin Meister as an independent director. Ms. Perkins is an accomplished senior executive with extensive experience as a chief financial officer, chief operating officer and chief administrative officer at major asset management businesses and global investment banks. Her

 

3

Table of Contents

expertise includes growth management, strategic planning and modeling, organizational development, and management of financial systems and processes. For seven years she served as Chief Financial Officer/Senior Vice President at First Eagle Investment Management, based in New York. Previously she was Managing Director, Global Chief Operating Officer, Asset Management Distribution and Marketing at Credit Suisse (New York), and Founding Partner and Chief Administrative Officer at Perella Weinberg Partners. For 20 years she held a variety of senior management positions at Morgan Stanley, including Chief Operating Officer, Investment Banking Division and Head of Institutional Liquidity Sales. As a business leader, Lynn is known for her integrity, work ethic and empathy. She holds a BA in Accounting and Economics from the University of North Carolina. She is a Board Member at CMC Berkshires.

There are no agreements or understandings between any of our executive officers or directors and any other person pursuant to which such executive officer or director was selected to serve as a director or executive officer of our Company. Directors are elected until their successors are duly elected and qualified. There are no family relationships among our directors or officers.

Director Qualifications

We seek directors with established strong professional reputations and experience in areas relevant to the strategy and operations of our businesses. We seek directors who possess qualities such as integrity and candor, who have strong analytical skills and who are willing to engage management and each other in a constructive and collaborative fashion. We also seek directors who have the ability and commitment to devote significant time and energy to service on our board and its committees. We believe that all of our directors meet the foregoing qualifications.

Director Independence

Our Board has affirmatively determined that Lynn Perkins, Robin Meister, and Michael Tomczyk are independent directors under applicable Nasdaq rules. As a result, our Board is composed of a majority of independent directors.

Board Committees

Audit Committee

Our audit committee is composed of Lynn Perkins, Robin Meister and Michael Tomczyk. Lynn Perkins will serve as chair of the audit committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least three members on the audit committee. The rules of the Nasdaq and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. Each of Lynn Perkins, Robin Meister and Michael Tomczyk qualifies as an independent director under applicable rules. Each member of the audit committee is financially literate and our board of directors has determined that Lynn Perkins, Robin Meister and Michael Tomczyk qualifies as an “audit committee financial expert” as defined in applicable SEC rules. We have adopted an audit committee charter, which details the principal functions of the audit committee, including:

 

  •  

the appointment, compensation, retention, replacement, and oversight of the work of the independent registered accounting firm and any other independent registered public accounting firm engaged by us;

 

  •  

pre-approving all audit and non-audit services to be provided by the independent registered accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;

 

  •  

reviewing and discussing with the independent registered accounting firm all relationships the auditors have with us in order to evaluate their continued independence;

 

4

Table of Contents
  •  

setting clear hiring policies for employees or former employees of the independent registered accounting firm;

 

  •  

setting clear policies for audit partner rotation in compliance with applicable laws and regulations;

 

  •  

obtaining and reviewing a report, at least annually, from the independent registered accounting firm describing (i) the independent registered accounting firm’s internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within, the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;

 

  •  

reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and

 

  •  

reviewing with management, the independent registered accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our consolidated financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.

Compensation Committee

Our Compensation Committee consists of Robin Meister, Lynn Perkins, and Michael Tomczyk. Robin Meister will serve as chair of the compensation committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least two members on the compensation committee, all of whom must be independent. Each of Lynn Perkins, Robin Meister and Michael Tomczyk qualifies as an independent director under applicable rules.

We adopted a compensation committee charter, which details the principal functions of the compensation committee, including:

 

  •  

reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;

 

  •  

reviewing and approving the compensation of all of our other executive officers;

 

  •  

reviewing our executive compensation policies and plans;

 

  •  

implementing and administering our incentive compensation equity-based remuneration plans;

 

  •  

assisting management in complying with our proxy statement and annual report disclosure requirements;

 

  •  

approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees;

 

  •  

producing a report on executive compensation to be included in our annual proxy statement; and

 

  •  

reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.

The charter also states that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by the Nasdaq and the SEC.

 

5

Table of Contents

Nominating and Corporate Governance Committee

Our nominating and corporate governance committee consists of Michael Tomczyk, Robin Meister and Lynn Perkins. Michael Tomczyk will serve as chair of the nominating and corporate governance committee.

The primary purposes of our nominating and corporate governance committee is to assist the board in:

 

  •  

identifying, screening and reviewing individuals qualified to serve as directors and recommending to the board of directors candidates for nomination for election at the annual meeting of stockholders or to fill vacancies on the board of directors;

 

  •  

developing, recommending to the board of directors and overseeing implementation of our corporate governance guidelines;

 

  •  

coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of the company; and

 

  •  

reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary.

The nominating and corporate governance committee is governed by a charter that complies with the rules of the Nasdaq.

Director Nominations

Our nominating and corporate governance committee will recommend to the board of directors candidates for nomination for election at the annual meeting of the stockholders. The board of directors will also consider director candidates recommended for nomination by our stockholders during such times as they are seeking proposed nominees to stand for election at the next annual meeting of stockholders (or, if applicable, a special meeting of stockholders).

We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our stockholders. Prior to our initial business combination, holders of our public shares will not have the right to recommend director candidates for nomination to our board of directors.

Compensation Committee Interlocks and Insider Participation

None of our executive officers currently serves, and in the past year has not served, as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving on our board of directors.

Code of Ethics

We have adopted a Code of Ethics applicable to our directors, officers and employees. You will be able to review these documents by accessing our public filings at the SEC’s website at www.sec.gov. In addition, a copy of the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 8-K. See “Where You Can Find Additional Information.”

Conflicts of Interest

Each of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to another entity pursuant to which such officer or director is or will be required to

 

6

Table of Contents

present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor these fiduciary obligations under applicable law. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our business combination. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue.

Below is a table summarizing the entities to which our executive officers, directors and director nominees currently have fiduciary duties, contractual obligations or other material management relationships:

 

Individual

   

Entity

   

Entity’s Business

   

Affiliation

Dr. Saiful Khandaker    N/A    N/A    N/A
Jenny Junkeer    Junkeer Pty Ltd    Business consulting    CEO
Mubasshir Karim   

Fama Financial Holdings, Inc.

    Mobile financial services   

Director of Operations and Board Member

Michael S. Tomczyk    N/A    N/A    N/A
Robin Meister    N/A    N/A    N/A

Lynn Perkins

   

N/A

   

N/A

   

N/A

Potential investors should also be aware of the following other potential conflicts of interest:

 

  •  

None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities.

 

  •  

In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented. For a complete description of our management’s other affiliations, see “Management—Directors and Executive Officers.”

 

  •  

Our sponsor subscribed for founder shares prior to the date of this annual report and will purchase private placement shares in a transaction that will close simultaneously with the closing of this offering. On March 27, 2021, our sponsor sold 15,000 founder shares to our Chief Financial Officer, Jenny Junkeer, and 10,000 founder shares to each of our three independent directors, Michael Tomczyk, Robin Meister and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which our sponsor purchased such founder shares from us. The founder shares held by our independent directors are not subject to forfeiture in the event that the underwriters’ over-allotment is not exercised. Our sponsor and each of the initial stockholders have entered into a letter agreement with us, pursuant to which it has agreed to waive (i) its redemption rights with respect to all shares of our common stock then owned by it in connection with the completion of our initial business combination and (ii) its rights to liquidating distributions from the trust account with respect to its founder shares and private placement warrants if we fail to complete our initial business combination within 18 months from the effective date of the registration statement consummating our initial public offering (although its will be entitled to liquidating distributions from the trust account with respect to any public shares it holds if we fail to complete our business combination within the prescribed time frame). If we do not complete our initial business combination within the allotted time period, the proceeds of the sale of the private placement warrants will be used to fund the redemption of our public

 

7

Table of Contents
 

shares, and the private placement warrants will expire worthless. Except for transfers to permitted transferees, the founder shares will not be transferable, assignable or salable by our sponsor until the earlier of (i) the first anniversary of the completion of our initial business combination and (ii) the date on which we complete a liquidation, merger, stock exchange or other similar transaction after our initial business combination that results in all of our public stockholders having the right to exchange their shares of common stock for cash, securities or other property. The private placement warrants cannot be transferred (except to certain permitted transferees) until the completion of our initial business combination. Given these characteristics of certain of our securities held by our sponsor, our sponsor may have a conflict of interest with respect to whether a particular target business is an appropriate business with which to effectuate our initial business combination.

 

  •  

Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.

 

  •  

Our sponsor, officers or directors may have a conflict of interest with respect to evaluating a business combination and financing arrangements as we may obtain loans from our sponsor or an affiliate of our sponsor or any of our officers or directors to finance transaction costs in connection with an intended initial business combination.

The conflicts described above may not be resolved in our favor. In general, officers and directors of a corporation incorporated under the laws of the State of Delaware are required to present business opportunities to a corporation if:

 

  •  

the corporation could financially undertake the opportunity;

 

  •  

the opportunity is within the corporation’s line of business; and

 

  •  

it would not be fair to the corporation and its stockholders for the opportunity not to be brought to the attention of the corporation.

Accordingly, as a result of multiple business affiliations, our officers and directors may have similar legal obligations relating to presenting business opportunities meeting the above-listed criteria to multiple entities. Furthermore, our amended and restated certificate of incorporation will provide that the doctrine of corporate opportunity will not apply with respect to any of our officers or directors in circumstances where the application of the doctrine would conflict with any fiduciary duties or contractual obligations they may have. We do not believe that these contractual obligations will materially affect our ability to complete our business combination. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue.

We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors. In the event we seek to complete our initial business combination with such a company, we, or a committee of independent directors, would obtain an opinion from an independent investment banking firm which is a member of FINRA, or from an independent accounting firm, that such an initial business combination is fair to our company from a financial point of view. In the event that we submit our initial business combination to our public stockholders for a vote, our sponsor has agreed to vote all shares of our common stock having voting rights that it then owns in favor of our initial business combination.

Limitation on Liability and Indemnification of Officers and Directors

Our amended and restated certificate of incorporation will provide that our officers and directors will be indemnified by us to the fullest extent authorized by Delaware law, as it now exists or may in the future be

 

8

Table of Contents

amended. In addition, our amended and restated certificate of incorporation will provide that our directors will not be personally liable for monetary damages to us for breaches of their fiduciary duty as directors, except to the extent such exemption from liability or limitation thereof is not permitted by the DGCL.

We will enter into agreements with our officers and directors to provide contractual indemnification in addition to the indemnification provided for in our amended and restated certificate of incorporation. Our bylaws also permit us to maintain insurance on behalf of any officer, director or employee for any liability arising out of his or her actions, regardless of whether Delaware law would permit such indemnification. We will obtain a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.

These provisions may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action, if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.

We believe that these provisions, the directors’ and officers’ liability insurance and the indemnification agreements are necessary to attract and retain talented and experienced officers and directors.

Involvement in Certain Legal Proceedings

None.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Exchange Act requires our executive officers and directors and persons who own more than ten percent of a registered class of the Company’s equity securities to file reports of ownership and changes in ownership with the Securities and Exchange Commission. Executive officers, directors and ten-percent stockholders are required by SEC regulation to furnish the Company with copies of all Section 16(a) forms they file. Our executive officers and directors and persons who own more than ten percent of our common stock failed to file a Form 3 upon becoming a Section 16 filer.

Item 11. Executive Compensation.

On March 27, 2021, our sponsor sold 15,000 founder shares to our Chief Financial Officer, Jenny Junkeer, and 10,000 founder shares to each of our three independent directors, Michael Tomczyk, Robin Meister and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which our sponsor purchased such founder shares from the company. The founder shares held by our independent directors are not subject to forfeiture in the event that the underwriters’ over-allotment is not exercised. None of our executive officers or director nominees have received any cash compensation for services rendered to us. Commencing on the effective date of the registration statement consummating our initial public offering through the 18 months (upon our election to extend the initial 12-month term for two additional three month terms) after such effective date or the consummation of our initial business combination, we will pay our sponsor $5,000 per month for providing us with office space, utilities, secretarial and administrative services. However, this arrangement is solely for our benefit and is not intended to provide our officers or directors compensation in lieu of a salary. Our sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no limit on the amount of out-of-pocket expenses reimbursable by us; provided, however, that to the extent such expenses exceed the available proceeds not deposited in the trust account, such expenses would not be reimbursed by us unless we consummate an initial

 

9

Table of Contents

business combination. Our audit committee will review and approve all reimbursements and payments made to our sponsor, officers, directors or our or their respective affiliates, with any interested director abstaining from such review and approval.

Other than the $5,000 per month administrative fee for office space, utilities, secretarial and administrative services, and the reimbursement for out-of-pocket expenses, no compensation or fees of any kind will be paid to our sponsor, members of our management team or their respective affiliates, for services rendered prior to or in connection with the consummation of our initial business combination (regardless of the type of transaction that it is).

After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting, management or other fees from the combined company. All of these fees will be fully disclosed to stockholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our stockholders in connection with a proposed business combination. It is unlikely the amount of such compensation will be known at the time, because the directors of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will be determined by a compensation committee consisting solely of independent directors.

We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain with us after the initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The following table sets forth information regarding the beneficial ownership of our common stock as of the date of this annual report, and as adjusted to reflect the sale of our common stock included in the units offered by our initial public offering prospectus, and assuming no purchase of units in this offering, by:

 

  •  

each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;

 

  •  

each of our executive officers, directors and director nominees; and

 

  •  

all our executive officers, directors and director nominees as a group.

 

10

Table of Contents

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially owned by them. The following table does not reflect record or beneficial ownership of the private placement warrants as these securities are not exercisable within 60 days of the date of this from 10-K.

 

Name and Address of Beneficial Owner (1)    Number of
Shares
Beneficially
Owned
(2)		      Approximate
Percentage of
Outstanding
Common Stock		  
   Before
Offering		     After
Offering
(3)		  

Revofast LLC (our sponsor) (4)

      2,780,000        96.7 %      21.51 % 

Saiful Khandaker

      2,780,000        96.7 %      21.51 % 

ARC Capital

      50,000        1.73 %      0.39 % 

EF Hutton

      57,500        —         0.44 % 

Jenny Junkeer

      15,000        0.52 %      0.12 % 

Mubasshir Karim

      —          —         —    

Michael S. Tomczyk

      10,000        0.35 %      0.08 % 

Robin Meister

      10,000        0.35 %      0.08 % 

Lynn Perkins

      10,000        0.35 %      0.08 % 

All directors and executive officers as a group (6 individuals)

      2,875,000        100 %      22.25 % 

 

(1)

Unless otherwise noted, the business address of each of the following entities or individuals is 100 Springhouse Drive, Suite 204, Collegeville, Pennsylvania 19426.

(2)

Consists solely of founder shares.

(3)

Based on 12,925,000 shares of common stock outstanding immediately after this offering

(4)

Revofast LLC’s Manager is Saiful Khandaker, who has voting and dispositive control over the securities held by Revofast LLC.

On March 8, 2021, our sponsor purchased 2,875,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.009 per share. The 2,875,000 founder shares held by our sponsor include an aggregate of up to 375,000 shares subject to forfeiture to the extent that the over-allotment option is not exercised by the underwriter in full or in part. On March 27, 2021, our sponsor sold 15,000 founder shares to our Chief Financial Officer, Jenny Junkeer, and 10,000 founder shares to each of our three independent directors, Michael Tomczyk, Robin Meister and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which our sponsor purchased such founder shares from us. Additionally, as consideration for financial advisory services rendered in connection with this offering, on March 11, 2021, ARC Capital received from our sponsor 50,000 of our sponsor’s 2,500,000 founder shares, at a price of $0.009 per share. The founder shares held by our independent directors and financial advisor are not subject to forfeiture in the event that the underwriters’ over-allotment is not exercised. After giving effect to the issuance of founder shares, our sponsor and initial stockholders will collectively own approximately 20% of the outstanding common stock following the offering assuming they do not purchase any units in this offering or the public market. Because of this ownership block, our sponsor and initial stockholders and the holders of private placement warrants will have significant influence over the outcome of all matters requiring approval by our stockholders, including the election of directors, amendments to our amended and restated certificate of incorporation and approval of significant corporate transactions other than approval of our initial business combination. If we increase or decrease the size of the offering, we will effect a stock dividend or a share contribution back to capital, or other appropriate mechanism, as applicable, with respect to our Class B common stock immediately prior to the consummation of the offering in such amount as to maintain the ownership of our sponsor and initial stockholders at 20% of the issued and outstanding shares of our Class A common stock upon the consummation of this offering. Our sponsor and the initial stockholders have agreed (A) to vote any shares owned by them in favor of any proposed initial business combination and (B) not to redeem any shares in connection with a stockholder vote to approve a proposed initial business combination.

 

11

Table of Contents

Our sponsor has purchased from us an aggregate of 3,900,250 private placement warrants at a price of $1.00 per warrant for a total purchase price of $3,900,250 in a private placement that will close simultaneously with the consummation of this offering. Our sponsor has also agreed that if the over-allotment option is exercised by the underwriter in full or in part, our sponsor and/or its designees will purchase from us additional private placement warrants on a pro rata basis in an amount that is necessary to maintain in the trust account $10.10 per unit sold to the public in this offering. These additional private placement warrants will be purchased in a private placement that will occur simultaneously with the purchase of units resulting from the exercise of the over-allotment option. The private placement warrants cannot be transferred (except to certain permitted transferees) until the completion of our initial business combination. The purchase price of the private placement warrants will be added to the proceeds from this offering to be held in the trust account. If we do not complete our business combination within 18 months (after we elected to extend the initial 12-month term for two additional three month terms) from the effective date of the registration statement consummating our initial public offering, the proceeds from the sale of the private placement warrants held in the trust will be used to fund the redemption of our public shares (subject to the requirements of applicable law) and the private placement warrants will expire worthless. The private placement warrants are identical to the units sold in this offering except that (i) the private placement warrants cannot be transferred (except to certain permitted transferees, as described below) until the completion of our initial business combination, (ii) the private placement warrants will be entitled to registration rights and (iii) the private placement warrants included in the private placement warrants, so long as they are held by our sponsor or its permitted transferees, (x) will not be redeemable by us and (y) may be exercised by the holders on a cashless basis. If the private placement warrants included in the private placement warrants are held by holders other than our sponsor or any of its permitted transferees, such warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants included in the units being sold in this offering.

Our sponsor and our executive officers and directors may be deemed to be “promoters” as such term is defined under the federal securities laws.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

On March 8, 2021, we issued 2,875,000 founder shares to our sponsor (up to 375,000 shares of which are subject to forfeiture depending on the extent to which the underwriter’s over-allotment option is exercised), at a price of $0.009 per share, for an aggregate purchase price of $25,000 in cash. On March 27, 2021, our sponsor sold 15,000 founder shares to our Chief Financial Officer, Jenny Junkeer, and 10,000 founder shares to each of our three independent directors, Michael Tomczyk, Robin Meister and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which our sponsor purchased such founder shares from us. As consideration for financial advisory services rendered in connection with this offering, on March 11, 2021, ARC Capital received from our sponsor 50,000 of our sponsor’s 2,500,000 founder shares (assuming forfeiture of 375,000 founder shares in the event the underwriter’s over-allotment option is exercised), at a price of $0.009 per share. The founder shares held by our independent directors and financial advisor are not subject to forfeiture in the event that the underwriters’ over-allotment is not exercised. The purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. If we increase or decrease the size of the offering, we will effect a stock dividend or a share contribution back to capital or other appropriate mechanism, as applicable with respect to our common stock immediately prior to the consummation of the offering in such amount as to maintain the ownership of founder shares by our sponsor and initial stockholders at approximately 20% of our issued and outstanding shares of common stock upon the consummation of this offering (assuming our sponsor does not purchase units in this offering). Our sponsor and the initial stockholders have agreed not transfer any of their ownership interest in the founder shares (except to certain permitted transferees) until the earlier of (i) the first anniversary of the completion of our initial business combination and (ii) the date on which we complete a liquidation, merger, stock exchange or other similar transaction after our initial business combination that results in all of our public stockholders having the right to exchange their shares of common stock for cash, securities or other property.

 

12

Table of Contents

On March 27, 2021, we entered into an Administrative Services Agreement with our sponsor, pursuant to which we will pay our sponsor up to $5,000 per month for up to 12 months (or 15 or 18 months, depending on whether we elect to extend the initial 12-month term for up to two additional three month terms) from the effective date of the registration statement consummating our initial public offering for office space, utilities, secretarial and administrative services. None of the up to $5,000 per month payment will be received by our officers or directors or their other affiliates (other than our sponsor).

Our sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review and approve all reimbursements and payments made to our sponsor, officers, directors or our or their respective affiliates, with any interested director abstaining from such review and approval. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf; provided, however, that to the extent such expenses exceed the available proceeds not deposited in the trust account, such expenses would not be reimbursed by us unless we consummate an initial business combination.

Our sponsor has purchased an aggregate of 3,900,250 private placement warrants at a price of $1.00 per warrant in a private placement that will close simultaneously with the closing of this offering. Our sponsor has also agreed that if the over-allotment option is exercised by the underwriter in full or in part, our sponsor and/or its designees will purchase from us additional private placement warrants on a pro rata basis in an amount that is necessary to maintain in the trust account $10.10 per unit sold to the public in this offering. The private placement warrants cannot be transferred except to certain permitted transferees until the completion of our initial business combination. Such permitted transferees will include our executive officers and directors and other persons or entities affiliated with or related to them. Any permitted transferees receiving such securities will be subject to the same agreements with respect to such securities as our sponsor. The private placement warrants so long as they are held by our sponsor or its permitted transferees, (x) will not be redeemable by us and (y) may be exercised by the holders on a cashless basis. If the private placement warrants are held by holders other than our sponsor or any of its permitted transferees, such warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants included in the units being sold in this offering.

Caltech Trading indicated its intention to provide financing to our sponsor in connection with our sponsor’s purchase of the private placement warrants. On October 20, 2021, the Company announced that Caltech Trading will not provide that financing to our sponsor. As a result, our sponsor expects to admit a third party institutional investor as a new member which would make a capital contribution to raise the funds required to purchase the private placement warrants. The Investor would own 95% of the equity of our sponsor and Saiful Khandaker, our Chief Executive Officer, would own 5% of the equity of our sponsor. Mr. Khandaker will remain our Chief Executive Officer and will remain the sole managing member with voting and dispositive control over our sponsor’s securities.

In order to finance transaction costs in connection with a business combination, our sponsor or an affiliate of our sponsor, or our officers and directors may, but are not obligated to, loan us funds as may be required for working capital. Such working capital loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a business combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a business combination into working capital warrants at a price of $1.50 per working capital warrant. The working capital warrants will be identical to the private placement warrants. In the event that a business combination does not close, we may use a portion of proceeds held outside the trust account to repay the working capital loans, but no proceeds held in the trust account would be used to repay the working capital loans.

We will have until 12 months from the closing of this offering to consummate an initial business combination. If we anticipate that we may not be able to consummate our initial business combination within 12 months,

 

13

Table of Contents

however, we may, by resolution of our board of directors if requested by our sponsor, extend the period of time to consummate a business combination up to two times, each by an additional three months (for a total of 18 months to complete a business combination), subject to the sponsor depositing additional funds into the trust account as set out below. In connection with any such extension, public shareholders will not be offered the opportunity to vote on or redeem their shares. Pursuant to the terms of our amended and restated certificate of incorporation and the trust agreement to be entered into between us and Continental Stock Transfer & Trust Company on the date of this annual report, in order to extend the time available for us to consummate our initial business combination for an additional three months, our sponsor or its affiliates or designees must deposit into the trust account $1,000,000, or up to $1,150,000 if the underwriters’ over-allotment option is exercised in full ($0.10 per share in either case) on or prior to the date of the deadline, for each of the available three-month extensions, providing a total possible business combination period of 18 months at a total payment value of $2,000,000, or $2,300,000 if the underwriters’ over-allotment option is exercised in full ($0.20 per unit in either case). Any such payments would be made in exchange for additional private placement warrants to be issued by us to our sponsor or its affiliates or designees, as applicable, at a price of $1.00 per warrant (for a total of 2,000,000 additional private placement warrants (or 2,300,000 if the over-allotment option is exercised in full) if payments are made for two such extensions), which warrants will be identical to the private placement warrants. We will only be able to extend the period to consummate a business combination up to two times, each by an additional three months (for a total of six months). We will issue a press release announcing each extension, at least three days prior to the deadline for each extension and we will issue a press release the day after the deadline announcing whether the funds have been timely deposited. Our sponsor and its affiliates or designees are obligated to fund the trust account in order to extend the time for us to complete our initial business combination, but our sponsor will not be obligated to extend such time.

Pursuant to a registration rights agreement we will enter into with our sponsor on or prior to the closing of this offering, we may be required to register certain securities for sale under the Securities Act. Our sponsor, holders of the representative shares and holders of warrants issued upon conversion of working capital loans, if any, will be entitled under the registration rights agreements to make up to two demands in the case of the founder shares, excluding short form registration demands, and one demand in the case of the private placement warrants, the working capital loan warrants and, in each case, the underlying or constituent securities, that we register certain of our securities held by them for sale under the Securities Act and to have the securities covered thereby registered for resale pursuant to Rule 415 under the Securities Act. In addition, these holders have the right to include their securities in other registration statements filed by us. However, the registration rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until the securities covered thereby are released from their lock-up restrictions, as described herein. We will bear the costs and expenses of filing any such registration statements.

Item 14. Principal Accounting Fees and Services.

Audit Fees

The firm of Marcum LLP, or Marcum, acts as our independent registered public accounting firm. The following is a summary of fees paid to Marcum for services rendered.

Audit Fees.

For the year ended December 31, 2022 and 2021, fees for our independent registered public accounting firm were approximately $103,000 and $94,245, respectively, for the services Marcum performed in connection with the audit of our December 31, 2022 consolidated financial statements included in this Annual Report on Form 10-K.

 

14

Table of Contents

Audit-Related Fees.

For the year ended December 31, 2022, and for the period from March 5, 2021 (inception) through December 31, 2021, our independent registered public accounting firm did not render assurance and related services related to the performance of the audit or review of consolidated financial statements.

Tax Fees.

For the year ended December 31, 2022, and for the period from March 5, 2021 (inception) through December 31, 2021, there were no fees for tax compliance, tax advice and tax planning services by our independent registered public accounting firm.

All Other Fees.

For the year ended December 31, 2022, and for the period from March 5, 2021 (inception) through December 31, 2021, there were no fees billed for products and services provided by our independent registered public accounting firm other than those set forth above.

 

15

Table of Contents

PART IV

Item 15. Exhibits and Financial Statement Schedules.

 

(a)

The following documents are filed as part of this Form 10-K:

 

  (1)

Financial Statements:

The audited consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related statements of operations and comprehensive income, changes in stockholders’ equity (deficit) and cash flows for the year then ended and for the period from March 5, 2021 (inception) through December 31, 2021, the footnotes thereto, and the report of Marcum LLP, independent auditors, are filed herewith.

 

  (2)

Financial Statement Schedules:

None.

 

  (3)

Exhibits:

We hereby file as part of this Annual Report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference can be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Copies of such material can also be obtained from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates or on the SEC website at www.sec.gov.

Item 16. Exhibits and Financial Statement Schedules.

The following exhibits are filed as part of this Report

 

Exhibit
Number		    Description
    3.1 (1)    Certificate of Incorporation
    3.2 (2)    Amended and Restated Certificate of Incorporation
    3.3 (1)    Bylaws
    4.1 (1)    Specimen Unit Certificate
    4.2 (1)    Specimen Common Stock Certificate
    4.3 (1)    Specimen Warrant Certificate
    4.4 (1)    Specimen Right Certificate
    4.5 (2)    Warrant Agreement, dated October 18, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.
    4.6 (2)    Rights Agreement, dated October 18, 2021, between the Company and Continental Stock Transfer & Trust Company, as right agent.
  10.1 (2)    Letter Agreement, dated October 18, 2021, among the Company, and its directors, officers and Revofast LLC
  10.2 (3)    Amended and Restated Promissory Note
  10.3 (2)    Investment Management Trust Agreement, dated October 18, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee.
  10.4 (2)    Registration Rights Agreement, dated October 18, 2021, between the Company and its directors, and Revofast LLC.
  10.5 (1)    Subscription Agreement, dated March 8, 2021, between the Registrant and Revofast LLC.

 

1

Table of Contents
Exhibit
Number		    Description
  10.6 (2)    Private Placement Warrants Purchase Agreement, dated October 18, 2021 between the Company and Revofast LLC.
  10.7 (2)    Indemnity Agreement, dated January 28, 2021, between the Company and Saiful Khandaker.
  10.8 (2)    Indemnity Agreement, dated January 28, 2021, between the Company and Jenny Junkeer
  10.9 (2)    Indemnity Agreement, dated January 28, 2021, between the Company and Mubasshir Karim
  10.10 (2)    Indemnity Agreement, dated January 28, 2021, between the Company and Michael Tomczyk
  10.11 (2)    Indemnity Agreement, dated January 28, 2021, between the Company and Robin Meister
  10.12 (2)    Indemnity Agreement, dated January 28, 2021, between the Company and Lynn Perkins
  10.13 (1)    Form of Administrative Support Agreement, by and between the Registrant and Revofast LLC.
  10.14 (1)    Forward Purchase Agreement, by and between the Registrant and Caltech Trading Corp.
  14.1 (2)    Form of Code of Ethics.
  31.1*    Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
  31.2*    Certification of the Principal Financial and Accounting Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
  32.1+    Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
  32.2+    Certification of the Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
101.INS   

Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its

XBRL tags are embedded within the Inline XBRL document

101.SCH    Inline XBRL Taxonomy Extension Schema Document
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

(1)

Incorporated by reference to the Amendment No. 1 to the Registration Statement on Form S-1 filed with the SEC on August 18, 2021.

(2)

Incorporated by reference to the Current Report on Form 8-K filed with the SEC on October 22, 2021.

(3)

Incorporated by reference to the Current Report on Form 8-K filed with the SEC on November 5, 2021.

*

Filed herewith.

+

In accordance with SEC Release 33-8238, Exhibit 32.1 and 32.2 are being furnished and not filed.

 

2

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   

FINTECH ECOSYSTEM DEVELOPMENT CORP.

Date: April 20, 2023

    

By:

  

/s/ Saiful Khandaker

      Saiful Khandaker
     

Chief Executive Officer

(Principal Executive Officer)

Date: April 20, 2023

    

By:

  

/s/ Jenny Junkeer

      Jenny Junkeer
     

Chief Financial Officer

(Principal Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

   

Title

  

Date

/s/ Saiful Khandaker

Saiful Khandaker

   

Chief Executive Officer and Director

(Principal Executive Officer)

   April 20, 2023

/s/ Jenny Junkeer

Jenny Junkeer

   

Chief Financial Officer

(Principal Accounting Officer)

   April 20, 2023

 

1

EX-31.1 2 d456943dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Saiful Khandaker, certify that:

 

1.

I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2022 of Fintech Ecosystem Development Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 20, 2023     By:   /s/ Saiful Khandaker
      Saiful Khandaker
     

Chief Executive Officer

(Principal Executive Officer)

 EX-31.2 3 d456943dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jenny Junkeer, certify that:

 

1.

I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2022 of Fintech Ecosystem Development Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15€ and 15d-15(e)) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 20, 2023     By:   /s/ Jenny Junkeer
      Jenny Junkeer
     

Chief Financial Officer

(Principal Financial Officer)

 EX-32.1 4 d456943dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Fintech Ecosystem Development Corp. (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 20, 2023     By:   /s/ Saiful Khandaker
      Saiful Khandaker
      Chief Executive Officer
      (Principal Executive Officer)
 EX-32.2 5 d456943dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Fintech Ecosystem Development Corp. (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 20, 2023     By:   /s/ Jenny Junkeer
      Jenny Junkeer
      Chief Financial Officer
      (Principal Financial Officer)
 EX-101.SCH 6 fexd-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - INITIAL PUBLIC OFFERING link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - PRIVATE PLACEMENT link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - INCOME TAX link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - INCOME TAX (Tables) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share, Basic and Diluted (Detail) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Basic and Diluted Net Income (Loss) Per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - INITIAL PUBLIC OFFERING - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - PRIVATE PLACEMENT - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Liabilities Measured on Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Significant Inputs to the Black-Scholes Option Pricing Model for the Fair Value of the Founder Warrants (Detail) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments that are Measured at Fair Value (Detail) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - STOCKHOLDERS' EQUITY - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - INCOME TAX - Summary of Net Deferred Tax Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - INCOME TAX - Summary of Income Tax Provision (Detail) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - INCOME TAX - Summary of Effective Income Tax Rate Reconciliation (Detail) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - INCOME TAX - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - SUBSEQUENT EVENTS - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 fexd-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 fexd-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 fexd-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 fexd-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 31, 2023
Jun. 30, 2022
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Registrant Name FINTECH ECOSYSTEM DEVELOPMENT CORP.    
Entity Central Index Key 0001852407    
Entity File Number 001-40914    
Entity Tax Identification Number 86-2438985    
Current Fiscal Year End Date --12-31    
Entity Shell Company true    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Address, Address Line One 100 Springhouse Drive    
Entity Address, Address Line Two Suite 204    
Entity Address, City or Town Collegeville    
Entity Address, State or Province PA    
Entity Address, Postal Zip Code 19426    
City Area Code 610    
Local Phone Number 226-8101    
Entity Incorporation, State or Country Code DE    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Public Float     $ 79,187,378
Auditor Name Marcum LLP    
Auditor Firm ID 688    
Auditor Location Boston, MA    
Capital Units [Member]      
Document Information [Line Items]      
Title of 12(b) Security Units, each consisting of one share of Class A common stock, one right and one-half of one redeemable warrant    
Trading Symbol FEXDU    
Security Exchange Name NASDAQ    
Common Class A [Member]      
Document Information [Line Items]      
Title of 12(b) Security Class A common stock, par value $0.0001 per share    
Trading Symbol FEXD    
Security Exchange Name NASDAQ    
Entity Common Stock, Shares Outstanding   11,557,500  
Common Class B [Member]      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   2,875,000  
Warrant [Member]      
Document Information [Line Items]      
Title of 12(b) Security Rights included as part of the units    
Trading Symbol FEXDR    
Security Exchange Name NASDAQ    
One share Of Class A Common Stock [Member]      
Document Information [Line Items]      
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share    
Trading Symbol FEXDW    
Security Exchange Name NASDAQ    
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash $ 10,335 $ 612,750
Prepaid expenses 38,951 86,557
Total current assets 49,286 699,307
Long-term prepaid expenses 0 38,633
Investments held in trust account 118,985,048 116,152,113
Total assets 119,034,334 116,890,053
Current liabilities    
Accounts payable and accrued liabilities 990,605 179,371
Income tax payable 290,342 0
Promissory notes from related parties 527,502 0
Total current liabilities 1,808,449 179,371
Derivative forward purchase liability 285,567 1,726,908
Derivative warrant liabilities 756,018 3,706,098
Deferred underwriter fee payable 3,737,500 3,737,500
Total liabilities 6,587,534 9,349,877
COMMITMENTS AND CONTINGENCIES (NOTE 6)
Class A common stock subject to possible redemption; 11,500,000 shares at redemption value 118,392,240 116,150,000
Stockholders' deficit:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 0 0
Additional paid-in capital 0 0
Accumulated deficit (5,945,734) (8,610,118)
Total stockholders' deficit (5,945,440) (8,609,824)
Total liabilities, common shares subject to possible redemption and stockholders' deficit 119,034,334 116,890,053
Common Class A [Member]    
Stockholders' deficit:    
Common Stock 6 6
Common Class B [Member]    
Stockholders' deficit:    
Common Stock $ 288 $ 288
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 1,000,000 1,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Class A [Member]    
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 200,000,000 200,000,000
Common Stock, Shares, Issued 57,500 57,500
Common Stock, Shares, Outstanding 57,500 57,500
Temporary equity shares authorized 11,500,000 11,500,000
Common Class B [Member]    
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 20,000,000 20,000,000
Common Stock, Shares, Issued 2,875,000 2,875,000
Common Stock, Shares, Outstanding 2,875,000 2,875,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Operating Expenses:    
Formation and Operating Costs $ 243,849 $ 2,027,390
Total operating expenses 243,849 2,027,390
Other Income (Expenses):    
Offering costs associated with derivative warrant liabilities (102,600) 0
Change in fair value of derivative warrant liabilities (1,312,034) 3,030,580
Change in fair value of derivative forward purchase liability (226,233) 1,441,341
Income from investments held in Trust Account 2,113 1,682,935
Total other income (expenses), net (1,638,754) 6,154,856
Income (loss) before income taxes (1,882,603) 4,127,466
Income taxes 0 290,342
Net income (loss) (1,882,603) 3,837,124
Common Class A [Member]    
Other Income (Expenses):    
Net income (loss) $ (916,293) $ 3,072,757
Basic, net income (loss) per share $ (0.34) $ 0.27
Diluted, net income (loss) per share $ (0.34) $ 0.27
Weighted average number of ordinary shares-basic 2,726,188 11,557,500
Weighted average number of ordinary shares-diluted 2,726,188 11,557,500
Common Class B [Member]    
Other Income (Expenses):    
Net income (loss) $ (966,310) $ 764,367
Basic, net income (loss) per share $ (0.34) $ 0.27
Diluted, net income (loss) per share $ (0.34) $ 0.27
Weighted average number of ordinary shares-basic 2,875,000 2,875,000
Weighted average number of ordinary shares-diluted 2,875,000 2,875,000
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Total
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Common Class A [Member]
Common Class A [Member]
Common Stock [Member]
Common Class A [Member]
Additional Paid-in Capital [Member]
Common Class A [Member]
Accumulated Deficit [Member]
Common Class B [Member]
Common Class B [Member]
Common Stock [Member]
Common Class B [Member]
Additional Paid-in Capital [Member]
Beginning balance at Mar. 04, 2021 $ 0 $ 0 $ 0   $ 0       $ 0  
Beginning balance, Shares at Mar. 04, 2021         0       0  
Share issuance       $ 351,038 $ 6 $ 351,032   $ 25,000 $ 288 $ 24,712
Share issuance, Shares         57,500       2,875,000  
Net income (loss) (1,882,603)   (1,882,603) (916,293)       (966,310)    
Sale of Private Placement Warrants 2,886,185 2,886,185                
Accretion\Remeasurement of Class A common stock subject to possible redemption amount (9,989,444) (3,261,929)         $ (6,727,515)      
Remeasurement of Class A common stock subject to possible redemption 0                  
Ending balance at Dec. 31, 2021 (8,609,824) 0 (8,610,118)   $ 6       $ 288  
Ending balance, Shares at Dec. 31, 2021         57,500       2,875,000  
Net income (loss) 3,837,124   3,837,124 $ 3,072,757       $ 764,367    
Sale of Private Placement Warrants 1,069,500 1,069,500                
Remeasurement of Class A common stock subject to possible redemption (2,242,240) (1,069,500) (1,172,740)              
Ending balance at Dec. 31, 2022 $ (5,945,440) $ 0 $ (5,945,734)   $ 6       $ 288  
Ending balance, Shares at Dec. 31, 2022         57,500       2,875,000  
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Cash flows from operating activities:    
Net income (loss) $ (1,882,603) $ 3,837,124
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Offering costs associated with derivative warrant liabilities 102,600 0
Change in fair value of derivative forward purchase liability 226,233 (1,441,341)
Change in fair value of warrant liabilities 1,312,034 (3,030,580)
Related party promissory note accrued interest 0 7,545
Income from investments held in trust account (2,113) (1,682,935)
Changes in operating assets and liabilities:    
Prepaid expenses (125,190) 86,239
Accounts payable and accrued liabilities 179,371 811,234
Income tax payable 0 290,342
Net cash used in operating activities (189,669) (1,122,372)
Cash flows from investing activities:    
Cash deposited in Trust Account (116,150,000) (1,150,000)
Net cash used in investing activities (116,150,000) (1,150,000)
Cash flows from financing activities:    
Proceeds from issuance of common shares to Sponsor 25,000 0
Proceeds from issuance of warrants to Sponsor 0 1,150,000
Proceeds from promissory notes from related parties 35,000 520,000
Repayment of promissory notes (141,768) (43)
Proceeds from the Initial Public Offering, gross 115,000,000 0
Proceeds from private placement 3,900,250 0
Payment of underwriter commission fee (1,437,500) 0
Payment of offering costs (428,563) 0
Net cash provided by financing activities 116,952,419 1,669,957
Net (decrease) increase in cash 612,750 (602,415)
Cash, beginning of period 0 612,750
Cash, end of period 612,750 10,335
Supplemental Disclosures of Noncash Financing Activities    
Offering costs paid by related party under promissory note 106,768 0
Deferred underwriter commission for the Initial Public Offering 3,737,500 0
Issuance of Class A shares in connection with Initial Public Offering 351,038 0
Remeasurement of Class A shares subject to redemption $ 0 $ 2,242,240
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN
 12 Months Ended
Dec. 31, 2022
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [Abstract]  
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN
Fintech Ecosystem Development Corp. (the “Company” or “FEXD”) is a blank check company incorporated in the State of Delaware on 
March 5, 2021. The Company was formed for the purpose of acquiring, merging with, engaging in capital stock exchange with, purchasing all or substantially all of the assets of, engaging in contractual arrangements, or engaging in any other similar business combination with a single operating entity, or one or more related or unrelated operating entities operating in any sector (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies in the financial technology development industry.
On December 31, 2022, the Company had not yet commenced any operations. All activity through December 31, 2022, relates to the Company’s formation, general operating expenses, the search for a target business with which to consummate an initial business combination and the Initial Public Offering (the “Initial Public Offering” or “IPO”) as described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will
generate non-operating income
in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its
fiscal year-end.
The Company is an early stage and emerging growth company, and, as such, the Company is subject to all of the risks associated with early-stage and emerging growth companies.
The Company’s sponsor is Revofast LLC, a Wyoming limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on October 18, 2021, and on October 21, 2021. On October 21, 2021, the Company consummated its Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $115,000,000, and incurring offering costs of $6,061,368, of which $3,737,500 was for deferred underwriting commissions (see Note 6). In addition, the Company granted the underwriter a
45-day
option to purchase an additional 1,500,000 Units at the Initial Public Offering price to cover over-allotments, if any. Simultaneous with the close of the Initial Public Offering, the over-allotment option was exercised in full.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement of an aggregate of 3,900,250 warrants (the “Private Placement Warrants”) to the Sponsor, for $1.00 per Private Placement Warrant, generating total gross proceeds of $3,900,250 (the “Private Place”) (see Note 4).
Following the closing of the Initial Public Offering on October 21, 2021, an amount of $116,150,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and held as cash items or invested only in U.S. government securities within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of paragraph (d) of
Rule 2a-7 of
the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s Stockholders, as described below.
The Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a
 
proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which public stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.
If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Class A Common Shares without the Company’s prior written consent.
The public stockholders will be entitled to redeem their Class A Common Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The
per-share
amount to be distributed to public stockholders who redeem their Class A Common Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants or rights. All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and restated certificate of incorporation. In accordance with SEC and its guidance on redeemable equity instruments, which has been codified in
ASC 480-10-S99, redemption
provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A common stock classified as temporary equity will be the allocated proceeds determined in accordance with ASC
470-20.
The Class A common stock is subject to
ASC 480-10-S99. If
it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in the absence of retained earnings,
additional paid-in capital).
While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.
If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
The Sponsor has agreed (a) to vote its Class B Common Stock, the Class A Common Shares underlying the Private Placement Warrants and any Class A Common Shares purchased during or after the Proposed Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation with respect to the
Company’s pre-Business Combination
activities prior to the consummation of a Business Combination unless the Company provides dissenting public stockholders with the opportunity to redeem their Class A Common Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Class B Common Stock) and into the right to receive cash from the Trust Account in
 
connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights
of pre-Business Combination
activity and (d) that the Class B Common Stock and Private Placement Warrants (including underlying Class A Common Shares) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Class A Common Shares purchased during or after the Proposed Offering if the Company fails to complete its Business Combination.
The Company will have until 12 months, being October 21, 2022, (or 15 or 18
 
months, depending on whether we elect to extend the initial 12-month term for up to two additional three-month terms) from the effective date of the registration statement to consummate a Business Combination (the “Combination Period”)
.
If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 
100
% of the outstanding Class A Common Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to
 
$
50,000),
 
divided by the number of then outstanding Class A Common Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Class A Common Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Proposed Offering price per Unit 
($10.00).
The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.10 per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Proposed Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Business Combinations
On September 11, 2022, the Company entered into two business combination agreements. Refer to Note 6.
On October 21, 2022, the Company’s board of directors approved to extend the time by which the Company has to consummate a business combination from October 21, 2022 until January 21, 2023.
On January 20, 2023, the Company’s board of directors further approved to extend the time by which the Company has to consummate a business combination from January 21, 2023 to April 21, 2023 (Note 11).

 
On April 10, 2023, the Company sent a letter to Rana Financial, Inc. and David Kretzmer a letter notifying Rana Financial, Inc. of its failure to deliver audited financial statements pursuant to the business combination agreement dated September 9, 2022. The Company notified Rana of its intent to propose the termination of the agreement and abandonment of the contemplated business combination within if the audited financial statements are not received by April 21, 2023. Refer to Note 11.
Liquidity and Capital Resources
As of December 31, 2022, the Company had $10,335 in its operating bank account, $118,985,048 investments held in its trust account, and working capital deficit of approximately $1,759,163.
The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (as defined in Note 5), and a loan from the Sponsor of approximately $141,768 under the Note (as defined in Note 5). The $141,768 loan was fully repaid as of December 31, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of December 31, 2022, there were no amounts outstanding under any Working Capital Loan.
On August 2, 2022, the Company borrowed $200,000 through a promissory note with HRT North America Ltd. LLC to support its liquidity needs. The Company borrowed an additional $300,000 through a promissory note with the Sponsor on October 19, 2022 (refer to Note 5).
On January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant generating total proceeds of $1,150,000 (refer to Note 11).
On January 20, 2023, the Company entered into a $200,000 promissory note with its Sponsor (refer to Note 11).
Based on the foregoing, management does not believe that the Company will have sufficient working capital to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. The Company believes it may need to raise additional funds in order to meet the expenditures required for operating the business. Furthermore, if the Company’s estimate of the costs of identifying a target business, undertaking
in-depth
due diligence and negotiating an Initial Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate the business prior to the Initial Business Combination. Moreover, the Company may need to obtain additional financing either to complete the Initial Business Combination or to redeem a significant number of our public shares upon completion of the Initial Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Initial Business Combination. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in what ever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The
con
solidate
d
financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.
In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic
205-40,
“Presentation of Financial
 
Statements – Going Concern,” the Company has until April 21, 2023, to consummate an initial business combination. It is uncertain that the Company will be able to consummate an initial business combination by this time. If an initial business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and the mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 21, 2023.

Risks and Uncertainties
Management is currently evaluating the impact of
the COVID-19 pandemic
on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States of America, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these consolidated financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Principle of consolidation
The consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Fama Financial Services, Inc. (“Fama”), which was incorporated on August 23, 2022 in the State of Georgia. There were no material business activities in Fama for the period from its incorporation date to December 31, 2022. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.
Emerging growth company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act’’), and it may take advantage of certain exemptions from various reporting requirements that apply to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can opt-out of
the extended transition period and comply with the requirements that apply
 
to non-emerging growth
companies, but any such election
to opt-out is
irrevocable. The Company has elected not
to opt-out of
such an extended transition period, which means that when a standard is issued or
 
revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison of the Company’s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult
or
impossible because of the potential differences in accounting standards used.
Use of estimates
The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As a result, the Company had cash of $10,335 and no cash equivalents on December 31, 2022. The Company had cash of $612,750 and no cash equivalents on December 31, 2021.
Investment Held in Trust Account
As of December 31, 2022 and 2021, the Company had $118,985,048 and $116,152,113 investments held in the Trust Account, respectively. The investments held in the Trust Account were held in marketable treasury funds. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest income in the accompanying statements of operations. The estimated fair value of investments held in Trust Account are determined using available market information.
Income taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. In addition, valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as an income tax expense. There were 
no
 unrecognized tax benefits and 
no
 amounts accrued for interest and penalties as of December 
31
,
2022
and
2021
. The Company is currently not aware of any issues under review resulting in significant payments, accruals, or material deviation from its position.
 
The Company may be subject to potential examination by federal, state, and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions, and compliance with federal, state, and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company has been subject to income tax examinations by major taxing authorities since its inception.
O
n August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023.
 
The exercise tax imposes a 1% tax on covered corporations on the fair market value of any stock of the corporation which is repurchased by such corporation for taxable years beginning after December 31, 2022. The exercise tax is applicable to certain SPAC redemptions, including in connection with a SPAC’s business combination. The amount of a redemption subject to the exercise tax is reduced by the fair market value of any stock issued by the SPAC during the taxable year of the redemption. The Company has not completed its initial business combination and there were no share redemptions during the year ended December 31, 2022. The exercise tax will only be applicable to the Company for its taxable years post December 31, 2022. The Company is still in the process of assessing the effects of the exercise tax to its consolidated financial statements.
Net income (loss) per common share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.
The calculation of diluted net income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 9,650,250 shares of Class A Common Stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from inception to December 31, 2022. Accretion associated with the redeemable Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021:
Year ended December 31, 2022
 
Description
   
Class A
     
Class B
  
Basic and diluted net income per common stock:
                  
Numerator:
                  
Allocation of net income
    $ 3,072,757      $ 764,367  
Denominator:
                  
Basic and diluted weighted average common stock outstanding
      11,557,500        2,875,000  
Basic and diluted net income per common stock
    $ 0.27      $ 0.27  
 
Period from March 5, 2021 (inception) to December 31, 2021
 
Description
   
Class A
     
Class B
  
Basic and diluted net income per common stock:
                  
Numerator:
                  
Allocation of net loss
    $ (916,293 )     $ (966,310 ) 
Denominator:
                  
Basic and diluted weighted average common stock outstanding
      2,726,188        2,875,000  
Basic and diluted net loss per common stock
    $ (0.34 )     $ (0.34 ) 
Concentration of credit risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account.
Fair value of financial instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative financial instruments
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC
480 and ASC 815-15. The classification of
derivative instruments, including whether such instruments
 
should be recorded as liabilities or
as equity, is re-assessed at the end
of each reporting period. In accordance with ASC
825-10
“Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statements of operations as incurred.
The 5,750,000 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,900,250 Private Placement Warrants are recognized as derivative liabilities in accordance
with ASC 815-40. Accordingly,
the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject
to re-measurement at
each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo or Black-Scholes simulation model at each measurement date. Derivative warrant liabilities are classified
as non-current liabilities as their
liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements
of ASC 340-10-S99-1 and
SEC Staff Accounting Bulletin Topic 5A-
Expenses of offering.
 Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented
as non-operating expenses
in the statements of operations. Offering costs associated with the Class A common stock were charged to stockholders’ deficit upon the completion of the Initial Public Offering.
Class A Common Stock Subject to Possible Redemption
All of the 11,500,000 shares of Class A common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with ASC 480, conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, 11,500,000 shares of Class A common stock subject to possible redemption at the redemption
amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
 
As of December 31, 2022 and 2021, the common shares reflected on the balance sheets are reconciled in the following table:

 
Gross proceeds from IPO
   
$
 115,000,000  
Less:
         
Proceeds allocated to Public Warrants
      (1,380,000 ) 
Class A common share issuance costs
      (6,309,800 ) 
    
 
 
  
Plus:
         
Accretion of carrying value to redemption value
      8,839,800  
    
 
 
  
Class A common shares subject to redemption at December 31, 2021
   
$
116,150,000
 
    
 
 
  
Plus:
         
Remeasurement to common stock subject to possible redemption amount
      2,242,240  
Class A common shares subject to redemption at December 31, 2022
   
$
118,392,240
 
    
 
 
  
Issued and adopted accounting standards
In August 2020, the FASB issued
ASU 2020-06, Debt-Debt
with Conversion and Other Options
(Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity’s Own Equity
(Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity
(“ASU 2020-06”), which
simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions required for equity-linked contracts to qualify for scope exception. In addition, it simplifies the diluted earnings per share calculation in certain areas.
ASU 2020-06
is effective January 1, 2024 for fiscal years beginning after December 15, 2023 for smaller reporting companies, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021.
 The Company adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have a material impact on the Company’s consolidated financial statements.
Outside of the above, management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s
consolidated
financial
statements
.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
INITIAL PUBLIC OFFERING
 12 Months Ended
Dec. 31, 2022
INITIAL PUBLIC OFFERING [Abstract]  
INITIAL PUBLIC OFFERING
NOTE 3. INITIAL PUBLIC
OFFERING
On October 21, 2021, the Company consummated its
Initial
Public Offering of 10,000,000 Units at $10.00 per Unit, generating gross proceeds of $100,000,000. Simultaneously, the underwriters exercised over-allotments, purchasing 1,500,000 additional Units, generating gross proceeds of $15,000,000.
Each Unit consists of one share of Class A Common
Stock, one-half of
one Public Warrant, and one Public Right. Each Public Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $11.50 per share (see Note 7). Each Public Right entitles the holder to
receive one-tenth of
one share of Class A Common Stock upon completion of a Business Combination (see Note 8).
The Company incurred offering costs related to the Initial Public Offering of $6,061,368, of which $1,437,500 was for underwriting fees, $3,737,500 was for deferred underwriting commissions, and $886,368 was for other offering costs.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
PRIVATE PLACEMENT
 12 Months Ended
Dec. 31, 2022
PRIVATE PLACEMENT [Abstract]  
PRIVATE PLACEMENT
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased an aggregate of 3,900,250 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($3,900,250 
in the
 
agg
regate). The excess of the proceeds over the fair value of the Private Placement Warrants has been recognized as a capital contribution from the Sponsor.
Each Private Placement Warrant is exercisable to purchase one share of Class A Common Stock at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Proposed Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Class A Common Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.
On October 21, 2022, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “October 2022 Private Placement Warrants”), generating total proceeds of $1,150,000. The October 2022 Private Placement Warrants were purchased by the Sponsor and are substantially similar to the private placement warrants issued to the Sponsor at the time of IPO in October 2021. The October 2022 Private Placement Warrants have been issued pursuant to and are governed by a Warrant Agreement that is substantially similar to the Warrant Agreement that the Company entered into at the time of the IPO. Similar to the private placement warrants issued at the time of the IPO, the October 2022 Private Placement Warrants will not be transferable, assignable or salable until 30 days after the Company’s initial business combination and, unlike such private placement warrants, are not redeemable by the Company at any time (including following transfer by the Sponsor or its permitted transferees).
The proceeds received by the Company in connection with the issuance of the October 2022 Private Placement Warrants have been deposited in the trust account (the “Trust Account”) established at the time of the IPO. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account on or prior to October 21, 2022 will extend by three months until January 21, 2023, which is the time the Company will have to consummate an initial business combination.
On January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “January 2023 Private Placement Warrants”), generating total proceeds of $1,150,000. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account
 
will extend by another three months until April 21, 2023, which is the time the Company will have to consummate an initial business combination.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2022
RELATED PARTY TRANSACTIONS [Abstract]  
RELATED PARTY TRANSACTIONS
NOTE 5. RELATED PARTY TRANSACTIONS
Class B Common Stock
On March 8, 2021, the Company issued an aggregate of 2,875,000 shares of Class B common stock (“Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000 in cash. In addition, such Founder Shares includes an aggregate of up to 375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor and initial stockholders will collectively own 20% of the Company’s issued and outstanding shares after the Proposed Offering (assuming our Sponsor and initial stockholders do not purchase any Class A Common Shares in the Proposed Offering and excluding the Private Placement Warrants and underlying securities).
On March 27, 2021, the Sponsor sold 15,000 Founder Shares to the Chief Financial Officer, Jenny Junkeer, and 10,000 Founder Shares to each of the Company’s three independent directors, Michael Tomczyk, Robin Meister, and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which the Sponsor purchased such Founder Shares from the Company. Thus, after giving effect to the issuance of Founder Shares, our Sponsor and initial stockholders will collectively own approximately 20% of the outstanding common stock following the offering, assuming they do not purchase any units in this offering or the public market.
Additionally, as consideration for financial advisory services rendered in connection with this offering, on March 11, 2021, ARC Capital received 50,000 shares of Class B Common Stock from our Sponsor at a
price of
 
$0.009 per share. The Founder Shares held by the independent directors and financial advisor are not subject to forfeiture in the event that the underwriters’ over-allotment is not exercised.
The initial stockholders have agreed not to transfer, assign or sell any of the Class B common stock (except to certain permitted transferees) until, with respect to 50% of the Class B common stock, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any
30-trading day
period commencing after a Business Combination, with respect to the remaining 50% of the Class B common stock, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property.
Promissory Notes
On March 8, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Sponsor Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $400,000, of which $141,768 was borrowed by the Company during 2021. The Sponsor Note
was non-interest bearing
and was fully repaid as of December 31, 2021.
On June 16, 2022, an affiliate of the Sponsor issued an unsecured promissory note (“June 2022 Note”) to the Company, pursuant to which the Company borrowed principal amount of $20,000. The June 2022 Note is
non-interest
bearing and matures on the earlier of: i) the consummation of the Company’s initial business combination;
or
 ii) May 15, 2023. As of December 31, 2022, $19,957 remains outstanding on this June 2022 Note.
On August 2, 2022, a company owned by a director of our potential business combination target, issued an unsecured promissory note (“August 2022 Note”), pursuant to which the Company borrowed principal amount of $200,000. The August 2022 Note has an interest rate of 9% per annum and matures on the earlier of: i) the consummation of the Company’s initial business combination;
or
 ii) February 2, 2023.
The Company is currently renewing the August 2022 Note with the lender.
 As 
of December 31, 2022, there was $200,000 outstanding on the August 2022 Note and accrued interest of $7,545.
On October 19, 2022, the Sponsor issued an unsecured promissory note (“October 2022 Note”), pursuant to which the Company borrowed principal amount of $300,000. The October 2022 Note is
non-interest
bearing and matures on May 15, 2023.
Administrative services agreement
The Company’s Sponsor has agreed, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $5,000 per month for these services. For the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021, the Company has paid $30,000 and $20,000 to the Sponsor for these administrative services, respectively. As of December 31, 2022 and 2021,
 
the Company accrued $
30,000 and $nil, respectively, for unpaid administrative services.
Related party loans
To finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or the Company’s officers and directors may, but are not obligated to, loan the Company funds as
 
may be requir
ed (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants (“Working Capital Warrants”) at a price of $1.50 per Working Capital Warrant. The Working Capital Warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021,
 
there have been no amounts borrowed under
 
the 
Working Capital Loans.
Forward Purchase Agreement
In connection with the IPO, the Company entered into a forward purchase agreement with Caltech Trading Corp., providing for the purchase by Caltech Trading Corp. of an aggregate of 9,000,000 forward purchase units at a purchase price of $10.00 per unit. The purchase of the Forward Purchase Units will occur concurrently and only in connection with the closing of the Business Combination.
The terms and provisions of the forward purchase warrants to be issued as part of the forward purchase units are identical to those of the Private Placement Warrants.
Representative Shares
In connection with the IPO, the Company issued the Representative 57,500 shares upon full exercise of the Over-allotment Option (the “Representative Shares”). The Representative has agreed not to transfer, assign or sell any such Representative Shares without prior consent of the Company until the completion of the initial Business Combination. In addition, the Representative has agreed (i) to waive its redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of the initial Business Combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete the initial Business Combination within 12 months (or up to 18 months, if applicable) from the Closing of the Offering.
The Representative will not sell, transfer, assign, pledge or hypothecate the Representative Shares, or cause the Representative Shares to be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the Representative Shares by any person, for a period of 180 days (pursuant to Rule 5110(e)(1) of the Conduct Rules of FINRA) following the Effective Date to anyone other than (i) the Representative or an underwriter or selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Representative or of any such underwriter or selected dealer. On and after the 181st day following the Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws.
Private Placement Warrants
The Company consummated certain private placement warrants with its Sponsor. Refer to Note 4 for details.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2022
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration rights
The holders of shares Class B Common Stock, Private Placement Warrants (and underlying securities), and any securities issued in payment of working capital loans made to the Company will be entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of Proposed Public Offering. The majorit
y
 
of
 these securities holders are entitled to make up to 
two
 demands that the Company registers such
securities.

 
Notwithstanding anything to the contrary, the underwriters (and/or their designees) may only make a demand registration (i) on one occasion and (ii) during the five-year period beginning on the effective date of the Proposed Public Offering. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these Common Stock are to be released from escrow. The holders of a majority of the Private Placement Warrants (and underlying securities) and securities issued in payment of working capital loans (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. Notwithstanding anything to the contrary, the underwriters (and/or their designees) may participate in a “piggy-back” registration only during the seven year period beginning on the effective date of the Proposed Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Notwithstanding anything to the contrary, under FINRA Rule 5110, the underwriters and/or their designees may only make a demand registration (i) on one occasion and (ii) during the five-year period beginning on the effective date of the registration statement relating to the Proposed Public Offering, and the underwriters and/ or their designees may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the registration statement relating to the Proposed Public Offering.
Underwriting agreement
The Underwriter purchased the 1,500,000 of additional Units to cover over-allotments, less the underwriting discounts and commissions.
The underwriters received a cash underwriting discount
of one and one-quarter percent (1.25%) of
the gross proceeds of the Initial Public Offering, or $1,437,500, as the underwriters’ over-allotment was exercised in full. In addition, upon closing of the Business Combination, the underwriters are entitled to a deferred fee of three and
one-quarter
percent (3.25%) of the gross proceeds of the Initial Public Offering, or $3,737,500, as the underwriters’ over- allotment was exercised in full. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.
Right of First Refusal
For a period beginning on the closing of this offering and ending on the earlier of the twelve (12) month anniversary of the closing of a Business Combination or the three year anniversary of the effective date of the registration statement, we have granted EF Hutton a right of first refusal to act as lead-left book-running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statement
consummating our initial public offering
.
Forward Purchase Agreement
On July 16, 2021, the Company entered into a forward purchase agreement with an anchor investor. Refer to Note 7 below for details.
Business Combination Agreements
Rana Business Combination Agreement
On September 11, 2022, the Company announced that it, with Fama Financial Services, Inc., a Georgia corporation and wholly-owned subsidiary of the Company (“Merger Sub”), Rana Financial Inc., a Georgia
 
corporation (“Rana”) and David Kretzmer, as representative of the Shareholders (“Shareholder Representative”), had entered into a business combination agreement (the “Rana Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Merger Sub will be merged with and into Rana (the “Merger”), with Rana surviving the Merger as a wholly-owned subsidiary of the Company. The key terms of the Rana Business Combination Agreement are as follows:
Structure of the Rana Business Combination
 
  (a)
The transaction is structured as a reverse triangular merger. Pursuant to the Rana Business Combination Agreement, on the closing date, Merger Sub will be merged with and into Rana, with Rana surviving the Merger (together with the other transactions related thereto, the “Proposed Rana Transactions”) as a wholly-owned direct subsidiary of the Company (the “Surviving Company”).
 
  (b)
At the effective time of the Merger (the “Effective Time”), the certificate of incorporation of Rana, as in effect immediately prior to the Effective Time, shall be the certificate of incorporation of the Surviving Company, until thereafter amended as provided by law and such certificate of incorporation.
 
  (b)
At the Effective Time, the bylaws of Merger Sub, as in effect immediately prior to the Effective Time, shall be the bylaws of the Surviving Company until thereafter amended as provided by law, the certificate of incorporation of the Surviving Company and such bylaws, as applicable.
 
  (c)
At the closing, the Company shall amend and restate, effective as of the Effective Time, its certificate of incorporation to be as set forth in the Rana Business Combination Agreement, pursuant to which the Company shall have a single class structure with shares of Class A common stock, par value $0.0001 per share, having voting rights of one vote per share (the “New Acquiror Class A Common Stock”).
 
  (d)
The Company shall pay a combination of Rana Cash Consideration and Rana Equity Consideration for the Company Common Stock subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $5,711,662 (the “Rana Escrow Amount”).
The Rana Cash Consideration means $7,800,000 and the Rana Equity Consideration means 7,020,000 shares of New Acquiror Class A Common Stock.
Rana Representations, Warranties and Covenants
The Rana Business Combination Agreement contains customary representations, warranties and covenants of Rana, FEXD and Merger Sub, relating to, among other things, their ability to enter into the Rana Business Combination Agreement and their outstanding capitalization. Rana has agreed to customary “no shop” obligations.
Conditions to Rana Closing
Mutual
The obligations of Rana, FEXD and Merger Sub to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Rana Closing, of the following conditions:
 
 
(a)
the Acquiror Proposals have been approved and adopted by the requisite affirmative vote of the stockholders of Acquiror in accordance with the Proxy Statement, the Delaware General Corporation Law, the organizational documents of FEXD and the rules and regulations of Nasdaq;
 
 
(b)
no Governmental Authority has enacted, issued, promulgated, enforced or entered any Law, rule, regulation, judgment, decree, executive order or award which is then in effect and has the effect of making the Proposed Rana Transactions illegal or otherwise prohibiting consummation of the Proposed Rana Transactions, including the Merger; and
 
  (c)
the shares of New Acquiror Class A Common Stock to be issued in connection with the Proposed Rana Transactions shall have been approved for listing on Nasdaq, and immediately following the Rana Closing Acquiror shall satisfy any applicable listing requirements of Nasdaq and Acquiror shall not have received any notice
of non-compliance therewith.
FEXD and Merger Sub
The obligations of FEXD and Merger Sub to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Rana Closing, of the following additional conditions:
 
  (a)
the representations and warranties of Rana contained in the sections titled (i) Organization and Qualification; Subsidiaries, (ii) Capitalization, (iii) Authority Relative to this Business Combination Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Rana contained in the Rana Business Combination Agreement shall be true and correct (without giving any effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect;
 
  (b)
Rana, the Shareholders and the Shareholder Representative, as applicable, have performed or complied in all material respects with all agreements and covenants required by the Rana Business Combination Agreement to be performed or complied with by each of them on or prior to the Effective Time;
 
  (c)
the Shareholder Representative has delivered to Acquiror the Escrow Agreement, duly executed by the Shareholder Representative;
 
  (d)
Rana has delivered to FEXD a customary officer’s certificate, dated the date of the Rana Closing, certifying as to the satisfaction of certain conditions;
 
  (d)
no Company Material Adverse Effect has occurred between the date of the Rana Business Combination Agreement and the Closing Date;
 
  (e)
on or prior to the Rana Closing, Rana delivered to Acquiror a properly executed certification, in form and substance reasonably acceptable to Acquiror, that the Company Common Stock, capital stock of Enova and capital stock of Fama, as applicable, are not “U.S. real property interests” in accordance with the Treasury Regulations under Sections 897 and 1445 of the Code, together with a notice to the IRS (which will be filed by Acquiror with the IRS following the Rana Closing) in accordance with the provisions
of Section 1.897-2(h)(2) of
the Treasury Regulations;
 
  (f)
Rana has delivered to Acquiror the PCAOB Financials together with an unqualified report therein of the auditors of the Company and its subsidiaries, if applicable, and the PCAOB Financials for periods covered by the Unaudited Financials and Latest Balance Sheet (and the related unaudited consolidated statements of operations and comprehensive loss and cash flows of the Company and its subsidiaries for
the six-month period
then ended) do not differ from those disclosed on the Company Disclosure Schedule;
 
  (g)
all conditions to consummation of the Afinoz Business Combination Agreement have been satisfied or waived by the applicable parties thereto; and
 
  (j)
the Trust Fund contains funds sufficient to pay the Rana Cash Consideration and the Afinoz Cash Consideration (defined below), in full.
Rana
The obligations of Rana to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to Rana Closing of the following additional conditions:
 
  (a)
the representations and warranties of FEXD and Merger Sub contained in the sections titled (i) Corporation Organization (ii) Capitalization, (iii) Authority Relative to this Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Acquiror and Merger Sub contained in the Rana Business Combination Agreement are true and correct (without giving any effect to any limitation as to “materiality” or “Acquiror Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in an Acquiror Material Adverse Effect;
 
  (b)
FEXD and Merger Sub have performed or complied in all material respects with all agreements and covenants required by the Rana Business Combination Agreement to be performed or complied with by them on or prior to the Effective Time;
 
  (c)
FEXD has delivered to the Shareholder Representative, the Escrow Agreement, duly executed by FEXD; and
 
  (d)
FEXD has delivered to Rana a customary officer’s certificate dated the date of the Rana Closing, certifying as to the satisfaction of certain conditions.
Termination
The Rana Business Combination Agreement may be terminated and the Proposed Rana Transactions may be abandoned at any time prior to the Effective Time, notwithstanding any requisite approval and adoption of the Rana Business Combination Agreement and the Proposed Rana Transactions by the stockholders of Rana or Acquiror, as follows:
 
  (a)
by mutual written consent of Rana and the Company;
 
  (b)
by either FEXD or Rana, if: (i) the Effective Time has not occurred prior to the twelve-month anniversary of the date of the Rana Business Combination Agreement (the “
Rana Outside Date
”); provided, however, that the Rana Business Combination Agreement may not be terminated by or on behalf of any party (A) that either directly or indirectly through its affiliates is in breach or violation of any representation, warranty, covenant, agreement or obligation contained in the Rana Business Combination Agreement and such breach or violation is the principal cause of the failure of a condition to the Proposed Rana Transactions on or prior to the Rana Outside Date, or (B) against which any legal proceeding is brought by a party to the Rana Business Combination Agreement for specific performance or injunctive or other forms of equitable relief in connection with the Rana Business
 
 
Combination Agreement (which prohibition on such party’s right to terminate the Rana Business Combination Agreement continues throughout the pendency of such legal proceeding); (ii) any Governmental Authority in the United States has enacted, issued, promulgated, enforced or entered any permanent injunction, order, decree or ruling which has become final
and non-appealable and
has the effect of making consummation of the Proposed Rana Transactions, including the Merger, illegal or otherwise prevents or prohibits consummation of the Proposed Rana Transactions or the Merger; or (iii) any of the Acquiror Proposals fail to receive the requisite vote for approval at the Acquiror Stockholders’ Meeting;
 
 
(c)
by FEXD if (i) there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of the Company set forth in the Rana Business Combination Agreement, or if any representation or warranty of the Company has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of the Company specified above would not be satisfied (“
Terminating Company Breach
”); provided, however, that FEXD has not waived such Terminating Company Breach and FEXD and Merger Sub are not then in material breach of their representations, warranties, covenants or agreements in the Rana Business Combination Agreement; provided further, however, that, if such Terminating Company Breach is curable by Rana, FEXD may not terminate the Rana Business Combination Agreement under this provision for so long as the Company continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by FEXD to Rana; (ii) the PCAOB Financials (together with an unqualified report therein of the auditors of Rana and its subsidiaries, if applicable) are not delivered to FEXD by Rana on or before the dates required under the Rana Business Combination Agreement; or (iii) if the PCAOB Financials delivered to Acquiror by the Company for periods covered by the Unaudited Financials and Latest Balance Sheet (and the related unaudited consolidated statements of operations and comprehensive loss and cash flows of the Company and its subsidiaries for the
six-month
period then ended) differ from those disclosed on the Company Disclosure Schedule;
 
 
(d)
by Rana if there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of FEXD and Merger Sub set forth in the Rana Business Combination Agreement, or if any representation or warranty of FEXD and Merger Sub has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of FEXD and Merger Sub specified above would not be satisfied (“
Terminating Acquiror/Merger Sub Breach
”); provided, however, that Rana has not waived such Terminating Acquiror/Merger Sub Breach and Rana is not then in material breach of its representations, warranties, covenants or agreements in the Rana Business Combination Agreement; provided further, however, that, if such Terminating Acquiror/Merger Sub Breach is curable by FEXD and Merger Sub, Rana may not terminate the Rana Business Combination Agreement under this section for so long as FEXD and Merger Sub continue to exercise their reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by Rana to FEXD.
Effect of Termination
If the Rana Business Combination Agreement is terminated, the agreement will forthwith become void, and there will be no liability under the Rana Business Combination Agreement on the part of any party thereto, except as set forth in the Rana Business Combination Agreement or in the case of termination subsequent to a willful material breach of the Rana Business Combination Agreement by a party thereto.
The closing of the Proposed
Rana
Transactions (the “Rana Closing”) will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Rana Business Combination has not been closed.
 
Afinoz Business Combination Agreement
On September 11, 2022, the Company, announced that it, Fama Financial Services, Inc., a Georgia corporation and wholly owned subsidiary of the Company (“Merger Sub”), Monisha Sahni, Rachna Suneja and Ritscapital, LLC (collectively the “Members”) and Monisha Sahni as representative of the Members (“Member Representative”), had entered into a business combination agreement (the “Afinoz Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Mobitech International LLC, a limited liability company organized in the United Arab Emirates (“Afinoz”) will become as a wholly-owned subsidiary of the Company. The key terms of the Afinoz Business Combination Agreement are as follows:
 
(a)
The transaction is structured as a purchase of limited liability company membership interests. Pursuant to the Afinoz Business Combination Agreement, on the closing date, the Company will purchase the limited liability company membership interests of Afinoz, with Afinoz continuing as a wholly-owned direct subsidiary of the Company (together with the other transactions related thereto, the “Proposed Afinoz Transactions”).
 
(b)
The Company shall pay a combination of Afinoz Cash Consideration and Afinoz Equity Consideration for the Company Membership Interests subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $700,000 (the “Afinoz Escrow Amount”).
The Afinoz Cash Consideration means $5,000,000 and the Afinoz Equity Consideration means 11,500,000 shares of New Acquiror Class A Common Stock.
Afinoz Representations, Warranties and Covenants
The Afinoz Business Combination Agreement contains customary representations, warranties and covenants of Afinoz and FEXD relating to, among other things, their ability to enter into the Afinoz Business Combination Agreement and their outstanding capitalization. Afinoz has agreed to customary “no shop” obligations.
Conditions to Afinoz Closing
Mutual
The obligations of Afinoz and FEXD to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to the Afinoz Closing, of the following conditions:
 
  (a)
the Acquiror Proposals have been approved and adopted by the requisite affirmative vote of the stockholders of Acquiror in accordance with the Proxy Statement, the Delaware General Corporation Law, the organizational documents of FEXD and the rules and regulations of Nasdaq;
 
  (b)
no Governmental Authority has enacted, issued, promulgated, enforced or entered any Law, rule, regulation, judgment, decree, executive order or award which is then in effect and has the effect of making the Proposed Afinoz Transactions illegal or otherwise prohibiting consummation of the Proposed Afinoz Transactions; and
 
  (c)
the shares of New Acquiror Class A Common Stock to be issued in connection with the Proposed Afinoz Transactions shall have been approved for listing on Nasdaq, and immediately following the Closing Acquiror shall satisfy any applicable listing requirements of Nasdaq and Acquiror shall not have received any notice
of non-compliance therewith.
FEXD
The obligations of FEXD to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to the Afinoz Closing of the following additional conditions:
 
  (a)
the representations and warranties of FEXD contained in the sections titled (i) Organization and Qualification; Subsidiaries, (ii) Capitalization, (iii) Authority Relative to this Business Combination
 
Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Afinoz contained in the Afinoz Business Combination Agreement shall be true and correct (without giving any effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect;
 
  (b)
Afinoz, the Members and Member Representative, as applicable, have performed or complied in all material respects with all agreements and covenants required by the Afinoz Business Combination Agreement to be performed or complied with by each of them on or prior to the Afinoz Closing;
 
  (c)
the Member Representative has delivered to Acquiror the Escrow Agreement, duly executed by the Member Representative;
 
  (d)
Afinoz has delivered to FEXD a customary officer’s certificate, dated the date of the Afinoz Closing, certifying as to the satisfaction of certain conditions;
 
  (e)
no Company Material Adverse Effect has occurred between the date of the Rana Business Combination Agreement and the Closing Date;
 
  (f)
on or prior to the Afinoz Closing, each of the Members shall deliver to Acquiror a properly executed and duly completed Internal Revenue Service
Form W-8BEN;
 
  (g)
on or prior to the Afinoz Closing, each of the Members delivered to Acquiror the relevant ‘Tax residency certificate’ or any other similar requirements/certifications or evidences, as mandated under any of the domestic tax laws of their respective jurisdiction or territory, in order to claim the benefits of
the India-UAE Double
Tax Avoidance Agreement and to establish that no Indian withholding Tax is required to be deducted or withheld from the payment of consideration to such Member;
 
  (h)
Afinoz has delivered to Acquiror the PCAOB Financials required to be delivered under the Afinoz Business Combination Agreement;
 
  (i)
Afinoz has delivered to Acquiror evidence that it has executed certain regulatory filings with either the free-zone authority in the Sharjah Media City Free-Zone of the United Arab Emirates or the United Arab Emirates Ministry of Economy, as required pursuant to the Afinoz Business Combination Agreement;
 
  (j)
the Rana Business Combination Agreement has been consummated;
 
  (k)
the Trust Fund contains funds sufficient to pay the Rana Cash Consideration and the Afinoz Cash Consideration, in full; and
 
  (l)
Acquiror has completed its due diligence exercise on Afinoz and its subsidiaries, and Afinoz and its subsidiaries has resolved to Acquiror’s satisfaction any issues arising therefrom, including but not limited to, confirmation that each of the Members, Afinoz and its subsidiaries, have complied with certain conditions set forth in schedules to the Afinoz Business Combination Agreement.
 
Afinoz
The obligations of the Members and the Member Representative to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to Closing of the following additional conditions:
 
 
(a)
the representations and warranties of FEXD contained in the sections titled (i) Corporation Organization (ii) Capitalization, (iii) Authority Relative to this Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Acquiror contained in the Afinoz Business Combination Agreement are true and correct (without giving any effect to any limitation as to “materiality” or “Acquiror Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in an Acquiror Material Adverse Effect;
 
 
(b)
FEXD has performed or complied in all material respects with all agreements and covenants required by the Afinoz Business Combination Agreement to be performed or complied with by it on or prior to the Afinoz Closing;
 
 
(c)
FEXD has delivered to the Member Representative, the Escrow Agreement, duly executed by FEXD; and
 
 
(d)
FEXD has delivered to Afinoz a customary officer’s certificate dated the date of the Afinoz Closing, certifying as to the satisfaction of certain conditions.
Termination
The Afinoz Business Combination Agreement may be terminated and the Proposed Afinoz Transactions may be abandoned at any time prior to the Closing, notwithstanding any requisite approval and adoption of the Afinoz Business Combination Agreement and the Proposed Afinoz Transactions by the Members and stockholders of Acquiror, as follows:
 
 
(a)
by mutual written consent of the Acquiror and Member Representative;
 
 
(b)
by either FEXD or the Member Representative, if: (i) the Closing has not occurred prior to the twelve-month anniversary of the date of the Afinoz Business Combination Agreement (the “
Afinoz Outside
Date
”); provided, however, that the Afinoz Business Combination Agreement may not be terminated by or on behalf of any party (A) that either directly or indirectly through its affiliates is in breach or violation of any representation, warranty, covenant, agreement or obligation contained in the Afinoz Business Combination Agreement and such breach or violation is the principal cause of the failure of a condition to the Proposed Afinoz Transactions on or prior to the Afinoz Outside Date, or (B) against which any legal proceeding is brought by a party to the Rana Business Combination Agreement for specific performance or injunctive or other forms of equitable relief in connection with the Afinoz Business Combination Agreement (which prohibition on such party’s right to terminate the Afinoz Business Combination Agreement continues throughout the pendency of such legal proceeding); (ii) any Governmental Authority in the United States has enacted, issued, promulgated, enforced or entered any permanent injunction, order, decree or ruling which has become final and
non-appealable
and has the effect of making consummation of the Proposed Afinoz Transactions, illegal or otherwise
 
prevents or prohibits consummation of the Proposed Afinoz Transactions; or (iii) any of the Acquiror Proposals fail to receive the requisite vote for approval at the Acquiror Stockholders’ Meeting;
 
 
(c)
by FEXD if: (i) there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of any Member set forth in the Afinoz Business Combination Agreement, or if any representation or warranty of any Member has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of the Members specified above would not be satisfied (“
Terminating Member Breach
”); provided, however, that FEXD has not waived such Terminating Member Breach and FEXD is not then in material breach of its representations, warranties, covenants or agreements in the Afinoz Business Combination Agreement; provided further, however, that, if such Terminating Member Breach is curable by the applicable Member, FEXD may not terminate the Afinoz Business Combination Agreement under this provision for so long as such Member continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by FEXD to the applicable Member; (ii) the PCAOB Financials are not delivered to FEXD by the Member Representative on or before the dates required under the Afinoz Business Combination Agreement; (iii) the Rana Business Combination Agreement is terminated; or (iv) if Afinoz fails to comply, within thirty days of signing the Afinoz Business Combination Agreement, with certain specific conditions precedent set forth in schedules to the Afinoz Business Combination Agreement.
 
 
(d)
by the Member Representative if there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of FEXD set forth in the Afinoz Business Combination Agreement, or if any representation or warranty of FEXD has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of FEXD specified above would not be satisfied (“
Terminating Acquiror Breach
”); provided, however, that Afinoz has not waived such Terminating Acquiror Breach and Afinoz is not then in material breach of its representations, warranties, covenants or agreements in the Afinoz Business Combination Agreement; provided further, however, that, if such Terminating Acquiror Breach is curable by FEXD, Afinoz may not terminate the Afinoz Business Combination Agreement under this section for so long as FEXD continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by Afinoz to FEXD.
Effect of Termination
If the Afinoz Business Combination Agreement is terminated, the agreement will forthwith become void, and there will be no liability under the Afinoz Business Combination Agreement on the part of any party thereto, except as set forth in the Afinoz Business Combination Agreement or in the case of termination subsequent to a willful material breach of the Afinoz Business Combination Agreement by a party thereto.
The Afinoz Closing will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Afinoz Business Combination has not been closed.
Lock-Up Agreements
The Company has entered into the three general forms
of lock-up agreements
described below with stockholders and employees of Rana and Afinoz. The general terms below apply to
all lock-up agreements.
The employee-specific terms apply to the Employee
Stockholder Lock-Up and
Protective Covenant Agreement and the Employee
Optionholder Lock-Up, Unvested
Stock & Protective Covenant Agreement. The employee optionholder-specific terms apply only to the Employee
Optionholder Lock-Up, Unvested
Stock & Protective Covenant Agreement. Capitalized terms used but not otherwise defined in the description of the
lock-up
agreements below have the meanings given to them in the applicable form of
lock-up
agreement.
 
General Terms
The stockholders and certain employees of Rana and Afinoz that own equity interests have entered into lock-up agreements with Acquiror wherein they have agreed not to Transfer any shares of New Acquiror Class A Common Stock for the period commencing upon the Effective Time and ending one year after the Effective Time, provided, however, that such restriction shall expire if the reported last sale price of New Acquiror Class A Common Stock equals or exceeds $
12.00
per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any
twenty trading days within any thirty-trading day period commencing at least 150 days after the Effective Time.
Such
stockholders and employees have further agreed not to Transfer more than 200,000 Shares during any three-month period until the three-year anniversary of the Effective Date and not to Transfer more than 1,000,000 Shares during a further period thereafter, in each case subject to Permitted Transfers and the termination of restrictions upon expiration or termination of the
applicable lock-up agreement.
Employee-Specific Terms
The lock-up agreements
of certain employees of Rana and Afinoz also contain restrictive covenants regarding confidentiality, conflicts of interest, non-competition,
non-solicitation,
non-inducement
and
non-interference
during a Restricted Period commencing on the Effective Time and ending on the later to occur of (a) the fifth anniversary of the Effective Time and (b) the second anniversary of the date on which the employee’s employment with FEXD and its subsidiaries terminates for any reason.
Employee Optionholder-Specific Terms
The lock-up agreements
of the optionholder employees of Afinoz (“
Employee Optionholders
”) provide that Afinoz options outstanding prior to the Closing will convert into unvested shares of New Acquiror Class A Common Stock at Closing. The resulting Unvested Stock shall be eligible to vest on the following schedule: (a) the first quarter, as of twelve months from the Effective Time; (b) the second quarter, as of twenty-four months from the Effective Time; (c) the third quarter, as of thirty months from the Effective Time and (d) the fourth quarter, as
of thirty-six months
from the Effective Time. If the Employee Optionholder terminates the Employee Optionholder’s employment with FEXD and its subsidiaries, at any time before the Unvested Stock has vested and become Vested Stock, then the Employee Option holder’s Unvested Stock outstanding on the date of termination of employment shall be automatically forfeited. If the Employee Optionholder’s employment with FEXD and its subsidiaries is terminated by FEXD or any of its subsidiaries for Cause at any time before all of the Unvested Stock has vested and become Vested Stock, then all of the Employee Optionholder’s Unvested Stock and Vested Stock shall be automatically forfeited.
Employment Offer Letters
On December 20, 2022, the Company entered into a conditional offer letter with an individual for the position of Chief Marketing Officer of FEXD (the “CMO Offer Letter”). Pursuant to the CMO Offer Letter, the individual will become the Chief Marketing Officer of FEXD on June 1, 2023. The appointment is contingent upon the consummation of the business combination among FEXD, Rana and Afinoz and shareholder approval. Upon effectiveness, the Chief Marketing Officer will receive an annual salary of $
400,000
, up to $
150,000
in performance bonuses with $
15,000
guaranteed, $
200,000
in FEXD stock vesting over
three
years with a
12-month
cliff and standard benefits.
On December 20, 2022, the Company entered into a conditional offer letter with an individual for the position of Chief Executive Officer of Fama Financial Services (the “CEO Offer Letter”). Pursuant to the CEO Offer Letter, the individual will become the Chief Executive Officer of FEXD on June 1, 2023. The appointment is contingent upon the consummation of the business combination among FEXD, Rana and Afinoz and shareholder approval. Upon effectiveness, the Chief Executive Officer will receive an annual salary of $
500,000, a minimum cash
 
bonus of 30 percent of the annual salary year one, 20% percent on year two and 15% from year three onwards (subject to a objective based target bonus of up to 200% of prevailing salary which will be split equally with stocks vested over a period of three years and cash), $50,000 in FEXD stock vesting over three years with a
12-month
cliff and standard
benefits
.
De-SPAC Service agreement
On December 12, 2022, the Company entered a service agreement, effective January 15, 2023, with a
third-party
de-SPAC
service provider. Pursuant to the agreement, the service provider will provide investor relation services to the Company for an initial
12-month
period. The service provider will receive compensation of $90,000 from the Company for its services covering the initial
12-month
period. In addition, the service provider will receive $22,500 worth of shares in the de-SPAC company quarterly, with the value accruing from the effective date of the service agreement.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE FINANCIAL INSTRUMENTS
 12 Months Ended
Dec. 31, 2022
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS
NOTE 7. DERIVATIVE FINANCIAL INSTRUMENTS
Warrant Liability
Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units, and only whole Public Warrants will trade. The Public Warrants will become exercisable on the date tha
t is 30 days after the completion of the initial Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable, and the Company will not be obligated to issue any shares of Class A common stock upon exercise of a Public Warrant unless Class A common stock issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Public Warrants.
The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, the Company will use its best efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the Public Warrants. The Company will use its reasonable best efforts to maintain the effectiveness of such registration statement and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the Public Warrant agreement. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $11.50 per share of Class A common
stock

(with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 
60
% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of Class A common stock during the 
10-trading day
period starting on the trading day after to the day
on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $
9.20
 
per share, then the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Description of Securities—Warrants—Public Stockholders’ Warrants—Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the 
higher of the Market Value and the Newly Issued Price, and the $
10.00
 
per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the market value and the Newly Issued Price. 
The Company may call the Public Warrants for redemption:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption, or
the 30-day
redemption period, to each warrant holder; and
 
  •  
if, and only if, the last reported sale price of Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like and for certain issuances of Class A common stock and equity-linked securities as described above) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant holders.
If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and the number of shares of Class A Common Stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances, including in the event of a stock dividend or recapitalization, reorganization, merger, or consolidation. However, the Public Warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period or during any Extension Period, and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
The Private Placement Warrants, including the October 2022 Private Placement Warrants, will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Private Placement Warrants and the Class A Common Stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and
be non-redeemable so
long as they are held by the initial purchasers or their permitted transferees (except as set forth above). If the Private Placement Warrants are held by someone other than th
e

 
initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Company accounted for the 9,650,250 warrants issued in connection with the Initial Public Offering (including
5,750,000
Public Warrants and
3,900,250
Private Placement Warrants as the underwriters’ over-allotment option was exercised in full) and the 1,150,000 October 2022 Private Placement Warrants in accordance with the guidance contained in
ASC 815-
40.
Su
ch guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The warrant agreement contains an Alternative Issuance provision that if less than 
70
% of the consideration receivable by the holders of the Class A Common Stock in the Business Combination is payable in the form of common equity in the successor entity, and if the holders of the warrants properly exercise the warrants within thirty days following the public disclosure of the consummation of Business Combination by the Company, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration paid to holders of the common stock consists exclusively of cash, the amount of such cash per common stock, and (ii) in all other cases, the volume-weighted average price of the common stock as reported during
the ten-trading day
period ending on the trading day prior to the effective date of the Business Combination.
The Company believes that the adjustments to the exercise price of the warrants are based on a variable that is not an input to the fair value of
a “fixed-for-fixed” option
as defined under FASB ASC Topic
No
. 
815
–
40
, and thus the warrants are not eligible for an exception from derivative accounting. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon closing the Proposed Public Offering. Accordingly, the Company will classify its Public Warrant, Private Placement Warrant as a liability at its fair value, and the warrants will be estimated using a valuation model prepared by an outside valuation firm. The valuation model uses inputs such as assumed share prices, volatility, discount factors, and other assumptions and may not reflect the price at which they can be settled. This liability is subject to remeasurement at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.
Forward Purchase Agreement
On July 
16
,
2021
, the Company entered into a forward purchase agreement (the “Forward Purchase Agreement”) with Caltech Trading Corp., an anchor investor. Pursuant to the Forward Purchase Agreement, Caltech Trading Corp. will agree to purchase a minimum of 
8,000,000
 units and a maximum of 
9,000,000
 units (the “Forward Purchase Units”), with each Forward Purchase Unit consisting of
one
share of Class A common stock (a “Forward Purchase Share”),
one
right to
receive one-tenth (1/10)
of
one
share of its Class A common stock (a “Forward Purchase Right”)
and one-half of
one
warrant to purchase
one
share of Class A common stock (a “Forward Purchase Warrant”), at a price of $
10.00
 per Forward Purchase Unit, for a minimum aggregate purchase price of $
80.0
 million and a maximum aggregate purchase price of up to $
90.0
 million. The shares of Class A common stock to be issued under the Forward Purchase Agreement will have
no
redemption rights and
no
right to liquidate distributions from the Trust Account. The Forward Purchase Shares, the Forward Purchase Rights and Forward Purchase Warrants will be identical to the shares of Class A Common Stock, the Public Rights, and the Public Warrants, respectively, included in the Public Units to be sold in the Proposed Offering. The purchase of the Forward Purchase Units will occur concurrently and only in connection with the closing of the Business Combination. The Forward Purchase Shares, Forward Purchase Rights and Forward Purchase
Warrants (and the shares of Class A common stock underlying such securities) are subject to registration rights. Caltech’s Trading commitment under the Forward Purchase Agreement is subject to customary closing conditions, including that the Business Combination must be consummated substantially concurrently with the purchase of the Forward Purchase Units. The obligations of Caltech Trading under the Forward Purchase Agreement do not depend on whether any Class A common shares held by public shareholders are redeemed by the Company.
The Company accounted for the Forward Purchase Agreement in accordance with the guidance
in ASC 815-40 and accounts
for such agreement as a derivative liability. The liability is subject to
re-measurement
at each balance sheet date, with changes in fair value recognized in the statements of operations.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE OF FINANCIAL INSTRUMENTS
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS
NOTE 8. FAIR VALUE OF FINANCIAL INSTRUMENTS
The following table presents information about the Company’s derivative warrant liabilities and forward purchase agreement liability that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:
As of December 31, 2022
 
Description
   
Quoted Prices in
Active Markets
(Level 1)
     
Significant Other
Observable Inputs
(Level 2)
     
Significant Other
Unobservable Inputs
(Level 3)
  
Public Warrants
    $ 402,500      $ —        $ —    
Private Placement Warrants
      —          353,518        —    
Forward Purchase Agreement Liability
      —          —          285,567  
    
 
 
     
 
 
     
 
 
  
Total
    $ 402,500      $ 353,518      $ 285,567  
As of December 31, 2021
 
Description
   
Quoted Prices in
Active Markets
(Level 1)
     
Significant Other
Observable Inputs
(Level 2)
     
Significant Other
Unobservable Inputs
(Level 3)
  
Public Warrants
    $ —        $ —        $ 2,185,000  
Private Placement Warrants
      —          —          1,521,098  
Forward Purchase Agreement Liability
      —          —          1,726,908  
    
 
 
     
 
 
     
 
 
  
Total
    $ —        $ —        $ 5,433,006  
The estimated fair value of the Forward Purchase Agreement is determined using Level 3 inputs. Inherent in a Monte Carlo or Black-Scholes simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on
the U.S. Treasury zero-coupon yield curve on
the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
 
The change in the fair value of the derivative liabilities, measured using level 3 inputs, for the year ended December 31, 2022
 
and for the period from March 5, 2021 (inception) through December 31, 2021, is summarized as follows:
 
Derivative liabilities – level 3, at March 5, 2021 (inception)
  
$
 —  
 
Issuance of public warrants, private placement warrants, forward purchase agreement – level 3
  
  
3,894,740
 
Change in fair value
  
 
1,538,266
 
  
 
 
 
Derivative liabilities – level 3, at December 31, 2021
  
$
5,433,006
 
Transfer of public warrants to level 1 measurement
  
 
(2,185,000
) 
Transfer of private placement warrants to level 2 measurement
  
 
(1,521,098
) 
Change in fair value
  
 
(1,441,341
) 
  
 
 
 
Derivative liabilities – level 3, at December 31, 2022
  
$
285,567
 
  
 
 
 
The following table presents information about the Company’s liabilities that are measured at fair value at October 21, 2021 (Initial Public Offering date):
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      6.5 %      6.5 %      6.5 % 
Expected term
      5.75 years       5.75 years       0.75 year  
Risk-free rate
      1.33 %      1.33 %      0.09 % 
Probability of acquisition
      100.0 %      100.0 %      100.0 % 
Dividend yield
      0 %      0 %      0 % 
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2021:
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      8.4 %      8.4 %      8.4 % 
Expected term
      5.56 years       5.56 years       0.56 year  
Risk-free rate
      1.30 %      1.30 %      0.21 % 
Probability of acquisition
      100.0 %      100.0 %      100.0 % 
Dividend yield
      0 %      0 %      0 % 
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2022:
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      4.6 %      4.6 %      5.2 % 
Expected term
      5.06 years       5.06 years       0.06 year  
Risk-free rate
      3.91 %      3.91 %      4.04 % 
Probability of acquisition
      7.5 %      7.5 %      7.5 % 
Dividend yield
      0 %      0 %      0 % 
 
The following table provides a summary of the changes in the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis:
 
 
  
Private
Placement
warrants
 
  
Public
Warrants
 
  
Total
Warrant
Liability
 
  
Forward
Purchase
Agreement
 
Fair value as of March 5, 2021 (inception)
    $ —        $ —        $ —        $ —    
Issuance of Public Warrants, Private Warrants upon IPO
   
 

 1,014,065     
 

 1,380,000     
 

 2,394,065     
 

 —    
Signing of Forward Purchase Agreement upon IPO
      —          —          —          1,500,675  
Change in fair value
      507,033        805,000        1,312,033        226,233  
    
 
 
     
 
 
     
 
 
     
 
 
  
Fair value as of December 31, 2021
    $ 1,521,098      $ 2,185,000      $ 3,706,098      $ 1,726,908  
Issuance of Private Warrants
      80,500        —          80,500        —    
Change in fair value
      (1,248,080 )       (1,782,500 )       (3,030,580 )       (1,441,341 ) 
    
 
 
     
 
 
     
 
 
     
 
 
  
Fair value as of December 31, 2022
    $ 353,518      $ 402,500      $ 756,018      $ 285,567  
    
 
 
     
 
 
     
 
 
     
 
 
  
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2022
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY
NOTE 9. STOCKHOLDER’S EQUITY
Preferred Shares
The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At December 31, 2022 and 2021, there were no preferred shares issued or outstanding.
Class A Common Stock
The Company is authorized to issue 200,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 57,500 Class A Common Stock issued and outstanding excluding 11,500,000 shares subject to redemption.
Class B Common Stock
The Company is authorized to issue 20,000,000 shares of Class B Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class B Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 2,875,000 shares of Class B Common Stock issued and outstanding. Class B common stock will automatically convert into shares of Class A common stock at the time of the initial business combination
on a 
one-for-one
 basis.
Public Rights
Each holder of a Public Right will be entitled to
receive one-tenth (1/10) of
 
one share of Class A Common Stock upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon the exchange of the Public Rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination as the consideration related thereto has been included in the unit purchase price paid for by investors in the Proposed Offering. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the Class A Common Stock will receive in the transaction on
an as-converted into
Class A Common Stock
 
basis and each holder of a right will be required to affirmatively convert its rights in order to receive 1/10 share underlying each right (without paying additional consideration). The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company).
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAX
NOTE 10. INCOME TAX
The Company’s net deferred tax assets are as follows:

 
 
  
December 31,
2022
 
  
December 31,
2021
 
Deferred tax asset
                  
Start-up
costs
    $ 187,396      $ 29,691  
Net operating loss
      —          21,704  
    
 
 
     
 
 
  
Total deferred tax asset
      187,396        50,765  
    
 
 
     
 
 
  
Valuation allowance
      (187,396 )       (50,765 ) 
    
 
 
     
 
 
  
Deferred tax asset, net of allowance
    $ —        $ —    
    
 
 
     
 
 
  
The income tax provision consists of the following:

 
    
For the year
ended
December 31,

2022
     
From March 5, 2021
(inception) through
December 31,

2021
  
Federal
                  
Current
    $ 290,342      $ —    
Less:
                  
Loss carryforward
                  
Deferred
      (136,631 )       (50,765 ) 
State
                  
Current
      —          —    
Deferred
      —          —    
Change in valuation allowance
      136,631        50,765  
Income tax provision
    $ 290,342      $ —    
As of December 31, 2022, the Company has $nil of U.S. federal net operating loss carryovers.
In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2022 and for the period from March 5 (inception) through to December 31, 2021, the change in the valuation allowance was $136,631 and $50,765, respectively.
 
A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and 2021 is as follows:
 
 
  
December 31,
2022
 
 
December 31,
2021
 
Statutory federal income tax rate
      21 %      21 % 
Transaction costs associated with the Initial Public Offering
      6 %      (1 )% 
Change in valuation allowance
      3 %      (3 )% 
Change in fair value of warrant liabilities and forward purchase agreement
      (23 )%     (17 )% 
 
 
 
 
 
 
 
 
 
Income tax provision
      7 %      0 % 
Income tax is generally
open
for three years
for
examination by IRS.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2022
SUBSEQUENT EVENTS [Abstract]  
SUBSEQUENT EVENTS
NOTE 11. SUBSEQUENT EVENTS
In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued. Based on this review, except the event below, the Company did not identify any subsequent events through the date of the issuance of the
consolidated
financial statements that would have required disclosure or adjustment in the
consolidated
financial statements:
O
n January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “January 2023 Private Placement Warrants”), generating total proceeds of $1,150,000. The January 2023 Private Placement Warrants were purchased by the Sponsor and are substantially similar to the private placement warrants issued to the Sponsor at the time of IPO in October 2021. The January 2023 Private Placement Warrants have been issued pursuant to and are governed by a Warrant Agreement that is substantially similar to the Warrant Agreement that the Company entered into at the time of the IPO. Similar to the private placement warrants issued at the time of the IPO, the January 2023 Private Placement Warrants will not be transferable, assignable or salable until 30 days after the Company’s initial business combination and, unlike such private placement warrants, are not redeemable by the Company at any time (including following transfer by the Sponsor or its permitted transferees).
The proceeds received by the Company in connection with the issuance of the January 2023 Private Placement Warrants have been deposited in the trust account (the “Trust Account”) established at the time of the IPO. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account on or prior to January 21, 2023 will extend by three months until April 21, 2023, the time the Company will have to consummate an initial business combination.
On January 20, 2023, the Company entered into a $200,000 promissory note (the “January 2023 Note”) with its Sponsor. The January 2023 Note is
non-interest
bearing and has a maturity date on the earlier of: (i) the Initia
l
 Business Combination date; and (ii) July 15, 2023.
On April 10, 2023, timely, pursuant to the terms of the Rana Business Combination Agreement dated September 9, 2022, the Company sent a letter to Rana Financial, Inc. regarding its failure to deliver audited financial statements.
The Company also notified Rana of its intent to propose the termination of the Rana Business Combination Agreement and abandonment of the proposed business combination if the audited financial statements are not delivered to the Company by April 21, 2023.
 
On April 20, 2023, the Company held a special meeting of stockholders in lieu of its 2023 annual meeting to consider and vote upon (a) a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company has to consummate its initial business combination for a maximum of twelve (12) additional one month periods, from April 21, 2023 to April 21, 2024, or such earlier date as determined by its board of directors and (b) a proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the aforementioned extension. In connection with this vote, the Company expects that eighty (80) holders will redeem an aggregate of 7,527,997 shares of the Company at an estimated redemption price of $10.48 per share or $78,893,408.56 in the aggregate.
 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Basis of presentation
Basis of presentation
The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Principle of consolidation
Principle of consolidation
The consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Fama Financial Services, Inc. (“Fama”), which was incorporated on August 23, 2022 in the State of Georgia. There were no material business activities in Fama for the period from its incorporation date to December 31, 2022. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.
Emerging growth company
Emerging growth company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act’’), and it may take advantage of certain exemptions from various reporting requirements that apply to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can opt-out of
the extended transition period and comply with the requirements that apply
 
to non-emerging growth
companies, but any such election
to opt-out is
irrevocable. The Company has elected not
to opt-out of
such an extended transition period, which means that when a standard is issued or
 
revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison of the Company’s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult
or
impossible because of the potential differences in accounting standards used.
Use of estimates
Use of estimates
The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As a result, the Company had cash of $10,335 and no cash equivalents on December 31, 2022. The Company had cash of $612,750 and no cash equivalents on December 31, 2021.
Investment Held in Trust Account
Investment Held in Trust Account
As of December 31, 2022 and 2021, the Company had $118,985,048 and $116,152,113 investments held in the Trust Account, respectively. The investments held in the Trust Account were held in marketable treasury funds. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest income in the accompanying statements of operations. The estimated fair value of investments held in Trust Account are determined using available market information.
Income taxes
Income taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. In addition, valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as an income tax expense. There were 
no
 unrecognized tax benefits and 
no
 amounts accrued for interest and penalties as of December 
31
,
2022
and
2021
. The Company is currently not aware of any issues under review resulting in significant payments, accruals, or material deviation from its position.
 
The Company may be subject to potential examination by federal, state, and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions, and compliance with federal, state, and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company has been subject to income tax examinations by major taxing authorities since its inception.
O
n August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023.
 
The exercise tax imposes a 1% tax on covered corporations on the fair market value of any stock of the corporation which is repurchased by such corporation for taxable years beginning after December 31, 2022. The exercise tax is applicable to certain SPAC redemptions, including in connection with a SPAC’s business combination. The amount of a redemption subject to the exercise tax is reduced by the fair market value of any stock issued by the SPAC during the taxable year of the redemption. The Company has not completed its initial business combination and there were no share redemptions during the year ended December 31, 2022. The exercise tax will only be applicable to the Company for its taxable years post December 31, 2022. The Company is still in the process of assessing the effects of the exercise tax to its consolidated financial statements.
Net income (loss) per common share
Net income (loss) per common share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.
The calculation of diluted net income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 9,650,250 shares of Class A Common Stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from inception to December 31, 2022. Accretion associated with the redeemable Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021:
Year ended December 31, 2022
 
Description
   
Class A
     
Class B
  
Basic and diluted net income per common stock:
                  
Numerator:
                  
Allocation of net income
    $ 3,072,757      $ 764,367  
Denominator:
                  
Basic and diluted weighted average common stock outstanding
      11,557,500        2,875,000  
Basic and diluted net income per common stock
    $ 0.27      $ 0.27  
 
Period from March 5, 2021 (inception) to December 31, 2021
 
Description
   
Class A
     
Class B
  
Basic and diluted net income per common stock:
                  
Numerator:
                  
Allocation of net loss
    $ (916,293 )     $ (966,310 ) 
Denominator:
                  
Basic and diluted weighted average common stock outstanding
      2,726,188        2,875,000  
Basic and diluted net loss per common stock
    $ (0.34 )     $ (0.34 ) 
Concentration of credit risk
Concentration of credit risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account.
Fair value of financial instruments
Fair value of financial instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Fair Value Measurements
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative financial instruments
Derivative financial instruments
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC
480 and ASC 815-15. The classification of
derivative instruments, including whether such instruments
 
should be recorded as liabilities or
as equity, is re-assessed at the end
of each reporting period. In accordance with ASC
825-10
“Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statements of operations as incurred.
The 5,750,000 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,900,250 Private Placement Warrants are recognized as derivative liabilities in accordance
with ASC 815-40. Accordingly,
the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject
to re-measurement at
each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo or Black-Scholes simulation model at each measurement date. Derivative warrant liabilities are classified
as non-current liabilities as their
liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Offering Costs Associated with the Initial Public Offering
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements
of ASC 340-10-S99-1 and
SEC Staff Accounting Bulletin Topic 5A-
Expenses of offering.
 Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented
as non-operating expenses
in the statements of operations. Offering costs associated with the Class A common stock were charged to stockholders’ deficit upon the completion of the Initial Public Offering.
Class A Common Stock Subject to Possible Redemption
Class A Common Stock Subject to Possible Redemption
All of the 11,500,000 shares of Class A common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with ASC 480, conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, 11,500,000 shares of Class A common stock subject to possible redemption at the redemption
amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
 
As of December 31, 2022 and 2021, the common shares reflected on the balance sheets are reconciled in the following table:

 
Gross proceeds from IPO
   
$
 115,000,000  
Less:
         
Proceeds allocated to Public Warrants
      (1,380,000 ) 
Class A common share issuance costs
      (6,309,800 ) 
    
 
 
  
Plus:
         
Accretion of carrying value to redemption value
      8,839,800  
    
 
 
  
Class A common shares subject to redemption at December 31, 2021
   
$
116,150,000
 
    
 
 
  
Plus:
         
Remeasurement to common stock subject to possible redemption amount
      2,242,240  
Class A common shares subject to redemption at December 31, 2022
   
$
118,392,240
 
    
 
 
  
Issued and adopted accounting standards
Issued and adopted accounting standards
In August 2020, the FASB issued
ASU 2020-06, Debt-Debt
with Conversion and Other Options
(Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity’s Own Equity
(Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity
(“ASU 2020-06”), which
simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions required for equity-linked contracts to qualify for scope exception. In addition, it simplifies the diluted earnings per share calculation in certain areas.
ASU 2020-06
is effective January 1, 2024 for fiscal years beginning after December 15, 2023 for smaller reporting companies, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021.
 The Company adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have a material impact on the Company’s consolidated financial statements.
Outside of the above, management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s
consolidated
financial
statements
.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021:
Year ended December 31, 2022
 
Description
   
Class A
     
Class B
  
Basic and diluted net income per common stock:
                  
Numerator:
                  
Allocation of net income
    $ 3,072,757      $ 764,367  
Denominator:
                  
Basic and diluted weighted average common stock outstanding
      11,557,500        2,875,000  
Basic and diluted net income per common stock
    $ 0.27      $ 0.27  
 
Period from March 5, 2021 (inception) to December 31, 2021
 
Description
   
Class A
     
Class B
  
Basic and diluted net income per common stock:
                  
Numerator:
                  
Allocation of net loss
    $ (916,293 )     $ (966,310 ) 
Denominator:
                  
Basic and diluted weighted average common stock outstanding
      2,726,188        2,875,000  
Basic and diluted net loss per common stock
    $ (0.34 )     $ (0.34 ) 
Summary of Basic and Diluted Net Income (Loss) Per Share
Gross proceeds from IPO
   
$
 115,000,000  
Less:
         
Proceeds allocated to Public Warrants
      (1,380,000 ) 
Class A common share issuance costs
      (6,309,800 ) 
    
 
 
  
Plus:
         
Accretion of carrying value to redemption value
      8,839,800  
    
 
 
  
Class A common shares subject to redemption at December 31, 2021
   
$
116,150,000
 
    
 
 
  
Plus:
         
Remeasurement to common stock subject to possible redemption amount
      2,242,240  
Class A common shares subject to redemption at December 31, 2022
   
$
118,392,240
 
    
 
 
  
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities measured at fair value on a recurring basis
The following table presents information about the Company’s derivative warrant liabilities and forward purchase agreement liability that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:
As of December 31, 2022
 
Description
   
Quoted Prices in
Active Markets
(Level 1)
     
Significant Other
Observable Inputs
(Level 2)
     
Significant Other
Unobservable Inputs
(Level 3)
  
Public Warrants
    $ 402,500      $ —        $ —    
Private Placement Warrants
      —          353,518        —    
Forward Purchase Agreement Liability
      —          —          285,567  
    
 
 
     
 
 
     
 
 
  
Total
    $ 402,500      $ 353,518      $ 285,567  
As of December 31, 2021
 
Description
   
Quoted Prices in
Active Markets
(Level 1)
     
Significant Other
Observable Inputs
(Level 2)
     
Significant Other
Unobservable Inputs
(Level 3)
  
Public Warrants
    $ —        $ —        $ 2,185,000  
Private Placement Warrants
      —          —          1,521,098  
Forward Purchase Agreement Liability
      —          —          1,726,908  
    
 
 
     
 
 
     
 
 
  
Total
    $ —        $ —        $ 5,433,006  
Schedule Of Fair Value Of Derivative Liabilities Measured On Recurring Basis [Table Text Block]
The change in the fair value of the derivative liabilities, measured using level 3 inputs, for the year ended December 31, 2022
 
and for the period from March 5, 2021 (inception) through December 31, 2021, is summarized as follows:
 
Derivative liabilities – level 3, at March 5, 2021 (inception)
  
$
 —  
 
Issuance of public warrants, private placement warrants, forward purchase agreement – level 3
  
  
3,894,740
 
Change in fair value
  
 
1,538,266
 
  
 
 
 
Derivative liabilities – level 3, at December 31, 2021
  
$
5,433,006
 
Transfer of public warrants to level 1 measurement
  
 
(2,185,000
) 
Transfer of private placement warrants to level 2 measurement
  
 
(1,521,098
) 
Change in fair value
  
 
(1,441,341
) 
  
 
 
 
Derivative liabilities – level 3, at December 31, 2022
  
$
285,567
 
  
 
 
 
Summary of significant inputs to the black-scholes option pricing model for the fair value of the founder warrants
The change in the fair value of the derivative liabilities, measured using level 3 inputs, for the year ended December 31, 2022
 
and for the period from March 5, 2021 (inception) through December 31, 2021, is summarized as follows:
 
Derivative liabilities – level 3, at March 5, 2021 (inception)
  
$
 —  
 
Issuance of public warrants, private placement warrants, forward purchase agreement – level 3
  
  
3,894,740
 
Change in fair value
  
 
1,538,266
 
  
 
 
 
Derivative liabilities – level 3, at December 31, 2021
  
$
5,433,006
 
Transfer of public warrants to level 1 measurement
  
 
(2,185,000
) 
Transfer of private placement warrants to level 2 measurement
  
 
(1,521,098
) 
Change in fair value
  
 
(1,441,341
) 
  
 
 
 
Derivative liabilities – level 3, at December 31, 2022
  
$
285,567
 
  
 
 
 
The following table presents information about the Company’s liabilities that are measured at fair value at October 21, 2021 (Initial Public Offering date):
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      6.5 %      6.5 %      6.5 % 
Expected term
      5.75 years       5.75 years       0.75 year  
Risk-free rate
      1.33 %      1.33 %      0.09 % 
Probability of acquisition
      100.0 %      100.0 %      100.0 % 
Dividend yield
      0 %      0 %      0 % 
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2021:
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      8.4 %      8.4 %      8.4 % 
Expected term
      5.56 years       5.56 years       0.56 year  
Risk-free rate
      1.30 %      1.30 %      0.21 % 
Probability of acquisition
      100.0 %      100.0 %      100.0 % 
Dividend yield
      0 %      0 %      0 % 
The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2022:
 
Inputs
   
Public Warrants
    
Private Placement
Warrants
    
Forward Purchase
Units
  
Exercise price
    $ 11.50     $ 11.50     $ 10.00  
Volatility
      4.6 %      4.6 %      5.2 % 
Expected term
      5.06 years       5.06 years       0.06 year  
Risk-free rate
      3.91 %      3.91 %      4.04 % 
Probability of acquisition
      7.5 %      7.5 %      7.5 % 
Dividend yield
      0 %      0 %      0 % 
Summary of changes in the fair value of the company's level 3 financial instruments that are measured at fair value
 
The following table provides a summary of the changes in the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis:
 
 
  
Private
Placement
warrants
 
  
Public
Warrants
 
  
Total
Warrant
Liability
 
  
Forward
Purchase
Agreement
 
Fair value as of March 5, 2021 (inception)
    $ —        $ —        $ —        $ —    
Issuance of Public Warrants, Private Warrants upon IPO
   
 

 1,014,065     
 

 1,380,000     
 

 2,394,065     
 

 —    
Signing of Forward Purchase Agreement upon IPO
      —          —          —          1,500,675  
Change in fair value
      507,033        805,000        1,312,033        226,233  
    
 
 
     
 
 
     
 
 
     
 
 
  
Fair value as of December 31, 2021
    $ 1,521,098      $ 2,185,000      $ 3,706,098      $ 1,726,908  
Issuance of Private Warrants
      80,500        —          80,500        —    
Change in fair value
      (1,248,080 )       (1,782,500 )       (3,030,580 )       (1,441,341 ) 
    
 
 
     
 
 
     
 
 
     
 
 
  
Fair value as of December 31, 2022
    $ 353,518      $ 402,500      $ 756,018      $ 285,567  
    
 
 
     
 
 
     
 
 
     
 
 
  
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Summary of Net Deferred Tax Assets
The Company’s net deferred tax assets are as follows:

 
 
  
December 31,
2022
 
  
December 31,
2021
 
Deferred tax asset
                  
Start-up
costs
    $ 187,396      $ 29,691  
Net operating loss
      —          21,704  
    
 
 
     
 
 
  
Total deferred tax asset
      187,396        50,765  
    
 
 
     
 
 
  
Valuation allowance
      (187,396 )       (50,765 ) 
    
 
 
     
 
 
  
Deferred tax asset, net of allowance
    $ —        $ —    
    
 
 
     
 
 
  
Summary of Income Tax Provision
The income tax provision consists of the following:

 
    
For the year
ended
December 31,

2022
     
From March 5, 2021
(inception) through
December 31,

2021
  
Federal
                  
Current
    $ 290,342      $ —    
Less:
                  
Loss carryforward
                  
Deferred
      (136,631 )       (50,765 ) 
State
                  
Current
      —          —    
Deferred
      —          —    
Change in valuation allowance
      136,631        50,765  
Income tax provision
    $ 290,342      $ —    
Summary of Effective Income Tax Rate Reconciliation
 
A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and 2021 is as follows:
 
 
  
December 31,
2022
 
 
December 31,
2021
 
Statutory federal income tax rate
      21 %      21 % 
Transaction costs associated with the Initial Public Offering
      6 %      (1 )% 
Change in valuation allowance
      3 %      (3 )% 
Change in fair value of warrant liabilities and forward purchase agreement
      (23 )%     (17 )% 
 
 
 
 
 
 
 
 
 
Income tax provision
      7 %      0 % 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Additional Information (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Jan. 20, 2023
Oct. 21, 2022
Oct. 21, 2021
Dec. 31, 2021
Dec. 31, 2022
Oct. 19, 2022
Aug. 02, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Entity incorporation date         Mar. 05, 2021    
Stock issued during period, Shares     1,500,000        
Proceeds from issuance initial public offering       $ 115,000,000 $ 0    
Term of restricted investments         185 days    
Minimum net worth required for compliance         $ 5,000,001    
Combination period description         The Company will have until 12 months, being October 21, 2022, (or 15 or 18 months, depending on whether we elect to extend the initial 12-month term for up to two additional three-month terms) from the effective date of the registration statement to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem     
Combination period, term one         12 months    
Combination period, term two         15 months    
Combination period, term three         18 months    
Liquidation basis of accounting, accrued costs to dispose of assets and liabilities         $ 50,000    
Per share value of restricted assets         $ 10.1    
Working Capital         $ 1,759,163    
Payments to acquire restricted investments       116,150,000 1,150,000    
Payments of Stock Issuance Costs     $ 6,061,368 6,309,800      
Deferred underwriting commissions     $ 3,737,500        
Underwriter stock option period     45 days        
Operating Bank Account Balance         10,335    
Assets Held-in-trust       116,152,113 118,985,048    
Proceeds from Issuance of Private Placement       $ 3,900,250 $ 0    
Promisory Note [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Debt instrument, Face amount             $ 200,000
Initial Public Offering And Private Placement Of Warrants [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Payments to acquire restricted investments     $ 116,150,000        
Per unit amount placed in trust account     $ 10.1        
IPO [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, Shares     11,500,000        
Private Placement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Proceeds from issuance initial public offering     $ 115,000,000        
Over-Allotment Option [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, Shares     1,500,000        
Common Class A [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Temporary equity, redemption price per share         $ 10.1    
Percentage of common shares to be redeemed in case business combination is not completed within the combination period         100.00%    
Common Class A [Member] | Minimum [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Percentage of common stock for which redemption rights restriction applied         15.00%    
Common Class A [Member] | IPO [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, Shares     10,000,000   11,500,000    
Shares issued, price per share     $ 10        
Subsequent Event [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Proceeds from Issuance of Private Placement $ 1,150,000            
Subsequent Event [Member] | Private Placement Warrants [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Number of Warrants Issued 1,150,000            
Price Per Warrant $ 1            
Sponsor [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Loans Received         $ 141,768    
Loans Repaid         141,768    
Proceeds from Issuance of Private Placement   $ 1,150,000          
Sponsor [Member] | Promisory Note [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Debt instrument, Face amount           $ 300,000  
Sponsor [Member] | Founder Shares [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Cash Received For Offering Cost In exchange Of Shares         $ 25,000    
Sponsor [Member] | Private Placement Warrants [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Number of Warrants Issued   1,150,000          
Price Per Warrant   $ 1          
Sponsor [Member] | Private Placement Warrants [Member] | Private Placement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Number of Warrants Issued     3,900,250   3,900,250    
Price Per Warrant     $ 1   $ 1    
FEXD Sponsor [Member] | January 2023 Promissory Note [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Debt instrument, Face amount $ 200,000            
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share, Basic and Diluted (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Earnings Per Share Basic And Diluted [Line Items]    
Allocation of net loss $ (1,882,603) $ 3,837,124
Common Class A [Member]    
Earnings Per Share Basic And Diluted [Line Items]    
Allocation of net loss $ (916,293) $ 3,072,757
Basic weighted average common stock outstanding 2,726,188 11,557,500
Diluted weighted average common stock outstanding 2,726,188 11,557,500
Basic net income (loss) per common stock $ (0.34) $ 0.27
Diluted net income (loss) per common stock $ (0.34) $ 0.27
Common Class B [Member]    
Earnings Per Share Basic And Diluted [Line Items]    
Allocation of net loss $ (966,310) $ 764,367
Basic weighted average common stock outstanding 2,875,000 2,875,000
Diluted weighted average common stock outstanding 2,875,000 2,875,000
Basic net income (loss) per common stock $ (0.34) $ 0.27
Diluted net income (loss) per common stock $ (0.34) $ 0.27
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) - USD ($)
 12 Months Ended
Aug. 16, 2022
Oct. 21, 2021
Dec. 31, 2022
Dec. 31, 2021
Cash     $ 10,335 $ 612,750
Cash Equivalents     0 0
Assets Held-in-trust     118,985,048 116,152,113
Unrecognized tax benefits     0 0
Unrecognized tax benefits, Income tax penalties and interest accrued     0 0
Cash, FDIC insured amount     $ 250,000 $ 250,000
Shares Issued   1,500,000    
Percentage of fair market value of shares repurchased 1.00%      
Inflation Reduction Act 2022 [Member]        
Percentage of excise tax on repurchase of stock 1.00%      
Common Class A [Member]        
Temporary Equity, Shares Issued     11,500,000  
Private Placement [Member] | Private Placement Warrants [Member]        
Warrant as Derivative Liability     3,900,250  
IPO [Member]        
Shares Issued   11,500,000    
IPO [Member] | Common Class A [Member]        
Shares Issued   10,000,000 11,500,000  
IPO [Member] | Warrant [Member]        
Number of Warrants Issued     5,750,000  
IPO [Member] | Warrant [Member] | Private Placement Warrants [Member] | Common Class A [Member]        
Number of Shares Purchased Against Warrants     9,650,250  
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Basic and Diluted Net Income (Loss) Per Share (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Oct. 21, 2021
Dec. 31, 2021
Dec. 31, 2022
Temporary Equity [Line Items]      
Gross proceeds from IPO   $ 115,000,000 $ 0
Less: Proceeds allocated to Public Warrants   (1,380,000)  
Less: Class A ordinary share issuance costs $ (6,061,368) (6,309,800)  
Plus: Accretion of carrying value to redemption value   8,839,800  
Remeasurement to common stock subject to possible redemption amount     2,242,240
Class A common shares subject to redemption   $ 116,150,000 $ 118,392,240
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
INITIAL PUBLIC OFFERING - Additional Information (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Oct. 21, 2021
Dec. 31, 2021
Dec. 31, 2022
Initial Public Offering [Line Items]      
Stock issued during period, Shares 1,500,000    
Proceeds from issuance of warrants   $ 0 $ 1,150,000
Total Offering costs incurred in Initial public offering $ 6,061,368    
Underwriting fees 1,437,500    
Deferred underwriting commissions 3,737,500    
Other Offering Costs $ 886,368    
Class of warrant or right, Number of securities called by each warrant or right 0.1    
Public Warrants [Member]      
Initial Public Offering [Line Items]      
Class of warrant or right, Exercise price of warrants or rights $ 11.5    
Common Class A [Member]      
Initial Public Offering [Line Items]      
Proceeds from issuance of warrants $ 100,000,000    
Common Class A [Member] | Public Warrants [Member]      
Initial Public Offering [Line Items]      
Class of warrant or right, Number of securities called by each warrant or right 1    
IPO [Member]      
Initial Public Offering [Line Items]      
Stock issued during period, Shares 11,500,000    
IPO [Member] | Common Class A [Member]      
Initial Public Offering [Line Items]      
Stock issued during period, Shares 10,000,000   11,500,000
Shares issued, price per share $ 10    
Over-Allotment Option [Member]      
Initial Public Offering [Line Items]      
Stock issued during period, Shares 1,500,000    
Proceeds from issuance of warrants $ 15,000,000    
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
PRIVATE PLACEMENT - Additional Information (Detail) - USD ($)
 1 Months Ended 10 Months Ended 12 Months Ended
Jan. 20, 2023
Oct. 21, 2022
Oct. 21, 2021
Oct. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Private Placement [Line Items]            
Proceeds from issuance of warrants         $ 0 $ 1,150,000
Proceeds from Issuance of Private Placement         $ 3,900,250 $ 0
Number of days warrents are not transferable after initial business combination       30 days    
Class of warrant or right, Number of securities called by each warrant or right     0.1      
Common Class A [Member]            
Private Placement [Line Items]            
Proceeds from issuance of warrants     $ 100,000,000      
Sponsor [Member]            
Private Placement [Line Items]            
Proceeds from Issuance of Private Placement   $ 1,150,000        
Subsequent Event [Member]            
Private Placement [Line Items]            
Proceeds from Issuance of Private Placement $ 1,150,000          
Private Placement Warrants [Member]            
Private Placement [Line Items]            
Class of warrant or right, Exercise price of warrants or rights           $ 11.5
Private Placement Warrants [Member] | Sponsor [Member]            
Private Placement [Line Items]            
Class of warrants or rights issued during period, Warrants   1,150,000        
Warrants issued, price per warrant   $ 1        
Private Placement Warrants [Member] | Subsequent Event [Member]            
Private Placement [Line Items]            
Class of warrants or rights issued during period, Warrants 1,150,000          
Warrants issued, price per warrant $ 1          
Private Placement [Member] | Common Class A [Member]            
Private Placement [Line Items]            
Class of warrant or right, Number of securities called by each warrant or right           1
Private Placement [Member] | Private Placement Warrants [Member] | Sponsor [Member]            
Private Placement [Line Items]            
Class of warrants or rights issued during period, Warrants     3,900,250     3,900,250
Warrants issued, price per warrant     $ 1     $ 1
Proceeds from issuance of warrants           $ 3,900,250
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS - Additional Information (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Aug. 02, 2022
Jun. 16, 2022
Oct. 21, 2021
Mar. 27, 2021
Mar. 11, 2021
Mar. 08, 2021
Dec. 31, 2021
Dec. 31, 2022
Oct. 19, 2022
Oct. 31, 2021
Notes payable, Related parties, Current             $ 0 $ 527,502    
Stock issued during period, Shares     1,500,000              
IPO [Member]                    
Stock issued during period, Shares     11,500,000              
Working Capital Loans [Member] | Working Capital Warrants [Member]                    
Debt instrument, Convertible, Carrying amount of equity component               $ 1,500,000    
Debt instrument, Convertible, Conversion price               $ 1.5    
Caltech Trading Corp [Member] | Forward Purchase Units [Member] | IPO [Member]                    
Purchase of units issued               9,000,000    
Purchase of units issued per share               $ 10    
Administrative Service [Member]                    
Accrual Expense               $ 30,000   $ 0
Sponsor [Member] | Unsecured Promissory Note [Member]                    
Debt instrument, Face amount           $ 400,000     $ 300,000  
Notes payable, Related parties, Current           $ 141,768        
Sponsor [Member] | General And Administrative Services [Member]                    
Related party transaction, Amount of transaction               5,000    
Sponsor [Member] | Working Capital Loans [Member]                    
Bank Overdrafts             0 0    
Sponsor [Member] | June 2022 Note [Member]                    
Debt instrument, Face amount   $ 20,000                
Debt instrument maturity date   May 15, 2023                
Due to Related party               19,957    
Sponsor [Member] | August 2022 Note [Member]                    
Debt instrument, Face amount $ 200,000                  
Debt instrument maturity date Feb. 02, 2023                  
Due to Related party               200,000    
Debt Instrument, Interest Rate, Stated Percentage 9.00%                  
Sponsor [Member] | August 2022 Note [Member] | Accrued Interest [Member]                    
Due to Related party               7,545    
Sponsor [Member] | Administrative Service [Member]                    
Related party transaction, Amount of transaction             20,000 $ 30,000    
Sponsor And Initial Stockholders [Member] | Common Stock [Member]                    
Sale of Stock, Percentage of Ownership after Transaction       20.00%            
Representative [Member] | Minimum [Member]                    
Liquidation rights waived On Failure Of Business Combination               12 months    
Representative [Member] | Maximum [Member]                    
Liquidation rights waived On Failure Of Business Combination               18 months    
Common Class B [Member]                    
Stock issued during period, Value, Issued for services             $ 25,000      
Common Class B [Member] | Common Stock [Member]                    
Stock issued during period, Shares, Issued for services             2,875,000      
Stock issued during period, Value, Issued for services             $ 288      
Common Class B [Member] | Sponsor [Member]                    
Stock issued during period, Shares, Issued for services           2,875,000        
Stock issued during period, Value, Issued for services           $ 25,000        
Shares are subject to forfeiture           375,000        
Percentage of common stock issued and outstanding           20.00%        
Common Class B [Member] | Sponsor [Member] | Jenny Junkeer Chief Financial Officer [Member]                    
Sale of stock, Number of shares issued in transaction       15,000            
Sale of stock, Price per share       $ 0.009            
Common Class B [Member] | Sponsor [Member] | Michael Tomczyk Independent Director [Member]                    
Sale of stock, Number of shares issued in transaction       10,000            
Sale of stock, Price per share       $ 0.009            
Common Class B [Member] | Sponsor [Member] | Robin Meister Independent Director [Member]                    
Sale of stock, Number of shares issued in transaction       10,000            
Sale of stock, Price per share       $ 0.009            
Common Class B [Member] | Sponsor [Member] | Lynn Perkins Independent Director [Member]                    
Sale of stock, Number of shares issued in transaction       10,000            
Sale of stock, Price per share       $ 0.009            
Common Class B [Member] | Sponsor [Member] | ARC Capita [Member]                    
Sale of stock, Number of shares issued in transaction         50,000          
Sale of stock, Price per share         $ 0.009          
Common Class B [Member] | Initial Stockholders [Member] | Restriction On Transfer [Member]                    
Percentage of shares subject to lock in               50.00%    
Lock in period for shares               6 months    
Number of trading days for determining the share price               20 days    
Number of consecutive trading days for determining the share price               30 days    
Percentage of shares subject to lock in, Remaining shares               50.00%    
Lock in period for remaining shares               6 months    
Common Class B [Member] | Initial Stockholders [Member] | Restriction On Transfer [Member] | Share Price Equals Or Exceeds Twelve USD [Member]                    
Share price               $ 12    
Representative Shares [Member]                    
Stock issued during period, Shares               57,500    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES - Additional Information (Detail)
 12 Months Ended
Dec. 20, 2022
USD ($)
Oct. 21, 2021
USD ($)
shares
Oct. 18, 2021
Demand
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 12, 2022
USD ($)
Oct. 31, 2021
Commitments And Contingencies [Line Items]            
Number of months from closing of a business combination determing ending period       12 months    
Threshold years from the effective date of the registration statement determining right of first refusal       3 years    
Stock Issued During Period, Shares, New Issues | shares   1,500,000        
Deferred underwriting commissions   $ 3,737,500        
Underwriting fees   $ 1,437,500        
Percentage Of Underwriting Discount           1.25%
Percentage Of Deferred Underwriting Discount           3.25%
Description of expiration of restriction       twenty trading days within any thirty-trading day period commencing at least 150 days after the Effective Time.    
Description of share transfer in lock up agreements       stockholders and employees have further agreed not to Transfer more than 200,000 Shares during any three-month period until the three-year anniversary of the Effective Date and not to Transfer more than 1,000,000 Shares during a further period thereafter, in each case subject to Permitted Transfers and the termination of restrictions upon expiration or termination of the applicable lock-up agreement.    
FEXD Sponsor [Member]            
Commitments And Contingencies [Line Items]            
Number of months of cliff vesting period 12 months          
De SPAC Service agreement [Member] | Service Compensation Provided form Monetary [Member]            
Commitments And Contingencies [Line Items]            
Other commitment         $ 90,000  
De SPAC Service agreement [Member] | Service Compensation Provided form Shares [Member]            
Commitments And Contingencies [Line Items]            
Other commitment         $ 22,500  
Chief Marketing Officer [Member] | FEXD Sponsor [Member]            
Commitments And Contingencies [Line Items]            
Officer compensation $ 400,000          
Stock Issued During Period, Value, Issued for Services 200,000          
Performance bonus 150,000          
Guaranteed performance bonus 15,000          
Chief Marketing Officer [Member] | Fama Financial Services [Member]            
Commitments And Contingencies [Line Items]            
Officer compensation 500,000          
Stock Issued During Period, Value, Issued for Services $ 50,000          
Number of months of cliff vesting period 12 months          
Percentage of cash bonus at the end of first year 30.00%          
Percentage of cash bonus at the end of second year 20.00%          
Percentage of cash bonus at the end of third year 15.00%          
Target bonus rate based on prevailing salary 200.00%          
Rana Business Combination Agreement [Member]            
Commitments And Contingencies [Line Items]            
Business Combination Of Adjustments Of An Escrow Amount       $ 5,711,662    
Payments To Acquire Businesses Gross       7,800,000    
Afinoz Business Combination Agreement [Member]            
Commitments And Contingencies [Line Items]            
Business Combination Of Adjustments Of An Escrow Amount       700,000    
Payments To Acquire Businesses Gross       $ 5,000,000    
New Acquiror Class A Common Stock [Member]            
Commitments And Contingencies [Line Items]            
Common Stock, Voting Rights       one    
Common Stock, Par or Stated Value Per Share | $ / shares       $ 0.0001    
New Acquiror Class A Common Stock [Member] | Rana Business Combination Agreement [Member]            
Commitments And Contingencies [Line Items]            
Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued | shares       11,500,000    
New Acquiror Class A Common Stock [Member] | Afinoz Business Combination Agreement [Member]            
Commitments And Contingencies [Line Items]            
Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued | shares       7,020,000    
New Acquiror Class A Common Stock [Member] | Rana and Afinoz Business Combination Agreement [Member] | Share Price Equal To or Exceeds Twelve Point Zero Zero [Member]            
Commitments And Contingencies [Line Items]            
Sale of Stock, Price Per Share | $ / shares       $ 12    
Registration Rights [Member]            
Commitments And Contingencies [Line Items]            
Number of demands that can be made | Demand     2      
Period beginning on the effective date of the initial public offering during which demand registration can be made     5 years      
Commencing period determining registration rights exercise     3 months      
Period beginning on the effective date of the initial public offering during which participation take place     7 years      
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE FINANCIAL INSTRUMENTS - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Mar. 05, 2021
Dec. 31, 2022
Jul. 16, 2021
Derivative [Line Items]      
Minimum notice period to be given to the holders of warrant prior to redemption   30 days  
Caltech Trading [Member] | Forward Purchase Units [Member] | Forward Purchase Agreement [Member]      
Derivative [Line Items]      
Price per unit to be issued pursuant to agreement     $ 10
Caltech Trading [Member] | Minimum [Member] | Forward Purchase Units [Member] | Forward Purchase Agreement [Member]      
Derivative [Line Items]      
Number of units to be issued pursuant to agreement     8,000,000
Units To Be Issued Pursuant To Agreement Value     $ 80.0
Caltech Trading [Member] | Maximum [Member] | Forward Purchase Units [Member] | Forward Purchase Agreement [Member]      
Derivative [Line Items]      
Number of units to be issued pursuant to agreement     9,000,000
Units To Be Issued Pursuant To Agreement Value     $ 90.0
Public Warrants [Member]      
Derivative [Line Items]      
Class of warrants or rights period after which the warrants are excercisable from the date of consummation of business combination   30 days  
Percentage of warrants to be settled in shares for the price of warrants to be reduced 70.00%    
Class of warrants or rights warrants issued during the period units 9,650,250    
Public Warrants [Member] | Prospective Redemption Of Warrants [Member]      
Derivative [Line Items]      
Class of warrants or rights term   5 years  
Shares issued, price per share   $ 11.5  
Percentage of proceeds from equity issuance to be used for consummating business combination   60.00%  
Consecutive trading day period for determining the volume weighted average price per share   10 days  
Weighted volume average price per share   $ 9.2  
Adjusted exercise price of warrants percentage   115.00%  
Adjusted share price percentage   180.00%  
Public Warrants [Member] | Prospective Redemption Of Warrants [Member] | Share Price Trigerring Redemption Of Warrants One [Member]      
Derivative [Line Items]      
Share Price   $ 18  
Class of warrants or rights redemption price per warrant   $ 0.01  
Number of trading days for determining the share price   20 days  
Number of consecutive trading days for determining the share price   30 days  
Public Warrants [Member] | Prospective Redemption Of Warrants [Member] | Share Price Trigerring Redemption Of Warrants Two [Member]      
Derivative [Line Items]      
Share Price   $ 10  
Private Placement Warrants [Member]      
Derivative [Line Items]      
Class of warrants or rights lock in period   30 days  
Class of warrants or rights warrants issued during the period units 1,150,000    
Common Class A [Member] | Public Warrants [Member]      
Derivative [Line Items]      
Period within which registration statement shall be filed with securities exchange commission from the date of consummation of initial business combination   20 days  
Period within which registration statement shall be effective with securities exchange commission from the date of consummation of initial business combination   60 days  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Mar. 04, 2021
Fair Value, Inputs, Level 3 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure $ 285,567 $ 5,433,006 $ 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 402,500 0  
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 353,518 0  
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 285,567 5,433,006  
Public Warrants [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 402,500 0  
Public Warrants [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 0 0  
Public Warrants [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 0 2,185,000  
Private Placement Warrants [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 0 0  
Private Placement Warrants [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 353,518 0  
Private Placement Warrants [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 0 1,521,098  
Forward Purchase Agreement Liability [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 0 0  
Forward Purchase Agreement Liability [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure 0 0  
Forward Purchase Agreement Liability [Member] | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Financial Liabilities Fair Value Disclosure $ 285,567 $ 1,726,908  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Liabilities Measured on Recurring Basis (Detail) - Fair Value, Inputs, Level 3 [Member] - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities – level 3, at March 5, 2021 (inception) $ 0 $ 5,433,006
Issuance of public warrants, private placement warrants, forward purchase agreement – level 3 3,894,740  
Change in fair value 1,538,266 (1,441,341)
Derivative liabilities - ending balance $ 5,433,006 285,567
Public Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Transfer of public warrants to level 1 measurement   (2,185,000)
Private Placement Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Transfer of private placement warrants to level 2 measurement   $ (1,521,098)
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Significant Inputs to the Black-Scholes Option Pricing Model for the Fair Value of the Founder Warrants (Detail)
Dec. 31, 2022
yr
Dec. 31, 2021
yr
Oct. 21, 2021
yr
Exercise price [Member] | Public Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 11.5 11.5 11.5
Exercise price [Member] | Private Placement Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 11.5 11.5 11.5
Exercise price [Member] | Forward Purchase Units [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 10 10 10
Volatility [Member] | Public Warrants [Member] | Postmerger [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 4.6 8.4 6.5
Volatility [Member] | Private Placement Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 4.6 8.4 6.5
Volatility [Member] | Forward Purchase Units [Member] | Postmerger [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 5.2 8.4 6.5
Expected term [Member] | Public Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 5.06 5.56 5.75
Expected term [Member] | Private Placement Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 5.06 5.56 5.75
Expected term [Member] | Forward Purchase Units [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 0.06 0.56 0.75
Risk-free rate [Member] | Public Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 3.91 1.3 1.33
Risk-free rate [Member] | Private Placement Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 3.91 1.3 1.33
Risk-free rate [Member] | Forward Purchase Units [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 4.04 0.21 0.09
Probability of acquisition [Member] | Public Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 7.5 100 100
Probability of acquisition [Member] | Private Placement Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 7.5 100 100
Probability of acquisition [Member] | Forward Purchase Units [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 7.5 100 100
Dividend yield [Member] | Public Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 0 0 0
Dividend yield [Member] | Private Placement Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 0 0 0
Dividend yield [Member] | Forward Purchase Units [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Warrants and Rights Outstanding, Measurement Input 0 0 0
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments that are Measured at Fair Value (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]   Operating Expenses
Private Placement Warrants [Member] | IPO [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value as of March 5, 2021 (inception) $ 0 $ 1,521,098
Issuance of Warrants 1,014,065 80,500
Signing of Forward Purchase Agreement upon IPO 0  
Change in fair value 507,033 (1,248,080)
Fair value , ending balance 1,521,098 353,518
Public Warrants [Member] | IPO [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value as of March 5, 2021 (inception) 0 2,185,000
Issuance of Warrants 1,380,000 0
Signing of Forward Purchase Agreement upon IPO 0  
Change in fair value 805,000 (1,782,500)
Fair value , ending balance 2,185,000 402,500
Warrant [Member] | IPO [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value as of March 5, 2021 (inception) 0 3,706,098
Issuance of Warrants 2,394,065 80,500
Signing of Forward Purchase Agreement upon IPO 0  
Change in fair value 1,312,033 (3,030,580)
Fair value , ending balance 3,706,098 756,018
Forward Purchase Units [Member] | IPO [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value as of March 5, 2021 (inception) 0 1,726,908
Issuance of Warrants 0 0
Signing of Forward Purchase Agreement upon IPO 1,500,675  
Change in fair value 226,233 (1,441,341)
Fair value , ending balance $ 1,726,908 $ 285,567
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY - Additional information (Detail) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Class of Stock [Line Items]    
Preferred Stock, Shares Authorized 1,000,000 1,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Number Of Shares Entitles For Each Right Held one-tenth (1/10)  
Common Class A [Member]    
Class of Stock [Line Items]    
Common Stock, Shares Authorized 200,000,000 200,000,000
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Voting Rights one  
Common Stock, Shares, Issued 57,500 57,500
Common Stock, Shares, Outstanding 57,500 57,500
Common Class B [Member]    
Class of Stock [Line Items]    
Common Stock, Shares Authorized 20,000,000 20,000,000
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Voting Rights one  
Common Stock, Shares, Issued 2,875,000 2,875,000
Common Stock, Shares, Outstanding 2,875,000 2,875,000
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX - Summary of Net Deferred Tax Assets (Detail) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred tax asset    
Start-up costs $ 187,396 $ 29,691
Net operating loss 0 21,704
Total deferred tax asset 187,396 50,765
Valuation allowance (187,396) (50,765)
Deferred tax asset, net of allowance $ 0 $ 0
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX - Summary of Income Tax Provision (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Federal    
Current $ 0 $ 290,342
Deferred (50,765) (136,631)
State    
Current 0 0
Deferred 0 0
Change in valuation allowance 50,765 136,631
Income tax provision $ 0 $ 290,342
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX - Summary of Effective Income Tax Rate Reconciliation (Detail)
 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Statutory federal income tax rate 21.00% 21.00%
Transaction costs associated with the Initial Public Offering (1.00%) 6.00%
Change in fair value of warrant liabilities and forward purchase agreement (17.00%) (23.00%)
Change in valuation allowance (3.00%) 3.00%
Income tax provision 0.00% 7.00%
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX - Additional Information (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Change in the valuation allowance $ 50,765 $ 136,631
Domestic Tax Authority [Member]    
Net operating loss carryovers   $ 0
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS - Additional information (Detail) - USD ($)
 10 Months Ended 12 Months Ended
Apr. 20, 2023
Jan. 20, 2023
Dec. 31, 2021
Dec. 31, 2022
Subsequent Event [Line Items]        
Proceeds from Issuance of Private Placement     $ 3,900,250 $ 0
January 2023 Promissory Note [Member] | FEXD Sponsor [Member]        
Subsequent Event [Line Items]        
Debt instrument, Face amount   $ 200,000    
Subsequent Event [Member]        
Subsequent Event [Line Items]        
Proceeds from Issuance of Private Placement   $ 1,150,000    
Temporary equity stock redeemed during the period shares 7,527,997      
Cash withdrawn from Trust Account per share for redemption of shares $ 10.48      
Cash withdrawn from Trust Account for redemption of shares $ 78,893,408.56      
Subsequent Event [Member] | Private Placement Warrants [Member]        
Subsequent Event [Line Items]        
Class of warrants or rights issued during period, Warrants   1,150,000    
Warrants issued, Price per warrant   $ 1    
XML 51 d456943d10k_htm.xml IDEA: XBRL DOCUMENT 0001852407 2021-12-31 0001852407 2022-12-31 0001852407 2021-03-05 2021-12-31 0001852407 2022-01-01 2022-12-31 0001852407 2022-10-01 2022-10-31 0001852407 2021-10-21 2021-10-21 0001852407 2021-10-21 0001852407 2021-10-31 0001852407 2022-06-30 0001852407 2022-08-16 2022-08-16 0001852407 2021-03-04 0001852407 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001852407 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001852407 fexd:InitialStockholdersMember us-gaap:CommonClassBMember fexd:RestrictionOnTransferMember 2022-01-01 2022-12-31 0001852407 fexd:GeneralAndAdministrativeServicesMember fexd:SponsorMember 2022-01-01 2022-12-31 0001852407 us-gaap:AdministrativeServiceMember fexd:SponsorMember 2022-01-01 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember fexd:SponsorMember us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember 2022-01-01 2022-12-31 0001852407 us-gaap:CapitalUnitsMember 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001852407 fexd:OneShareOfClassACommonStockMember 2022-01-01 2022-12-31 0001852407 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember fexd:SharePriceTrigerringRedemptionOfWarrantsOneMember 2022-01-01 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassBMember 2022-01-01 2022-12-31 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember fexd:CaltechTradingCorpMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 fexd:RepresentativeSharesMember 2022-01-01 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852407 srt:MinimumMember fexd:RepresentativeMember 2022-01-01 2022-12-31 0001852407 srt:MaximumMember fexd:RepresentativeMember 2022-01-01 2022-12-31 0001852407 fexd:NewAcquirorClassACommonStockMember 2022-01-01 2022-12-31 0001852407 fexd:RanaBusinessCombinationAgreementMember 2022-01-01 2022-12-31 0001852407 fexd:AfinozBusinessCombinationAgreementMember 2022-01-01 2022-12-31 0001852407 fexd:AfinozBusinessCombinationAgreementMember fexd:NewAcquirorClassACommonStockMember 2022-01-01 2022-12-31 0001852407 fexd:RanaBusinessCombinationAgreementMember fexd:NewAcquirorClassACommonStockMember 2022-01-01 2022-12-31 0001852407 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001852407 us-gaap:CommonClassAMember 2021-12-31 0001852407 us-gaap:CommonClassBMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember fexd:PostmergerMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputPriceVolatilityMember fexd:PostmergerMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001852407 fexd:PublicWarrantsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001852407 fexd:WorkingCapitalLoansMember fexd:SponsorMember 2021-12-31 0001852407 us-gaap:CommonClassAMember 2022-12-31 0001852407 us-gaap:CommonClassBMember 2022-12-31 0001852407 srt:MinimumMember us-gaap:CommonClassAMember 2022-12-31 0001852407 fexd:InitialStockholdersMember us-gaap:CommonClassBMember fexd:RestrictionOnTransferMember 2022-12-31 0001852407 fexd:InitialStockholdersMember us-gaap:CommonClassBMember fexd:RestrictionOnTransferMember fexd:SharePriceEqualsOrExceedsTwelveUsdMember 2022-12-31 0001852407 fexd:WorkingCapitalWarrantsMember fexd:WorkingCapitalLoansMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember fexd:SponsorMember us-gaap:PrivatePlacementMember 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember fexd:SharePriceTrigerringRedemptionOfWarrantsTwoMember 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:ProspectiveRedemptionOfWarrantsMember fexd:SharePriceTrigerringRedemptionOfWarrantsOneMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember us-gaap:WarrantMember us-gaap:IPOMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-12-31 0001852407 fexd:FounderSharesMember fexd:SponsorMember 2022-12-31 0001852407 fexd:SponsorMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember fexd:CaltechTradingCorpMember us-gaap:IPOMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember fexd:PostmergerMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputPriceVolatilityMember fexd:PostmergerMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001852407 fexd:PublicWarrantsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001852407 us-gaap:DomesticCountryMember 2022-12-31 0001852407 fexd:June2022NoteMember fexd:SponsorMember 2022-12-31 0001852407 fexd:August2022NoteMember fexd:SponsorMember 2022-12-31 0001852407 fexd:AccruedInterestMember fexd:August2022NoteMember fexd:SponsorMember 2022-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2022-12-31 0001852407 fexd:PrivatePlacementWarrantsMember 2022-12-31 0001852407 fexd:NewAcquirorClassACommonStockMember 2022-12-31 0001852407 us-gaap:AdministrativeServiceMember 2022-12-31 0001852407 fexd:RanaAndAfinozBusinessCombinationAgreementMember fexd:NewAcquirorClassACommonStockMember fexd:SharePriceEqualToOrExceedsTwelvePointZeroZeroMember 2022-12-31 0001852407 fexd:WorkingCapitalLoansMember fexd:SponsorMember 2022-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:AdditionalPaidInCapitalMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassAMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassBMember us-gaap:AdditionalPaidInCapitalMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassBMember 2021-03-05 2021-12-31 0001852407 us-gaap:RetainedEarningsMember 2021-03-05 2021-12-31 0001852407 us-gaap:AdditionalPaidInCapitalMember 2021-03-05 2021-12-31 0001852407 us-gaap:AdministrativeServiceMember fexd:SponsorMember 2021-03-05 2021-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:RetainedEarningsMember 2021-03-05 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:IPOMember 2021-03-05 2021-12-31 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2021-03-05 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember 2021-03-05 2021-12-31 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:IPOMember 2021-03-05 2021-12-31 0001852407 us-gaap:FairValueInputsLevel3Member 2021-03-05 2021-12-31 0001852407 us-gaap:IPOMember 2021-10-21 2021-10-21 0001852407 us-gaap:OverAllotmentOptionMember 2021-10-21 2021-10-21 0001852407 us-gaap:PrivatePlacementMember 2021-10-21 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember fexd:SponsorMember us-gaap:PrivatePlacementMember 2021-10-21 2021-10-21 0001852407 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-10-21 2021-10-21 0001852407 us-gaap:CommonClassAMember 2021-10-21 2021-10-21 0001852407 fexd:InitialPublicOfferingAndPrivatePlacementOfWarrantsMember 2021-10-21 2021-10-21 0001852407 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember fexd:SponsorMember us-gaap:PrivatePlacementMember 2021-10-21 0001852407 fexd:PublicWarrantsMember 2021-10-21 0001852407 fexd:PublicWarrantsMember us-gaap:CommonClassAMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExercisePriceMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputPriceVolatilityMember fexd:PostmergerMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-10-21 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-10-21 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember fexd:PostmergerMember 2021-10-21 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-10-21 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-10-21 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:MeasurementInputExpectedTermMember 2021-10-21 0001852407 fexd:PublicWarrantsMember fexd:MeasurementInputProbabilityOfAcquisitionMember 2021-10-21 0001852407 fexd:PublicWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-10-21 0001852407 fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-08 2021-03-08 0001852407 fexd:UnsecuredPromissoryNoteMember fexd:SponsorMember 2021-03-08 0001852407 fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-08 0001852407 us-gaap:AdministrativeServiceMember 2021-10-31 0001852407 fexd:PublicWarrantsMember 2021-03-05 2021-03-05 0001852407 fexd:PrivatePlacementWarrantsMember 2021-03-05 2021-03-05 0001852407 fexd:PublicWarrantsMember 2021-03-05 0001852407 srt:MinimumMember fexd:ForwardPurchaseUnitsMember fexd:ForwardPurchaseAgreementMember fexd:CaltechTradingMember 2021-07-16 0001852407 srt:MaximumMember fexd:ForwardPurchaseUnitsMember fexd:ForwardPurchaseAgreementMember fexd:CaltechTradingMember 2021-07-16 0001852407 fexd:ForwardPurchaseUnitsMember fexd:ForwardPurchaseAgreementMember fexd:CaltechTradingMember 2021-07-16 0001852407 fexd:June2022NoteMember fexd:SponsorMember 2022-06-16 0001852407 fexd:August2022NoteMember fexd:SponsorMember 2022-08-02 0001852407 fexd:PromisoryNoteMember 2022-08-02 0001852407 fexd:UnsecuredPromissoryNoteMember fexd:SponsorMember 2022-10-19 0001852407 fexd:PromisoryNoteMember fexd:SponsorMember 2022-10-19 0001852407 fexd:ArcCapitaMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-11 2021-03-11 0001852407 fexd:ArcCapitaMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-11 0001852407 us-gaap:CommonClassAMember 2023-03-31 0001852407 us-gaap:CommonClassBMember 2023-03-31 0001852407 fexd:JennyJunkeerChiefFinancialOfficerMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 2021-03-27 0001852407 fexd:MichaelTomczykIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 2021-03-27 0001852407 fexd:RobinMeisterIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 2021-03-27 0001852407 fexd:LynnPerkinsIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 2021-03-27 0001852407 fexd:SponsorAndInitialStockholdersMember us-gaap:CommonStockMember 2021-03-27 2021-03-27 0001852407 fexd:JennyJunkeerChiefFinancialOfficerMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 0001852407 fexd:MichaelTomczykIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 0001852407 fexd:RobinMeisterIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 0001852407 fexd:LynnPerkinsIndependentDirectorMember fexd:SponsorMember us-gaap:CommonClassBMember 2021-03-27 0001852407 fexd:RegistrationRightsMember 2021-10-18 2021-10-18 0001852407 fexd:InflationReductionActTwoThousandAndTwentyTwoMember 2022-08-16 0001852407 fexd:June2022NoteMember fexd:SponsorMember 2022-06-16 2022-06-16 0001852407 fexd:August2022NoteMember fexd:SponsorMember 2022-08-02 2022-08-02 0001852407 fexd:PrivatePlacementWarrantsMember fexd:SponsorMember 2022-10-21 2022-10-21 0001852407 fexd:SponsorMember 2022-10-21 2022-10-21 0001852407 fexd:PrivatePlacementWarrantsMember fexd:SponsorMember 2022-10-21 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:SubsequentEventMember 2023-01-20 2023-01-20 0001852407 us-gaap:SubsequentEventMember 2023-01-20 2023-01-20 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:SubsequentEventMember 2023-01-20 0001852407 fexd:January2023PromissoryNoteMember fexd:FexdSponsorMember 2023-01-20 0001852407 fexd:ChiefMarketingOfficerMember fexd:FexdSponsorMember 2022-12-20 2022-12-20 0001852407 fexd:ChiefMarketingOfficerMember fexd:FamaFinancialServicesMember 2022-12-20 2022-12-20 0001852407 fexd:FexdSponsorMember 2022-12-20 2022-12-20 0001852407 fexd:ServiceCompensationProvidedFormMonetaryMember fexd:DeSpacServiceAgreementMember 2022-12-12 0001852407 fexd:ServiceCompensationProvidedFormSharesMember fexd:DeSpacServiceAgreementMember 2022-12-12 0001852407 us-gaap:SubsequentEventMember 2023-04-20 2023-04-20 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:IPOMember 2022-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:IPOMember 2022-12-31 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2022-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember 2022-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001852407 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001852407 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001852407 us-gaap:RetainedEarningsMember 2022-12-31 0001852407 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852407 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-04 0001852407 us-gaap:AdditionalPaidInCapitalMember 2021-03-04 0001852407 us-gaap:RetainedEarningsMember 2021-03-04 0001852407 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-04 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:IPOMember 2021-03-04 0001852407 fexd:PublicWarrantsMember us-gaap:IPOMember 2021-03-04 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2021-03-04 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember 2021-03-04 0001852407 fexd:PrivatePlacementWarrantsMember us-gaap:IPOMember 2021-12-31 0001852407 fexd:PublicWarrantsMember us-gaap:IPOMember 2021-12-31 0001852407 us-gaap:WarrantMember us-gaap:IPOMember 2021-12-31 0001852407 fexd:ForwardPurchaseUnitsMember us-gaap:IPOMember 2021-12-31 0001852407 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001852407 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001852407 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001852407 us-gaap:RetainedEarningsMember 2021-12-31 0001852407 us-gaap:FairValueInputsLevel3Member 2021-03-04 0001852407 us-gaap:FairValueInputsLevel3Member 2021-12-31 iso4217:USD shares utr:Day pure utr:Month utr:Year iso4217:USD shares fexd:Demand utr:Y false FY 0001852407 PA 10-K true 2022-12-31 --12-31 2022 false 001-40914 FINTECH ECOSYSTEM DEVELOPMENT CORP. DE 86-2438985 100 Springhouse Drive Suite 204 Collegeville 610 226-8101 19426 Units, each consisting of one share of Class A common stock, one right and one-half of one redeemable warrant FEXDU NASDAQ Class A common stock, par value $0.0001 per share FEXD NASDAQ Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share FEXDW NASDAQ Rights included as part of the units FEXDR NASDAQ No No Yes Yes Non-accelerated Filer true true false true 79187378 11557500 2875000 0.1 http://fasb.org/us-gaap/2022#OperatingExpenses 688 Marcum LLP Boston, MA 10335 612750 38951 86557 49286 699307 0 38633 118985048 116152113 119034334 116890053 990605 179371 290342 0 527502 0 1808449 179371 285567 1726908 756018 3706098 3737500 3737500 6587534 9349877 11500000 11500000 118392240 116150000 0.0001 0.0001 1000000 1000000 0 0 0 0 0 0 0.0001 0.0001 200000000 200000000 57500 57500 57500 57500 11500000 11500000 6 6 0.0001 0.0001 20000000 20000000 2875000 2875000 2875000 2875000 288 288 0 0 -5945734 -8610118 -5945440 -8609824 119034334 116890053 -2027390 -243849 -2027390 -243849 0 102600 -3030580 1312034 -1441341 226233 1682935 2113 6154856 -1638754 4127466 -1882603 290342 0 3837124 -1882603 0.27 0.27 -0.34 -0.34 11557500 11557500 2726188 2726188 0.27 0.27 -0.34 -0.34 2875000 2875000 2875000 2875000 0 0 0 0 0 0 0 57500 6 351032 351038 2875000 288 24712 25000 -1882603 -1882603 2886185 2886185 3261929 6727515 9989444 57500 6 2875000 288 0 -8610118 -8609824 3837124 3837124 1069500 1069500 1069500 1172740 2242240 57500 6 2875000 288 0 -5945734 -5945440 3837124 -1882603 0 102600 -1441341 226233 -3030580 1312034 7545 0 1682935 2113 -86239 125190 811234 179371 290342 0 -1122372 -189669 1150000 116150000 -1150000 -116150000 0 25000 1150000 0 520000 35000 43 141768 0 115000000 0 3900250 0 -1437500 0 428563 1669957 116952419 -602415 612750 612750 0 10335 612750 0 106768 0 3737500 0 351038 2242240 0 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Fintech Ecosystem Development Corp. (the “Company” or “FEXD”) is a blank check company incorporated in the State of Delaware on </div>March 5, 2021. The Company was formed for the purpose of acquiring, merging with, engaging in capital stock exchange with, purchasing all or substantially all of the assets of, engaging in contractual arrangements, or engaging in any other similar business combination with a single operating entity, or one or more related or unrelated operating entities operating in any sector (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies in the financial technology development industry. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">On December 31, 2022, the Company had not yet commenced any operations. All activity through December 31, 2022, relates to the Company’s formation, general operating expenses, the search for a target business with which to consummate an initial business combination and the Initial Public Offering (the “Initial Public Offering” or “IPO”) as described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">generate non-operating income</div> in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">fiscal year-end.</div> The Company is an early stage and emerging growth company, and, as such, the Company is subject to all of the risks associated with early-stage and emerging growth companies. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company’s sponsor is Revofast LLC, a Wyoming limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on October 18, 2021, and on October 21, 2021. On October 21, 2021, the Company consummated its Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $115,000,000, and incurring offering costs of $6,061,368, of which $3,737,500 was for deferred underwriting commissions (see Note 6). In addition, the Company granted the underwriter a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option to purchase an additional 1,500,000 Units at the Initial Public Offering price to cover over-allotments, if any. Simultaneous with the close of the Initial Public Offering, the over-allotment option was exercised in full. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement of an aggregate of 3,900,250 warrants (the “Private Placement Warrants”) to the Sponsor, for $1.00 per Private Placement Warrant, generating total gross proceeds of $3,900,250 (the “Private Place”) (see Note 4). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Following the closing of the Initial Public Offering on October 21, 2021, an amount of $116,150,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and held as cash items or invested only in U.S. government securities within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of paragraph (d) of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Rule 2a-7 of</div> the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s Stockholders, as described below. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which public stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Class A Common Shares without the Company’s prior written consent. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The public stockholders will be entitled to redeem their Class A Common Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> amount to be distributed to public stockholders who redeem their Class A Common Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants or rights. All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and restated certificate of incorporation. In accordance with SEC and its guidance on redeemable equity instruments, which has been codified in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 480-10-S99, redemption</div></div> provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A common stock classified as temporary equity will be the allocated proceeds determined in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20.</div> The Class A common stock is subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 480-10-S99. If</div></div> it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in the absence of retained earnings, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">additional paid-in capital).</div> While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed (a) to vote its Class B Common Stock, the Class A Common Shares underlying the Private Placement Warrants and any Class A Common Shares purchased during or after the Proposed Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation with respect to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Company’s pre-Business Combination</div> activities prior to the consummation of a Business Combination unless the Company provides dissenting public stockholders with the opportunity to redeem their Class A Common Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Class B Common Stock) and into the right to receive cash from the Trust Account in </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of pre-Business Combination</div> activity and (d) that the Class B Common Stock and Private Placement Warrants (including underlying Class A Common Shares) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Class A Common Shares purchased during or after the Proposed Offering if the Company fails to complete its Business Combination. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company will have until 12 months, being October 21, 2022, (or 15 or 18<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">months, depending on whether we elect to extend the initial 12-month term for up to two additional three-month terms) from the effective date of the registration statement to consummate a Business Combination (the “Combination Period”)<div style="letter-spacing: 0px; top: 0px;;display:inline;">. </div>If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem </div>100<div style="letter-spacing: 0px; top: 0px;;display:inline;">% of the outstanding Class A Common Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div>50,000),<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>divided by the number of then outstanding Class A Common Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Class A Common Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Proposed Offering price per Unit </div>($10.00). </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.10 per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Proposed Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Business Combinations </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 11, 2022, the Company entered into two business combination agreements. Refer to Note 6. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October 21, 2022, the Company’s board of directors approved to extend the time by which the Company has to consummate a business combination from October 21, 2022 until January 21, 2023. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January 20, 2023, the Company’s board of directors further approved to extend the time by which the Company has to consummate a business combination from January 21, 2023 to April 21, 2023 (Note 11).</div></div><br/></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April 10, 2023, the Company sent a letter to Rana Financial, Inc. and David Kretzmer a letter notifying Rana Financial, Inc. of its failure to deliver audited financial statements pursuant to the business combination agreement dated September 9, 2022. The Company notified Rana of its intent to propose the termination of the agreement and abandonment of the contemplated business combination within if the audited financial statements are not received by April 21, 2023. Refer to Note 11. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Liquidity and Capital Resources </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, the Company had $10,335 in its operating bank account, $118,985,048 investments held in its trust account, and working capital deficit of approximately $1,759,163. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (as defined in Note 5), and a loan from the Sponsor of approximately $141,768 under the Note (as defined in Note 5). The $141,768 loan was fully repaid as of December 31, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of December 31, 2022, there were no amounts outstanding under any Working Capital Loan. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August 2, 2022, the Company borrowed $200,000 through a promissory note with HRT North America Ltd. LLC to support its liquidity needs. The Company borrowed an additional $300,000 through a promissory note with the Sponsor on October 19, 2022 (refer to Note 5). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant generating total proceeds of $1,150,000 (refer to Note 11). </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January 20, 2023, the Company entered into a $200,000 promissory note with its Sponsor (refer to Note 11). </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Based on the foregoing, management does not believe that the Company will have sufficient working capital to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. The Company believes it may need to raise additional funds in order to meet the expenditures required for operating the business. Furthermore, if the Company’s estimate of the costs of identifying a target business, undertaking <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-depth</div> due diligence and negotiating an Initial Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate the business prior to the Initial Business Combination. Moreover, the Company may need to obtain additional financing either to complete the Initial Business Combination or to redeem a significant number of our public shares upon completion of the Initial Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Initial Business Combination. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in what ever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The <div style="letter-spacing: 0px; top: 0px;;display:inline;">con<div style="letter-spacing: 0px; top: 0px;;display:inline;">solidate<div style="letter-spacing: 0px; top: 0px;;display:inline;">d</div> </div></div>financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">205-40,</div> “Presentation of Financial</div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Statements – Going Concern,” the Company has until April 21, 2023, to consummate an initial business combination. It is uncertain that the Company will be able to consummate an initial business combination by this time. If an initial business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and the mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 21, 2023. </div></div><br/></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks and Uncertainties </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Management is currently evaluating the impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 pandemic</div> on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States of America, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these consolidated financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. </div></div></div> 2021-03-05 11500000 10 115000000 6061368 3737500 P45D 1500000 3900250 1 116150000 10.1 P185D 5000001 0.15 10.1 5000001 The Company will have until 12 months, being October 21, 2022, (or 15 or 18 months, depending on whether we elect to extend the initial 12-month term for up to two additional three-month terms) from the effective date of the registration statement to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem  P12M P15M P18M 1 50000 10 10.1 10335 118985048 1759163 25000 141768 141768 200000 300000 1150000 1 1150000 200000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Basis of presentation </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principle of consolidation </div></div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Fama Financial Services, Inc. (“Fama”), which was incorporated on August 23, 2022 in the State of Georgia. There were no material business activities in Fama for the period from its incorporation date to December 31, 2022. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging growth company </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act’’), and it may take advantage of certain exemptions from various reporting requirements that apply to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">can opt-out of</div> the extended transition period and comply with the requirements that apply</div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; font-size: 10pt; white-space: nowrap; top: 0px;;display:inline;">to non-emerging growth</div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> companies, but any such election </div><div style="letter-spacing: 0px; font-size: 10pt; white-space: nowrap; top: 0px;;display:inline;">to opt-out is</div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> irrevocable. The Company has elected not </div><div style="letter-spacing: 0px; font-size: 10pt; white-space: nowrap; top: 0px;;display:inline;">to opt-out of</div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> such an extended transition period, which means that when a standard is issued or</div><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison of the Company’s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult <div style="display:inline;">or</div> impossible because of the potential differences in accounting standards used.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of estimates </div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Cash and Cash Equivalents </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As a result, the Company had cash of $10,335 and no cash equivalents on December 31, 2022. The Company had cash of $612,750 and no cash equivalents on December 31, 2021. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Investment Held in Trust Account </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and 2021, the Company had $118,985,048 and $116,152,113 investments held in the Trust Account, respectively. The investments held in the Trust Account were held in marketable treasury funds. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest income in the accompanying statements of operations. The estimated fair value of investments held in Trust Account are determined using available market information. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Income taxes </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. In addition, valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as an income tax expense. There were </div></div>no<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> unrecognized tax benefits and </div>no<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> amounts accrued for interest and penalties as of December </div>31<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, </div>2022<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> and </div>2021<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">. The Company is currently not aware of any issues under review resulting in significant payments, accruals, or material deviation from its position.</div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may be subject to potential examination by federal, state, and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions, and compliance with federal, state, and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company has been subject to income tax examinations by major taxing authorities since its inception. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">O</div></div>n August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The exercise tax imposes a 1% tax on covered corporations on the fair market value of any stock of the corporation which is repurchased by such corporation for taxable years beginning after December 31, 2022. The exercise tax is applicable to certain SPAC redemptions, including in connection with a SPAC’s business combination. The amount of a redemption subject to the exercise tax is reduced by the fair market value of any stock issued by the SPAC during the taxable year of the redemption. The Company has not completed its initial business combination and there were no share redemptions during the year ended December 31, 2022. The exercise tax will only be applicable to the Company for its taxable years post December 31, 2022. The Company is still in the process of assessing the effects of the exercise tax to its consolidated financial statements. </div></div> </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Net income (loss) per common share </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The calculation of diluted net income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 9,650,250 shares of Class A Common Stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from inception to December 31, 2022. Accretion associated with the redeemable Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021: </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Year ended December 31, 2022 </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:66%"/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,072,757</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">764,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average common stock outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,557,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,875,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="clear:both;max-height:0pt;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Period from March 5, 2021 (inception) to December 31, 2021 </div></div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:66%"/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(916,293</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(966,310</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average common stock outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,726,188</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,875,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per common stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Concentration of credit risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account. <br/></div> <div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value of financial instruments </div></div></div></div> <div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative financial instruments </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">480 and ASC 815-15. The classification of</div> derivative instruments, including whether such instruments </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">should be recorded as liabilities or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as equity, is re-assessed at the end</div> of each reporting period. In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10</div> “Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statements of operations as incurred. </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 5,750,000 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,900,250 Private Placement Warrants are recognized as derivative liabilities in accordance <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">with ASC 815-40. Accordingly,</div> the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to re-measurement at</div> each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo or Black-Scholes simulation model at each measurement date. Derivative warrant liabilities are classified <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as non-current liabilities as their</div> liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with the requirements <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of ASC 340-10-S99-1 and</div></div></div> SEC Staff Accounting Bulletin Topic 5A-<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of offering.</div></div> Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as non-operating expenses</div> in the statements of operations. Offering costs associated with the Class A common stock were charged to stockholders’ deficit upon the completion of the Initial Public Offering. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A Common Stock Subject to Possible Redemption </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the 11,500,000 shares of Class A common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with ASC 480, conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, 11,500,000 shares of Class A common stock subject to possible redemption at the redemption <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, the common shares reflected on the balance sheets are reconciled in the following table:</div></div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds from IPO</div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds allocated to Public Warrants</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,380,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A common share issuance costs</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,309,800</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion of carrying value to redemption value</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,839,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: bottom; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class A common shares subject to redemption at December 31, 2021</div></div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">116,150,000</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement to common stock subject to possible redemption amount</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,242,240</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: bottom; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class A common shares subject to redemption at December 31, 2022</div></div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">118,392,240</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;, Times, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt;;font-weight:bold;display:inline;">Issued and adopted accounting standards </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2020-06, Debt-Debt</div> with Conversion and Other Options <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(Subtopic 470-20) and</div> Derivatives and Hedging-Contracts in Entity’s Own Equity <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(Subtopic 815-40):</div> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">(“ASU 2020-06”), which</div> simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions required for equity-linked contracts to qualify for scope exception. In addition, it simplifies the diluted earnings per share calculation in certain areas. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">ASU 2020-06</div> is effective January 1, 2024 for fiscal years beginning after December 15, 2023 for smaller reporting companies, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021.<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> The Company adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have a material impact on the Company’s consolidated financial statements.</div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outside of the above, management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s <div style="letter-spacing: 0px; top: 0px;;display:inline;">consolidated </div>financial <div style="display:inline;">statements</div>.</div></div></div></div></div></div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Basis of presentation </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principle of consolidation </div></div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Fama Financial Services, Inc. (“Fama”), which was incorporated on August 23, 2022 in the State of Georgia. There were no material business activities in Fama for the period from its incorporation date to December 31, 2022. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging growth company </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act’’), and it may take advantage of certain exemptions from various reporting requirements that apply to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">can opt-out of</div> the extended transition period and comply with the requirements that apply</div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; font-size: 10pt; white-space: nowrap; top: 0px;;display:inline;">to non-emerging growth</div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> companies, but any such election </div><div style="letter-spacing: 0px; font-size: 10pt; white-space: nowrap; top: 0px;;display:inline;">to opt-out is</div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> irrevocable. The Company has elected not </div><div style="letter-spacing: 0px; font-size: 10pt; white-space: nowrap; top: 0px;;display:inline;">to opt-out of</div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> such an extended transition period, which means that when a standard is issued or</div><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison of the Company’s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult <div style="display:inline;">or</div> impossible because of the potential differences in accounting standards used.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of estimates </div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation, or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Cash and Cash Equivalents </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As a result, the Company had cash of $10,335 and no cash equivalents on December 31, 2022. The Company had cash of $612,750 and no cash equivalents on December 31, 2021. </div> 10335 0 612750 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Investment Held in Trust Account </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and 2021, the Company had $118,985,048 and $116,152,113 investments held in the Trust Account, respectively. The investments held in the Trust Account were held in marketable treasury funds. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest income in the accompanying statements of operations. The estimated fair value of investments held in Trust Account are determined using available market information. </div> 118985048 116152113 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Income taxes </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. In addition, valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as an income tax expense. There were </div></div>no<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> unrecognized tax benefits and </div>no<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> amounts accrued for interest and penalties as of December </div>31<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, </div>2022<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> and </div>2021<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">. The Company is currently not aware of any issues under review resulting in significant payments, accruals, or material deviation from its position.</div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may be subject to potential examination by federal, state, and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions, and compliance with federal, state, and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company has been subject to income tax examinations by major taxing authorities since its inception. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">O</div></div>n August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The exercise tax imposes a 1% tax on covered corporations on the fair market value of any stock of the corporation which is repurchased by such corporation for taxable years beginning after December 31, 2022. The exercise tax is applicable to certain SPAC redemptions, including in connection with a SPAC’s business combination. The amount of a redemption subject to the exercise tax is reduced by the fair market value of any stock issued by the SPAC during the taxable year of the redemption. The Company has not completed its initial business combination and there were no share redemptions during the year ended December 31, 2022. The exercise tax will only be applicable to the Company for its taxable years post December 31, 2022. The Company is still in the process of assessing the effects of the exercise tax to its consolidated financial statements. </div></div> </div> 0 0 0 0 0.01 0.01 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Net income (loss) per common share </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The calculation of diluted net income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 9,650,250 shares of Class A Common Stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from inception to December 31, 2022. Accretion associated with the redeemable Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021: </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Year ended December 31, 2022 </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:66%"/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,072,757</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">764,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average common stock outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,557,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,875,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="clear:both;max-height:0pt;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Period from March 5, 2021 (inception) to December 31, 2021 </div></div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:66%"/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(916,293</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(966,310</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average common stock outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,726,188</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,875,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per common stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> 9650250 <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock for the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021: </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Year ended December 31, 2022 </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:66%"/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,072,757</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">764,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average common stock outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,557,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,875,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="clear:both;max-height:0pt;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Period from March 5, 2021 (inception) to December 31, 2021 </div></div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:66%"/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per common stock:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(916,293</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(966,310</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average common stock outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,726,188</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,875,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per common stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> 3072757 764367 11557500 11557500 2875000 2875000 0.27 0.27 0.27 0.27 -916293 -966310 2726188 2726188 2875000 2875000 -0.34 -0.34 -0.34 -0.34 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Concentration of credit risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account. <br/></div> 250000 250000 <div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value of financial instruments </div></div></div></div> <div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative financial instruments </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">480 and ASC 815-15. The classification of</div> derivative instruments, including whether such instruments </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">should be recorded as liabilities or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as equity, is re-assessed at the end</div> of each reporting period. In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10</div> “Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statements of operations as incurred. </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 5,750,000 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 3,900,250 Private Placement Warrants are recognized as derivative liabilities in accordance <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">with ASC 815-40. Accordingly,</div> the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to re-measurement at</div> each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo or Black-Scholes simulation model at each measurement date. Derivative warrant liabilities are classified <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as non-current liabilities as their</div> liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> 5750000 3900250 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with the requirements <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of ASC 340-10-S99-1 and</div></div></div> SEC Staff Accounting Bulletin Topic 5A-<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of offering.</div></div> Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as non-operating expenses</div> in the statements of operations. Offering costs associated with the Class A common stock were charged to stockholders’ deficit upon the completion of the Initial Public Offering. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A Common Stock Subject to Possible Redemption </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the 11,500,000 shares of Class A common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with ASC 480, conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, 11,500,000 shares of Class A common stock subject to possible redemption at the redemption <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, the common shares reflected on the balance sheets are reconciled in the following table:</div></div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds from IPO</div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds allocated to Public Warrants</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,380,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A common share issuance costs</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,309,800</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion of carrying value to redemption value</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,839,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: bottom; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class A common shares subject to redemption at December 31, 2021</div></div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">116,150,000</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement to common stock subject to possible redemption amount</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,242,240</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: bottom; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class A common shares subject to redemption at December 31, 2022</div></div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">118,392,240</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 11500000 11500000 <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds from IPO</div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds allocated to Public Warrants</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,380,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A common share issuance costs</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,309,800</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion of carrying value to redemption value</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,839,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: bottom; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class A common shares subject to redemption at December 31, 2021</div></div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">116,150,000</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remeasurement to common stock subject to possible redemption amount</div></td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,242,240</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: bottom; width: 77%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class A common shares subject to redemption at December 31, 2022</div></div></td> <td style="vertical-align: bottom; text-indent: 0px; text-align: right; width: 7%;">  </td> <td style="vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">118,392,240</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 77%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 115000000 -1380000 6309800 8839800 116150000 2242240 118392240 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;, Times, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt;;font-weight:bold;display:inline;">Issued and adopted accounting standards </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2020-06, Debt-Debt</div> with Conversion and Other Options <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(Subtopic 470-20) and</div> Derivatives and Hedging-Contracts in Entity’s Own Equity <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(Subtopic 815-40):</div> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">(“ASU 2020-06”), which</div> simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions required for equity-linked contracts to qualify for scope exception. In addition, it simplifies the diluted earnings per share calculation in certain areas. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">ASU 2020-06</div> is effective January 1, 2024 for fiscal years beginning after December 15, 2023 for smaller reporting companies, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021.<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> The Company adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have a material impact on the Company’s consolidated financial statements.</div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outside of the above, management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s <div style="letter-spacing: 0px; top: 0px;;display:inline;">consolidated </div>financial <div style="display:inline;">statements</div>.</div></div></div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 3. INITIAL PUBLIC <div style="display:inline;">OFFERING</div> </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October 21, 2021, the Company consummated its <div style="display:inline;">Initial </div>Public Offering of 10,000,000 Units at $10.00 per Unit, generating gross proceeds of $100,000,000. Simultaneously, the underwriters exercised over-allotments, purchasing 1,500,000 additional Units, generating gross proceeds of $15,000,000. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Unit consists of one share of Class A Common <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Stock, one-half of</div> one Public Warrant, and one Public Right. Each Public Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $11.50 per share (see Note 7). Each Public Right entitles the holder to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">receive <span style="-sec-ix-hidden:hidden76565337">one-ten</span>th of</div> one share of Class A Common Stock upon completion of a Business Combination (see Note 8). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company incurred offering costs related to the Initial Public Offering of $6,061,368, of which $1,437,500 was for underwriting fees, $3,737,500 was for deferred underwriting commissions, and $886,368 was for other offering costs. </div> 10000000 10 100000000 1500000 15000000 1 11.5 6061368 1437500 3737500 886368 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">NOTE 4. PRIVATE PLACEMENT </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased an aggregate of 3,900,250 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($3,900,250 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in the </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">agg</div></div>regate). The excess of the proceeds over the fair value of the Private Placement Warrants has been recognized as a capital contribution from the Sponsor. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Private Placement Warrant is exercisable to purchase one share of Class A Common Stock at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Proposed Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Class A Common Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October 21, 2022, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “October 2022 Private Placement Warrants”), generating total proceeds of $1,150,000. The October 2022 Private Placement Warrants were purchased by the Sponsor and are substantially similar to the private placement warrants issued to the Sponsor at the time of IPO in October 2021. The October 2022 Private Placement Warrants have been issued pursuant to and are governed by a Warrant Agreement that is substantially similar to the Warrant Agreement that the Company entered into at the time of the IPO. Similar to the private placement warrants issued at the time of the IPO, the October 2022 Private Placement Warrants will not be transferable, assignable or salable until 30 days after the Company’s initial business combination and, unlike such private placement warrants, are not redeemable by the Company at any time (including following transfer by the Sponsor or its permitted transferees). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The proceeds received by the Company in connection with the issuance of the October 2022 Private Placement Warrants have been deposited in the trust account (the “Trust Account”) established at the time of the IPO. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account on or prior to October 21, 2022 will extend by three months until January 21, 2023, which is the time the Company will have to consummate an initial business combination. </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “January 2023 Private Placement Warrants”), generating total proceeds of $1,150,000. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>will extend by another three months until April 21, 2023, which is the time the Company will have to consummate an initial business combination. <br/></div> 3900250 1 3900250 1 11.5 1150000 1 1150000 P30D 1150000 1 1150000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 5. RELATED PARTY TRANSACTIONS </div></div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class B Common Stock </div></div></div></div><div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March 8, 2021, the Company issued an aggregate of 2,875,000 shares of Class B common stock (“Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000 in cash. In addition, such Founder Shares includes an aggregate of up to 375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor and initial stockholders will collectively own 20% of the Company’s issued and outstanding shares after the Proposed Offering (assuming our Sponsor and initial stockholders do not purchase any Class A Common Shares in the Proposed Offering and excluding the Private Placement Warrants and underlying securities). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March 27, 2021, the Sponsor sold 15,000 Founder Shares to the Chief Financial Officer, Jenny Junkeer, and 10,000 Founder Shares to each of the Company’s three independent directors, Michael Tomczyk, Robin Meister, and Lynn Perkins, in each case, at a price of $0.009 per share, the same price at which the Sponsor purchased such Founder Shares from the Company. Thus, after giving effect to the issuance of Founder Shares, our Sponsor and initial stockholders will collectively own approximately 20% of the outstanding common stock following the offering, assuming they do not purchase any units in this offering or the public market. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, as consideration for financial advisory services rendered in connection with this offering, on March 11, 2021, ARC Capital received 50,000 shares of Class B Common Stock from our Sponsor at a <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">price of </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;">$0.009 per share. The Founder Shares held by the independent directors and financial advisor are not subject to forfeiture in the event that the underwriters’ over-allotment is not exercised. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The initial stockholders have agreed not to transfer, assign or sell any of the Class B common stock (except to certain permitted transferees) until, with respect to 50% of the Class B common stock, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading day</div> period commencing after a Business Combination, with respect to the remaining 50% of the Class B common stock, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Promissory Notes </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March 8, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Sponsor Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $400,000, of which $141,768 was borrowed by the Company during 2021. The Sponsor Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">was non-interest bearing</div> and was fully repaid as of December 31, 2021. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 16, 2022, an affiliate of the Sponsor issued an unsecured promissory note (“June 2022 Note”) to the Company, pursuant to which the Company borrowed principal amount of $20,000. The June 2022 Note is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing and matures on the earlier of: i) the consummation of the Company’s initial business combination; <div style="letter-spacing: 0px; top: 0px;;display:inline;">or</div> ii) May 15, 2023. As of December 31, 2022, $19,957 remains outstanding on this June 2022 Note. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August 2, 2022, a company owned by a director of our potential business combination target, issued an unsecured promissory note (“August 2022 Note”), pursuant to which the Company borrowed principal amount of $200,000. The August 2022 Note has an interest rate of 9% per annum and matures on the earlier of: i) the consummation of the Company’s initial business combination; <div style="letter-spacing: 0px; top: 0px;;display:inline;">or</div> ii) February 2, 2023. <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is currently renewing the August 2022 Note with the lender.<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> As </div></div></div></div>of December 31, 2022, there was $200,000 outstanding on the August 2022 Note and accrued interest of $7,545. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">On October 19, 2022, the Sponsor issued an unsecured promissory note (“October 2022 Note”), pursuant to which the Company borrowed principal amount of $300,000. The October 2022 Note is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing and matures on May 15, 2023. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Administrative services agreement </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company’s Sponsor has agreed, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $5,000 per month for these services. For the year ended December 31, 2022 and for the period from March 5, 2021 (inception) to December 31, 2021, the Company has paid $30,000 and $20,000 to the Sponsor for these administrative services, respectively. As of December 31, 2022 and 2021,<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">the Company accrued $</div>30,000 and $nil, respectively, for unpaid administrative services. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related party loans </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or the Company’s officers and directors may, but are not obligated to, loan the Company funds as </div></div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">may be requir</div></div>ed (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants (“Working Capital Warrants”) at a price of $1.50 per Working Capital Warrant. The Working Capital Warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021,<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">there have been no amounts borrowed under<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div>the <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Working Capital Loans.</div></div></div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Forward Purchase Agreement </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In connection with the IPO, the Company entered into a forward purchase agreement with Caltech Trading Corp., providing for the purchase by Caltech Trading Corp. of an aggregate of 9,000,000 forward purchase units at a purchase price of $10.00 per unit. The purchase of the Forward Purchase Units will occur concurrently and only in connection with the closing of the Business Combination. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The terms and provisions of the forward purchase warrants to be issued as part of the forward purchase units are identical to those of the Private Placement Warrants. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Representative Shares </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In connection with the IPO, the Company issued the Representative 57,500 shares upon full exercise of the Over-allotment Option (the “Representative Shares”). The Representative has agreed not to transfer, assign or sell any such Representative Shares without prior consent of the Company until the completion of the initial Business Combination. In addition, the Representative has agreed (i) to waive its redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of the initial Business Combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete the initial Business Combination within 12 months (or up to 18 months, if applicable) from the Closing of the Offering. <br/></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">The Representative will not sell, transfer, assign, pledge or hypothecate the Representative Shares, or cause the Representative Shares to be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the Representative Shares by any person, for a period of 180 days (pursuant to Rule 5110(e)(1) of the Conduct Rules of FINRA) following the Effective Date to anyone other than (i) the Representative or an underwriter or selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Representative or of any such underwriter or selected dealer. On and after the 181st day following the Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Private Placement Warrants </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company consummated certain private placement warrants with its Sponsor. Refer to Note 4 for details. </div> 2875000 25000 375000 0.20 15000 10000 10000 10000 0.009 0.009 0.009 0.009 0.20 50000 0.009 0.50 P6M 12 P20D P30D 0.50 P6M 400000 141768 20000 2023-05-15 19957 200000 0.09 2023-02-02 200000 7545 300000 5000 30000 20000 30000 0 1500000 1.5 0 0 9000000 10 57500 P12M P18M <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">NOTE 6. COMMITMENTS AND CONTINGENCIES </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Registration rights </div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;">The holders of shares Class B Common Stock, Private Placement Warrants (and underlying securities), and any securities issued in payment of working capital loans made to the Company will be entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of Proposed Public Offering. The majorit</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px; line-height: 10pt; font-size: 10pt;;display:inline;"><div style="background-color:#ffffff;;display:inline;">y</div><div style="display:inline;"><div style="background-color:#ffffff;;display:inline;"> </div></div></div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 10pt; font-size: 10pt;;display:inline;"><div style="background-color:#ffffff;;display:inline;">of</div></div><div style="line-height: 10pt; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;"> these securities holders are entitled to make up to </div></div><div style="background-color:#ffffff;;display:inline;">two</div><div style="line-height: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;"> demands that the Company registers such </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; text-align: left; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;">securities.</div></div><br/></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;"> </div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;"/></div></div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Notwithstanding anything to the contrary, the underwriters (and/or their designees) may only make a demand registration (i) on one occasion and (ii) during the five-year period beginning on the effective date of the Proposed Public Offering. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these Common Stock are to be released from escrow. The holders of a majority of the Private Placement Warrants (and underlying securities) and securities issued in payment of working capital loans (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. Notwithstanding anything to the contrary, the underwriters (and/or their designees) may participate in a “piggy-back” registration only during the seven year period beginning on the effective date of the Proposed Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Notwithstanding anything to the contrary, under FINRA Rule 5110, the underwriters and/or their designees may only make a demand registration (i) on one occasion and (ii) during the five-year period beginning on the effective date of the registration statement relating to the Proposed Public Offering, and the underwriters and/ or their designees may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the registration statement relating to the Proposed Public Offering. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Underwriting agreement </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Underwriter purchased the 1,500,000 of additional Units to cover over-allotments, less the underwriting discounts and commissions. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters received a cash underwriting discount <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of one and one-quarter percent (1.25%) of</div> the gross proceeds of the Initial Public Offering, or $1,437,500, as the underwriters’ over-allotment was exercised in full. In addition, upon closing of the Business Combination, the underwriters are entitled to a deferred fee of three and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-quarter</div> percent (3.25%) of the gross proceeds of the Initial Public Offering, or $3,737,500, as the underwriters’ over- allotment was exercised in full. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement. <br/></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Right of First Refusal </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">For a period beginning on the closing of this offering and ending on the earlier of the twelve (12) month anniversary of the closing of a Business Combination or the three year anniversary of the effective date of the registration statement, we have granted EF Hutton a right of first refusal to act as lead-left book-running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statement <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">consummating our initial public offering</div></div>. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Forward Purchase Agreement </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">On July 16, 2021, the Company entered into a forward purchase agreement with an anchor investor. Refer to Note 7 below for details. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Business Combination Agreements </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Rana Business Combination Agreement </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 11, 2022, the Company announced that it, with Fama Financial Services, Inc., a Georgia corporation and wholly-owned subsidiary of the Company (“Merger Sub”), Rana Financial Inc., a Georgia </div></div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">corporation (“Rana”) and David Kretzmer, as representative of the Shareholders (“Shareholder Representative”), had entered into a business combination agreement (the “Rana Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Merger Sub will be merged with and into Rana (the “Merger”), with Rana surviving the Merger as a wholly-owned subsidiary of the Company. The key terms of the Rana Business Combination Agreement are as follows: </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Structure of the Rana Business Combination </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The transaction is structured as a reverse triangular merger. Pursuant to the Rana Business Combination Agreement, on the closing date, Merger Sub will be merged with and into Rana, with Rana surviving the Merger (together with the other transactions related thereto, the “Proposed Rana Transactions”) as a wholly-owned direct subsidiary of the Company (the “Surviving Company”). </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">At the effective time of the Merger (the “Effective Time”), the certificate of incorporation of Rana, as in effect immediately prior to the Effective Time, shall be the certificate of incorporation of the Surviving Company, until thereafter amended as provided by law and such certificate of incorporation. </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">At the Effective Time, the bylaws of Merger Sub, as in effect immediately prior to the Effective Time, shall be the bylaws of the Surviving Company until thereafter amended as provided by law, the certificate of incorporation of the Surviving Company and such bylaws, as applicable. </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">At the closing, the Company shall amend and restate, effective as of the Effective Time, its certificate of incorporation to be as set forth in the Rana Business Combination Agreement, pursuant to which the Company shall have a single class structure with shares of Class A common stock, par value $0.0001 per share, having voting rights of one vote per share (the “New Acquiror Class A Common Stock”). </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(d)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company shall pay a combination of Rana Cash Consideration and Rana Equity Consideration for the Company Common Stock subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $5,711,662 (the “Rana Escrow Amount”). </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Rana Cash Consideration means $7,800,000 and the Rana Equity Consideration means 7,020,000 shares of New Acquiror Class A Common Stock. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Rana Representations, Warranties and Covenants </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Rana Business Combination Agreement contains customary representations, warranties and covenants of Rana, FEXD and Merger Sub, relating to, among other things, their ability to enter into the Rana Business Combination Agreement and their outstanding capitalization. Rana has agreed to customary “no shop” obligations. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Conditions to Rana Closing </div></div></div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Mutual </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The obligations of Rana, FEXD and Merger Sub to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Rana Closing, of the following conditions: </div></div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Acquiror Proposals have been approved and adopted by the requisite affirmative vote of the stockholders of Acquiror in accordance with the Proxy Statement, the Delaware General Corporation Law, the organizational documents of FEXD and the rules and regulations of Nasdaq; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">no Governmental Authority has enacted, issued, promulgated, enforced or entered any Law, rule, regulation, judgment, decree, executive order or award which is then in effect and has the effect of making the Proposed Rana Transactions illegal or otherwise prohibiting consummation of the Proposed Rana Transactions, including the Merger; and </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(c)</td> <td style="vertical-align: top;;text-align:left;"><div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">the shares of New Acquiror Class A Common Stock to be issued in connection with the Proposed Rana Transactions shall have been approved for listing on Nasdaq, and immediately following the Rana Closing Acquiror shall satisfy any applicable listing requirements of Nasdaq and Acquiror shall not have received any notice <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of non-compliance therewith.</div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">FEXD and Merger Sub </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The obligations of FEXD and Merger Sub to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Rana Closing, of the following additional conditions: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the representations and warranties of Rana contained in the sections titled (i) Organization and Qualification; Subsidiaries, (ii) Capitalization, (iii) Authority Relative to this Business Combination Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Rana contained in the Rana Business Combination Agreement shall be true and correct (without giving any effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rana, the Shareholders and the Shareholder Representative, as applicable, have performed or complied in all material respects with all agreements and covenants required by the Rana Business Combination Agreement to be performed or complied with by each of them on or prior to the Effective Time; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(c)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Shareholder Representative has delivered to Acquiror the Escrow Agreement, duly executed by the Shareholder Representative; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(d)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rana has delivered to FEXD a customary officer’s certificate, dated the date of the Rana Closing, certifying as to the satisfaction of certain conditions; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(d)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">no Company Material Adverse Effect has occurred between the date of the Rana Business Combination Agreement and the Closing Date; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(e)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">on or prior to the Rana Closing, Rana delivered to Acquiror a properly executed certification, in form and substance reasonably acceptable to Acquiror, that the Company Common Stock, capital stock of Enova and capital stock of Fama, as applicable, are not “U.S. real property interests” in accordance with the Treasury Regulations under Sections 897 and 1445 of the Code, together with a notice to the IRS (which will be filed by Acquiror with the IRS following the Rana Closing) in accordance with the provisions <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of Section 1.897-2(h)(2) of</div> the Treasury Regulations; </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(f)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Rana has delivered to Acquiror the PCAOB Financials together with an unqualified report therein of the auditors of the Company and its subsidiaries, if applicable, and the PCAOB Financials for periods covered by the Unaudited Financials and Latest Balance Sheet (and the related unaudited consolidated statements of operations and comprehensive loss and cash flows of the Company and its subsidiaries for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the six-month period</div> then ended) do not differ from those disclosed on the Company Disclosure Schedule; </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(g)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">all conditions to consummation of the Afinoz Business Combination Agreement have been satisfied or waived by the applicable parties thereto; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; font-size: 0px;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(j)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Trust Fund contains funds sufficient to pay the Rana Cash Consideration and the Afinoz Cash Consideration (defined below), in full. </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Rana </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The obligations of Rana to consummate the Proposed Rana Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to Rana Closing of the following additional conditions: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the representations and warranties of FEXD and Merger Sub contained in the sections titled (i) Corporation Organization (ii) Capitalization, (iii) Authority Relative to this Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Acquiror and Merger Sub contained in the Rana Business Combination Agreement are true and correct (without giving any effect to any limitation as to “materiality” or “Acquiror Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in an Acquiror Material Adverse Effect; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FEXD and Merger Sub have performed or complied in all material respects with all agreements and covenants required by the Rana Business Combination Agreement to be performed or complied with by them on or prior to the Effective Time; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(c)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FEXD has delivered to the Shareholder Representative, the Escrow Agreement, duly executed by FEXD; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(d)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FEXD has delivered to Rana a customary officer’s certificate dated the date of the Rana Closing, certifying as to the satisfaction of certain conditions. </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Termination </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Rana Business Combination Agreement may be terminated and the Proposed Rana Transactions may be abandoned at any time prior to the Effective Time, notwithstanding any requisite approval and adoption of the Rana Business Combination Agreement and the Proposed Rana Transactions by the stockholders of Rana or Acquiror, as follows: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">by mutual written consent of Rana and the Company; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">by either FEXD or Rana, if: (i) the Effective Time has not occurred prior to the twelve-month anniversary of the date of the Rana Business Combination Agreement (the “<div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Rana Outside Date</div>”); provided, however, that the Rana Business Combination Agreement may not be terminated by or on behalf of any party (A) that either directly or indirectly through its affiliates is in breach or violation of any representation, warranty, covenant, agreement or obligation contained in the Rana Business Combination Agreement and such breach or violation is the principal cause of the failure of a condition to the Proposed Rana Transactions on or prior to the Rana Outside Date, or (B) against which any legal proceeding is brought by a party to the Rana Business Combination Agreement for specific performance or injunctive or other forms of equitable relief in connection with the Rana Business</div></td></tr></table><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Combination Agreement (which prohibition on such party’s right to terminate the Rana Business Combination Agreement continues throughout the pendency of such legal proceeding); (ii) any Governmental Authority in the United States has enacted, issued, promulgated, enforced or entered any permanent injunction, order, decree or ruling which has become final <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and non-appealable and</div> has the effect of making consummation of the Proposed Rana Transactions, including the Merger, illegal or otherwise prevents or prohibits consummation of the Proposed Rana Transactions or the Merger; or (iii) any of the Acquiror Proposals fail to receive the requisite vote for approval at the Acquiror Stockholders’ Meeting; </div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">by FEXD if (i) there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of the Company set forth in the Rana Business Combination Agreement, or if any representation or warranty of the Company has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of the Company specified above would not be satisfied (“<div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Terminating Company Breach</div>”); provided, however, that FEXD has not waived such Terminating Company Breach and FEXD and Merger Sub are not then in material breach of their representations, warranties, covenants or agreements in the Rana Business Combination Agreement; provided further, however, that, if such Terminating Company Breach is curable by Rana, FEXD may not terminate the Rana Business Combination Agreement under this provision for so long as the Company continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by FEXD to Rana; (ii) the PCAOB Financials (together with an unqualified report therein of the auditors of Rana and its subsidiaries, if applicable) are not delivered to FEXD by Rana on or before the dates required under the Rana Business Combination Agreement; or (iii) if the PCAOB Financials delivered to Acquiror by the Company for periods covered by the Unaudited Financials and Latest Balance Sheet (and the related unaudited consolidated statements of operations and comprehensive loss and cash flows of the Company and its subsidiaries for the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-month</div> period then ended) differ from those disclosed on the Company Disclosure Schedule; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">by Rana if there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of FEXD and Merger Sub set forth in the Rana Business Combination Agreement, or if any representation or warranty of FEXD and Merger Sub has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of FEXD and Merger Sub specified above would not be satisfied (“<div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Terminating Acquiror/Merger Sub Breach</div>”); provided, however, that Rana has not waived such Terminating Acquiror/Merger Sub Breach and Rana is not then in material breach of its representations, warranties, covenants or agreements in the Rana Business Combination Agreement; provided further, however, that, if such Terminating Acquiror/Merger Sub Breach is curable by FEXD and Merger Sub, Rana may not terminate the Rana Business Combination Agreement under this section for so long as FEXD and Merger Sub continue to exercise their reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by Rana to FEXD. </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Effect of Termination </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Rana Business Combination Agreement is terminated, the agreement will forthwith become void, and there will be no liability under the Rana Business Combination Agreement on the part of any party thereto, except as set forth in the Rana Business Combination Agreement or in the case of termination subsequent to a willful material breach of the Rana Business Combination Agreement by a party thereto. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The closing of the Proposed <div style="display:inline;">Rana</div> Transactions (the “Rana Closing”) will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Rana Business Combination has not been closed. </div></div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Afinoz Business Combination Agreement </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 11, 2022, the Company, announced that it, Fama Financial Services, Inc., a Georgia corporation and wholly owned subsidiary of the Company (“Merger Sub”), Monisha Sahni, Rachna Suneja and Ritscapital, LLC (collectively the “Members”) and Monisha Sahni as representative of the Members (“Member Representative”), had entered into a business combination agreement (the “Afinoz Business Combination Agreement”), dated September 9, 2022, pursuant to which, among other things, Mobitech International LLC, a limited liability company organized in the United Arab Emirates (“Afinoz”) will become as a wholly-owned subsidiary of the Company. The key terms of the Afinoz Business Combination Agreement are as follows: </div></div></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The transaction is structured as a purchase of limited liability company membership interests. Pursuant to the Afinoz Business Combination Agreement, on the closing date, the Company will purchase the limited liability company membership interests of Afinoz, with Afinoz continuing as a wholly-owned direct subsidiary of the Company (together with the other transactions related thereto, the “Proposed Afinoz Transactions”). </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company shall pay a combination of Afinoz Cash Consideration and Afinoz Equity Consideration for the Company Membership Interests subject to adjustments for Working Capital and Debt, which adjustments shall be secured by an escrow amount equal to $700,000 (the “Afinoz Escrow Amount”). </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Afinoz Cash Consideration means $5,000,000 and the Afinoz Equity Consideration means 11,500,000 shares of New Acquiror Class A Common Stock. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Afinoz Representations, Warranties and Covenants </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Afinoz Business Combination Agreement contains customary representations, warranties and covenants of Afinoz and FEXD relating to, among other things, their ability to enter into the Afinoz Business Combination Agreement and their outstanding capitalization. Afinoz has agreed to customary “no shop” obligations. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Conditions to Afinoz Closing </div></div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Mutual </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The obligations of Afinoz and FEXD to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to the Afinoz Closing, of the following conditions: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Acquiror Proposals have been approved and adopted by the requisite affirmative vote of the stockholders of Acquiror in accordance with the Proxy Statement, the Delaware General Corporation Law, the organizational documents of FEXD and the rules and regulations of Nasdaq; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">no Governmental Authority has enacted, issued, promulgated, enforced or entered any Law, rule, regulation, judgment, decree, executive order or award which is then in effect and has the effect of making the Proposed Afinoz Transactions illegal or otherwise prohibiting consummation of the Proposed Afinoz Transactions; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(c)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">the shares of New Acquiror Class A Common Stock to be issued in connection with the Proposed Afinoz Transactions shall have been approved for listing on Nasdaq, and immediately following the Closing Acquiror shall satisfy any applicable listing requirements of Nasdaq and Acquiror shall not have received any notice <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of non-compliance therewith.</div> </div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">FEXD </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The obligations of FEXD to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to the Afinoz Closing of the following additional conditions: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the representations and warranties of FEXD contained in the sections titled (i) Organization and Qualification; Subsidiaries, (ii) Capitalization, (iii) Authority Relative to this Business Combination </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%; font-size: 0px;"/> <td style="vertical-align: top;;text-align:left;">Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Afinoz contained in the Afinoz Business Combination Agreement shall be true and correct (without giving any effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect; </td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Afinoz, the Members and Member Representative, as applicable, have performed or complied in all material respects with all agreements and covenants required by the Afinoz Business Combination Agreement to be performed or complied with by each of them on or prior to the Afinoz Closing; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(c)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Member Representative has delivered to Acquiror the Escrow Agreement, duly executed by the Member Representative; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(d)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Afinoz has delivered to FEXD a customary officer’s certificate, dated the date of the Afinoz Closing, certifying as to the satisfaction of certain conditions; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(e)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">no Company Material Adverse Effect has occurred between the date of the Rana Business Combination Agreement and the Closing Date; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(f)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">on or prior to the Afinoz Closing, each of the Members shall deliver to Acquiror a properly executed and duly completed Internal Revenue Service <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form W-8BEN;</div> </div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(g)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">on or prior to the Afinoz Closing, each of the Members delivered to Acquiror the relevant ‘Tax residency certificate’ or any other similar requirements/certifications or evidences, as mandated under any of the domestic tax laws of their respective jurisdiction or territory, in order to claim the benefits of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the India-UAE Double</div> Tax Avoidance Agreement and to establish that no Indian withholding Tax is required to be deducted or withheld from the payment of consideration to such Member; </div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(h)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Afinoz has delivered to Acquiror the PCAOB Financials required to be delivered under the Afinoz Business Combination Agreement; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(i)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Afinoz has delivered to Acquiror evidence that it has executed certain regulatory filings with either the free-zone authority in the Sharjah Media City Free-Zone of the United Arab Emirates or the United Arab Emirates Ministry of Economy, as required pursuant to the Afinoz Business Combination Agreement; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(j)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Rana Business Combination Agreement has been consummated; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(k)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Trust Fund contains funds sufficient to pay the Rana Cash Consideration and the Afinoz Cash Consideration, in full; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">(l)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Acquiror has completed its due diligence exercise on Afinoz and its subsidiaries, and Afinoz and its subsidiaries has resolved to Acquiror’s satisfaction any issues arising therefrom, including but not limited to, confirmation that each of the Members, Afinoz and its subsidiaries, have complied with certain conditions set forth in schedules to the Afinoz Business Combination Agreement. </div></div></td></tr></table><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Afinoz </div></div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">The obligations of the Members and the Member Representative to consummate the Proposed Afinoz Transactions are subject to the satisfaction or waiver (where permissible) at or prior to Closing of the following additional conditions: </div></div></div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">the representations and warranties of FEXD contained in the sections titled (i) Corporation Organization (ii) Capitalization, (iii) Authority Relative to this Agreement and (iv) Brokers, are each true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other representations and warranties of Acquiror contained in the Afinoz Business Combination Agreement are true and correct (without giving any effect to any limitation as to “materiality” or “Acquiror Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in an Acquiror Material Adverse Effect; </div></div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">FEXD has performed or complied in all material respects with all agreements and covenants required by the Afinoz Business Combination Agreement to be performed or complied with by it on or prior to the Afinoz Closing; </div></div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">FEXD has delivered to the Member Representative, the Escrow Agreement, duly executed by FEXD; and </div></div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">FEXD has delivered to Afinoz a customary officer’s certificate dated the date of the Afinoz Closing, certifying as to the satisfaction of certain conditions. </div></div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Termination </div></div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">The Afinoz Business Combination Agreement may be terminated and the Proposed Afinoz Transactions may be abandoned at any time prior to the Closing, notwithstanding any requisite approval and adoption of the Afinoz Business Combination Agreement and the Proposed Afinoz Transactions by the Members and stockholders of Acquiror, as follows: </div></div></div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">by mutual written consent of the Acquiror and Member Representative; </div></div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">by either FEXD or the Member Representative, if: (i) the Closing has not occurred prior to the twelve-month anniversary of the date of the Afinoz Business Combination Agreement (the “</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Afinoz Outside</div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Date</div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">”); provided, however, that the Afinoz Business Combination Agreement may not be terminated by or on behalf of any party (A) that either directly or indirectly through its affiliates is in breach or violation of any representation, warranty, covenant, agreement or obligation contained in the Afinoz Business Combination Agreement and such breach or violation is the principal cause of the failure of a condition to the Proposed Afinoz Transactions on or prior to the Afinoz Outside Date, or (B) against which any legal proceeding is brought by a party to the Rana Business Combination Agreement for specific performance or injunctive or other forms of equitable relief in connection with the Afinoz Business Combination Agreement (which prohibition on such party’s right to terminate the Afinoz Business Combination Agreement continues throughout the pendency of such legal proceeding); (ii) any Governmental Authority in the United States has enacted, issued, promulgated, enforced or entered any permanent injunction, order, decree or ruling which has become final and </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">non-appealable</div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> and has the effect of making consummation of the Proposed Afinoz Transactions, illegal or otherwise </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">prevents or prohibits consummation of the Proposed Afinoz Transactions; or (iii) any of the Acquiror Proposals fail to receive the requisite vote for approval at the Acquiror Stockholders’ Meeting; </div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">by FEXD if: (i) there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of any Member set forth in the Afinoz Business Combination Agreement, or if any representation or warranty of any Member has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of the Members specified above would not be satisfied (“<div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Terminating Member Breach</div>”); provided, however, that FEXD has not waived such Terminating Member Breach and FEXD is not then in material breach of its representations, warranties, covenants or agreements in the Afinoz Business Combination Agreement; provided further, however, that, if such Terminating Member Breach is curable by the applicable Member, FEXD may not terminate the Afinoz Business Combination Agreement under this provision for so long as such Member continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by FEXD to the applicable Member; (ii) the PCAOB Financials are not delivered to FEXD by the Member Representative on or before the dates required under the Afinoz Business Combination Agreement; (iii) the Rana Business Combination Agreement is terminated; or (iv) if Afinoz fails to comply, within thirty days of signing the Afinoz Business Combination Agreement, with certain specific conditions precedent set forth in schedules to the Afinoz Business Combination Agreement. </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">by the Member Representative if there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of FEXD set forth in the Afinoz Business Combination Agreement, or if any representation or warranty of FEXD has become untrue, in either case such that the closing conditions with respect to the accuracy of the representations and warranties and the performance of the agreements and covenants of FEXD specified above would not be satisfied (“<div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Terminating Acquiror Breach</div>”); provided, however, that Afinoz has not waived such Terminating Acquiror Breach and Afinoz is not then in material breach of its representations, warranties, covenants or agreements in the Afinoz Business Combination Agreement; provided further, however, that, if such Terminating Acquiror Breach is curable by FEXD, Afinoz may not terminate the Afinoz Business Combination Agreement under this section for so long as FEXD continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by Afinoz to FEXD. </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Effect of Termination </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Afinoz Business Combination Agreement is terminated, the agreement will forthwith become void, and there will be no liability under the Afinoz Business Combination Agreement on the part of any party thereto, except as set forth in the Afinoz Business Combination Agreement or in the case of termination subsequent to a willful material breach of the Afinoz Business Combination Agreement by a party thereto. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Afinoz Closing will occur as promptly as practicable, but in no event later than three business days following the satisfaction or waiver of all of the closing conditions. As of December 31, 2022, the Afinoz Business Combination has not been closed. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Lock-Up Agreements</div> </div></div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company has entered into the three general forms <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of lock-up agreements</div> described below with stockholders and employees of Rana and Afinoz. The general terms below apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">all lock-up agreements.</div> The employee-specific terms apply to the Employee <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Stockholder Lock-Up and</div> Protective Covenant Agreement and the Employee <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Optionholder Lock-Up, Unvested</div> Stock &amp; Protective Covenant Agreement. The employee optionholder-specific terms apply only to the Employee <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Optionholder Lock-Up, Unvested</div> Stock &amp; Protective Covenant Agreement. Capitalized terms used but not otherwise defined in the description of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> agreements below have the meanings given to them in the applicable form of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> agreement.</div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">General Terms </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The stockholders and certain employees of Rana and Afinoz that own equity interests have entered into lock-up agreements with Acquiror wherein they have agreed not to Transfer any shares of New Acquiror Class A Common Stock for the period commencing upon the Effective Time and ending one year after the Effective Time, provided, however, that such restriction shall expire if the reported last sale price of New Acquiror Class A Common Stock equals or exceeds $</div>12.00<div style="font-size: 10pt;;display:inline;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any </div>twenty trading days within any thirty-trading day period commencing at least 150 days after the Effective Time.<div style="font-size: 10pt;;display:inline;"> Such </div>stockholders and employees have further agreed not to Transfer more than 200,000 Shares during any three-month period until the three-year anniversary of the Effective Date and not to Transfer more than 1,000,000 Shares during a further period thereafter, in each case subject to Permitted Transfers and the termination of restrictions upon expiration or termination of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">applicable lock-up agreement.</div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Employee-Specific Terms </div></div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">The lock-up agreements</div> of certain employees of Rana and Afinoz also contain restrictive covenants regarding confidentiality, conflicts of interest, non-competition, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-solicitation,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-inducement</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interference</div> during a Restricted Period commencing on the Effective Time and ending on the later to occur of (a) the fifth anniversary of the Effective Time and (b) the second anniversary of the date on which the employee’s employment with FEXD and its subsidiaries terminates for any reason. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Employee Optionholder-Specific Terms </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">The lock-up agreements</div> of the optionholder employees of Afinoz (“<div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Employee Optionholders</div>”) provide that Afinoz options outstanding prior to the Closing will convert into unvested shares of New Acquiror Class A Common Stock at Closing. The resulting Unvested Stock shall be eligible to vest on the following schedule: (a) the first quarter, as of twelve months from the Effective Time; (b) the second quarter, as of twenty-four months from the Effective Time; (c) the third quarter, as of thirty months from the Effective Time and (d) the fourth quarter, as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of thirty-six months</div> from the Effective Time. If the Employee Optionholder terminates the Employee Optionholder’s employment with FEXD and its subsidiaries, at any time before the Unvested Stock has vested and become Vested Stock, then the Employee Option holder’s Unvested Stock outstanding on the date of termination of employment shall be automatically forfeited. If the Employee Optionholder’s employment with FEXD and its subsidiaries is terminated by FEXD or any of its subsidiaries for Cause at any time before all of the Unvested Stock has vested and become Vested Stock, then all of the Employee Optionholder’s Unvested Stock and Vested Stock shall be automatically forfeited. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Employment Offer Letters </div></div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">On December 20, 2022, the Company entered into a conditional offer letter with an individual for the position of Chief Marketing Officer of FEXD (the “CMO Offer Letter”). Pursuant to the CMO Offer Letter, the individual will become the Chief Marketing Officer of FEXD on June 1, 2023. The appointment is contingent upon the consummation of the business combination among FEXD, Rana and Afinoz and shareholder approval. Upon effectiveness, the Chief Marketing Officer will receive an annual salary of $</div></div>400,000<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;">, up to $</div>150,000<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> in performance bonuses with $</div>15,000<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> guaranteed, $</div>200,000<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> in FEXD stock vesting over </div>three<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> years with a </div><div style="letter-spacing: 0px; font-size: 10pt; white-space: nowrap; top: 0px;;display:inline;">12-month</div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> cliff and standard benefits.</div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">On December 20, 2022, the Company entered into a conditional offer letter with an individual for the position of Chief Executive Officer of Fama Financial Services (the “CEO Offer Letter”). Pursuant to the CEO Offer Letter, the individual will become the Chief Executive Officer of FEXD on June 1, 2023. The appointment is contingent upon the consummation of the business combination among FEXD, Rana and Afinoz and shareholder approval. Upon effectiveness, the Chief Executive Officer will receive an annual salary of $</div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"/>500,000, a minimum cash </div></div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">bonus of 30 percent of the annual salary year one, 20% percent on year two and 15% from year three onwards (subject to a objective based target bonus of up to 200% of prevailing salary which will be split equally with stocks vested over a period of three years and cash), $50,000 in FEXD stock vesting over three years with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-month</div> cliff and standard <div style="letter-spacing: 0px; top: 0px;;display:inline;">benefits</div>.</div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">De-SPAC Service agreement </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On December 12, 2022, the Company entered a service agreement, effective January 15, 2023, with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">third-party</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">de-SPAC</div> service provider. Pursuant to the agreement, the service provider will provide investor relation services to the Company for an initial <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-month</div> period. The service provider will receive compensation of $90,000 from the Company for its services covering the initial <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-month</div> period. In addition, the service provider will receive $22,500 worth of shares in the de-SPAC company quarterly, with the value accruing from the effective date of the service agreement. </div></div> 2 P5Y P3M P7Y 1500000 0.0125 1437500 0.0325 3737500 P12M P3Y 0.0001 one 5711662 7800000 7020000 700000 5000000 11500000 12 twenty trading days within any thirty-trading day period commencing at least 150 days after the Effective Time. stockholders and employees have further agreed not to Transfer more than 200,000 Shares during any three-month period until the three-year anniversary of the Effective Date and not to Transfer more than 1,000,000 Shares during a further period thereafter, in each case subject to Permitted Transfers and the termination of restrictions upon expiration or termination of the applicable lock-up agreement. 400000 150000 15000 200000 P12M 500000 0.30 0.20 0.15 2 50000 P12M 90000 22500 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 7. DERIVATIVE FINANCIAL INSTRUMENTS </div></div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liability </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units, and only whole Public Warrants will trade. The Public Warrants will become exercisable on the date tha</div></div>t is 30 days after the completion of the initial Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable, and the Company will not be obligated to issue any shares of Class A common stock upon exercise of a Public Warrant unless Class A common stock issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Public Warrants. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, the Company will use its best efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the Public Warrants. The Company will use its reasonable best efforts to maintain the effectiveness of such registration statement and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the Public Warrant agreement. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $11.50 per share of Class A common <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">stock </div></div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><br/></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">(with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than </div>60<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of Class A common stock during the </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">10-trading day</div> period starting on the trading day after to the day <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $</div>9.20<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">per share, then the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Description of Securities—Warrants—Public Stockholders’ Warrants—Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">higher of the Market Value and the Newly Issued Price, and the $</div></div>10.00<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the market value and the Newly Issued Price. </div></div><div/><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may call the Public Warrants for redemption: </div></div></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">in whole and not in part; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">at a price of $0.01 per warrant; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">upon a minimum of 30 days’ prior written notice of redemption, or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the 30-day</div> redemption period, to each warrant holder; and </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">if, and only if, the last reported sale price of Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like and for certain issuances of Class A common stock and equity-linked securities as described above) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant holders. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and the number of shares of Class A Common Stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances, including in the event of a stock dividend or recapitalization, reorganization, merger, or consolidation. However, the Public Warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period or during any Extension Period, and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Placement Warrants, including the October 2022 Private Placement Warrants, will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Private Placement Warrants and the Class A Common Stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">be non-redeemable so</div> long as they are held by the initial purchasers or their permitted transferees (except as set forth above). If the Private Placement Warrants are held by someone other than th<div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div><br/></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounted for the 9,650,250 warrants issued in connection with the Initial Public Offering (including <div style="letter-spacing: 0px; top: 0px;;display:inline;">5,750,000</div> Public Warrants and <div style="letter-spacing: 0px; top: 0px;;display:inline;">3,900,250</div> Private Placement Warrants as the underwriters’ over-allotment option was exercised in full) and the 1,150,000 October 2022 Private Placement Warrants in accordance with the guidance contained in <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 815-</div></div><div style="background-color:#ffffff;;display:inline;">40.</div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Su</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ch guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The warrant agreement contains an Alternative Issuance provision that if less than </div>70<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the consideration receivable by the holders of the Class A Common Stock in the Business Combination is payable in the form of common equity in the successor entity, and if the holders of the warrants properly exercise the warrants within thirty days following the public disclosure of the consummation of Business Combination by the Company, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration paid to holders of the common stock consists exclusively of cash, the amount of such cash per common stock, and (ii) in all other cases, the volume-weighted average price of the common stock as reported during <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the ten-trading day</div> period ending on the trading day prior to the effective date of the Business Combination.</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;">The Company believes that the adjustments to the exercise price of the warrants are based on a variable that is not an input to the fair value of </div><div style="letter-spacing: 0px; font-size: 10pt; white-space: nowrap; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">a “fixed-for-fixed” option</div></div><div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> as defined under FASB ASC Topic </div>No<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;">. </div>815<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> </div>–<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;"> </div>40<div style="letter-spacing: 0px; font-size: 10pt; top: 0px;;display:inline;">, and thus the warrants are not eligible for an exception from derivative accounting. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon closing the Proposed Public Offering. Accordingly, the Company will classify its Public Warrant, Private Placement Warrant as a liability at its fair value, and the warrants will be estimated using a valuation model prepared by an outside valuation firm. The valuation model uses inputs such as assumed share prices, volatility, discount factors, and other assumptions and may not reflect the price at which they can be settled. This liability is subject to remeasurement at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forward Purchase Agreement </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July </div>16<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, </div>2021<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, the Company entered into a forward purchase agreement (the “Forward Purchase Agreement”) with Caltech Trading Corp., an anchor investor. Pursuant to the Forward Purchase Agreement, Caltech Trading Corp. will agree to purchase a minimum of </div>8,000,000<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> units and a maximum of </div>9,000,000<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> units (the “Forward Purchase Units”), with each Forward Purchase Unit consisting of </div>one<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> share of Class A common stock (a “Forward Purchase Share”), </div>one<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> right to </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">receive one-tenth (1/10)</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> of </div>one<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> share of its Class A common stock (a “Forward Purchase Right”) </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and one-half of</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div>one<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> warrant to purchase </div>one<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> share of Class A common stock (a “Forward Purchase Warrant”), at a price of $</div>10.00<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> per Forward Purchase Unit, for a minimum aggregate purchase price of $</div>80.0<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> million and a maximum aggregate purchase price of up to $</div>90.0<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> million. The shares of Class A common stock to be issued under the Forward Purchase Agreement will have </div>no<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> redemption rights and </div>no<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> right to liquidate distributions from the Trust Account. The Forward Purchase Shares, the Forward Purchase Rights and Forward Purchase Warrants will be identical to the shares of Class A Common Stock, the Public Rights, and the Public Warrants, respectively, included in the Public Units to be sold in the Proposed Offering. The purchase of the Forward Purchase Units will occur concurrently and only in connection with the closing of the Business Combination. The Forward Purchase Shares, Forward Purchase Rights and Forward Purchase</div><div style="display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants (and the shares of Class A common stock underlying such securities) are subject to registration rights. Caltech’s Trading commitment under the Forward Purchase Agreement is subject to customary closing conditions, including that the Business Combination must be consummated substantially concurrently with the purchase of the Forward Purchase Units. The obligations of Caltech Trading under the Forward Purchase Agreement do not depend on whether any Class A common shares held by public shareholders are redeemed by the Company. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company accounted for the Forward Purchase Agreement in accordance with the guidance <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in ASC 815-40 and accounts</div> for such agreement as a derivative liability. The liability is subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at each balance sheet date, with changes in fair value recognized in the statements of operations. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> P30D P20D P60D P5Y 11.5 0.60 P10D 9.2 1.15 18 1.80 10 0.01 P30D 18 P20D P30D P30D 9650250 1150000 0.70 8000000 9000000 10 80000000 90000000 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 8. FAIR VALUE OF FINANCIAL INSTRUMENTS </div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">The following table presents information about the Company’s derivative warrant liabilities and forward purchase agreement liability that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">As of December 31, 2022</div></div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 84%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:40%"/> <td style="vertical-align:bottom;width:12%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:12%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:12%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Observable Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Unobservable Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Public Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">402,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Private Placement Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">353,518</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward Purchase Agreement Liability</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">402,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">353,518</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">As of December 31, 2021</div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 84%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:40%"/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Observable Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Unobservable Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Public Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,185,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Private Placement Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,521,098</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward Purchase Agreement Liability</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,726,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,433,006</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The estimated fair value of the Forward Purchase Agreement is determined using Level 3 inputs. Inherent in a Monte Carlo or Black-Scholes simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the U.S. Treasury zero-coupon yield curve on</div> the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the derivative liabilities, measured using level 3 inputs, for the year ended December 31, 2022<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and for the period from March 5, 2021 (inception) through December 31, 2021, is summarized as follows:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 85%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at March 5, 2021 (inception)</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/>$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of public warrants, private placement warrants, forward purchase agreement – level 3</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,894,740</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,538,266</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at December 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,433,006</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfer of public warrants to level 1 measurement</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2,185,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfer of private placement warrants to level 2 measurement</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1,521,098</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1,441,341</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at December 31, 2022</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">285,567</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s liabilities that are measured at fair value at October 21, 2021 (Initial Public Offering date): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 84%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:42%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward Purchase<br/> Units</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.75 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.75 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75 year</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.33</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.33</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability of acquisition</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:42%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward Purchase<br/> Units</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.56 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.56 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.56 year</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.30</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.30</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.21</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability of acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:42%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward Purchase<br/> Units</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.06 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.06 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.06 year</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.91</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.91</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.04</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability of acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="clear:both;max-height:0pt;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a summary of the changes in the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/>Placement<br/>warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public<br/>Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/>Warrant<br/>Liability</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward<br/>Purchase<br/>Agreement</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of March 5, 2021 (inception)</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of Public Warrants, Private Warrants upon IPO</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,014,065</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,380,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,394,065</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Signing of Forward Purchase Agreement upon IPO</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">507,033</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">805,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,312,033</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,233</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of December 31, 2021</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,521,098</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,185,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,706,098</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,726,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of Private Warrants</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">80,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">80,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden76565786">Change in fair value</span></div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,248,080</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,782,500</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,030,580</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,441,341</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of December 31, 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">353,518</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">402,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">756,018</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">The following table presents information about the Company’s derivative warrant liabilities and forward purchase agreement liability that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">As of December 31, 2022</div></div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 84%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:40%"/> <td style="vertical-align:bottom;width:12%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:12%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:12%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Observable Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Unobservable Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Public Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">402,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Private Placement Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">353,518</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward Purchase Agreement Liability</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">402,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">353,518</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">As of December 31, 2021</div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 84%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:40%"/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Observable Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Unobservable Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Public Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,185,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Private Placement Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,521,098</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward Purchase Agreement Liability</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,726,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,433,006</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> 402500 0 0 0 353518 0 0 0 285567 402500 353518 285567 0 0 2185000 0 0 1521098 0 0 1726908 0 0 5433006 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the derivative liabilities, measured using level 3 inputs, for the year ended December 31, 2022<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and for the period from March 5, 2021 (inception) through December 31, 2021, is summarized as follows:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 85%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at March 5, 2021 (inception)</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/>$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of public warrants, private placement warrants, forward purchase agreement – level 3</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,894,740</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,538,266</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at December 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,433,006</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfer of public warrants to level 1 measurement</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2,185,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfer of private placement warrants to level 2 measurement</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1,521,098</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1,441,341</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at December 31, 2022</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">285,567</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s liabilities that are measured at fair value at October 21, 2021 (Initial Public Offering date): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 84%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:42%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward Purchase<br/> Units</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise price</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.75 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.75 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75 year</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.33</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.33</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability of acquisition</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:42%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward Purchase<br/> Units</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.56 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.56 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.56 year</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.30</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.30</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.21</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability of acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:42%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward Purchase<br/> Units</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.06 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.06 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.06 year</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.91</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.91</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.04</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability of acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the derivative liabilities, measured using level 3 inputs, for the year ended December 31, 2022<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and for the period from March 5, 2021 (inception) through December 31, 2021, is summarized as follows:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 85%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at March 5, 2021 (inception)</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/>$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of public warrants, private placement warrants, forward purchase agreement – level 3</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,894,740</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,538,266</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at December 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,433,006</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfer of public warrants to level 1 measurement</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2,185,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfer of private placement warrants to level 2 measurement</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1,521,098</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1,441,341</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities – level 3, at December 31, 2022</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">285,567</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; width: 76%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom; width: 2%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> 0 3894740 1538266 5433006 -2185000 -1521098 -1441341 285567 11.5 11.5 10 6.5 6.5 6.5 5.75 5.75 0.75 1.33 1.33 0.09 100 100 100 0 0 0 11.5 11.5 10 8.4 8.4 8.4 5.56 5.56 0.56 1.3 1.3 0.21 100 100 100 0 0 0 11.5 11.5 10 4.6 4.6 5.2 5.06 5.06 0.06 3.91 3.91 4.04 7.5 7.5 7.5 0 0 0 <div style="clear:both;max-height:0pt;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a summary of the changes in the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/>Placement<br/>warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public<br/>Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/>Warrant<br/>Liability</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward<br/>Purchase<br/>Agreement</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of March 5, 2021 (inception)</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of Public Warrants, Private Warrants upon IPO</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,014,065</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,380,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,394,065</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Signing of Forward Purchase Agreement upon IPO</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">507,033</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">805,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,312,033</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,233</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of December 31, 2021</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,521,098</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,185,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,706,098</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,726,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of Private Warrants</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">80,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">80,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden76565786">Change in fair value</span></div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,248,080</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,782,500</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,030,580</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,441,341</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of December 31, 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">353,518</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">402,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">756,018</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> 0 0 0 0 1014065 1380000 2394065 0 0 0 0 1500675 507033 805000 1312033 226233 1521098 2185000 3706098 1726908 80500 0 80500 0 -1248080 -1782500 -3030580 -1441341 353518 402500 756018 285567 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">NOTE 9. STOCKHOLDER’S EQUITY </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Preferred Shares </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At December 31, 2022 and 2021, there were no preferred shares issued or outstanding. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Class A Common Stock </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue 200,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 57,500 Class A Common Stock issued and outstanding excluding 11,500,000 shares subject to redemption. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class B Common Stock </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue 20,000,000 shares of Class B Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class B Common Stock are entitled to one vote for each share. At December 31, 2022 and 2021, there were 2,875,000 shares of Class B Common Stock issued and outstanding. Class B common stock will automatically convert into shares of Class A common stock at the time of the initial business combination <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on a <div style="letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div> basis.</div></div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Rights </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each holder of a Public Right will be entitled to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">receive one-tenth (1/10) of</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>one share of Class A Common Stock upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon the exchange of the Public Rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination as the consideration related thereto has been included in the unit purchase price paid for by investors in the Proposed Offering. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the Class A Common Stock will receive in the transaction on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">an as-converted into</div> Class A Common Stock </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">basis and each holder of a right will be required to affirmatively convert its rights in order to receive 1/10 share underlying each right (without paying additional consideration). The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). </div></div></div> 1000000 0.0001 0 0 0 0 200000000 0.0001 one 57500 57500 57500 57500 20000000 0.0001 one 2875000 2875000 2875000 2875000 one-tenth (1/10) <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">NOTE 10. INCOME TAX</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s net deferred tax assets are as follows:</div></div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax asset</div></td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Start-up</div> costs</div></td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">187,396</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,691</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 65%; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss</div></td> <td style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—   </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">21,704</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 65%; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; width: 65%; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax asset</div></td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">187,396</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,765</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 65%; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 65%; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td> <td style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(187,396</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(50,765</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 65%; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; width: 65%; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Deferred tax asset, net of allowance</div></div></td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 65%; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">The income tax provision consists of the following:</div></div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 76%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:59%"/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year<br/> ended<br/> December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">From March 5, 2021<br/> (inception) through<br/> December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,342</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss carryforward</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(136,631</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50,765</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">136,631</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">50,765</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; padding-bottom: 1.25pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Income tax provision</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1.25pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black;">$</td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black;;text-align:right;">290,342</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1.25pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1.25pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black;">$</td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black;;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1.25pt;"> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, the Company has $nil of U.S. federal net operating loss carryovers. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2022 and for the period from March 5 (inception) through to December 31, 2021, the change in the valuation allowance was $136,631 and $50,765, respectively.</div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and 2021 is as follows:</div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 17%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 16%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Statutory federal income tax rate</div></td> <td style="vertical-align: bottom; width: 17%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align: bottom; width: 16%;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transaction costs associated with the Initial Public Offering</div></td> <td style="vertical-align: bottom; width: 17%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align: bottom; width: 16%;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td> <td style="vertical-align: bottom; width: 17%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align: bottom; width: 16%;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of warrant liabilities and forward purchase agreement</div></td> <td style="vertical-align: bottom; width: 17%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right;">(23</td> <td style="white-space:nowrap;vertical-align:bottom">)%</td> <td style="vertical-align: bottom; width: 16%;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td></tr> <tr> <td style="vertical-align: top; width: 65%; background-color: rgb(204, 238, 255);"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td> <td style="vertical-align: bottom; width: 17%; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; width: 65%; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax provision</div></td> <td style="vertical-align: bottom; width: 17%; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);;text-align:right;">7</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);">% </td> <td style="vertical-align: bottom; width: 16%; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgba(255, 255, 255, 0);;text-align:right;">0</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);">% </td></tr></table> <div style="margin-top: 1em; margin-bottom: 1em"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income tax is generally <div style="letter-spacing: 0px; top: 0px;;display:inline;">open</div> for three years <div style="letter-spacing: 0px; top: 0px;;display:inline;">for</div> examination by IRS. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s net deferred tax assets are as follows:</div></div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax asset</div></td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Start-up</div> costs</div></td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">187,396</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,691</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 65%; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss</div></td> <td style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—   </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">21,704</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 65%; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; width: 65%; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax asset</div></td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">187,396</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,765</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 65%; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 65%; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td> <td style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(187,396</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(50,765</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 65%; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; width: 65%; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Deferred tax asset, net of allowance</div></div></td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; width: 65%; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; width: 9%; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr></table> 187396 29691 0 21704 187396 50765 187396 50765 0 0 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">The income tax provision consists of the following:</div></div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 76%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:59%"/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:14%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year<br/> ended<br/> December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">From March 5, 2021<br/> (inception) through<br/> December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,342</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss carryforward</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(136,631</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50,765</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">136,631</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">50,765</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; padding-bottom: 1.25pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Income tax provision</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1.25pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black;">$</td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black;;text-align:right;">290,342</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1.25pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1.25pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black;">$</td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black;;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1.25pt;"> </td></tr></table> 290342 0 136631 50765 0 0 0 0 136631 50765 290342 0 0 136631 50765 <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and 2021 is as follows:</div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 17%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 16%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Statutory federal income tax rate</div></td> <td style="vertical-align: bottom; width: 17%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align: bottom; width: 16%;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transaction costs associated with the Initial Public Offering</div></td> <td style="vertical-align: bottom; width: 17%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align: bottom; width: 16%;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td> <td style="vertical-align: bottom; width: 17%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align: bottom; width: 16%;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 65%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of warrant liabilities and forward purchase agreement</div></td> <td style="vertical-align: bottom; width: 17%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right;">(23</td> <td style="white-space:nowrap;vertical-align:bottom">)%</td> <td style="vertical-align: bottom; width: 16%;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td></tr> <tr> <td style="vertical-align: top; width: 65%; background-color: rgb(204, 238, 255);"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td> <td style="vertical-align: bottom; width: 17%; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; width: 65%; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax provision</div></td> <td style="vertical-align: bottom; width: 17%; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);;text-align:right;">7</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);">% </td> <td style="vertical-align: bottom; width: 16%; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgba(255, 255, 255, 0);;text-align:right;">0</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt; background-color: rgba(255, 255, 255, 0);">% </td></tr></table> 0.21 0.21 0.06 -0.01 0.03 -0.03 -0.23 -0.17 0.07 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 11. SUBSEQUENT EVENTS </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued. Based on this review, except the event below, the Company did not identify any subsequent events through the date of the issuance of the <div style="letter-spacing: 0px; top: 0px;;display:inline;">consolidated </div>financial statements that would have required disclosure or adjustment in the <div style="letter-spacing: 0px; top: 0px;;display:inline;">consolidated </div>financial statements: </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">O</div></div>n January 20, 2023, the Company consummated the private placement of 1,150,000 warrants at a price of $1.00 per warrant (the “January 2023 Private Placement Warrants”), generating total proceeds of $1,150,000. The January 2023 Private Placement Warrants were purchased by the Sponsor and are substantially similar to the private placement warrants issued to the Sponsor at the time of IPO in October 2021. The January 2023 Private Placement Warrants have been issued pursuant to and are governed by a Warrant Agreement that is substantially similar to the Warrant Agreement that the Company entered into at the time of the IPO. Similar to the private placement warrants issued at the time of the IPO, the January 2023 Private Placement Warrants will not be transferable, assignable or salable until 30 days after the Company’s initial business combination and, unlike such private placement warrants, are not redeemable by the Company at any time (including following transfer by the Sponsor or its permitted transferees). </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The proceeds received by the Company in connection with the issuance of the January 2023 Private Placement Warrants have been deposited in the trust account (the “Trust Account”) established at the time of the IPO. In accordance with the Company’s Amended and Restated Certificate of Incorporation, the deposit of such proceeds into the Trust Account on or prior to January 21, 2023 will extend by three months until April 21, 2023, the time the Company will have to consummate an initial business combination. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January 20, 2023, the Company entered into a $200,000 promissory note (the “January 2023 Note”) with its Sponsor. The January 2023 Note is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing and has a maturity date on the earlier of: (i) the Initia<div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div> Business Combination date; and (ii) July 15, 2023.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April 10, 2023, timely, pursuant to the terms of the Rana Business Combination Agreement dated September 9, 2022, the Company sent a letter to Rana Financial, Inc. regarding its failure to deliver audited financial statements. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also notified Rana of its intent to propose the termination of the Rana Business Combination Agreement and abandonment of the proposed business combination if the audited financial statements are not delivered to the Company by April 21, 2023. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;"/></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;">On April 20, 2023, the Company held a special meeting of stockholders in lieu of its 2023 annual meeting to consider and vote upon (a) a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company has to consummate its initial business combination for a maximum of twelve (12) additional one month periods, from April 21, 2023 to April 21, 2024, or such earlier date as determined by its board of directors and (b) a proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the aforementioned extension. In connection with this vote, the Company expects that eighty (80) holders will redeem an aggregate of 7,527,997 shares of the Company at an estimated redemption price of $10.48 per share or $78,893,408.56 in the aggregate. </div></div></div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;"> </div></div></div></div> 1150000 1 1150000 200000 7527997 10.48 78893408.56 EXCEL 52 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 54 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 55 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 249 284 1 false 75 0 false 9 false false R1.htm 1001 - Document - Cover Page Sheet http://fin.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://fin.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://fin.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://fin.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 1006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW Sheet http://fin.com/role/ConsolidatedStatementsOfCashFlow CONSOLIDATED STATEMENTS OF CASH FLOW Statements 6 false false R7.htm 1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN Sheet http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcern DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN Notes 7 false false R8.htm 1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://fin.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 1009 - Disclosure - INITIAL PUBLIC OFFERING Sheet http://fin.com/role/InitialPublicOffering INITIAL PUBLIC OFFERING Notes 9 false false R10.htm 1010 - Disclosure - PRIVATE PLACEMENT Sheet http://fin.com/role/PrivatePlacement PRIVATE PLACEMENT Notes 10 false false R11.htm 1011 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://fin.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 1012 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://fin.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 12 false false R13.htm 1013 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS Sheet http://fin.com/role/DerivativeFinancialInstruments DERIVATIVE FINANCIAL INSTRUMENTS Notes 13 false false R14.htm 1014 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS Sheet http://fin.com/role/FairValueOfFinancialInstruments FAIR VALUE OF FINANCIAL INSTRUMENTS Notes 14 false false R15.htm 1015 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://fin.com/role/StockholdersEquity STOCKHOLDERS' EQUITY Notes 15 false false R16.htm 1016 - Disclosure - INCOME TAX Sheet http://fin.com/role/IncomeTax INCOME TAX Notes 16 false false R17.htm 1017 - Disclosure - SUBSEQUENT EVENTS Sheet http://fin.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 1018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 1019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://fin.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://fin.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 1020 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) Sheet http://fin.com/role/FairValueOfFinancialInstrumentsTables FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) Tables http://fin.com/role/FairValueOfFinancialInstruments 20 false false R21.htm 1021 - Disclosure - INCOME TAX (Tables) Sheet http://fin.com/role/IncomeTaxTables INCOME TAX (Tables) Tables http://fin.com/role/IncomeTax 21 false false R22.htm 1022 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Additional Information (Detail) Sheet http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Additional Information (Detail) Details 22 false false R23.htm 1023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share, Basic and Diluted (Detail) Sheet http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share, Basic and Diluted (Detail) Details 23 false false R24.htm 1024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Sheet http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Details 24 false false R25.htm 1025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Basic and Diluted Net Income (Loss) Per Share (Detail) Sheet http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Basic and Diluted Net Income (Loss) Per Share (Detail) Details 25 false false R26.htm 1026 - Disclosure - INITIAL PUBLIC OFFERING - Additional Information (Detail) Sheet http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail INITIAL PUBLIC OFFERING - Additional Information (Detail) Details 26 false false R27.htm 1027 - Disclosure - PRIVATE PLACEMENT - Additional Information (Detail) Sheet http://fin.com/role/PrivatePlacementAdditionalInformationDetail PRIVATE PLACEMENT - Additional Information (Detail) Details 27 false false R28.htm 1028 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Detail) Sheet http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail RELATED PARTY TRANSACTIONS - Additional Information (Detail) Details 28 false false R29.htm 1029 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Sheet http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Details 29 false false R30.htm 1030 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS - Additional Information (Detail) Sheet http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail DERIVATIVE FINANCIAL INSTRUMENTS - Additional Information (Detail) Details 30 false false R31.htm 1031 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) Sheet http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) Details 31 false false R32.htm 1032 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Liabilities Measured on Recurring Basis (Detail) Sheet http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Liabilities Measured on Recurring Basis (Detail) Details 32 false false R33.htm 1033 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Significant Inputs to the Black-Scholes Option Pricing Model for the Fair Value of the Founder Warrants (Detail) Sheet http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Significant Inputs to the Black-Scholes Option Pricing Model for the Fair Value of the Founder Warrants (Detail) Details 33 false false R34.htm 1034 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments that are Measured at Fair Value (Detail) Sheet http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments that are Measured at Fair Value (Detail) Details 34 false false R35.htm 1035 - Disclosure - STOCKHOLDERS' EQUITY - Additional information (Detail) Sheet http://fin.com/role/StockholdersEquityAdditionalInformationDetail STOCKHOLDERS' EQUITY - Additional information (Detail) Details 35 false false R36.htm 1036 - Disclosure - INCOME TAX - Summary of Net Deferred Tax Assets (Detail) Sheet http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail INCOME TAX - Summary of Net Deferred Tax Assets (Detail) Details 36 false false R37.htm 1037 - Disclosure - INCOME TAX - Summary of Income Tax Provision (Detail) Sheet http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail INCOME TAX - Summary of Income Tax Provision (Detail) Details 37 false false R38.htm 1038 - Disclosure - INCOME TAX - Summary of Effective Income Tax Rate Reconciliation (Detail) Sheet http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail INCOME TAX - Summary of Effective Income Tax Rate Reconciliation (Detail) Details 38 false false R39.htm 1039 - Disclosure - INCOME TAX - Additional Information (Detail) Sheet http://fin.com/role/IncomeTaxAdditionalInformationDetail INCOME TAX - Additional Information (Detail) Details 39 false false R40.htm 1040 - Disclosure - SUBSEQUENT EVENTS - Additional information (Detail) Sheet http://fin.com/role/SubsequentEventsAdditionalInformationDetail SUBSEQUENT EVENTS - Additional information (Detail) Details 40 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesClassifiedCurrent in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d456943d10k.htm 1848, 1852, 3545 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d456943d10k.htm 3545 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince, us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight - d456943d10k.htm 9, 1626 d456943d10k.htm d456943dex311.htm d456943dex312.htm d456943dex321.htm d456943dex322.htm fexd-20221231.xsd fexd-20221231_cal.xml fexd-20221231_def.xml fexd-20221231_lab.xml fexd-20221231_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 58 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d456943d10k.htm": { "axisCustom": 8, "axisStandard": 20, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 487, "http://xbrl.sec.gov/dei/2022": 48 }, "contextCount": 249, "dts": { "calculationLink": { "local": [ "fexd-20221231_cal.xml" ] }, "definitionLink": { "local": [ "fexd-20221231_def.xml" ] }, "inline": { "local": [ "d456943d10k.htm" ] }, "labelLink": { "local": [ "fexd-20221231_lab.xml" ] }, "presentationLink": { "local": [ "fexd-20221231_pre.xml" ] }, "schema": { "local": [ "fexd-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 476, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://xbrl.sec.gov/dei/2022": 4, "total": 6 }, "keyCustom": 105, "keyStandard": 179, "memberCustom": 48, "memberStandard": 24, "nsprefix": "fexd", "nsuri": "http://fin.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://fin.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "fexd:DisclosureOfPrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - PRIVATE PLACEMENT", "menuCat": "Notes", "order": "10", "role": "http://fin.com/role/PrivatePlacement", "shortName": "PRIVATE PLACEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "fexd:DisclosureOfPrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "11", "role": "http://fin.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "12", "role": "http://fin.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS", "menuCat": "Notes", "order": "13", "role": "http://fin.com/role/DerivativeFinancialInstruments", "shortName": "DERIVATIVE FINANCIAL INSTRUMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS", "menuCat": "Notes", "order": "14", "role": "http://fin.com/role/FairValueOfFinancialInstruments", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - STOCKHOLDERS' EQUITY", "menuCat": "Notes", "order": "15", "role": "http://fin.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - INCOME TAX", "menuCat": "Notes", "order": "16", "role": "http://fin.com/role/IncomeTax", "shortName": "INCOME TAX", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "17", "role": "http://fin.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "18", "role": "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "19", "role": "http://fin.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://fin.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)", "menuCat": "Tables", "order": "20", "role": "http://fin.com/role/FairValueOfFinancialInstrumentsTables", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - INCOME TAX (Tables)", "menuCat": "Tables", "order": "21", "role": "http://fin.com/role/IncomeTaxTables", "shortName": "INCOME TAX (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityIncorporationDateOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Additional Information (Detail)", "menuCat": "Details", "order": "22", "role": "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityIncorporationDateOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share, Basic and Diluted (Detail)", "menuCat": "Details", "order": "23", "role": "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share, Basic and Diluted (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)", "menuCat": "Details", "order": "24", "role": "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Basic and Diluted Net Income (Loss) Per Share (Detail)", "menuCat": "Details", "order": "25", "role": "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Basic and Diluted Net Income (Loss) Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:TemporaryEquityTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "lang": null, "name": "fexd:ProceedsAllocatedToPublicWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P10_21_2021To10_21_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - INITIAL PUBLIC OFFERING - Additional Information (Detail)", "menuCat": "Details", "order": "26", "role": "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "shortName": "INITIAL PUBLIC OFFERING - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "fexd:DisclosureofinitialpublicofferingTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P10_21_2021To10_21_2021", "decimals": "0", "lang": null, "name": "fexd:TotalOfferingCostsAssociatedWithInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - PRIVATE PLACEMENT - Additional Information (Detail)", "menuCat": "Details", "order": "27", "role": "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "shortName": "PRIVATE PLACEMENT - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P10_01_2022To10_31_2022", "decimals": null, "lang": "en-US", "name": "fexd:NumberOfDaysWarrentsAreNotTransferableAfterInitialBusinessCombination", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Detail)", "menuCat": "Details", "order": "28", "role": "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "RELATED PARTY TRANSACTIONS - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022_WorkingCapitalLoansMemberusgaapRelatedPartyTransactionAxis_WorkingCapitalWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "fexd:NumberOfMonthsFromClosingOfABusinessCombinationDetermingEndingPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail)", "menuCat": "Details", "order": "29", "role": "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "COMMITMENTS AND CONTINGENCIES - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "fexd:NumberOfMonthsFromClosingOfABusinessCombinationDetermingEndingPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:TemporaryEquitySharesAuthorized", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "lang": null, "name": "us-gaap:TemporaryEquitySharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "fexd:MinimumNoticePeriodToBeGivenToTheHoldersOfWarrantPriorToRedemption", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS - Additional Information (Detail)", "menuCat": "Details", "order": "30", "role": "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "shortName": "DERIVATIVE FINANCIAL INSTRUMENTS - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "fexd:MinimumNoticePeriodToBeGivenToTheHoldersOfWarrantPriorToRedemption", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "fexd:ScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)", "menuCat": "Details", "order": "31", "role": "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "lang": null, "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "fexd:ScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn03_04_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Liabilities Measured on Recurring Basis (Detail)", "menuCat": "Details", "order": "32", "role": "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Liabilities Measured on Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "fexd:ScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "0", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Significant Inputs to the Black-Scholes Option Pricing Model for the Fair Value of the Founder Warrants (Detail)", "menuCat": "Details", "order": "33", "role": "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Significant Inputs to the Black-Scholes Option Pricing Model for the Fair Value of the Founder Warrants (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn03_04_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments that are Measured at Fair Value (Detail)", "menuCat": "Details", "order": "34", "role": "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS - Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments that are Measured at Fair Value (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn03_04_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - STOCKHOLDERS' EQUITY - Additional information (Detail)", "menuCat": "Details", "order": "35", "role": "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "shortName": "STOCKHOLDERS' EQUITY - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "lang": "en-US", "name": "fexd:NumberOfSharesEntitlesForEachRightHeld", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "fexd:DeferredTaxAssetsStartUpCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - INCOME TAX - Summary of Net Deferred Tax Assets (Detail)", "menuCat": "Details", "order": "36", "role": "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail", "shortName": "INCOME TAX - Summary of Net Deferred Tax Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "fexd:DeferredTaxAssetsStartUpCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - INCOME TAX - Summary of Income Tax Provision (Detail)", "menuCat": "Details", "order": "37", "role": "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail", "shortName": "INCOME TAX - Summary of Income Tax Provision (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - INCOME TAX - Summary of Effective Income Tax Rate Reconciliation (Detail)", "menuCat": "Details", "order": "38", "role": "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail", "shortName": "INCOME TAX - Summary of Effective Income Tax Rate Reconciliation (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - INCOME TAX - Additional Information (Detail)", "menuCat": "Details", "order": "39", "role": "http://fin.com/role/IncomeTaxAdditionalInformationDetail", "shortName": "INCOME TAX - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis", "decimals": "0", "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "fexd:FormationAndOperatingCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://fin.com/role/ConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "fexd:FormationAndOperatingCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - SUBSEQUENT EVENTS - Additional information (Detail)", "menuCat": "Details", "order": "40", "role": "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "shortName": "SUBSEQUENT EVENTS - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P04_20_2023To04_20_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "INF", "lang": null, "name": "fexd:TemporaryEquityStockRedeemedDuringThePeriodShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn03_04_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "menuCat": "Statements", "order": "5", "role": "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "PAsOn03_04_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW", "menuCat": "Statements", "order": "6", "role": "http://fin.com/role/ConsolidatedStatementsOfCashFlow", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOW", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P03_05_2021To12_31_2021", "decimals": "0", "lang": null, "name": "fexd:OfferingCostOfDerivativeWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN", "menuCat": "Notes", "order": "7", "role": "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcern", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://fin.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "fexd:DisclosureofinitialpublicofferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - INITIAL PUBLIC OFFERING", "menuCat": "Notes", "order": "9", "role": "http://fin.com/role/InitialPublicOffering", "shortName": "INITIAL PUBLIC OFFERING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d456943d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "fexd:DisclosureofinitialpublicofferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 75, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r402", "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r402", "r403", "r404" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r402", "r403", "r404" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r402", "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Entity Incorporation, Date of Incorporation", "terseLabel": "Entity incorporation date" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "fexd_AccrualExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrual expense.", "label": "Accrual Expense", "terseLabel": "Accrual Expense" } } }, "localname": "AccrualExpense", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_AccruedInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued interest [Member].", "label": "Accrued Interest [Member]" } } }, "localname": "AccruedInterestMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_AdjustedExercisePriceOfWarrantsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted exercise price of warrants percentage.", "label": "Adjusted Exercise Price Of Warrants Percentage", "terseLabel": "Adjusted exercise price of warrants percentage" } } }, "localname": "AdjustedExercisePriceOfWarrantsPercentage", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_AdjustedSharePricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted share price percentage.", "label": "Adjusted Share Price Percentage", "terseLabel": "Adjusted share price percentage" } } }, "localname": "AdjustedSharePricePercentage", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_AfinozBusinessCombinationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Afinoz business combination agreement.", "label": "Afinoz Business Combination Agreement [Member]" } } }, "localname": "AfinozBusinessCombinationAgreementMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_ArcCapitaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ARC capita.", "label": "ARC Capita [Member]" } } }, "localname": "ArcCapitaMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_August2022NoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "August 2022 note.", "label": "August 2022 Note [Member]" } } }, "localname": "August2022NoteMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_BasisAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis.", "label": "Basis [Axis]" } } }, "localname": "BasisAxis", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_BasisDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis.", "label": "Basis [Domain]" } } }, "localname": "BasisDomain", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_Businesscombinationofadjustmentsofanescrowamount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination of adjustments of an escrow amount.", "label": "BusinessCombinationOfAdjustmentsOfAnEscrowAmount", "terseLabel": "Business Combination Of Adjustments Of An Escrow Amount" } } }, "localname": "Businesscombinationofadjustmentsofanescrowamount", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_CaltechTradingCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Caltech Trading Corp [Member]" } } }, "localname": "CaltechTradingCorpMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_CaltechTradingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Caltech trading.", "label": "Caltech Trading [Member]" } } }, "localname": "CaltechTradingMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_CashHeldInTrustAccountPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Held in Trust Account.", "label": "Cash Held in Trust Account [Policy Text Block]", "terseLabel": "Investment Held in Trust Account" } } }, "localname": "CashHeldInTrustAccountPolicyTextBlock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "fexd_CashWithdrawnFromTrustAccountForRedemptionOfTemporaryEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash withdrawn from trust account for redemption of shares.", "label": "Cash Withdrawn From Trust Account For Redemption Of Temporary Equity", "terseLabel": "Cash withdrawn from Trust Account for redemption of shares" } } }, "localname": "CashWithdrawnFromTrustAccountForRedemptionOfTemporaryEquity", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_CashWithdrawnFromTrustAccountPerShareForRedemptionOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash withdrawn from trust account per share for redemption of shares.", "label": "Cash Withdrawn From Trust Account Per Share For Redemption Of Shares", "terseLabel": "Cash withdrawn from Trust Account per share for redemption of shares" } } }, "localname": "CashWithdrawnFromTrustAccountPerShareForRedemptionOfShares", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_ChangeInFairValueOfDerivativeForwardPurchaseLiability": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of derivative forward purchase liability.", "label": "Change in fair value of derivative forward purchase liability", "negatedLabel": "Change in fair value of derivative forward purchase liability", "terseLabel": "Change in fair value of derivative forward purchase liability" } } }, "localname": "ChangeInFairValueOfDerivativeForwardPurchaseLiability", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow", "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "fexd_ChangeInFairValueOfDerivativeWarrantLiabilities": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of derivative warrant liabilities.", "label": "Change in Fair Value of Derivative Warrant Liabilities", "negatedLabel": "Change in fair value of derivative warrant liabilities" } } }, "localname": "ChangeInFairValueOfDerivativeWarrantLiabilities", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "fexd_ChiefMarketingOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Marketing Officer [Member]" } } }, "localname": "ChiefMarketingOfficerMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_ClassACommonStockSubjectToPossibleRedemptionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class A Common Stock Subject to Possible Redemption.", "label": "Class A Common Stock Subject to Possible Redemption [Policy Text Block]", "terseLabel": "Class A Common Stock Subject to Possible Redemption" } } }, "localname": "ClassACommonStockSubjectToPossibleRedemptionPolicyTextBlock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "fexd_ClassOfWarrantOrRightAsDerivativeLiability": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right As Derivative Liability.", "label": "Class Of Warrant Or Right As Derivative Liability", "terseLabel": "Warrant as Derivative Liability" } } }, "localname": "ClassOfWarrantOrRightAsDerivativeLiability", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "fexd_ClassOfWarrantsOrRightsIssuedDuringPeriodWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights issued during period warrants.", "label": "Class of warrants or rights issued during period, Warrants", "positiveLabel": "Number of Warrants Issued", "terseLabel": "Class of warrants or rights issued during period, Warrants", "verboseLabel": "Number of Warrants Issued" } } }, "localname": "ClassOfWarrantsOrRightsIssuedDuringPeriodWarrants", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "fexd_ClassOfWarrantsOrRightsLockInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights lock in period.", "label": "Class Of Warrants Or Rights Lock In Period", "terseLabel": "Class of warrants or rights lock in period" } } }, "localname": "ClassOfWarrantsOrRightsLockInPeriod", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_ClassOfWarrantsOrRightsPeriodAfterWhichTheWarrantsAreExcercisableFromTheDateOfConsummationOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights period after which the warrants are excercisable from the date of consummation of business combination.", "label": "Class Of Warrants Or Rights Period After Which The Warrants Are Excercisable From The Date Of Consummation Of Business Combination", "terseLabel": "Class of warrants or rights period after which the warrants are excercisable from the date of consummation of business combination" } } }, "localname": "ClassOfWarrantsOrRightsPeriodAfterWhichTheWarrantsAreExcercisableFromTheDateOfConsummationOfBusinessCombination", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_ClassOfWarrantsOrRightsRedemptionPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights redemption price per warrant.", "label": "Class Of Warrants Or Rights Redemption Price Per Warrant", "terseLabel": "Class of warrants or rights redemption price per warrant" } } }, "localname": "ClassOfWarrantsOrRightsRedemptionPricePerWarrant", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights issued during the period units.", "label": "Class Of Warrants Or Rights Warrants Issued During The Period Units", "terseLabel": "Class of warrants or rights warrants issued during the period units" } } }, "localname": "ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "fexd_CombinationPeriodDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Combination period description.", "label": "Combination Period Description", "terseLabel": "Combination period description" } } }, "localname": "CombinationPeriodDescription", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_CombinationPeriodTermOne": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Combination period term one.", "label": "Combination Period, Term One", "terseLabel": "Combination period, term one" } } }, "localname": "CombinationPeriodTermOne", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_CombinationPeriodTermThree": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Combination period term three.", "label": "Combination Period, Term Three", "terseLabel": "Combination period, term three" } } }, "localname": "CombinationPeriodTermThree", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_CombinationPeriodTermTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Combination period term two.", "label": "Combination Period, Term Two", "terseLabel": "Combination period, term two" } } }, "localname": "CombinationPeriodTermTwo", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_CommencingPeriodDeterminingRegistrationRightsExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commencing period determining registration rights exercise.", "label": "Commencing Period Determining Registration Rights Exercise", "terseLabel": "Commencing period determining registration rights exercise" } } }, "localname": "CommencingPeriodDeterminingRegistrationRightsExercise", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies.", "label": "Commitments And Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies [table].", "label": "Commitments And Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_ConsecutiveTradingDayPeriodForDeterminingTheWeightedVolumeAveragePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consecutive trading day period for determining the weighted volume average price per share.", "label": "Consecutive Trading Day Period For Determining The Weighted Volume Average Price Per Share", "terseLabel": "Consecutive trading day period for determining the volume weighted average price per share" } } }, "localname": "ConsecutiveTradingDayPeriodForDeterminingTheWeightedVolumeAveragePricePerShare", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_DeSpacServiceAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "De SPAC Service agreement [Member]" } } }, "localname": "DeSpacServiceAgreementMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_DeferredTaxAssetsStartUpCosts": { "auth_ref": [], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets start up costs.", "label": "Deferred Tax Assets Start Up Costs", "terseLabel": "Start-up costs" } } }, "localname": "DeferredTaxAssetsStartUpCosts", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "fexd_DeferredUnderwriteFeePayable": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwrite fee payable.", "label": "Deferred underwrite fee payable", "terseLabel": "Deferred underwriter fee payable" } } }, "localname": "DeferredUnderwriteFeePayable", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "fexd_DeferredUnderwritingCommissionPayableForInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commission payable for initial public offering.", "label": "Deferred Underwriting Commission Payable For Initial Public Offering", "terseLabel": "Deferred underwriter commission for the Initial Public Offering" } } }, "localname": "DeferredUnderwritingCommissionPayableForInitialPublicOffering", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "fexd_DeferredUnderwritingCommissions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions.", "label": "Deferred Underwriting Commissions", "terseLabel": "Deferred underwriting commissions" } } }, "localname": "DeferredUnderwritingCommissions", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_DescriptionOfExpirationOfRestriction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of expiration of restriction.", "label": "Description of Expiration of Restriction", "terseLabel": "Description of expiration of restriction" } } }, "localname": "DescriptionOfExpirationOfRestriction", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_DescriptionOfShareTransferInLockUpAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of share transfer in lock up agreements.", "label": "Description of Share Transfer in Lock Up Agreements", "terseLabel": "Description of share transfer in lock up agreements" } } }, "localname": "DescriptionOfShareTransferInLockUpAgreements", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_DisclosureOfPrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of private placement.", "label": "Disclosure Of Private Placement [Text Block]", "terseLabel": "PRIVATE PLACEMENT" } } }, "localname": "DisclosureOfPrivatePlacementTextBlock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "fexd_DisclosureofinitialpublicofferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of initial public offering.", "label": "Disclosureofinitialpublicoffering [Text Block]", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "localname": "DisclosureofinitialpublicofferingTextBlock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "fexd_EarningsPerShareBasicAndDilutedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share Basic And Diluted.", "label": "Earnings Per Share Basic And Diluted [Line Items]" } } }, "localname": "EarningsPerShareBasicAndDilutedLineItems", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "fexd_EarningsPerShareBasicAndDilutedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share Basic And Diluted,", "label": "Earnings Per Share Basic And Diluted [Table]" } } }, "localname": "EarningsPerShareBasicAndDilutedTable", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "fexd_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesAndForwardPurchaseAgreement": { "auth_ref": [], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation change in fair value of warrant liabilities and forward purchase agreement.", "label": "Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities And Forward Purchase Agreement", "terseLabel": "Change in fair value of warrant liabilities and forward purchase agreement" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesAndForwardPurchaseAgreement", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "fexd_EffectiveIncomeTaxRateReconciliationTransactionCostsAssociatedWithTheInitialPublicOffering": { "auth_ref": [], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation transaction costs associated with the initial public offering.", "label": "Effective Income Tax Rate Reconciliation Transaction Costs Associated With The Initial Public Offering", "terseLabel": "Transaction costs associated with the Initial Public Offering" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTransactionCostsAssociatedWithTheInitialPublicOffering", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "fexd_EmerginggrowthcompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging growth company.", "label": "EmergingGrowthCompany [Policy Text Block]", "terseLabel": "Emerging growth company" } } }, "localname": "EmerginggrowthcompanyPolicyTextBlock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "fexd_EventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event.", "label": "Event [Axis]" } } }, "localname": "EventAxis", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "stringItemType" }, "fexd_EventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event.", "label": "Event [Domain]" } } }, "localname": "EventDomain", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "fexd_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation liability transfers into level2.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level2", "terseLabel": "Transfer of private placement warrants to level 2 measurement" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "fexd_FairValueMeasurementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value Measurements.", "label": "Fair Value Measurements [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementsPolicyTextBlock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "fexd_Fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersintolevel1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation liability transfers into level1.", "label": "Fair value measurement with unobservable inputs reconciliation liability transfers into level1", "terseLabel": "Transfer of public warrants to level 1 measurement" } } }, "localname": "Fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersintolevel1", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "fexd_FamaFinancialServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fama Financial Services [Member]" } } }, "localname": "FamaFinancialServicesMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_FexdSponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "FEXD Sponsor.", "label": "FEXD Sponsor [Member]" } } }, "localname": "FexdSponsorMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_FormationAndOperatingCosts": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Formation and operating costs.", "label": "Formation And Operating Costs", "negatedLabel": "Formation and Operating Costs" } } }, "localname": "FormationAndOperatingCosts", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "fexd_ForwardPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forward purchase agreement.", "label": "Forward Purchase Agreement [Member]" } } }, "localname": "ForwardPurchaseAgreementMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_ForwardPurchaseUnitLiability": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Forward purchase unit liability.", "label": "Forward purchase unit liability", "terseLabel": "Derivative forward purchase liability" } } }, "localname": "ForwardPurchaseUnitLiability", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "fexd_ForwardPurchaseUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forward Purchase Units.", "label": "Forward Purchase Units [Member]", "terseLabel": "Forward Purchase Agreement Liability [Member]" } } }, "localname": "ForwardPurchaseUnitsMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_GeneralAndAdministrativeServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General and administrative services.", "label": "General And Administrative Services [Member]" } } }, "localname": "GeneralAndAdministrativeServicesMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_GuaranteedPerformanceBonus": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Guaranteed performance bonus.", "label": "Guaranteed Performance Bonus", "terseLabel": "Guaranteed performance bonus" } } }, "localname": "GuaranteedPerformanceBonus", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_IncreaseDecreaseInAccumulatedDeficitThroughSaleOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in accumulated deficit through sale of warrants.", "label": "Increase decrease in accumulated deficit through sale of warrants", "terseLabel": "Sale of Private Placement Warrants" } } }, "localname": "IncreaseDecreaseInAccumulatedDeficitThroughSaleOfWarrants", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "fexd_InflationReductionActAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inflation Reduction Act [Axis]" } } }, "localname": "InflationReductionActAxis", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_InflationReductionActDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inflation Reduction Act [Domain]" } } }, "localname": "InflationReductionActDomain", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_InflationReductionActTwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inflation Reduction Act Two Thousand And Twenty Two [Member]", "terseLabel": "Inflation Reduction Act 2022 [Member]" } } }, "localname": "InflationReductionActTwoThousandAndTwentyTwoMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_InitialPublicOfferingAndPrivatePlacementOfWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Public Offering And Private Placement Of Warrants.", "label": "Initial Public Offering And Private Placement Of Warrants [Member]" } } }, "localname": "InitialPublicOfferingAndPrivatePlacementOfWarrantsMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_InitialPublicOfferingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offering.", "label": "Initial Public Offering [Line Items]" } } }, "localname": "InitialPublicOfferingLineItems", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_InitialPublicOfferingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offering.", "label": "Initial Public Offering [Table]" } } }, "localname": "InitialPublicOfferingTable", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_InitialStockholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Stockholders.", "label": "Initial Stockholders [Member]" } } }, "localname": "InitialStockholdersMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_InvestorAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor.", "label": "Investor [Axis]" } } }, "localname": "InvestorAxis", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_InvestorDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor.", "label": "Investor [Domain]" } } }, "localname": "InvestorDomain", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_IssuanceOfSharesInConnectionWithInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of shares in connection with initial public offering.", "label": "Issuance Of Shares In Connection With Initial Public Offering", "terseLabel": "Issuance of Class A shares in connection with Initial Public Offering" } } }, "localname": "IssuanceOfSharesInConnectionWithInitialPublicOffering", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "fexd_January2023PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 2023 Promissory Note.", "label": "January 2023 Promissory Note [Member]" } } }, "localname": "January2023PromissoryNoteMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_JennyJunkeerChiefFinancialOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jenny Junkeer chief financial officer.", "label": "Jenny Junkeer Chief Financial Officer [Member]" } } }, "localname": "JennyJunkeerChiefFinancialOfficerMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_June2022NoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June 2022 note [Member].", "label": "June 2022 Note [Member]" } } }, "localname": "June2022NoteMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_LockInPeriodForRemainingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lock in period for remaining shares.", "label": "Lock In Period For Remaining Shares", "terseLabel": "Lock in period for remaining shares" } } }, "localname": "LockInPeriodForRemainingShares", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_LockInPeriodForShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lock in period for shares.", "label": "Lock In Period For Shares", "terseLabel": "Lock in period for shares" } } }, "localname": "LockInPeriodForShares", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_LongtermPrepaidExpenses": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-term prepaid expenses.", "label": "Longterm prepaid expenses", "terseLabel": "Long-term prepaid expenses" } } }, "localname": "LongtermPrepaidExpenses", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "fexd_LynnPerkinsIndependentDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lynn Perkins Independent director.", "label": "Lynn Perkins Independent Director [Member]" } } }, "localname": "LynnPerkinsIndependentDirectorMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_MeasurementInputProbabilityOfAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input probability of acquisition.", "label": "Measurement Input Probability Of Acquisition [Member]", "terseLabel": "Probability of acquisition [Member]" } } }, "localname": "MeasurementInputProbabilityOfAcquisitionMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "fexd_MichaelTomczykIndependentDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Michael tomczyk Independent director.", "label": "Michael Tomczyk Independent Director [Member]" } } }, "localname": "MichaelTomczykIndependentDirectorMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_MinimumNoticePeriodToBeGivenToTheHoldersOfWarrantPriorToRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum notice period to be given to the holders of warrant prior to redemption.", "label": "Minimum Notice Period To Be Given To The Holders Of Warrant Prior To Redemption", "terseLabel": "Minimum notice period to be given to the holders of warrant prior to redemption" } } }, "localname": "MinimumNoticePeriodToBeGivenToTheHoldersOfWarrantPriorToRedemption", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_NetWorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net working capital.", "label": "Net Working Capital", "terseLabel": "Working Capital" } } }, "localname": "NetWorkingCapital", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_NewAcquirorClassACommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New acquiror class\u00a0A common stock.", "label": "New Acquiror Class A Common Stock [Member]" } } }, "localname": "NewAcquirorClassACommonStockMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive trading days for determining the share price.", "label": "Number Of Consecutive Trading Days For Determining The Share Price", "terseLabel": "Number of consecutive trading days for determining the share price" } } }, "localname": "NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_NumberOfDaysWarrentsAreNotTransferableAfterInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days warrents are not transferable after initial business combination.", "label": "Number Of Days Warrents Are Not Transferable After Initial Business Combination", "terseLabel": "Number of days warrents are not transferable after initial business combination" } } }, "localname": "NumberOfDaysWarrentsAreNotTransferableAfterInitialBusinessCombination", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_NumberOfDemandsThatCanBeMade": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of demands that can be made.", "label": "Number Of Demands That Can Be Made", "terseLabel": "Number of demands that can be made" } } }, "localname": "NumberOfDemandsThatCanBeMade", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "fexd_NumberOfMonthsFromClosingOfABusinessCombinationDetermingEndingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of months from closing of a business combination determing ending period.", "label": "Number Of Months From Closing Of A Business Combination Determing Ending Period", "terseLabel": "Number of months from closing of a business combination determing ending period" } } }, "localname": "NumberOfMonthsFromClosingOfABusinessCombinationDetermingEndingPeriod", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_NumberOfMonthsOfCliffVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of months of cliff vesting period.", "label": "Number of Months of Cliff Vesting Period", "terseLabel": "Number of months of cliff vesting period" } } }, "localname": "NumberOfMonthsOfCliffVestingPeriod", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_NumberOfSharesEntitlesForEachRightHeld": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares entitles for each right held.", "label": "Number Of Shares Entitles For Each Right Held", "verboseLabel": "Number Of Shares Entitles For Each Right Held" } } }, "localname": "NumberOfSharesEntitlesForEachRightHeld", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_NumberOfTradingDaysForDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days for determining the share price.", "label": "Number Of Trading Days For Determining The Share Price", "terseLabel": "Number of trading days for determining the share price" } } }, "localname": "NumberOfTradingDaysForDeterminingTheSharePrice", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_NumberOfUnitsToBeIssuedPursuantToAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of units to be issued pursuant to agreement.", "label": "Number Of Units To Be Issued Pursuant To Agreement", "terseLabel": "Number of units to be issued pursuant to agreement" } } }, "localname": "NumberOfUnitsToBeIssuedPursuantToAgreement", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "fexd_OfferingCostOfDerivativeWarrants": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering cost of derivative warrants.", "label": "Offering Cost Of Derivative Warrants", "terseLabel": "Offering costs associated with derivative warrant liabilities" } } }, "localname": "OfferingCostOfDerivativeWarrants", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "fexd_OfferingCostsAssociatedWithDerivativeWarrantLiabilities": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering costs associated with derivative warrant liabilities.", "label": "Offering costs associated with derivative warrant liabilities", "negatedLabel": "Offering costs associated with derivative warrant liabilities" } } }, "localname": "OfferingCostsAssociatedWithDerivativeWarrantLiabilities", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "fexd_OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering Costs Associated with the Initial Public Offering.", "label": "Offering Costs Associated with the Initial Public Offering [Policy Text Block]", "terseLabel": "Offering Costs Associated with the Initial Public Offering" } } }, "localname": "OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "fexd_OfferingCostsPaidByTheSponsorInExchangeForIssuanceOfFounderShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering Costs Paid By The Sponsor In Exchange For Issuance Of Founder Shares.", "label": "Offering Costs Paid By The Sponsor In Exchange For Issuance Of Founder Shares", "terseLabel": "Cash Received For Offering Cost In exchange Of Shares" } } }, "localname": "OfferingCostsPaidByTheSponsorInExchangeForIssuanceOfFounderShares", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_OfferingCostsPaidThroughPromissoryNoteRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering costs paid through promissory note related party.", "label": "Offering Costs Paid Through Promissory Note Related Party", "terseLabel": "Offering costs paid by related party under promissory note" } } }, "localname": "OfferingCostsPaidThroughPromissoryNoteRelatedParty", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "fexd_OneShareOfClassACommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One share Of Class A Common Stock [Member]" } } }, "localname": "OneShareOfClassACommonStockMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "fexd_OperatingBankBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Bank Balance.", "label": "Operating Bank Balance", "terseLabel": "Operating Bank Account Balance" } } }, "localname": "OperatingBankBalance", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_OtherOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Offering Costs.", "label": "Other Offering Costs", "terseLabel": "Other Offering Costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_PaymentOfDeferredOfferingCosts": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of deferred offering costs.", "label": "Payment Of Deferred Offering Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentOfDeferredOfferingCosts", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "fexd_PaymentOfUnderwritingCommissionFee": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payment of underwriting commission fee.", "label": "Payment Of Underwriting Commission Fee", "terseLabel": "Payment of underwriter commission fee" } } }, "localname": "PaymentOfUnderwritingCommissionFee", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "fexd_PerShareValueOfRestrictedAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share value of restricted assets.", "label": "Per Share Value Of Restricted Assets", "terseLabel": "Per share value of restricted assets" } } }, "localname": "PerShareValueOfRestrictedAssets", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_PerUnitAmountWasPlacedInTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per unit amount placed in trust account.", "label": "Per Unit Amount Was Placed In Trust Account", "terseLabel": "Per unit amount placed in trust account" } } }, "localname": "PerUnitAmountWasPlacedInTrustAccount", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_PercentageOfCashBonusAtTheEndOfFirstYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of cash bonus at the end of first year.", "label": "Percentage Of Cash Bonus At The End Of First Year", "terseLabel": "Percentage of cash bonus at the end of first year" } } }, "localname": "PercentageOfCashBonusAtTheEndOfFirstYear", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfCashBonusAtTheEndOfSecondYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of cash bonus at the end of second year.", "label": "Percentage Of Cash Bonus At The End Of Second Year", "terseLabel": "Percentage of cash bonus at the end of second year" } } }, "localname": "PercentageOfCashBonusAtTheEndOfSecondYear", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfCashBonusAtTheEndOfThirdYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of cash bonus at the end of third year.", "label": "Percentage Of Cash Bonus At The End Of Third Year", "terseLabel": "Percentage of cash bonus at the end of third year" } } }, "localname": "PercentageOfCashBonusAtTheEndOfThirdYear", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfCommonSharesToBeRedeemedInCaseBusinessCombinationIsNotCompletedWithinTheCombinationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common shares to be redeemed in case business combination is not completed within the combination period.", "label": "Percentage Of Common Shares To Be Redeemed In Case Business Combination Is Not Completed Within The Combination Period", "terseLabel": "Percentage of common shares to be redeemed in case business combination is not completed within the combination period" } } }, "localname": "PercentageOfCommonSharesToBeRedeemedInCaseBusinessCombinationIsNotCompletedWithinTheCombinationPeriod", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfCommonStockForWhichRedemptionRightsRestrictionApplied": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common stock for which redemption rights restriction applied.", "label": "Percentage Of Common Stock For Which Redemption Rights Restriction Applied", "terseLabel": "Percentage of common stock for which redemption rights restriction applied" } } }, "localname": "PercentageOfCommonStockForWhichRedemptionRightsRestrictionApplied", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfCommonStockIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common stock issued and outstanding.", "label": "Percentage Of Common Stock Issued And Outstanding", "terseLabel": "Percentage of common stock issued and outstanding" } } }, "localname": "PercentageOfCommonStockIssuedAndOutstanding", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfDeferredUnderwritingDiscount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of deferred underwriting discount.", "label": "Percentage Of Deferred Underwriting Discount" } } }, "localname": "PercentageOfDeferredUnderwritingDiscount", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfExciseTaxOnRepurchaseOfStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of excise tax on repurchase of stock.", "label": "Percentage Of Excise Tax On Repurchase Of Stock", "terseLabel": "Percentage of excise tax on repurchase of stock" } } }, "localname": "PercentageOfExciseTaxOnRepurchaseOfStock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfFairMarketValueOfSharesRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of fair market value of shares repurchased.", "label": "Percentage Of Fair Market Value Of Shares Repurchased", "terseLabel": "Percentage of fair market value of shares repurchased" } } }, "localname": "PercentageOfFairMarketValueOfSharesRepurchased", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfProceedsFromEquityIssuanceToBeUsedForConsummatingBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of proceeds from equity issuance to be used for consummating business combination.", "label": "Percentage Of Proceeds From Equity Issuance To Be Used For Consummating Business Combination", "terseLabel": "Percentage of proceeds from equity issuance to be used for consummating business combination" } } }, "localname": "PercentageOfProceedsFromEquityIssuanceToBeUsedForConsummatingBusinessCombination", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfSharesSubjectToLockIn": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of shares subject to lock in.", "label": "Percentage Of Shares Subject To Lock In", "terseLabel": "Percentage of shares subject to lock in" } } }, "localname": "PercentageOfSharesSubjectToLockIn", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfSharesSubjectToLockInRemainingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of shares subject to lock in, remaining shares.", "label": "Percentage Of Shares Subject To Lock In, Remaining Shares", "terseLabel": "Percentage of shares subject to lock in, Remaining shares" } } }, "localname": "PercentageOfSharesSubjectToLockInRemainingShares", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfUnderwritingDiscount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of underwriting discount.", "label": "Percentage Of Underwriting Discount" } } }, "localname": "PercentageOfUnderwritingDiscount", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PercentageOfWarrantsToBeSettledInSharesForThePriceOfWarrantsToBeReduced": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of warrants to be settled in cash for the price of warrants to be reduced.", "label": "Percentage Of Warrants To Be Settled In Shares For The Price Of Warrants To Be Reduced", "terseLabel": "Percentage of warrants to be settled in shares for the price of warrants to be reduced" } } }, "localname": "PercentageOfWarrantsToBeSettledInSharesForThePriceOfWarrantsToBeReduced", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_PerformanceBonus": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Performance bonus.", "label": "Performance Bonus", "terseLabel": "Performance bonus" } } }, "localname": "PerformanceBonus", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_PeriodBeginningOnTheEffectiveDateOfTheInitialPublicOfferingDuringWhichDemandRegistrationCanBeMade": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period beginning on the effective date of the initial public offering during which demand registration can be made.", "label": "Period Beginning On The Effective Date Of The Initial Public Offering During Which Demand Registration Can Be Made", "terseLabel": "Period beginning on the effective date of the initial public offering during which demand registration can be made" } } }, "localname": "PeriodBeginningOnTheEffectiveDateOfTheInitialPublicOfferingDuringWhichDemandRegistrationCanBeMade", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_PeriodBeginningOnTheEffectiveDateOfTheInitialPublicOfferingDuringWhichParticipationTakePlace": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period beginning on the effective date of the initial public offering during which participation take place.", "label": "Period Beginning On The Effective Date Of The Initial Public Offering During Which Participation Take Place", "terseLabel": "Period beginning on the effective date of the initial public offering during which participation take place" } } }, "localname": "PeriodBeginningOnTheEffectiveDateOfTheInitialPublicOfferingDuringWhichParticipationTakePlace", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_PeriodWithinRegistrationStatementShallBeFiledWithSecuritiesExchangeCommissionFromTheDateOfConsummationOfInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period within registration statement shall be filed with securities exchange commission from the date of consummation of initial business combination.", "label": "Period Within Registration Statement Shall Be Filed With Securities Exchange Commission From The Date Of Consummation Of Initial Business Combination", "terseLabel": "Period within which registration statement shall be filed with securities exchange commission from the date of consummation of initial business combination" } } }, "localname": "PeriodWithinRegistrationStatementShallBeFiledWithSecuritiesExchangeCommissionFromTheDateOfConsummationOfInitialBusinessCombination", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_PeriodWithinWhichRegistrationStatementShallBeMadeEffectiveWithSecuritiesExchangeCommissionFromTheDateOfConsummationOfInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period within which registration statement shall be made effective with securities exchange commission from the date of consummation of initial business combination.", "label": "Period Within Which Registration Statement Shall Be Made Effective With Securities Exchange Commission From the Date Of Consummation Of Initial Business Combination", "terseLabel": "Period within which registration statement shall be effective with securities exchange commission from the date of consummation of initial business combination" } } }, "localname": "PeriodWithinWhichRegistrationStatementShallBeMadeEffectiveWithSecuritiesExchangeCommissionFromTheDateOfConsummationOfInitialBusinessCombination", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_PostmergerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Postmerger [Member]" } } }, "localname": "PostmergerMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "fexd_PricePerUnitToBeIssuedPursuantToAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per unit to be issued pursuant to agreement.", "label": "Price Per Unit To Be Issued Pursuant To Agreement", "terseLabel": "Price per unit to be issued pursuant to agreement" } } }, "localname": "PricePerUnitToBeIssuedPursuantToAgreement", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_PrivatePlacementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement [Line Items]" } } }, "localname": "PrivatePlacementLineItems", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_PrivatePlacementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement [Table]" } } }, "localname": "PrivatePlacementTable", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants [Member]", "verboseLabel": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_PrivateplacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement,", "label": "PRIVATE PLACEMENT [Abstract]" } } }, "localname": "PrivateplacementAbstract", "nsuri": "http://fin.com/20221231", "xbrltype": "stringItemType" }, "fexd_ProceedsAllocatedToPublicWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds allocated to public warrants.", "label": "Proceeds allocated to Public Warrants", "terseLabel": "Less: Proceeds allocated to Public Warrants" } } }, "localname": "ProceedsAllocatedToPublicWarrants", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "fexd_PromisoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promisory note.", "label": "Promisory Note [Member]", "terseLabel": "Promisory Note [Member]" } } }, "localname": "PromisoryNoteMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_ProspectiveRedemptionOfWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prospective redemption of warrants.", "label": "Prospective Redemption Of Warrants [Member]" } } }, "localname": "ProspectiveRedemptionOfWarrantsMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Warrants [Member]", "terseLabel": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_RanaAndAfinozBusinessCombinationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rana and\u00a0Afinoz business combination agreement.", "label": "Rana and Afinoz Business Combination Agreement [Member]" } } }, "localname": "RanaAndAfinozBusinessCombinationAgreementMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_RanaBusinessCombinationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rana business combination agreement.", "label": "Rana Business Combination Agreement [Member]" } } }, "localname": "RanaBusinessCombinationAgreementMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_ReceiptOfLoans": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receipt Of Loans.", "label": "Receipt Of Loans", "terseLabel": "Loans Received" } } }, "localname": "ReceiptOfLoans", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_RegistrationRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Registration rights [Member].", "label": "Registration Rights [Member]" } } }, "localname": "RegistrationRightsMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_RemeasurementOfClassACommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Remeasurement of class a common stock subject to possible redemption.", "label": "Remeasurement Of Class A Common Stock Subject To Possible Redemption", "negatedLabel": "Remeasurement of Class A common stock subject to possible redemption", "terseLabel": "Remeasurement of Class A shares subject to redemption" } } }, "localname": "RemeasurementOfClassACommonStockSubjectToPossibleRedemption", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "fexd_RepaymentOfLoans": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Repayment Of Loans.", "label": "Repayment Of Loans", "terseLabel": "Loans Repaid" } } }, "localname": "RepaymentOfLoans", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_RepresentativeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Representative [Member]" } } }, "localname": "RepresentativeMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_RepresentativeSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Representative Shares [Member]" } } }, "localname": "RepresentativeSharesMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_RestrictionOnTransferMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restriction on transfer.", "label": "Restriction On Transfer [Member]" } } }, "localname": "RestrictionOnTransferMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_RobinMeisterIndependentDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Robin meister Independent director.", "label": "Robin Meister Independent Director [Member]" } } }, "localname": "RobinMeisterIndependentDirectorMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_ScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of fair value of derivative liabilities measured on recurring basis.", "label": "Schedule Of Fair Value Of Derivative Liabilities Measured On Recurring Basis [Table Text Block]" } } }, "localname": "ScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "fexd_ServiceCompensationProvidedFormMonetaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Service Compensation Provided form Monetary [Member]" } } }, "localname": "ServiceCompensationProvidedFormMonetaryMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_ServiceCompensationProvidedFormSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Service Compensation Provided form Shares [Member]" } } }, "localname": "ServiceCompensationProvidedFormSharesMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SharePriceEqualToOrExceedsTwelvePointZeroZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price equal to or exceeds twelve point zero zero.", "label": "Share Price Equal To or Exceeds Twelve Point Zero Zero [Member]" } } }, "localname": "SharePriceEqualToOrExceedsTwelvePointZeroZeroMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SharePriceEqualsOrExceedsTwelveUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price equals or exceeds twelve USD.", "label": "Share Price Equals Or Exceeds Twelve USD [Member]" } } }, "localname": "SharePriceEqualsOrExceedsTwelveUsdMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SharePriceRangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price range.", "label": "Share Price Range [Axis]" } } }, "localname": "SharePriceRangeAxis", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_SharePriceRangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price range.", "label": "Share Price Range [Domain]" } } }, "localname": "SharePriceRangeDomain", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SharePriceTrigerringRedemptionOfWarrantsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price trigerring redemption of warrants one.", "label": "Share Price Trigerring Redemption Of Warrants One [Member]" } } }, "localname": "SharePriceTrigerringRedemptionOfWarrantsOneMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SharePriceTrigerringRedemptionOfWarrantsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price trigerring redemption of warrants two.", "label": "Share Price Trigerring Redemption Of Warrants Two [Member]" } } }, "localname": "SharePriceTrigerringRedemptionOfWarrantsTwoMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SharePriceTriggeringRedemptionOfWarrantsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price triggering redemption of warrants.", "label": "Share Price Triggering Redemption Of Warrants [Axis]" } } }, "localname": "SharePriceTriggeringRedemptionOfWarrantsAxis", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_SharePriceTriggeringRedemptionOfWarrantsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price triggering redemption of warrants.", "label": "Share Price Triggering Redemption Of Warrants [Domain]" } } }, "localname": "SharePriceTriggeringRedemptionOfWarrantsDomain", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SourceOfInvestmentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Source Of Investment.", "label": "Source Of Investment [Axis]" } } }, "localname": "SourceOfInvestmentAxis", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "fexd_SourceOfInvestmentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Source Of Investment.", "label": "Source Of Investment [Domain]" } } }, "localname": "SourceOfInvestmentDomain", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SponsorAndInitialStockholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor and initial stockholders.", "label": "Sponsor And Initial Stockholders [Member]" } } }, "localname": "SponsorAndInitialStockholdersMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sponsor [Member]", "terseLabel": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_TargetBonusRateBasedOnPrevailingSalary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Target bonus rate based on prevailing salary.", "label": "Target Bonus Rate Based On Prevailing Salary", "terseLabel": "Target bonus rate based on prevailing salary" } } }, "localname": "TargetBonusRateBasedOnPrevailingSalary", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "fexd_TemporaryEquityStockRedeemedDuringThePeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity stock redeemed during the period shares.", "label": "Temporary Equity Stock Redeemed During The Period Shares", "terseLabel": "Temporary equity stock redeemed during the period shares" } } }, "localname": "TemporaryEquityStockRedeemedDuringThePeriodShares", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "fexd_TermOfRestrictedInvestments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of restricted investments.", "label": "Term Of Restricted Investments", "terseLabel": "Term of restricted investments" } } }, "localname": "TermOfRestrictedInvestments", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_ThresholdYearsFromtheeffectivedateoftheregistrationstatementdeterminingrightoffirstrefusal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold years from the effective date of the registration statement determining right of first refusal.", "label": "Threshold Years FromTheEffectiveDateOfTheRegistrationStatementDeterminingRightOfFirstRefusal", "terseLabel": "Threshold years from the effective date of the registration statement determining right of first refusal" } } }, "localname": "ThresholdYearsFromtheeffectivedateoftheregistrationstatementdeterminingrightoffirstrefusal", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_TotalOfferingCostsAssociatedWithInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Offering costs incurred in Initial public offering.", "label": "Total Offering Costs Associated With Initial Public Offering", "terseLabel": "Total Offering costs incurred in Initial public offering" } } }, "localname": "TotalOfferingCostsAssociatedWithInitialPublicOffering", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_UnderwriterStockOptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriter stock option period.", "label": "Underwriter Stock Option Period", "terseLabel": "Underwriter stock option period" } } }, "localname": "UnderwriterStockOptionPeriod", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_UnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Underwriting fees.", "label": "Underwriting Fees", "terseLabel": "Underwriting fees" } } }, "localname": "UnderwritingFees", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_UnitsIssuedDuringPeriodPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units issued during period per share.", "label": "Units Issued During Period Per Share", "terseLabel": "Purchase of units issued per share" } } }, "localname": "UnitsIssuedDuringPeriodPerShare", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_UnitsIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units Issued During Period Shares New Issues.", "label": "Units Issued During Period Shares New Issues", "terseLabel": "Purchase of units issued" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_UnitsToBeIssuedPursuantToAgreementValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Units to be issued pursuant to agreement value.", "label": "Units To Be Issued Pursuant To Agreement Value" } } }, "localname": "UnitsToBeIssuedPursuantToAgreementValue", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "fexd_UnsecuredPromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note.", "label": "Unsecured Promissory Note [Member]" } } }, "localname": "UnsecuredPromissoryNoteMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_WaiverOfLiquidationRightsPeriodOnBusinessCombinationCondition": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Waiver Of Liquidation Rights Period On Business Combination Condition.", "label": "Waiver Of Liquidation Rights Period On Business Combination Condition", "terseLabel": "Liquidation rights waived On Failure Of Business Combination" } } }, "localname": "WaiverOfLiquidationRightsPeriodOnBusinessCombinationCondition", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "fexd_WarrantLiabilities": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liabilities.", "label": "Warrant liabilities", "terseLabel": "Derivative warrant liabilities" } } }, "localname": "WarrantLiabilities", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "fexd_WarrantToPurchaseCommonStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant To Purchase Common Stock Shares.", "label": "Warrant To Purchase Common Stock Shares", "terseLabel": "Number of Shares Purchased Against Warrants" } } }, "localname": "WarrantToPurchaseCommonStockShares", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "fexd_WarrantsIssuedPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants issued price per warrant.", "label": "Warrants issued, Price per warrant", "terseLabel": "Warrants issued, price per warrant", "verboseLabel": "Price Per Warrant" } } }, "localname": "WarrantsIssuedPricePerWarrant", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_WeightedVolumeAveragePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted volume average price per share.", "label": "Weighted Volume Average Price Per Share", "terseLabel": "Weighted volume average price per share" } } }, "localname": "WeightedVolumeAveragePricePerShare", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "fexd_WorkingCapitalLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital loans.", "label": "Working Capital Loans [Member]" } } }, "localname": "WorkingCapitalLoansMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "fexd_WorkingCapitalWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital warrants.", "label": "Working Capital Warrants [Member]" } } }, "localname": "WorkingCapitalWarrantsMember", "nsuri": "http://fin.com/20221231", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r153", "r154", "r218", "r222", "r380", "r382" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r200", "r201", "r202", "r203", "r246", "r345", "r363", "r376", "r377", "r390", "r396", "r398", "r428", "r446", "r447", "r448", "r449", "r450", "r451" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r200", "r201", "r202", "r203", "r246", "r345", "r363", "r376", "r377", "r390", "r396", "r398", "r428", "r446", "r447", "r448", "r449", "r450", "r451" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r200", "r201", "r202", "r203", "r238", "r246", "r269", "r270", "r271", "r344", "r345", "r363", "r376", "r377", "r390", "r396", "r398", "r424", "r428", "r447", "r448", "r449", "r450", "r451" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r200", "r201", "r202", "r203", "r238", "r246", "r269", "r270", "r271", "r344", "r345", "r363", "r376", "r377", "r390", "r396", "r398", "r424", "r428", "r447", "r448", "r449", "r450", "r451" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r153", "r154", "r218", "r222", "r381", "r382" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r422", "r442" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r3", "r114", "r121" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income tax payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r7", "r397" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional\u00a0paid-in\u00a0capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r273", "r274", "r275", "r417", "r418", "r419", "r438" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeServiceMember": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Administrative assistance, including, but not limited to, accounting, tax, legal, regulatory filing, and share registration of managed fund and investment account of independent third party, and related and affiliated entity.", "label": "Administrative Service [Member]", "terseLabel": "Administrative Service [Member]" } } }, "localname": "AdministrativeServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r113", "r120", "r133", "r150", "r188", "r190", "r192", "r194", "r204", "r205", "r207", "r208", "r209", "r210", "r211", "r213", "r214", "r304", "r306", "r322", "r397", "r426", "r427", "r444" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r131", "r138", "r150", "r194", "r204", "r205", "r207", "r208", "r209", "r210", "r211", "r213", "r214", "r304", "r306", "r322", "r397", "r426", "r427", "r444" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrust": { "auth_ref": [ "r412" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.", "label": "Assets Held-in-trust", "terseLabel": "Assets Held-in-trust" } } }, "localname": "AssetsHeldInTrust", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r412" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "verboseLabel": "Investments held in trust account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r86", "r89" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BankOverdrafts": { "auth_ref": [ "r16", "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.", "label": "Bank Overdrafts", "terseLabel": "Bank Overdrafts" } } }, "localname": "BankOverdrafts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r302", "r394", "r395" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r76", "r77", "r302", "r394", "r395" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r127" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r369", "r370", "r397", "r410" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r34", "r39", "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r34", "r107" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r410" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash Equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Cash, FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental Disclosures of Noncash Financing Activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r134", "r135", "r136", "r150", "r171", "r172", "r174", "r176", "r179", "r180", "r194", "r204", "r207", "r208", "r209", "r213", "r214", "r220", "r221", "r224", "r228", "r235", "r322", "r378", "r409", "r413", "r420" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/CoverPage", "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r67", "r69" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Class of warrant or right, Exercise price of warrants or rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Class of warrant or right, Number of securities called by each warrant or right" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r20", "r116", "r124" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "COMMITMENTS AND CONTINGENCIES (NOTE 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r49", "r198", "r199", "r375", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/CoverPage", "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/CoverPage", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r417", "r418", "r438" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r59" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r6", "r397" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights", "terseLabel": "Common Stock, Voting Rights", "verboseLabel": "Common Stock, Voting Rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r119", "r183" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of credit risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r79", "r383" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "verboseLabel": "Principle of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r415", "r433", "r435" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r415", "r433", "r435" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Debt instrument, Convertible, Carrying amount of equity component" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r53", "r217" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt instrument, Convertible, Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r108", "r109", "r215", "r330", "r388", "r389" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, Face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r18", "r216" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r139", "r387", "r440" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r415", "r434", "r435" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "negatedLabel": "Deferred" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r415", "r434", "r435" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "Deferred" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r286" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax asset" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross [Abstract]", "terseLabel": "Deferred tax asset" } } }, "localname": "DeferredTaxAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r431" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Deferred tax asset, net of allowance" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r74", "r432" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r287" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfNetDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r87", "r88", "r91", "r92", "r382" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r81", "r82", "r83", "r84", "r85", "r90", "r91", "r93", "r95", "r96", "r308" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r97", "r105" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "Derivatives and Fair Value [Text Block]", "terseLabel": "DERIVATIVE FINANCIAL INSTRUMENTS" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r81", "r82", "r84", "r85", "r94", "r155" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r13", "r206", "r207", "r208", "r212", "r213", "r214", "r335", "r416" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to Related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r146", "r161", "r162", "r163", "r164", "r165", "r169", "r171", "r174", "r175", "r176", "r177", "r311", "r312", "r359", "r361", "r384" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net income (loss) per common stock", "verboseLabel": "Basic, net income (loss) per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r146", "r161", "r162", "r163", "r164", "r165", "r171", "r174", "r175", "r176", "r177", "r311", "r312", "r359", "r361", "r384" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted, net income (loss) per share", "verboseLabel": "Diluted net income (loss) per common stock" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r43", "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net income (loss) per common share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r280" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Income tax provision" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r151", "r280", "r296" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory federal income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r430", "r436" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INITIAL PUBLIC OFFERING [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r59", "r129", "r143", "r144", "r145", "r156", "r157", "r158", "r160", "r166", "r168", "r178", "r195", "r237", "r273", "r274", "r275", "r292", "r293", "r310", "r323", "r324", "r325", "r326", "r327", "r328", "r331", "r364", "r365", "r366" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/CoverPage", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r37", "r54" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "verboseLabel": "Change in fair value of warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r313", "r314", "r320" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "verboseLabel": "Summary of significant inputs to the black-scholes option pricing model for the fair value of the founder warrants" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r219", "r239", "r240", "r241", "r242", "r243", "r244", "r314", "r341", "r342", "r343", "r388", "r389", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r313", "r314", "r316", "r317", "r321" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE OF FINANCIAL INSTRUMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r219", "r239", "r244", "r314", "r341", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r219", "r239", "r244", "r314", "r342", "r388", "r389", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r219", "r239", "r240", "r241", "r242", "r243", "r244", "r314", "r343", "r388", "r389", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r98", "r99" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.", "label": "Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]", "terseLabel": "Schedule of assets and liabilities measured at fair value on a recurring basis" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r101", "r103" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r101", "r103" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of changes in the fair value of the company's level 3 financial instruments that are measured at fair value" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r318" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value", "verboseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Issuance of Warrants", "verboseLabel": "Issuance of public warrants, private placement warrants, forward purchase agreement \u2013 level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "terseLabel": "Signing of Forward Purchase Agreement upon IPO" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r101" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair value , ending balance", "periodStartLabel": "Fair value as of March\u00a05, 2021 (inception)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r219", "r239", "r240", "r241", "r242", "r243", "r244", "r341", "r342", "r343", "r388", "r389", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r319", "r321" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r104", "r106" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).", "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Federal" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "periodEndLabel": "Derivative liabilities - ending balance", "periodStartLabel": "Derivative liabilities \u2013 level 3, at March 5, 2021 (inception)" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfDerivativeLiabilitiesMeasuredOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r22", "r112", "r117", "r126", "r188", "r189", "r191", "r193", "r360", "r386" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "verboseLabel": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r151", "r281", "r284", "r290", "r294", "r297", "r299", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAX" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTax" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r152", "r167", "r168", "r187", "r279", "r295", "r298", "r362" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "totalLabel": "Income tax provision", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r142", "r277", "r278", "r284", "r285", "r289", "r291" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r36" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r36" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "verboseLabel": "Income tax payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the current portion (due within one year or one business cycle, whichever is longer) of the amount owed by the reporting entity in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Notes Payable, Related Parties, Current", "terseLabel": "Related party promissory note accrued interest" } } }, "localname": "IncreaseDecreaseInNotesPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r36" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r25", "r186" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Income from investments held in trust account" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r24", "r27" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Income from investments held in Trust Account" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r15", "r150", "r194", "r204", "r205", "r207", "r208", "r209", "r210", "r211", "r213", "r214", "r305", "r306", "r307", "r322", "r385", "r426", "r444", "r445" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r11", "r115", "r123", "r397", "r414", "r423", "r441" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, common shares subject to possible redemption and stockholders' deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "LIABILITIES, COMMON SHARES SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r17", "r132", "r150", "r194", "r204", "r205", "r207", "r208", "r209", "r210", "r211", "r213", "r214", "r305", "r306", "r307", "r322", "r397", "r426", "r444", "r445" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities": { "auth_ref": [ "r0" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of estimated accrued costs to dispose of assets or other items expected to be sold in liquidation.", "label": "Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities", "terseLabel": "Liquidation basis of accounting, accrued costs to dispose of assets and liabilities" } } }, "localname": "LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r19", "r51" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input, Exercise Price [Member]", "terseLabel": "Exercise price [Member]" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Dividend yield [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Expected term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk-free rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MinimumNetWorthRequiredForCompliance": { "auth_ref": [ "r371", "r372", "r373", "r374" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum net worth required for mortgage banking as defined by regulatory framework.", "label": "Banking Regulation, Mortgage Banking, Net Worth, Minimum", "terseLabel": "Minimum net worth required for compliance" } } }, "localname": "MinimumNetWorthRequiredForCompliance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r147" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r147" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r34", "r35", "r38" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 12.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r23", "r38", "r118", "r125", "r130", "r140", "r141", "r145", "r150", "r159", "r161", "r162", "r163", "r164", "r167", "r168", "r173", "r188", "r189", "r191", "r193", "r194", "r204", "r205", "r207", "r208", "r209", "r210", "r211", "r213", "r214", "r312", "r322", "r386", "r426" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)", "verboseLabel": "Allocation of net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Issued and adopted accounting standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r26" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expenses), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other Income (Expenses):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r12", "r110", "r416" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "disclosureGuidance": "Promissory notes from related parties", "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "verboseLabel": "Notes payable, Related parties, Current" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficersCompensation": { "auth_ref": [ "r411" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary and Wage, Officer, Excluding Cost of Good and Service Sold", "terseLabel": "Officer compensation" } } }, "localname": "OfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "negatedTotalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryovers" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r80" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "verboseLabel": "Other commitment" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Less: Class A ordinary share issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r28", "r303" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments To Acquire Businesses Gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "auth_ref": [ "r29" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.", "label": "Payments to Acquire Restricted Investments", "negatedLabel": "Cash deposited in Trust Account", "terseLabel": "Payments to acquire restricted investments" } } }, "localname": "PaymentsToAcquireRestrictedInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r5", "r220" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r5", "r220" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r5", "r397" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r137", "r196", "r197", "r379" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r30" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "presentationGuidance": "Gross proceeds from IPO", "terseLabel": "Proceeds from issuance initial public offering", "verboseLabel": "Proceeds from the Initial Public Offering, gross" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r30" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "positiveLabel": "Proceeds from issuance of common shares to Sponsor" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r30" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from private placement", "verboseLabel": "Proceeds from Issuance of Private Placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r30" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from issuance of warrants", "verboseLabel": "Proceeds from issuance of warrants to Sponsor" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r31" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "verboseLabel": "Proceeds from promissory notes from related parties" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r245", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r111", "r334" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related party transaction, Amount of transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r128", "r334", "r335", "r443" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r245", "r334", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r443" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r332", "r333", "r335", "r336", "r337" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r32" ], "calculation": { "http://fin.com/role/ConsolidatedStatementsOfCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Repayment of promissory notes" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r8", "r66", "r122", "r367", "r368", "r397" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r129", "r156", "r157", "r158", "r160", "r166", "r168", "r195", "r273", "r274", "r275", "r292", "r293", "r310", "r364", "r366" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Sale of stock, Number of shares issued in transaction" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.", "label": "Sale of Stock, Percentage of Ownership after Transaction" } } }, "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock, Price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Summary of Income Tax Provision" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Summary of Net Deferred Tax Assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Summary of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r55", "r57", "r58", "r60", "r61", "r62", "r63", "r64", "r65", "r66", "r134", "r135", "r136", "r179", "r220", "r221", "r222", "r224", "r228", "r233", "r235", "r390", "r409", "r413" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, Shares", "periodStartLabel": "Beginning balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r42", "r148" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "State" } } }, "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r134", "r135", "r136", "r150", "r171", "r172", "r174", "r176", "r179", "r180", "r194", "r204", "r207", "r208", "r209", "r213", "r214", "r220", "r221", "r224", "r228", "r235", "r322", "r378", "r409", "r413", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/CoverPage", "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/StockholdersEquityAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r21", "r59", "r129", "r143", "r144", "r145", "r156", "r157", "r158", "r160", "r166", "r168", "r178", "r195", "r237", "r273", "r274", "r275", "r292", "r293", "r310", "r323", "r324", "r325", "r326", "r327", "r328", "r331", "r364", "r365", "r366" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/CoverPage", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/IncomeTaxAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r156", "r157", "r158", "r178", "r346" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/IncomeTaxAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Share issuance, Shares", "verboseLabel": "Stock issued during period, Shares, Issued for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r5", "r6", "r59", "r66" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued during period, Shares", "verboseLabel": "Shares Issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Stock Issued During Period, Value, Issued for Services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Share issuance", "verboseLabel": "Stock issued during period, Value, Issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r5", "r6", "r59", "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "negatedLabel": "Accretion\\Remeasurement of Class\u00a0A common stock subject to possible redemption amount" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r6", "r9", "r10", "r48", "r397", "r414", "r423", "r441" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders' deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r68", "r149", "r221", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r234", "r237", "r309" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r329", "r339" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r329", "r339" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r329", "r339" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r329", "r339" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r338", "r340" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://fin.com/role/PrivatePlacementAdditionalInformationDetail", "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://fin.com/role/SubsequentEventsAdditionalInformationDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfDerivativeInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]" } } }, "localname": "SummaryOfDerivativeInstrumentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity [Abstract]" } } }, "localname": "TemporaryEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Remeasurement to common stock subject to possible redemption amount" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "terseLabel": "Plus: Accretion of carrying value to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityByClassOfStockTable": { "auth_ref": [ "r2", "r56" ], "lang": { "en-us": { "role": { "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.", "label": "Temporary Equity, by Class of Stock [Table]" } } }, "localname": "TemporaryEquityByClassOfStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r204", "r207", "r208", "r209", "r213", "r214" ], "calculation": { "http://fin.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Class A common stock subject to possible redemption; 11,500,000 shares at redemption value", "verboseLabel": "Class A common shares subject to redemption" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheets", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Temporary Equity [Line Items]" } } }, "localname": "TemporaryEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r2", "r56" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary equity, redemption price per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Temporary equity shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary Equity, Shares Issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Shares are subject to forfeiture" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r2", "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity [Table Text Block]", "terseLabel": "Summary of Basic and Diluted Net Income (Loss) Per Share" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r276", "r283" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r282" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits, Income tax penalties and interest accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r45", "r46", "r47", "r181", "r182", "r184", "r185" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r288" ], "calculation": { "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Change in valuation allowance", "verboseLabel": "Change in the valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/IncomeTaxAdditionalInformationDetail", "http://fin.com/role/IncomeTaxSummaryOfIncomeTaxProvisionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/CoverPage", "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfChangesInTheFairValueOfTheCompanysLevel3FinancialInstrumentsThatAreMeasuredAtFairValueDetail", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/FairValueOfFinancialInstrumentsSummaryOfSignificantInputsToTheBlackScholesOptionPricingModelForTheFairValueOfTheFounderWarrantsDetail" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Class of warrants or rights term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r170", "r176" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average common stock outstanding", "verboseLabel": "Weighted average number of ordinary shares-diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r169", "r176" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average common stock outstanding", "verboseLabel": "Weighted average number of ordinary shares-basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://fin.com/role/ConsolidatedStatementsOfOperations", "http://fin.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=95464943&loc=SL35686261-199414", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org/topic&trid=2155941", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=6490092&loc=d3e47080-110998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r399": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r401": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r402": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r403": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r404": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r405": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r406": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r407": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r408": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 59 0001193125-23-108202-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-108202-xbrl.zip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�Q:7JQ1FKWJAZZFUD]M&P-Z3Z[7^C( MVMN^^USVB?.W__G;__PTRJ>7T.9;Q._LF(G70FL3[X5_JT8QWOXZ!$Z M]@8%=7.O+?O).;1$_O^64&O5-Q$B! M7V%8R"F%4@F&-//1JU;VM^)E105K@BM.[L;Q7-@D@F6!J>9T#AM=[OO.UZ^_ M=SX[%R?G9Q=7SME7Y]/9Q9?-+RLWV\9VV;#'!N %QH)\H!NV4I&^]^8=)[7)F!3I5G%.]4M]4]L37+Y?PR-F?*:KIY(+J MDV%RBI(["T/T-1[I NO-A8;O6>.1Q4I<>_].9R)&;KU@'VKU F-P4L[ZE9S[ED#V>_9S,')LP.G ME&_9XAG!B"J(K23MZR_OP>!P<-F%JK8Y15ZS:KRKSO/O>64)4[#@/'GB2L5[ MB;^4O,KZV::AA2]],7U93PR!3T'S4S[T@]5C\+LR7I^J!+J'F)W^$B"9HDI()>)Z*/#9#C,'";;C\'C5KO%T^WAY6"6^/]MY_EM?"=P![>Y*:,-3H6Z/O M#/1]427T?;GW_@L8:\ZEZ,MD['PTW2=J)%X$B6M72!5HR_+EUC34F':@"B3$:] AG%&:98Q%62UU8_"WQ)#8I FLWT HH]665]+C7V%E; M%45^,A5>V&1M9_2X&HE7@,2OJH3$;Y#1!W 4Z+PTW!UMDC2.,2<8N7?'*HO+ M,/TX#%RN]\5K+F2<^EQ,>3;"OAE8>E<30DT(,PBA4O&H5G/O_?^')9=>(JA> M$[$:OO#UWY:ACDV:TT076&$8:V50O36WON,BU]F9=&(\)?I M:.33WR(:[Y0R\VF_9N(K0.TWE4+M]M[[8^K_@?6SA-# M<5U)!6*4Q.2#O<9 MH2I;T%XZ6=L1O,%2Y0W#WQ4:J"E@%110+37F$$@ %AZ%/G-T"I*YNQ1>J+%X M%5A0TZS)>XV\='=L.LK*C8W5XK Z/;2$*6[F7S4I)AJ.] M]Q\][.T51G'#.3'MMRU4>H[-F)I_8ELMU.AW1HFO<^-7@>35JNAXN?<^ MP^QCJ_/6'IQ-2!12DJOS #DL7-V&X"$&'@C:G$ NQ->X'R0 M@031@1X?_ITD2!854^&MJ0D.NY2VT*K33U=!EY5*GVZ]WGNO<9_0&B.U0!-Q M#M&I'3(W38H;RI/*6A>8Y*X<8=/G'5*J6K56M0K$KU3B=>L-%KQX0<\; :^W MW/Z?I%31+QG=@!&Q.Y[2%[6K:<>)S7(U_5%[FFI/T_9AL"4N-I:)75J@WD0C M?.!U/94;49(TX5SV!M)-_1T2&4N5&/ 8-;+%F=7,;0+7'!N'7A=Z5*VL!5=) MQRW/46VQ<">%'GY.W<9O&]KXO3_N_'YU>O:U<_%OY^O9U8ESRN;@7#?=6,[;R]V.D&0 COAR?68 MBS*W5UY^OC!_4G.=8]U##Q#K5D3NOA^&W]4P'9WBA=W#(^X8GT9.5W6-:5@3 M2GHZJ[>!,S-T2F]H4GJY5WT4QB,P!N,#Y\\0I_10?V\1F]FU=_3KQ(!<4+=1 M^4[DQ$\>XJD[\?7(!RNT^&57^IZ\F7Q&+.7WB2]EG'A#?*,]8C?VX%!$Y, Z M89,QC_O%GK^1)\SP7]K3+6T/)XCP"GE0NX?BSNN/9X"Z =!-Z$8.&_5+ J)Z, EI:FN"4]:&N#(+/TU<[JZ7F#,+T> MS +9LN"DP63/$+H.<4J6P)RT_Z3N-2D42&Q FD/C?FSHYOD90.&]8>"/<:8[ MM]Z'Y?1%3ZDI?6ZHH^<2PW4XRSW QLHI !5$0BQIOCV>TRQD(:3')NOTD#CM M_H<6#CCLQ=_Y72D>+3(?GMH$W\#+$4Z:=ZC&V;T003\48\?U^GV)^P,,\!!7 MG'X4#M68@9)[7"Y%8(RE*=Z:AYB) ;-02'47XI$#8/#[+H /9Y?1C* @B3P@ M4XF;(BCSZM"Q12=?NB(UF*-!R828!NX#-TD$\TR>083,T>NC?@3[$ZZ+3 8G M) 2NFGLSD#2WPS#,"X*H6FS),/ 5UF@N)K[L\ M.3YPKO@#()['TM(1SJWLQO!XY]GM[>U!+'L'U^'-CQI5U%7J:0V4>7=C J.7 MI23E=DQ80DE+]A69R*5>\AH7::E4/A:%@<(4>\4-A6=X(Y(MG@X2OO!C%"*" M>]+WPA$/H-+T!-M68+ ?YHA$?S3XP[,RLE[KP!2!#N%"T"R=3V#B1!+G;GP] M:3A_BG@ ZT@0P3\> ##;S:,7;[(UA5UR)@LC 7( X%H)?+W1(C0BE*\!QT4! M//2,+%S_7)QX_ 4B43BU_[K9W(>7[C MR*I!&X*WB'ZBF-92R;;!'^5=3XX2#58:!Z/&L@$6^.+V -X@7*TL,&N"7?3@ MKWZ*-(.P +@Q,9"WA!>+NER8LOS053M#>!+\&*',USB)>E.$?3B6O#%B?V9? ML'97QF"4\/*%2P>(*B4.IL,)AR(B$:HG[A@)V[<%&)T*2"@XOV7I[\J\W4;; MO%7;YEMOFZ/[VCE=,3^=6(EJ[6]W4#T%9JF(^,#1[51GF2 O5[$NT\C5.;O! M6!1X5G %C40,+5_MNDG+(&06.! 96'D;7(H!;@?>#V?]=S8S4PR ]>T@, ML.4O. Y*-?#@,7PH/H3S48+8P,?JR[7VBQJ)Y*G$R&)'*?P<$R5*8JE4 .3@ MK&09-4#"\/PQ'EHFU5AA4/) DP?IV0,I%2L^RY>,5&\+Y+MJ)TK7B8R_03-L MW%076#;]3HH:CKF!"X? =\Q5TFC1MZC5]EF Y^07#LUD><5Z*BG9*2J@L#;X MMNR%!Z@I#\0->R9BW<( 8:SMEO*%)G#T88 M28U#*]!X,.)T$0\@N2 M5&U)DIEFMJ(R9J,'B%X\&)QN->::M+%Y: -''H-T;]A/QTUK;Q,NIQ\"E/2 MQTS.)[(W"$ ,78^=9\I(!+/O2B)-D#WWHWHXOO02L&7@=&)/K-ZI@F=Q':(- M4#@+V(X,KD'*$AAFT(+U&VD] W);W4@?M!B7$,3\339"!@FZ7-O;,4$LD-(E M%0AG?>$I:$=%1F6Y>< TGASE/OD$$J1'&NZ)Z3#DN 49TL-=F&M@I()HLP+ M G@7LX+'6T-B)"4\)OI3/LR"KP?V(H:XO5L<@POLB5"(T3*6< !,\A9*9<0L M8+5@2EX[7='[?@T\@BQ5:XD-T*?3H#?0A8[T6O+*91/81R.PQX1*^J'#()8 M/Z%+%ZB"M%8 0A?QGF$Q\D6"O)7L##-K7H(B&@X!'DR=M#$\R('T\13G*M5J MW^<$4Q),:&L#P_=B$@Y=$$JQ'L=JC;MG!Q9.8M4'#1>2"38&W7Y( MF*07RB"+59[)&J@Q,.-!03H!#*DVMD]S74H."Y;J"IQ;[@S"6UQW-^*=Q\#T MK#'F:OUX!1M0@*RCU,^]'E&Y\KYE8/E3 MN=:R"PK3VPFR#3"2$=8\G=M0][4,P-I!X] -B;\S?9A']<"\]-"O*F[(!T<\ M$BQ$M'X/G%_"6T"]J,%*0A3Z7M_R6L1P(,EH *?(A'X-!@/:Q]G3%6(%,KD- M(\"7'ET1$SY:H@#5$)L%(0@ !\?9EM2#@/O#T:,%S,RQ^"*#;/I,\*'6V1KV MZ&6 YKRQ&(4^.PM:AV\8EJ'+?JDP&E\ M0O^=\;QFP! $!_P"L:Q!']CKIG"GW6R]TMY4-1_Y$Z8MW)F $0U@C@< >3Q_ M%":1E,Y8"@"]\C3_&4:^ZWR -QU0_IAY@T %M.E\^'KNG(O(ZYJYM@U+]A+_ M"S."]%$?B9/LQ&T:4FSF%M^H6'&K]0^+M. "'+ N&L[+PM?GXKN'6A;]DKL: MT1;OP%,^+-P%N[KVA2OC01EX@W&.PTVR MM?J0E+G0;\QB2';AN7Z UD24P/ M(AT?$"R#$NJ\.-@UM*4&ND[(H8[^*NW+0(%%0NX&H$@#,I&D(BHE,K00Q!HBYT53Q=X42HYD.$+E#YA9@<'DQ&,&!%)C MXAZ@1S;5.X>*JZ7:;QU8!O$K@8TFK;6A;@C1Q#-^R;X\L+]1VE-8K[T 9QN#G M8F>O8VCQ" B)0D9NIH9F*Z+UWV8 (2B8'< &:00L^]GI@&T @8)U"XAA'&F9 MNWT4HE>'5/10B:($S+<0F+V>UXV(1@O,B@EF\]C7*['T+R1Z8N*,CT>G6:S*R\&6.LA!DU=1C]40PAS/HFAL!/,#%<]#7H' M0"?./]&I #*DZ-4 ]@/$N!_>HIF YC7H6]BZ1\^$5^_5-N(7)4] MX_CP K=XHYD%.9%0P@"&D_,/:&F(9CU'EM'M< UL(:-C%IY=R9Y+5WO,%)$0 MWMN$P#=J7.>XN&82,5J(J/LX(D=2<"3TG&,!RN&QBK)E+(A^4]U\\[]J7ZM^ M@>H:3$5T=D*)J@*'($-0 MT0(3%F"7HG+P5\H"^8>CQBO@S"]?MB?9PPG?TJ%;\A":MGW*PW)^>-5XW6SB MO'GV%>D;2F'"M[QJ@+U =_#P>80QXD<'/8<1@(!&U#-N=')PXP5A3)/2^%0@ M/0K1F:W.PJ[=RFWS7N+UF%^AY*?A]H1N8:^'RER,"M!PE'!VQXA4IQY2,6>_ M@;OH;.N#% MO=<@?:YWC/N\ S85;X=VP.HIGK?T9 M"@0FX@DZ5(< ^1$4FXRT#G.">+H@0#N#O<$RH(=+=]5*V?(4H@Y89.%_MU$E M:I3I1(]4AYS'J$-?PL #HG0NQ2#P4#OJ#0!E+M- _D?SYV/G M&4@]7VJS(<=LH'SU6@H&1C+XI.%+; M20[PQ//5\1C?$V!+(Q?5<< L2JA,Z-\#NK(3B:YS,O0B\K8]R^TLS[RTM4HI M8 NISPN+207(*8)2_;J0J%3GC[7JIRI-)-Z0R'RE9%L)QLP0F=-!H83F$3XT M)S1GP8=O @YRU'R,W-2K4K)CRX79++K=:G%VPAX?U%_6+;/.>DF82:Q7&MRW MR@U%%0 8_X%;D6Y,@)Y<1.B^@D6GPR&EY97SX*[V+0-N)H.8XT>YU[;5*>/S M?A5!"API]\/A@?,IC9"=8L) _UD^9Q1Y?G'1VX)^GV62 M<+8%J8OK1D$+=BUSDGAR&""QQ2N=J,30JV(CB_C%"M+;>5/FIZ(*%1##>4 8 MC8P5,3NW&<60\'PL[\!PI_2)R8G4)>%LQ0O66-]A"VV*Y0(_]/J>-I.P;B;A M(#V#<\16E &K)=@7!2X%_[L"0RVZG$/%$=D^*Z4LCR^:!2RKDH@@RSD!]HD! M>6Z YJ8DD%G=AUY/?+! /OI:&.M4$#OK89KF_=F+;P4'_OX9 MA>EHYO%^"KDP!RMG.E\ZSB^ QFRC:&N38UXF"2E213:8;96EOS1R221<9ZAC M\J"]"QU=!D6RW6R^.>"7 9IR#9>V9@XN#U30D9889S_\=M#0(5\K6(OO^7\" MF(G8ZF3NP]IE76V7=0F)D4SUE6;I9F%$+?40P8\[E[_\!%QOLN?&JZ-_O'/* MVE* '?GB=1M0$&Y3Z*BR:2Q:U.0'^ALG RGG$ +=& M*/R)/^,E/KR0HL54.N*'*241C=)D,FF&-(,;L$5!Q8DQN01335TZ^ERHWY [ MD"RQE'W\AK*3=.J3+I3."!CLTM#QAFKJ1@YNCMEV"?#)OI/7H<]_0MBE@^8JU;X02YE(V] ;4TWOK%1*7Y7=8+8?JA=F"W:BA\B_A5]RB7X< MC[)D6*?,$B Q10=P([=Y3&C,/T6M"=TS"KR<_4=58:BZT@O.Q?CQ>$4X(P,\ M2OM,/!#Y(D;'(J:&?*>BO=#!LM%B_I,I_ M 9WK=7])8]\;&GQ0V[@*!VDD'K.+U9M!'T@"PC7 DZC=&;"74I82CQ#[J :! M?5NW:,GU$(N)'VB/5@%7X["?4,6%R;XEC^0GRG645$^:9=U8F 08#E>,P!#\ MQ2Z/0TLHZN$)]8@=F%QEK$K6695$N(I1@,7ED>'N]'T4AT[,37E4,P2L"$F$ MT^%K,!D-WD_)_91 MAW?D=TP#_4BNY+950'M+_SPQ);GPDAAL LK-S6IE<[EY!"MB'"J1.DB',L)" MQY[OD:$X#%WLMD"YXM*+C* TP@D@S]KP5<;MC3J<.%\\,!HO/92,[6;KM8/5 MZGA8+,G@TSDE]5IB'E76?4LCM9[;B>.PYQDK^BN@Q,#IP(H!-JM'_"E\%XPG MZ=W8L#-5'E@YY,8Y"0?+@;^#\$;Y\?&*K&?!GV"*^6C/6YL&Q$^'#77KBV:& M'CJ$47C&='BI*%?#>,B_:E&J3[5#CYI$$=PG^I)3JNV))?HRE) G AJ@T(*7 MY'BYSGIDM#>JD\ECIYQEE.'&'N5+(WF->:MAI*V>P(,K@7-XU)Y@*(ACFIH( M@C55!N!"P=BBLJV0BE5@TY;OP)7H6,'MG5D551@E8NT$HR,$QM\#=(K$'M?Q MG@]"6,(='L$74-C87KOL<7)@]DP+[M8[Z7E?9(3DD#VVX5PF$J@SP(Y?84A^ M>^,*PDV?< I]3XD; 0<"7,@/I[S[F%3-_'P3YU+#&9?P4?X!")FM8//>TYSC M8TV&??Z=6.X&S O$!GG LD%>5IINZQ7G;"NN:N>% MPS#7B8;_!,_F\?E7\* MO!R?G.'!Z1?CBDY &SPV5S6<&%.X 0]Q3>1QHB(C^IU&BZG*&>^_JOX!&3:' M>+0LY'H<[ALQ2KPA,FWC(+1*MG'=@,?[5(/(3[-I*#*\/\(:148?4%1]C@(. MI>NE0XX.C["DG[152H1VAKB9?:V@<\Q): +V4I@)&W!$YBM2.F\XF_I%T1@YB( MG-]$Y W7Q+0Z?DBQ932&)US.Q26IW/?HAC(25'D(%3^ ]KV0=]@S_;B3:?[A M+T83HG=Z[!JU\??,ZA"1L&N2$]]CHZDJSPNK#'TD0A;&R/PR-^5O)4[*AN6E MY$P'%+UH%MFV!%9D^:B@#VFN+C%98LVJ DH[SQW];N!7&32]V.(XKL[']R)W M'UTCN0H_-!RN(S@\8J7 %ONB)S._$94/EM@YF3.I5&W2:E*FK17NYQJ$9)PW M'93)1,H0R3?LJ,51*E@FI7M8UX^8TQ'@&^Q%6%33T#\1;_G30PM+<"?3G)Y# MJ:,QAQFY5-1RFV?JE%%^.B[ T4.6FA5#G@V\L%*JRQ?8K@!A=HG>MF'OO^/O M:V(%)2^>3O #/C)#S4Y&R!H[ G3U#D*:9H$Q>:QE4JDJ2AFGDY#DN*2")EWE M6UX02+IJKO85K!<'S#ZN>R,5Q[7M'\^(PUAWE<*,M,2[IG8[?Z)REFG)ZHJ" M>@[2/![[-Z *" 3!%[U$FQ]1#AS6B)X&\/ $F[3A=K8XPO&BCG!4.\+QM_\Y MS? \LP@;C(?'M"%"0F,XD@2S;B)#4-/9E4UG%S*6Z-5"515%3^;'R1PKZD'< MLN&"G2P8GTB]$20"CTTX ZNCO221]+ KB:IJ MCCU_(I$<9$1?]ES**O>U!?X%K(H>^MR.[6?/(7:Z"?-YB3L #*B3 THJTU81 M61Q+F7BNF/G]^',G,_))!3D);KR(PA%TRI3Q2 M8C0//O)-F9D MF[HBI@X;B$T(YTJBU#&^< MPHA8S.VRRFY<;6.[GP-[$'1S 2_K\%#HFI#%)W4#FBD]/K3!GN]0$(@;[$+( MCDQ?WI6O1IF[TWP!1 AVQG%F@/9:R;=6 \"MTE VN,._#I>BK MY;=QY(+\/^VF8F/HN&1'AJT_JYXJI+Q8Y?H-U?D +Z>(4@0KP,86+ %T,LDO MV'@3L(VR-"ZRU7;Z?>%%LR!!>MSNU7N>.HP#'HHQH&SU#9Z)4=#79(< M^!N[K)26.W:8;U!).3Z60S# KN!?E#B<6W--0T 9 3BOV*'.XKR(@N7($6\% M=U"T26)1[]8<65V;P:(-SMSC,R&R-O*6X)5!SF)'^.(NG%] N(;]+&7$@.D=_^ M&X-:G^$N+9P9+8"4D#T*Y]<4MJ;=],J\)&%8==)@@M M.:C?H.&7']U93'WB"D$IC]6 MB+FVZ(0*\\&GG,LJ"^5J-T^Q2U&NJ8Y4%G:,A21*4,74GD1SWBFYI,\O^4S^ MP*R=+ 2+OCH0/(ES(JY!J3_-P& ;,";#,*.L:97\V,CR\/$*\\Y MEXF^Y%=W\EABA:L!BT'2".=/Z07 SP XCYIBZX8NL]IN.NS7 MBE-N$T0<%0 TTO5\TWIB_3>\%&LW:!C?_9Y M4"T2U:L!.P_]&^99!8;O2NQRK\X)>X('"J3]%)26KY8Y&-H3X8WJI2P3(\!R M%I!N"FLW\#1J[5K;,U&S)%7Z2N59:'%1J_?96*815P8#]@*I.H,!]>0JU@BK MIO&F>:U5'TQP 4V::G2O(L[^.@ZCT4%95UK5=Q9>.2#_%3)!U#8XMUXGO1\V M)IY(/ 1!\"MFZXUS!=W<+M3EYH%#D,=LVR;J5I50(JQN5=SR-)>CBKBIX^48 M,X$=8F]7P&K\:RAUL2P(&$E?C60"3$Y2"@^I*7)(]!1KU?V\4($U'8B-,J!P MU 8O(4/'W$6,-R6_&YSP,*6$@M>Y(EFQS?[OH]K_777_-^5=,.*],8@W@=[H M8]*=\= <+;^"QS'$2NTG-UVN-KO'M=E4QDT-D$NXD?XQP(D(F-F9+! 2UW?S MB^#>?3PWU2H\[)NI60]9$*VBLG(VH6 M\*;XB :W>];.'QHHI"H=4(2CN*+J=)H39OPU>AF?F/S@G QB;7LCZ&W M9C.89L@^+]=J@?,/L"O$9)5^OJ-C69N=LFHYNF>DLSPOL0L#B39:RXKOJ.=P,O( MQ0SFDIG^%N)8,/(%\, :TSUS;-9G(PS/1,MZZV* '.@D*PQ$[[:)9?%""_U! M,2#D!0S5;/H/JUUD8P?.Z21$W%"R M:3?CZ7#ZNGTIMV]%!RF5C*AY$-JD4@76AID\0"M?O>5PFHW?*M&Q ^T\%X$9 M.H2XK<")U[PY>/,/3>%,!D7;G3(SD)5!N8$2F][)!IMX'YWP; M>8DJM(HQ=@#_3B#ZR+0*SU1^Q7T^2)[KIRU812MFM[I^ONNQC\D@4,RC +6 MB&UQW, VZ-P-O+@6"W-:' M+G!FA28@M])LD@F'NB7E!H<18/-KTMRT:*2(P(1AR.^;E)HR>B>Q>ACJ&FP< M>CRW88%M-"9QP$SF4*4:M.9T!!:2EN!X)5$ZQMU3^Q3U.-= U0B%D=W#@9>I MEVVLX\*^N.,/K4*OP$5+-])#'/7K[3<6/3H9C ^<8E\9U:"E-;,Y["09JQ$V M=G-CU3*-O1IJE$L9%I;3]%H84[O9>I$14+[=E^U8*#:9+;TCZT*F\"QFC1CS M0T6_#ZQ93:F;XKHHPV*=KZD!%BTF4NG L8OU+2%ZYK&BMF"8V(UL$C 4\R]9 MDJL_.(7!W*+U!:NLQMI ;ONV9^-+.!!#Q >,18O!$#N^4\,)#E8'JC.D5:U5 M?@8JX],*,B).3FF8H/3P"4>/O3L>/,>P %&I&5#/%][0Z*O3UZ+!H?JSF%.- MJ+THQJ /T/K4;[R'+X MJ-N9#>NS0%X4N*S06NB@<[PU+I0\_27;] ?%BPT)<(^^LE>1K: '!].(4>Z8 M;UKY8]PM2D=);YQE0$_ X4$;081&1C\0T;56UD5BO7 #A1$F,>U29R*LH<=- M%>^_,K.55BW/)FW['%I\4 M$%$&C8EEY@:&:=3!YSH@K](A2==L*@U/P>%VAZX$&+FY 5>)F3"!(>_(6DZ6 M+C0*O9B- M6:DW-\].P7-_2Q6MLN8,/AL/2X.:GMDF"KZCQ"&Z>&&8#7&M/) M9\)1MP]3H$VI-:1U4D<#+$S6QVI-E5 GITC8GOS5-_5I_"O.9NY*!00=]+'2 MTQ@&/.);';/KL0F,:G,_!/#C8:O^$X6>1GT>H1ZG!@TLLB]/1>/,LX;JU<"I M:73G9\2\0F'X=D8Y7M91CFI'.>8P\ X.X:*,#FIC9Y)7*)7%A*M/#!4;#FVF MW)E4(SNIT*[;BG4ZE#4O^YA)C!:>:JD*MO! T76BMPC-.4%+[ M6/.$(5DRE:<8].\)+HVV)^IEK+LXM)-8"X6NIZ96FXYL/'EP,LD@%_ZW1 *G MU+*U6!"=A:E!7+B=S6C3%8"&42["_NA]]F3.LCF):GG6D,7I3>:((9?U("$>O%EIPTPFU'/DLE]0_EK/*)^F2)H[("'/QR4V0AB'$IPMRMY8)\*M M9_@HY[*@@8VSXM!$1!>!&L"DN[>4RM[<#+-,B)6E*;+C-]2[.8,6)W\XKUYTS=*ZVP.C#1,13[I0IHOD(" 02DQ%;:YDN9;!'-+-,MV^5^:994WK//>N<_HCUSCB5E;I)1 'Q M?E?*D?FSK$-= ]>O!CF63F[$=L$--7P2+D3%$5L_QS))N$^!EB!#[*+$:,'V ME^HP.]9/6R/5%GBS(E)N#:4@G:NH+HY_S7C7))?J'/^256CWQIB'QG%7',/< M [HDUF4UGFKDNP=B__Y3'@V+O$6C5Y8K&,B^I]K'6+8)&-U1*+*V4=PD)"-6 M,]1<.:J JU,+/[5WTSO(WKFR73B-=((%?0;E(N62MM^_1[!XV GHUS=V'Z%) M?D*6Q&(%.\.<5E2J=! 4J.=M::(AK8+&F-/O>=B8!BID[+LW7AQN9#Q>QS*7 MCRDPX8E5.WF..6?&>)=ID+H&L*YY:9AHFC(//54LF,T=4"-PJ7Z%UDU6>NI1 M1ON4V8? "8 ]JH04B9U7*%_#&J">N8^T4/B3,:67OZ=\_'GFOV%GD-"Z75X MCC/G5'Y/Z/X#LH'MQ*!:Q&^+9Y$!^F5F(4XU&',&(M@WG-*K'O7A[.+CR<7^ M\=GGSYWSRY.W^L-L%"H>-6MA;YLY PR;SXTP5!M<_[S7Y+\Q=TC]S6LQ-IUE M_WDT#>.MN D]5UWFYDVNHW]DFTKZ"I M4<8R?\U?F#P*5,NYY1$6EW.N-M>(90:);KMP8RFJN1:+2" TN]8D)Y3-$F;> M22<#_XGP/_CJFG9JVEDK[70"NU?",>5@RSSI&.T](R <1%V,)ZBT"]!762:Z M)$Q\TCQ45#)0_8-<[*S&JLIS*EP<^2'Y=S 646SS/)220U3:H9UY%TR\P]@* M6@OCGHH\!MG2 ?.*CR'03,726H]R=FAU"]W4$?ZN-'-['D2N"J,FZIJH-T_4 M7SS7]>4^>TIQV )Z271P]* P.>=QKYK+*M OJ)1+*@.*N)?QD)?(]*H=.19+ M>::T9Y4R!T8J7$"$#<6,OW0YHB[B>C_ MT-)_XO^;-)9)CC;"6LD>4V&$U:(I4F-$O=;8%$:^@+^"?FR:7O>L\6_Z,S(7 MS%=.*5V3X*,&\)2Z282=%6PEVA5#4#9,D'&J8AOT1FFK8\Y0= Y;-52K<^70 M1I<%>3#Z6&'>PPZ(?=@A\6=5U&1GH>H6D34WK+GAYKGAAX*B@O1TJPPESSD"CC]3(JA .D#'.ZDFL>1(A@G]SBVOB\*ZZ!Y!(O?\R] MR'AN#=NKF+7#97(\]#Y-/(Q^TUB F&PU"GMBTV[,->"*!MLX%;I^##.C/%^5 M"&(UA^KKKWMX=Q48BVLQT2++;6>U1,P:,>7;&&*91<&#MX#*N8JN-;:AK NW M^.!T+BR(QX%(8P3Q@=.!O:H(&Q6-VF4-U.HF\C@D+"CF@#TNQ+R*8#'&MU!W MJ$:AV@O'VMQ043F70<)J=5#1BB-:*0Y<.: =*+K&$N>>Z[DP9K>F7MDR"G M M6$EJ7GS@G'((G$>NZX@E3I5Q)3L#$FY^%,ZO?5;9K07'!3_4%(L:-!)=S(B8 M$CMMF) _EB3X/"]8E486GS_WT5CE@L5<.*!>^3-ZN=E1?,Z,$/-VJ7Q)7$@, M:TMC,U>4>KP%*74%PGALPWBL=:(!^I4IG5^J6:B8D.^&O=342&(AR1@#4%[/ M2S0"T3:R?CSJL430QOES>7(\*WS??K&"\'V9.H1I)G90_YSS6]:1$CF1IE^6 MBY]RHP-*$E>ZM3:HK0P),ZO*"_I^BB8S][LALJ/,%PXX-O14&-7&)DNL(+]? MUDE7MX_"%^OWF9?8G?X"KCS,6M*J##)K-"0WUE&!?L->]>O^2K$Q9_GFN46= M6D:N_9*BE?744*.,H&/(K*5"8UVJ%YQ'AW9:A!K#Y6#;?C*EW!1+Y70*/ MBFFDSH2+U42-E.\Z6PK83B@ 9>)1>%AWK:.8EUD3=3#D]@I9"(G%+6>;8@] MMMR($) 'J^QE0)HAEA0P5\>"G&N=Z8FW*+,8+D;W<)!KT*@:S_GA6!)*J&52 M6Z9\V0@P=I>^UGQ&+8CQF;).5!FWRE_TN"&P\,O%WTM:(:NVK+Q3 MS$%.N+DO2QE55*O.+4O_- !K9*.)E.;"77>M^V#SV+?\1GB^;A>'G1!.^RRO M5'$X*2K(_'5%J9))EK#F0\\$#)T+\WX@QC0;AVCFOK+4D9@7K$JQRI,XL[K' M]63S925^61,VI>*H"(2K^B<,J4' F#NP4283(%ZJA@MBQJ(2?';:>X.ZE49X M4#[UL,8T5W1S *GU03PE^=)_+(OS_;#'^I+MB,3G,YYC3TB<7V'-MX+E*P3* MT$+S[SR'F)4XJ_M7(P'H=F1:IN<8P08RW$X5$S.^KF-K_2O.=+L,'9J21!JD M$W:IE)>E!B=M VGX2@KJ]HJQ:92C>W-\%;$K_FHLWOR&L^HL=]ED+(NUN?": MVZ.8WB"F]1'BH6;(%'QR) HV8N0))NW"FUXW33,-OD3]0=UL55,5I7@!86-[ M"F['Z3R3=V;T9# NZ3J I-272L(FX@[K'<2872:!ZL^A\%ZU;@Y+WO.C;N9! M)* J,XB9DJU%L466+%93)"JU#I@K9^F)L_N>4%.@"8 I:"C8AY$A%MU,QVJI MH3HTF%[@62-'5AG2$2H-UHF2:D(=M[.X+IJEHX2?EN^)KTM7Q\XSG>\-I)\J M7I_1N!I-I=VCC2PRJ5-+NF'XG??W(UAK/HA[G=]:LG;56X(UKY)UFDTT9CZ! MP\:@ZV.S>M/C0_=5R2"AY+%+1E76*(90TIJ+IZMJPU4IQFQ^L.2IFM%V=4Q$J-9\3XO'UIJ.6J# AJ M I^B.::F(YT(>-J?ADZZ%Z[N=YOU#O?'MA)SC[7E/4V96F.8O8-ICF::2Z%C M>:&C-RMET3#S$UG]ZS^=?KWH.%HSSYXALB;'=&^Q10LA.\ F[JL#XP:] \OH MR/>Z'15:?[+\<:+49T5SO)@4HJX,-XQ2@AN=JS;+S%%+!YBLP4S-6H @>?>\ MD:6VB=K9R;Z MRC7.H39)W3A8Z!'2*2F;Q\HMKBE^7<=QJEU3_+?_*>=YY/H J]KJ(Y89 M$48%BN;):=KXQJ%+.*-!0\6(AH"2\%17/5IV*6B\_CUA

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end

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